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Contents
Zusammenfassung vii
Abstract ix
1 Motivation 1
2 Fluorescence Correlation Spectroscopy 5
2.1 Photoluminescence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
2.2 Fluorescence Correlation Spectroscopy . . . . . . . . . . . . . . . . . . . . . 7
3 Analysis of Binding Affinity Reactions 23
3.1 Law of Mass Action and Binding Constants . . . . . . . . . . . . . . . . . . 23
3.2 Association and Dissociation Rates . . . . . . . . . . . . . . . . . . . . . . . 26
3.3 Strength of Binding and Strong Binding Model . . . . . . . . . . . . . . . . 28
3.4 Binding Probed by Fluorescence Correlation Spectroscopy . . . . . . . . . 29
3.5 Binding Probed by Microscale Thermophoresis . . . . . . . . . . . . . . . . 30
4 Proteins and Plasma 35
4.1 Biomolecular Corona . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
4.2 Plasma Proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
4.3 Amyloidogenic Proteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
4.4 Blood Plasma and Serum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4.5 Viscosity of Mixtures of Fetal Bovine Serum and Phosphate Buffered Saline 43
5 Interaction of Proteins with Solid Nanoparticles 47
5.1 Solid Nanoparticles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
5.2 Understanding the Kinetics of Protein-Nanoparticle Corona Formation . . 49
5.3 Hierarchy of Protein Nanoparticle Binding Affinities . . . . . . . . . . . . . 58
vi Zusammenfassung
6 Thermosensitive Liposomes as Drug Delivery Systems 69
6.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
6.2 Evaluation of Basic Parameters of Thermosensitive Liposomes . . . . . . . 71
6.3 Release from Thermosensitive Liposomes . . . . . . . . . . . . . . . . . . . 75
6.4 Binding of Proteins to Thermosensitive Liposomes and its Reversibility . . 79
6.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
7 Protein Self-assembly in Health and Disease 85
7.1 Background on Self-assembly . . . . . . . . . . . . . . . . . . . . . . . . . . 85
7.2 Quantification of Amyloid β1−42 Fibrillogenesis Using FCS . . . . . . . . . 88
7.3 Quantitative Study of α-synuclein Aggregates . . . . . . . . . . . . . . . . 94
8 Conclusion and Future Prospects 101
Publications and Manuscripts 107
P1 · Understanding the Kinetics of Protein-Nanoparticle Corona Formation . . 109
M2 · Hierarchy of Protein Binding to Nanoparticles . . . . . . . . . . . . . . . . 125
M3 · Impact of Plasma Protein Binding on Cargo Release by Thermosensitive
Liposomes Probed by Fluorescence Correlation Spectroscopy . . . . . . . . 141
P4 · Simultaneous Measurement of a Range of Particle Sizes During Abeta
Fibrillogenesis Quantified Using Fluorescence Correlation Spectroscopy . 155
M5 · Peptide Self-assembly Measured by Fluorescence Correlation Spectroscopy163
P6 · Quantitative Thermophoretic Study of Disease-related Protein Aggregates 173
Abbreviations 191
Bibliography 195
Zusammenfassung
Der Einsatz von Nanomaterialien für den zielgerichteten Medikamententransport ist ein
Schwerpunkt aktueller Forschung. Wenn Nanopartikel (NP) mit Proteinen in Kontakt
kommen, können diese auf den NP adsorbieren und bilden eine Schicht, die Proteinko-
rona, die die Wechselwirkungen des NP mit seiner Umgebung steuert. Für die Entwick-
lung von Nanotransportern ist es daher von Interesse, die Bindung von Proteinen an
NP, den Effekt der adsorbierten Moleküle auf die Funktionsweise des NP und die Wech-
selwirkung von Proteinen miteinander zu verstehen. Quantitative Messungen dieser
molekularen Wechselwirkungen sind für das optimale Design neuartiger Arzneimittel
und Diagnoseverfahren von großer Bedeutung.
In dieser Arbeit wird die Kinetik der Proteinkorona-Bildung mittels Fluoreszenzko-
rrelationsspektroskopie (FCS) untersucht. Die Technik erlaubt die Bestimmung der
hydrodynamischen Größe und des Anteils an gebundenen Proteinen bei geringem Mate-
rialverbrauch sowie der Möglichkeit in komplexen physiologischen Flüssigkeiten wie
Blutplasma oder -serum zu messen.
Im ersten Teil wurde die Entwicklung der Korona von Festkörper-NP in einem sich über
die Zeit ändernden Modellplasma untersucht. Die Ergebnisse von Einzelprotein-NP-Ex-
perimenten dienten als Startparameter für den kombinierten Simulations-Theorie-Ansatz.
Es wurde gezeigt, dass die auf Nicht-Langmuir-Differentialratengleichungen (NLDRE)
beruhende Theorie die Entwicklung der experimentell bestimmten Proteinkorona auf
Siliziumoxid-NP unter kompetitiver Proteinbindung vorhersagen kann. Der Nach-
weis eines “memory” Effekts der Korona während ihrer Weiterentwicklung durch sich
verändernde Umgebungsbedingungen wurde erbracht.
Darauf aufbauend wurde eine systematische Untersuchung von Einzelprotein-NP Wech-
selwirkungen mit repräsentativen Proteinen und NP durchgeführt. Das Ziel ist, die
Erstellung einer Datenbank solcher Wechselwirkungen in Kombination mit Modellen,
wie dem in der vorherigen Studie verwendeten. Dies könnte Vorhersagen über die
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Bildung der Proteinkorona erlauben. Drei Interaktionsklassen wurden identifiziert: Ag-
gregation, starke Bindung und schwache bzw. keine Bindung. Die aggregierenden
Kombinationen sind für die quantitative Analyse nicht zugänglich, wohingegen sich die
Bindung und Desorption der starken Binder charakterisieren ließ. Die Desorptionsraten
in Gegenwart von Serum wurden bestimmt und mit der hierarchischen Ordnung der
Bindungsaffinitäten verknüpft. Dies ermöglicht erste Annahmen darüber wie diese NP
im Körper reagieren und ob sie ihren Wirkstoff zielgerichtet transportieren könnten.
Aufgrund ihrer Eigenschaft eingekapselte Arzneimittel zielgerichtet freizusetzen und
damit eben jenen zielgerichteten Transport zu erlauben, gelten thermosensitive Lipo-
somen (TSL) als vielversprechende Nanotransporter. Allerdings ist die Untersuchung
der Auswirkungen von Proteinen auf den Abgabemechanismus und die Freisetzung
notwendig, um die Dosierung zu kontrollieren und eine unspezifische Abgabe zu vermei-
den. Deshalb wurde ein neuartiger Test für die Quantifizierung der temperaturabhängi-
gen Freisetzung für TSL entwickelt und validiert. Um zu klären, ob die Anwesenheit
von Proteinen das Verhalten bei gesteuerter Freisetzung verändert, wurden die Freiset-
zungsprofile von TSL in Puffer, Serum oder Plasma verschiedener Spezies sowie in
Einzelproteinlösungen gemessen. Die Bindungsaffinitäten von Blutproteinen und die
Reversibilität ihrer Bindung wurden bestimmt. Eine mögliche Korrelation zwischen dem
Abgabeverhalten und den Bindungsaffinitäten wurde untersucht.
Bei der Entstehung von Amyloidosen spielt das Auftreten von intermediären Aggre-
gaten während der Selbstorganisation von amyloidogenen Proteinen eine entscheidende
Rolle. Trotz ihrer Bedeutung ist die Kinetik dieses Prozesses noch nicht gut verstanden.
So wurde in dieser Arbeit FCS verwendet, um die Selbstorganisation über die Zeit zu
charakterisieren. Zu diesem Zweck wurde ein neuer Auswertealgorithmus zur gleichzeit-
igen Analyse einer Reihe von Teilchengrößen, das Gaussian Distribution Modell (GDM),
implementiert und durch den Vergleich mit dem etablierten MEMFCS-Algorithmus vali-
diert. Dieser Ansatz könnte auf α-Synuclein übertragen werden, das als Modellsystem
bei der Weiterentwicklung der Thermophorese von Polymeren in Elektrolytlösungen
diente. FCS lieferte hierzu komplementäre Parameter wie die Größe und die Diffu-
sionskonstanten verschiedener α-Synuclein-Multimere. Die Kombination von FCS und
Thermophorese könnte zum Verständnis auf dem Gebiet der Amyloidosen beitragen.
FCS ermöglichte die Bestimmung von Bindungsaffinitäten, Desorptionsraten und Größen-
verteilungen und damit ein besseres biophysikalisches Verständnis der Wechselwirkun-
gen von Proteinen und NP sowie Proteinen untereinander.
Abstract
Current research focuses on the usage of nanocarriers as specifically acting, targeted drug
delivery vehicles. When proteins are present in conjunction with nanoparticles (NPs)
they adsorb to them, forming a layer called the protein corona, which controls the
interactions of the NP with their environment. Thus, for the development of nanocarriers
it is of interest to understand binding of proteins to NPs, the impact of the adsorbed
molecules on the functioning of the NP and the interaction of proteins with each other.
A quantitative measurement of these molecular interactions is of eminent importance to
the rational design of novel drug and diagnostic tools.
In this thesis, the kinetics of the protein corona formation are investigated using fluores-
cence correlation spectroscopy (FCS). The technique provides a means to determine the
hydrodynamic size and the fraction of bound proteins, with the advantage of low sample
consumption, as well as the possibility to measure in complex physiological fluids, e.g.
blood plasma or serum.
In the first part, the development of the corona of solid NPs in a temporally changing
model plasma was studied. The results of single protein-NP experiments served as input
for the combined simulation-theory approach. It was demonstrated that non-Langmuir
differential rate equation (NLDRE) theory is capable of predicting the evolution of the
experimentally determined protein corona on silica NPs under competitive protein
binding conditions. Evidence of “memory” in the evolution of the corona was found
upon changes in the molecular composition of the environment, which would have
significant implications for medical applications.
Building on this, a systematic study of single protein-NP interactions was performed
using representative proteins and NPs. The goal here is the creation of a database of
such interactions combined with models, such as e.g. the one used in the previous
study, which would eventually allow predictive power concerning the protein corona
formation. Three classes of interactions were identified: aggregation, strong binding,
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and weak or no binding. While the class of aggregating combinations is not accessible
to quantitative evaluation, the binding and desorption were characterized for strong
binders. Desorption rates were measured in the presence of serum and linked to the
hierarchical order of the binding affinity enabling first assumptions on how these NPs
would react in the body and whether they would be capable of delivering a payload to a
specific site.
This possibility of specificity is also why thermosensitive liposomes (TSLs), which are
capable of controlled release of the encapsulated drug, are seen as promising nanocarriers.
However, evaluation of the impact of proteins on the trigger mechanism and release
is necessary for controlling the dosage and avoiding non-specific release in the final
application. Thus, a novel assay for the quantification of the temperature-dependent
release for TSLs was established and validated as part of this thesis. To clarify whether
the presence of proteins alters the behavior upon intentional release, the release profiles
of TSLs were measured in buffer, serum or plasma from different species, as well as in
single-protein solutions. The binding affinities of blood proteins and the reversibility of
their binding were determined. A possible correlation between the release behavior and
the binding affinities was probed.
In the development of amyloidosis, the appearance of intermediated sized species during
self-assembly of amyloidogenic proteins plays a crucial role. Despite its importance,
the kinetics of this process are not yet well understood. Thus, in this thesis FCS was
used to characterize this self-assembly process over time. To this end, a novel fitting
algorithm to enable the simultaneous measurement of a range of particle sizes, the
Gaussian distribution model (GDM), was implemented and validated by comparison
to the established MEMFCS algorithm. This approach, could be applied to α-synuclein
(α-syn) which served as a model system in the further development of thermophoresis
of polymers in electrolyte solutions. FCS provided complementary data and parameters
such as size and the diffusion constants of different species of α-syn. The combination of
FCS and thermophoresis might contribute to progress in the field of amyloid diseases.
FCS enabled the determination of binding affinities, desorption rates and size distribu-
tions, and thus, a better biophysical understanding of interactions of proteins and NPs
and of proteins with each other in complex fluids.
Chapter 1
Motivation
Nanomaterials are part of our modern, everyday life. In industry, they are employed as
catalysts, photovoltaic devices or for gas storage [1–3]. In addition to regular debates on
limits for fine dust and their related health risks, the potential hazards of NPs that are
present in food are heatedly discussed [4–6]. For instance, silicon dioxide (E551) is added
as a anti-caking agents to powdery food such as dried spices, salt or instant soups, or as
a flow enhancer in ketchup. Titania (E171) is applied to make the coating of chocolate
more shiny, but also acts as a sun blocker in sunscreen. In cosmetics, NP are used to
increase the stability of products or to improve absorption of nutrient-enriched skin care
products [7].
The characterization of all of these materials is of key importance in terms of nanosafety
and precaution, however, this aspect is not always considered and NPs are used as
additives without intense scientific testing for potential hazards. Furthermore, it is not
only bare nanomaterials whose physico-chemical characteristics need to be considered
in such studies. There is growing evidence that the molecules that adsorb to the NP’s
surface, building the so-called “biomolecular corona”, dominate the interactions of the
nanomaterial with its environment and thus influence the fate of the NP within living
organisms (Figure 1.1) [8–11]. For example, if certain signaling proteins bind to the NP,
cellular uptake can be enhanced for specific types of cells [12]. This impact of the corona
is negative if the NP has a suspected toxic effect, but it can be positive as well if the NP
is being used as a drug nanocarrier that reaches its target area in this way. It is not yet
understood how the physico-chemical properties of NP and the proteome of the medium
affect the composition of the protein corona and how the protein corona is built upon first
contact with biological fluids. The underlying mechanisms of the following evolution of
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the corona over time and with change of the surrounding environment, while traveling
through the body, are under discussion as well.
There is phenomenological evidence that all of these processes take place, but they are
far from being understood in a way that they can be controlled and applied in a target-
oriented manner. In the beginning, a better knowledge of basic patterns and principles
of these combined effects might help to at least classify nanomaterials.
Insights into these interactions are, moreover, of interest for deliberate administration in
medical applications of nanomaterials such as thermosensitive liposomes (TSLs). Due
to their versatility, NPs enjoy great popularity in medicine, pharmacology and related
life sciences. A lot of effort is put into developing novel smart drug nanocarriers [13–17].
For instance, NPs offer the possibility to transport water insoluble drugs, their surface
can be decorated with molecules that allow a targeted delivery of drugs or they can be
used as contrast agents [18]. In many cases, several of these functions can be united in a
single NP. In addition to issues regarding the corona composition, questions of how to
use NPs effectively as a delivery vehicle are of interest: How can a drug be loaded into a
drug nanocarrier? How does the drug stay inside the NP during movement to the target
region? How does one go about designing targeting? How can the release be controlled?
How does the corona affect the transport and the release? How do NPs interact with
cells? How do NPs pass biological barriers such as the blood-brain barrier?
Such multi-faceted questions call for versatile tools and efforts from mixed research
disciplines including physics. The evaluation and quantification of many of the listed
topics may be tackled effectively by in vitro experiments using fluorescence correlation
spectroscopy (FCS). FCS is a highly sensitive optical technique used to study interactions
of fluorescently labeled molecules on a single molecule level in strongly diluted solutions.
A broad range of research issues are addressed by FCS, such as the determination of
the size of complexes, the determination of the concentration of proteins in solution,
or studies of chemical reactions such as binding or cleavage or the interaction of NP
with proteins [19–22]. Since only small sample sizes with concentrations in the pico- to
nanomolar range are needed, FCS is highly attractive for expensive or rare materials.
Additionally, this also leads to a high sensitivity. Apart from these extremely dilute
conditions, its ”non-invasiveness” is a further advantage of FCS. This means that the act
of measuring hardly affects the sample. This fact makes FCS an ideal tool for measuring
processes that are easily influenced in an undesired way by changes in their environment.
3
Figure 1.1: Biomolecules form a corona by adsorption to a solid NP and a liposome
filled with a fluorescent dye in a biological fluid. The release of dye from the liposome
is indicated. The identity of the NPs is formed by the corona which interacts with the
biological environment. The relevance of the layer of adsorbed proteins has been seen in
biomaterial implants and cell scaffolds.
One of these processes is the self-assembly of proteins. Understanding this is relevant
on multiple levels. On the one hand, self-assembly of amyloidogenic proteins such
as amyloid beta (Aβ) or α-synuclein (α-syn) play a pivotal role in the onset of severe
neurodegenerative diseases such as Alzheimer’s or Parkinson’s Disease. In order to find
effective therapeutic approaches, the underlying protein-protein interactions need to be
quantified and related to the clinical picture. On the other hand, the structures built, the
so-called amyloid fibrils, are highly ordered and enormously stable. Understanding and
control of the self-assembly process would allow construction of artificial nanostructures
with these properties [23–26]. For instance, hybrid membranes to remove heavy metal
ions and radioactive waste from water are constructed from protein amyloid fibrils and
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activated porous carbon and the size of nanotubes that self-assemble in a similar way as
amyloid fibrils do, could be controlled.
In this thesis, FCS is applied to elucidate the aggregation kinetics of Aβ (Chapter 7).
For this purpose a novel fitting algorithm for the analysis of polydisperse systems is
introduced. In Chapter 6, an innovative approach to quantify the release of TSLs at low
temperatures is suggested. The binding of plasma proteins as well as their impact on the
release profile are investigated. The interactions of proteins and solid NPs are the focus
of Chapter 5. An approach that combines experiments with simulations and theory that
paves the way for a deeper understanding of the kinetics of the biomolecular corona is
presented. In order to perform and analyze experiments in complex fluids, such as body
fluids, correctly, the physical properties of mixtures of phosphate buffered saline (PBS)
and fetal bovine serum (FBS) are determined (Chapter 4).
Chapter 2
Fluorescence Correlation Spectroscopy
The focus of this dissertation lies on binding measurements. FCS is a highly sensitive
optical technique that enables gaining information on interactions such as binding or
cleavage of fluorescent molecules or particles in highly diluted solutions. Translational or
rotational diffusion are further dynamics that become accessible to FCS. In order to study
them, these processes need to cause fluctuations in the local concentration of particles
leading to measurable changes in the fluorescence intensity. Under the assumption of a
uniform illumination of the sample volume, even measurements in complex media such
as blood plasma, cells or bacteria are possible [27]. In this chapter, the basic principles of
fluorescence and FCS, as well as different approaches to data analysis are presented.
2.1 Photoluminescence
Photoluminescence denotes a process during which a physical system like a molecule is
excited by incoming photons of a specific wavelength, followed by the emission of red-
shifted photon during relaxation to the ground state S0. The absorption of light occurs
very fast, on the order of femtoseconds. There are two types of photoluminescence:
fluorescence and phosphorescence. These processes differ by the pathway the excited
electron uses to return to the ground state S0 as summarized by a Jablonski diagram
(Figure 2.1). Fluorescence describes the transition from the excited singlet state S1 to the
ground state S0 under the emission of a photon. This process occurs very fast (typical
lifetime of S1 ∼ 0.5− 20 ns) and therefore the emission of light ends quasi immediately
after turning off the source of excitation [28]. In Figure 2.1 this process is indicated by
the dark green arrow.
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Figure 2.1: Jablonski diagram. By absorption of a photon, a system is excited to a higher
energy level in the singlet state S′1 (blue). Due to subsequent internal radiationless
vibrational relaxation processes (VR), the molecule reaches the excited relaxed singlet
state S1. The direct transition from S1 to the ground state S0 while emitting a photon is
termed fluorescence (green). The intersystem crossing (ISC) to the triplet state T1 and the
subsequent quantum mechanically prohibited transition to the ground state S0 during
emission of a photon is called phosphorescence (dark red).
Phosphorescence includes the intersystem crossing (ISC) from the lowest excited singlet
state S1 via the state T1 to the ground state S0 (see Figure 2.1, dark red arrow). The
transition from T1 to S0 is quantum mechanically prohibited, which results in a long
lifetime of the state T1. During the period of time which the electron spends in the triplet
state T1, no light is emitted (. 10 µs), and the molecule cannot be excited again. Thus,
the system is situated in an “optical dark state” [29]. This effect is the origin of blinking
of a fluorophore while it diffuses through the observation volume (see Section 2.2.4).
Phosphorescence takes place on a much longer timescale than fluorescence (milliseconds
to seconds versus nanoseconds), since the electron remains in the triplet state longer than
in the excited singlet state. An afterglow can be detected, after turning off the exciting
light.
The so-called Stokes shift describes the difference in the exciting and the emitted wave-
length. In most cases, a system absorbs more energy than is actually needed to reach the
lowest excited state S1, so the system is excited to a higher energy level S′1. A molecule
reaches the excited relaxed singlet state S1 by radiationless processes such as vibrations
or rotations within picoseconds [28]. In this way, energy is released and the subsequently
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reduced energy the red-shift in the wavelength from incoming to emitted light is caused.
This phenomenon allows distinguishing and separating light used for excitation and flu-
orescent light. Further factors which may influence the characteristics of the Stokes shift
are interactions of the excited fluorophores with solvents or the formation of complexes.
2.2 Fluorescence Correlation Spectroscopy
2.2.1 Experimental Background of FCS
An exemplary set-up of a fluorescence correlation spectroscope is shown in a schematic
representation in Figure 2.2. A confocal microscope provides the foundation of the set-up.
Laser light with a specific wavelength is directed via a dichroic mirror into the objective
of the microscope to excite the fluorophores inside the sample. The objective obtains a
high numerical aperture (NA > 0.9) to achieve a small focal spot size. Typically, water
immersion objectives are used because of their high numerical apertures and their better
resolution. The laser light is focused into the sample, where fluorescent molecules that
cross the illuminated volume are excited. The fluorescence light emitted from these
molecules is guided back to the dichroic mirror along the same path. In order to separate
remaining laser light from fluorescence light, an emission filter is used. Finally, the
fluorescence light is focused through a pinhole onto an avalanche photodiode (APD).
The pinhole is positioned in the image plane to reject light that does not originate from
the observation volume. Thus, only fluctuations from within the confocal volume are
measured. A hardware correlator correlates the intensity fluctuations to obtain the au-
tocorrelation curves G(τ). These data sets can be further analyzed by adequate fitting
algorithms to extract physically relevant parameters such as the diffusion constant D or
the concentration c.
The size of the detection volume is typically below 1 fl. Its shape is an ellipsoid, but
its exact size depends on the properties of the specific set-up used (laser and pinhole
diameter). The structure parameter S describes the proportions of the diffraction-limited
three dimensional observation volume (inset in Figure 2.2). A low concentration of
fluorescent molecules is desirable to obtain clear variances in the fluctuating fluorescence
signal. With increasing number of particles inside the confocal volume, the relative
fluctuations are less pronounced. In the ideal case, only a small number of particles
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Figure 2.2: Schematic representation of the set-up of a fluorescence correlation spectro-
scope and a detailed sketch of the confocal volume. Laser light is focused into a sample
via a dichroic mirror and an objective. Here, fluorescent molecules are excited. Emitted
light is collected by the objective, passes the dichroic mirror, an emission filter and a
pinhole and finally hits an avalanche photodiode (APD). The signal is correlated by a
correlator. The resulting autocorrelation curve can be further analyzed. Inset: Visual-
ization of the shape and size of the confocal volume and the definition of the structure
parameter S. z0 describes the half height of the observation volume and ω0 the radius of
the beam waist.
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diffuse through the confocal volume at any time, allowing the realization of single
molecule studies [28].
2.2.2 Instrumentation
An Axiovert 200 microscope with a ConfoCor2 unit (Carl Zeiss Jena, Germany) was used
for the experiments performed in the course of this thesis. Available lasers for excitation
were an argon ion laser (488 nm) and two helium-neon lasers (543 nm and 633 nm).
Fluorescence emission was filtered from the excitation light using corresponding band-
and long passes filters. A 40x water immersion appochromat objective (Carl Zeiss) was
used with a numerical aperture of 1.2. Samples were measured in 8-well LabTek II
chamber slides (Nunc, Thermo Scientific) or in 384-well plates (Greiner Bio one). The
measured fluctuations were correlated with a hardware correlator. As defaults an argon
ion laser was used for excitation and a bandpass filter ranging from 500-550 nm for
separation of emission and excitation light. The set-up is located in a temperature-
controlled room (22◦C). For calibration fluorescent dyes with known diffusion constants,
Alexa488 and Alexa633, were used [30, 31]. The ConfoCor2 software was used for
analysis when not stated differently. Fitting procedures employing equations that are
not implemented in the software package were carried out using Igor Pro (WaveMetrics)
or Matlab (MathWorks).
2.2.3 Theoretical Background of FCS
FCS is a statistical analysis of a fluctuating fluorescence signal. Poisson statistics describe
the probability P(n, N) to detect a defined number of point-like particles (n) at a certain
time inside the confocal volume
P (n, N) =
Nn
n!
e−N, (2.1)
where N is the average number of particles in the observation volume. In this context,
point-like means much smaller than the beam waist of the observation volume (d 2ω0).
The fluctuations are initiated by movement of particles due to Brownian motion. The
number of fluorophores n inside the observation volume affects the fluorescence intensity
F(t) strongly. If fluorophores diffuse into the detection volume, the fluorescence signal
becomes more intense and if they diffuse out of the confocal volume the intensity is
10 2. Fluorescence Correlation Spectroscopy
F(
t)
t
G
(τ
)
τ
=⇒
G(τ) = 1 + 〈δF(t)δF(t+τ)〉〈F(t)〉2
Figure 2.3: Basic principle of FCS. The intensity time trace of fluorescent particles in
the observation volume is measured (left). Information on the molecules is gained by
autocorrelation of the fluorescence signal and analysis of the resulting autocorrelation
function (right). A model fitting function (red line) is needed to extract physically
relevant information from the correlation data (gray circles).
reduced (Figure 2.3). The autocorrelation function G̃(τ) is determined by temporal
correlation of the fluorescence intensity F(t) and the fluorescence intensity F(t + τ) at a
later time t + τ:
G̃(τ) =
1
T
∫ 0
T
F(t)F(t + τ)dt = 〈F(t + τ)F(t)〉 . (2.2)
The angular brackets denote averaging over time t and the parameter τ is called corre-
lation time or delay time. G̃(τ) is a means of describing the self-similarity between the
fluorescence intensity F(t) and itself at a later time t + τ. Alternately, one can interpret
G̃(τ) as a measure for the probability that the signal at various times still belongs to the
same molecule.
The normalized autocorrelation is defined as
G̃(τ) = 1 +
〈F(t)F(t + τ)〉
〈F(t)〉2
= 1 +
〈δF(t)δF(t + τ)〉
〈F(t)〉2
= 1 + G(τ) (2.3)
using the fluctuations of the intensity
δF(t) = F(t)− 〈F(t)〉 . (2.4)
For the remainder of this chapter the summand 1 will be dropped to obtain a clear
notation.
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G(τ) is an empirically determined and dimensionless function which contains no infor-
mation on the sources of the observed intensity fluctuations. Therefore, a theoretical
model fit is needed to interpret the correlation curves.
Generally, the required analysis model is based on the assumption that point-like particles
freely diffuse in three dimensions without constraints or external influence such as
directed flow. The fluorescence intensity F(t) is then defined to be
F(t) = B
∫
I(r) ·Oeff(r) · C(r, t) dr (2.5)
using the following parameters:
B: brightness, the average number of photon counts during a defined period of
time resulting from a single fluorophore.
I(r): spatial distribution of the illumination intensity
Oeff(r): detection probability of the set-up which is defined by the spatial positioning
of the optical components (objective and pinhole) in the beam line.
C(r, t): spatial distribution of the fluorescent particles at time t.
The expression
Ω(r) = Oeff(r) · I(r) (2.6)
is also known as fluorescence detection profile and the brightness is defined by
B = κ · ε ·Q (2.7)
with κ being the efficiency of the detector including its quantum efficiency and wave-
length dependency, the molar extinction coefficient ε of the fluorophore at the excitation
wavelength and the quantum efficiency of the fluorophore Q. The brightness should be
constant during the measurement.
Inserting Equation 2.6 in Equation 2.3, we obtain
G(τ) =
B2
∫ ∫
Ω(r)〈δC(r, t)δC(r’, t + τ)〉Ω(r’)drdr’
(B〈C〉
∫
Ω(r)dr)2
. (2.8)
Assuming an ideal Gaussian laser profile, the detection profile can be approximated by a
three-dimensional Gaussian distribution described by:
Ω(r) = Ω0 · exp
(
−2 · x
2 + y2
ω20
)
· exp
(
−2 · z
2
z20
)
(2.9)
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with the maximum of intensity Ω0, the spatial Cartesian coordinates x, y, z, the radius of
the laser beam ω0 and the half length of the confocal volume in z-direction z0.
The structure parameter
S =
z0
ω0
(2.10)
describes the ratio of the axial and radial axes. As shown in Figure 2.2, there are no
hard edges of the confocal volume. Under the above assumption of a Gaussian beam
profile, the axes are defined as the distances from the center of the confocal volume
to the position at which the laser intensity has decreased by a factor of e−2 in their
corresponding directions [27, 32]. The size of the confocal volume is typically less than
1 fl (< 1 µm3).
The fluctuations of the concentration 〈δC(r, t)δC(r’, t + τ)〉 contain the correlation within
time. For three-dimensional translational diffusion - without considering rotation - the
following expression is obtained
〈δC(r, t)δC(r’, t + τ)〉 = 〈C〉 (4πDτ)3/2 exp
(
−|r− r’|
4Dτ
)
(2.11)
with the diffusion coefficient D, which is a measure for the mobility of a particle and the
correlation time τ [28].
Using Equations 2.9, 2.11 and 2.8, the autocorrelation function is derived
G(τ) = G(0) ·
(
1 +
4Dτ
ω20
)−1
·
(
1 +
4Dτ
z20
)−1/2
. (2.12)
We can simplify this relation further to
G(τ) = G(0) ·
(
1 +
τ
τD
)−1
·
(
1 +
τ
S2 τD
)−1/2
, (2.13)
using Equation 2.10 and
τD =
ω20
4 D
. (2.14)
The translational diffusion time τD represents the average dwell time of a fluorophore
inside of the detection volume.
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Using τ = 0 and Equation 2.3, we obtain
G(0) =
〈δF(t)δF(t)〉
〈F(t)〉2 =
〈δNδN〉
〈N〉2 =
1
〈N〉 (2.15)
using the relative deviation of the average for Poissonian statistics
δN
N
=
1√
N
. (2.16)
At the same moment in time, positions can only be correlated with themselves. So, G(0)
is determined by replacing 〈δC(r, 0)δC(r’, 0)〉 by 〈C〉δ(r− r’) in Equation 2.8.
The maximum amplitude of the autocorrelation function is then
G(0) =
1
〈N〉 (2.17)
with 〈N〉 being the average number of particles inside the detection volume.
Finally, we obtain the fitting function for a three-dimensional freely diffusing species as
G(τ) =
1
N
(
1 +
τ
τD
)−1(
1 +
τ
S2 τD
)−1/2
=
1
N
g(τ) (2.18)
with N representing the number of particles inside the confocal volume, τ the correlation
time, S the structure parameter, τD the translational diffusion time of the molecule and
g(τ) the normalized correlation function.
2.2.4 Triplet State
Phosphorescence, or the so-called “optical dark state” was mentioned in Section 2.1.
This state is detected by the used photodetectors and therefore has to be taken into
consideration for analysis by adding an extra factor to the fitting function G(τ). The
triplet state is represented by the triplet function
Gtriplet(τ) =
(
1 +
T
1− T exp
(
− τ
τT
))
(2.19)
where τT describes the triplet state relaxation time and T the mean fraction of fluo-
rophores in the dark state [32, 33]. The total correlation curve is a product of the triplet
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function and the model function G(τ):
Gtotal(τ) = Gtriplet(τ) · G(τ) . (2.20)
The triplet contribution is an individual characteristic of each type of dye. A high-quality
dye shows a triplet fraction of only a few percent. The typical lifetime of a fluorophore in
the triplet state is in the range of 0.5-10 µs. The effect that a molecule is switched on and
off several times during its way through the confocal volume is called blinking. These are
fluctuations on their own that lead to an additional contribution in the autocorrelation
curve. While Gtriplet(τ) was included into the fitting to obtain stable results, triplet
kinetics were not subject of this work.
2.2.5 Polydispersity and Multicomponent Fitting
Since the focus of this thesis is the study of binding processes, we typically deal with
samples that contain more than one single species, such as solutions containing free and
bound proteins. In order to analyze such polydisperse systems, the model presented
above has to be extended. Polydispersity describes the fact that a sample contains
particles of various size. Each particle size is associated with its own diffusion time τDi.
The fluorescence intensities are added because the emission of the different types of
particles is not spatially correlated. In practice, this means that the correlation function
now becomes a weighted sum of the correlation functions of each particle species [29],
G(τ) =
∑ q2i Nigi(τ)
(∑ qiNi)2
(2.21)
with qi being the brightness, Ni the number of particles, fi the fraction and Gi(τ) the
correlation function of the ith species. In the case of equal brightness of the different
species, this equation simplifies to
G(τ) =
1
N ∑i
fi gi(τ) . (2.22)
For systems with unequal brightness of the various components, Equation 2.21 has to
be used for analysis. Alternatively, empirically determined correction factors need to
be applied to Equation 2.22 [34], if not all parameters of Equation 2.21 are accessible.
Difference in brightness can be caused, for instance, by quenching of the fluorescent
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Figure 2.4: Two-component autocorrelation function showing the correlation times τD1
and τD2. A freely diffusing fluorescent particle (red) has a diffusion time τD1 while small
particles bound onto the significantly larger NP (gray) have a much longer diffusion
time τD2.
molecules upon binding or when two dyes with the same spectral properties are present,
e.g. Alexa488 and fluorescein.
For only a few different species a multicomponent fit is appropriate, whereas for hetero-
geneous systems more sophisticated models are adequate. Among them are a maximum
entropy method for FCS data analysis (MEMFCS), a Gaussian distribution model (GDM)
based approach or other fitting algorithms like CONTIN [35–38]. MEMFCS and GDM
are used in this dissertation in Chapter 7, thus they are introduced in more detail in the
following.
Two-component Fitting
The most frequently multicomponent fit is the two-component fit. It is especially useful
to measure binding of a small fluorescent component - e.g. a protein - to a large non-
fluorescent component such as a NP or a liposome (see Figure 2.4). Two-component
fitting allows us to determine the fraction of protein bound to NPs in the case of equal
brightness of bound and unbound protein. The fitting function of a two-component fit is
defined as
G(τ) =
1
N
2
∑
i=1
fi gi(τ) =
1
N
((1− f2) g1(τ) + f2 g2(τ)) (2.23)
16 2. Fluorescence Correlation Spectroscopy
with the constraint
2
∑
i=1
fi = f1 + f2 = 1 (2.24)
and with N being the total number of particles inside the confocal volume, f2 representing
the fraction of the second component, and g1(τ) and g2(τ) denoting the normalized
correlation functions of the first and the second component, respectively. For two
components, it is possible to obtain a good and reasonable fit, but even with as little as
three components it is already more complicated due to the steadily increasing number
of free fitting parameters.
Multicomponent Fitting
A multicomponent fit is defined as the weighted sum of the characteristic correlation
functions of the single species i described by
G(τ) =
m
∑
i=1
xi
(
1 +
τ
τDi
)−1(
1 +
τ
S2 τDi
)−1/2
(2.25)
with weight xi and the diffusion time of the ith species τDi. The weight xi is defined as the
number of the ith particle species Ni divided by the total number of particles N = ∑i Ni
and is a measure of the abundance of this species. Even if one obtains a good fit, it might
not be considered a physically meaningful result. For instance, diffusion times which are
shorter than the one of a free fluorophore are obtained. On these grounds this type of
fitting is limited to systems with a really small discrete number of differently diffusing
species and is not suited for highly polydisperse systems.
Maximum Entropy Method for FCS Data Analysis (MEMFCS)
For polydisperse systems the number of free fitting parameters in a discrete multicompo-
nent-model becomes too high to achieve meaningful fitting results. Thus, other fitting
methods are required. The method of maximum entropy enables extracting information
from noisy data. A maximum entropy method for FCS data analysis (MEMFCS) allows
analyzing samples that contain multiple species. A lack of information can be compen-
sated by maximum entropy method based algorithms which chose the most uniform
solution that is consistent with the data. In 2003, Sengupta et al. developed the concept
of maximum entropy method for FCS data analysis (MEMFCS) [39]. A simple model
2.2 Fluorescence Correlation Spectroscopy 17
system, green fluorescent protein (GFP) in aqueous solution, and a set of simulated
highly polydisperse data were used to validate the functioning of MEMFCS. The results
of the fitting were compared to conventional fitting with a small number of different
species. Since then it has been used to study the aggregation of proteins [40–42], the
size of NPs [43, 44] or the interaction of biomolecules and NPs [45, 46]. MEMFCS uses
a quasicontinuous distribution of a large number of diffusing components to obtain an
unbiased fitting. Moreover, it guarantees a maximally wide distribution that is consistent
with the data. The formula is a sum of i different species weighted by their corresponding
amplitudes ai (τDi) [47].
According to these publications, the triplet can be neglected in biological diffusion studies
by separating it out in time. The model function is stated to be
G(τ) =
m
∑
i=1
ai (τDi)
(
1 +
τ
τDi
)−1(
1 +
τ
S2 τDi
)−1/2
(2.26)
with the number of species m, ai the relative amplitude of the ith species that is related to
its brightness and average number in the observation volume, τDi the diffusion time of
the ith species available, τ the delay time and the structure parameter S.
A range of possible diffusion times on a logarithmic time-scale is divided into m parts.
During the fitting process, the resulting distribution of possible diffusion times τDi is
fixed. In order to obtain a fit that is consistent with the data, the algorithm varies the
amplitudes ai. In comparison to other methods, MEMFCS does not use any a priori
assumptions on the distribution of the amplitude. Initially, the amplitudes ai (τDi) are
uniformly distributed. A least-squares fitting algorithm is applied for fitting, ideally
a Levenberg-Marquardt algorithm. The result of MEMFCS is a distribution of ai that
maximizes the entropy H and minimizes the difference of the measured data and the fit
at the same time. The entropy is defined as
H = −∑
i
pi ln pi (2.27)
using
pi =
ai (τDi)
∑i ai (τDi)
. (2.28)
This method results in the most acceptable distribution. For a discrete solution for τD,
the entropy is minimal. Minimal entropy is associated with complete knowledge of
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the system. So for noisy data, minimal entropy is the least acceptable solution, while
maximal entropy gives a solution that is consistent with the data available. MEMFCS
provides a safe limit for the interpretation of data without any a priori assumptions and
thus prevents the risk of overinterpreting the data of highly polydisperse systems. It is
disadvantageous that the input distribution of τDi spans several decades. As a result, not
all values for τD that correspond to physically relevant diffusion times of various particle
size, are precisely available during the fitting process. On the other hand, it is argued
that the absence of a particular diffusion constant in this analysis is a reliable indicator of
the absence of that specific species [48].
Gaussian Distribution Model (GDM)
An alternative to MEMFCS is provided by the Gaussian distribution model (GDM) [49].
It functions in a comparable way, except that an assumption is made on the form of the
initial distribution of the amplitude. The idea is that a component is not only represented
by a single sharp value for τD. Instead, a Gaussian distribution around a peak diffusion
time τP is assumed. A polydisperse system is analyzed and therefore the amplitude is
described as a sum of n Gaussian distributions, so a multimodal size distribution. The
total model function is then once more a sum of m one-component functions. As for
MEMFCS, the range of possible diffusion times τD is logarithmically scaled and divided
into m parts. The obtained set of τDi, i = 1 + m, is kept fixed during the fitting procedure.
In order to obtain a fit that minimizes the difference between measured data and fit, only
the amplitude ai is varied. More specifically, the parameters Ak, bk and τPk in Equation
2.30 are varied during fitting. Ak describes the relative amplitude of the components,
τPk is the peak diffusion time of the kth component and bk is related to the width of the
distribution.
The model is described by
G(τ) =
m
∑
i=1
ai (τDi)
(
1 +
τ
τDi
)−1(
1 +
τ
S2 τDi
)−1/2
(2.29)
using
ai (τDi) =
n
∑
k=1
exp (Ak) · exp
(
−
(
τDi − τPk
bk
)2)
(2.30)
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with peak diffusion time of the kth Gaussian τPk, bk is related to the width of the kth
Gaussian, ai is the relative amplitude of the ith species, τDi is the diffusion time of the ith
species, n the total number of Gaussian peaks and S is the structure parameter [49]. By
also including the triplet into the fitting, one obtains
G(τ) =
(
1 +
T
1− T
)
exp
(
− τ
τT
)
︸ ︷︷ ︸
triplet
·
m
∑
i=1
ai (τDi)
(
1 +
τ
τDi
)−1(
1 +
τ
S2 τDi
)−1/2
. (2.31)
The areas under the single Gaussian peaks are calculated and divided by the sum over
the areas under all Gaussian peaks to follow the development of the various species:
percentage of kth component =
(
areak (τPk)
∑nk=1 areak
)
· 100% (2.32)
with k = 1, 2, ..., n. The major advantages of this type of fitting are that it is much
faster and that it gives better resolved information on the distribution of particles than
MEMFCS. The disadvantage is that some a priori knowledge of the system under obser-
vation is needed to choose a number of Gaussians n that works for the complete fitting
process. Moreover, the starting values for the fitting procedure are educated guesses that
depend on a priori knowledge from literature or complementary experiments. Where
such a priori values are known or can be independently measured, however, GDM can
lead to better understanding of the kinetics of the measured process.
2.2.6 Analysis
The appearance of the correlation function can give first insights into the sample. The
shape of G(τ) gives a first hint on the particle size and on the number of particles inside
the confocal volume. For a monodisperse system, the point of the correlation curve,
where the maximal amplitude G(0) has decreased to half its value gives the size of the
particles. The amplitude of G(τ) is inversely proportional to the number of particles
inside the sample (see Equation 2.17).
Determination of Concentration
Binding processes are related to changes in size and concentration. Determination of
the kinetics of both parameters allows quantification of the underlying processes. The
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concentration of the particles in solution can be determined from fitting by
〈C〉 = 〈N〉
V
=
1
G (0) ·Veff
(2.33)
with the effective volume
Veff = π3/2 ω20 z0 = π
3/2 ω30 S , (2.34)
using the dimensions of the observation volume described by Equation 2.10 and shown
in Figure 2.2.
Hydrodynamic Size Determination
The particle size can be calculated from the diffusion time τD or coefficient D determined
by successful fitting, respectively. For spherical molecules, the Stokes-Einstein equation
links the diffusion properties D to the hydrodynamic radius RH using the Boltzmann
constant kB = 1.38064852 · 10−23 J/K, the viscosity η and the temperature T of the
surrounding medium:
D =
kBT
6πηRH
. (2.35)
The hydrodynamic radius RH describes a hypothetical sphere which obtains the same
properties of diffusion as the particle under observation. If the real geometry of a particle
deviates strongly from a sphere, RH can only give a rough estimation of the size and not
a precise value.
Not all particles studied in this thesis can be considered spherical. For instance, short
deoxyribonucleic acid (DNA) filaments or fibrils are more shaped like a rod. In order to
consider the differences in geometry of rigid rod-like molecules, the above formula is
modified to
D =
AkBT
3πηL
(2.36)
using the correction factor
A = ln
(
L
d
)
+ 0.312 + 0.565
(
d
L
)
− 0.1
(
d
L
)2
. (2.37)
L is the length and d the diameter of the rod-like object, respectively [50]. In order to
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Figure 2.5: Illustration of the impact of the finiteness of a particle. While a fluorescent
particle of finite size (gray) enters the confocal volume, its center of mass (black dot) is
still located outside of the detection area. Due to this, a fluorescence signal is detected for
a longer time and the apparent diffusion time τA is prolonged compared to a point-like
particle with the same diffusion properties.
reduce the number of free parameters and to receive meaningful results from fitting,
a priori information on the object is required, such as knowledge of the diameter d. This
data is often determined with a complementary imaging technique, such as transmission
electron microscopy or atomic force microscopy (AFM). For semiflexible long polymers,
more sophisticated approaches would need to be applied [51, 52].
Finite Size Correction
Up until now, nearly point-like spherical particles are considered. But NPs are particles
with a finite size that has to be taken into account in the analysis. The impact of the
finiteness of particles was first discussed by Starchev et al. [53]. If a particle obtains
a diameter that is comparable to the size of the beam waist of the confocal volume
(d ≈ 2ω0), then the shape of correlation curve G(τ) is influenced by the geometrical
size as well as the arrangement of the fluorophores on the particle. The time a particle
is detected inside the confocal volume increases with increasing particle size. While
its center of mass is still outside of the observation volume, the edge of the particle is
already inside the detection region (Figure 2.5). This apparent prolonged diffusion time
τA has to be corrected to obtain the actual hydrodynamic size of the particle using the
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Stokes-Einstein Equation (2.35) [54].
There are two cases of label positioning that have to be considered. On the one hand,
for a sphere that is only labeled on the surface (shell), the apparent diffusion time τA is
related to the actual diffusion time τD by
τA = τD ·
(
1 +
8
3
R2
ω20
)
. (2.38)
On the other hand, a particle can be a uniformly volume-labeled sphere. In this case, the
correction term is described by
τA = τD ·
(
1 +
8
5
R2
ω20
)
. (2.39)
It is recommended to use these corrections for a ratio of the radius of the particles R to
the radius of the beam waist R/ω0 > 0.2. For values above this threshold the error is
larger than 10 %.
For particles that obtain an even larger diameter than the beam waist, d 2ω0, correc-
tions according to Gapinski et al. have to be considered [55, 56]. This case did not occur
in present thesis.
Chapter 3
Analysis of Binding Affinity Reactions
In this chapter the analysis of titration experiments to quantify binding of proteins to
solid NPs and liposomes is discussed. With FCS it is possible to measure the fraction
of bound proteins as a function of the concentration of NPs, which can be used to
determine the equilibrium binding constant or binding affinity K. The underlying theory
for equilibrium binding constants is explained. Knowledge of the value of K and its
dependence on additional experimental parameters is crucial to elucidate mechanisms
of interactions of biophysical matter.
3.1 Law of Mass Action and Binding Constants
3.1.1 Monovalent Receptors
A biomolecular interaction of a single ligand L and a single receptor R leading to the
formation of a complex RL (Figure 3.1) is described by the following reaction equation
L + R RL . (3.1)
If the interaction is an equilibrium reaction, it is determined by the law of mass action.
The fraction of receptors occupied is given by
Y =
[RL]
[R]tot
=
[RL]
[R] + [RL]
=
K · [R]
1 + K · [R] (3.2)
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+
kA
kD
Figure 3.1: Illustration of binding process. A single ligand (gray) binds to a receptor
(red), building a complex.
using the definition of the equilibrium binding constant
K =
[RL]
[L] · [R] → [R] =
[RL]
K · [L] , (3.3)
where [X]tot describes the total available amount of species X (X = R, L), so the initial
concentration used for the experiment, and [X] is the amount of unbound X in solution
[57]. The binding affinity K provides information on the thermodynamic properties
of the reaction. Its value allows making a statement on the strength of binding, but it
does not say anything about the dynamics of the reaction. To this end, time-resolved
measurements are needed as discussed in Section 3.2.
In order to express Y in terms of the experimentally easier accessible parameters [L]tot,
[R]tot and K, the following relations are applied:
[L]tot = [L] + [RL]→ [L] = [L]tot − [RL] (3.4)
and
[R]tot = [R] + [RL] −−→
(3.3)
[R]tot =
[RL]
K · [L] + [RL] . (3.5)
If the last two expressions are combined, we obtain the following relation:
[R]tot = [RL] +
[RL]
K · [L] = [RL] +
[RL]
K · ([L]tot − [RL])
. (3.6)
Solving the resulting quadratic equation for [RL] and inserting the result in Relation 3.2,
we obtain
Y =
([R]tot + [L]tot + K−1)−
√
([R]tot + [L]tot + K−1)2 − 4[R]tot[L]tot
2[R]tot
. (3.7)
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In the limit of [L]tot  [R]tot, [L]tot ≈ [L] the above Relation 3.7 simplifies to
Y =
[RL]
[R]tot
=
[RL]
[R] + [RL]
=
K · [L]tot
1 + K[L]tot
. (3.8)
These expressions can be used to experimentally determine the equilibrium binding
constant K of a ligand receptor interaction. The fraction bound, as a function of the con-
centration of the titrated ligand, gives an S-shaped curve, the so-called binding isotherm.
Fitting with the above equations allows extracting a value of K from this graph.
In pharmacology or biochemistry, Relation 3.8 is also known as the Langmuir binding
isotherm. The Langmuir binding isotherm describes the state of equilibrium of adsorp-
tion and desorption at an interface at constant temperature. It is the simplest model of
adsorption that describes the complete adsorption on a surface. K is often noted as KL
and called Langmuir sorption coefficient [58].
Moreover, Equation 3.8 is known as a limit of the so-called Hill equation for the case of
n = 1:
YHill =
K · [L]ntot
1 + K · [L]ntot
(3.9)
The Hill coefficient n is an indicator of cooperativity. If n = 1, the binding of two ligands
is independent of each other. In the case of n 6= 1, the cooperativity is either positive
(n > 1) or negative (n < 1). For positive cooperativity, the affinity of the receptor for
further ligand molecules increases if one ligand is bound, and vice versa for negative
cooperativity. Hill himself refused a physical interpretation of n [59]. Only for the special
case of strong positive cooperativity, the Hill coefficient gives an exact estimation of the
number of binding sites, because n particles bind in an all-or-nothing fashion without
any intermediate states. But this assumption does not hold true for all cases and therefore
n only provides a lower limit of the number of binding sites [60–63].
3.1.2 Polyvalent Receptors
The above relations are derived under the assumption that a single ligand only binds to
a single receptor. This assumptions is not, however, universally valid for all biophysical
interactions. Frequently, receptors provide more than one binding site to the available
ligands. The theory above can be expanded for the universal case of ligands binding to
receptors with m binding sites to which between 1 and m ligands can adsorb. Applying a
statistical description of the bimolecular binding process, the theory can be generalized.
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This allows the integration of special cases such as cooperative processes including
different binding constants for different population of the receptor’s binding sites [57].
The fraction of bound ligands can be defined as the probability that a ligand is adsorbed
to a receptor. The probability pj of a ligand binding to a receptor with m binding sites
which are occupied by j ligands is identical for all j=0, 1, ..., m-1, if we assume that the
binding affinity K does not depend on the current number of filled binding sites on the
receptor. The same assumption is made for the analysis with the Langmuir binding
isotherm mentioned above. From this we can deduce an expression for the probability
pbound that a ligand is bound to a receptor with m possible binding sites:
pbound =
m−1
∑
j=0
pj =
m−1
∑
j=0
p = m · p . (3.10)
Due to the assumption that the probability of binding p is independent of the number
of occupied binding sites on the receptor, we can replace p by using Equation 3.8. The
probability pbound can then be rewritten as
pbound = m · p = m ·
K · [L]tot
1 + K[L]tot
. (3.11)
This equation enables us to extract the binding constant K from a titration series of
proteins (ligands) and a fixed concentration of NPs acting as receptors with an average
of m binding sites.
3.2 Association and Dissociation Rates
Equilibrium does not describe a static state in which the reaction has stopped. On the
contrary, in equilibrium there are as many ligands binding to the receptors as unbind
from them, so the association rate kA and dissociation rate constants kD are simply the
same. To add these new parameters to our considerations, Equation 3.1 is noted as
L + R
kA


kD
RL . (3.12)
The kinetics of the binding process are described by
d[RL]
dt
= kA · [R] · [L]− kD · [RL] . (3.13)
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With this equation we are able to analyze time-resolved measurements of the amount of
free protein [64]. This is possible because the underlying law of mass action describes
reactions that are reversible. The affinity constant K is related to kA and kD via
K =
kA
kD
. (3.14)
Most reactions are determined by the dissociation rate constant kD which has, for instance
a value of 10−1s−1 for the desorption of proteins from NPs as shown in Chapter 5.3.4.
In case of high values for K, the values for kD can decrease to 10−6s−1. These reactions
are nearly irreversible such as Avidin-Biotin, and often described by the strong binding
model presented in Section 3.3. Besides the dissociation rate constant kD, the dissociation
constant KD is also frequently used to describe binding reactions:
KD =
[L] · [R]
[RL]
=
kD
kA
= K−1 . (3.15)
KD is a measure of equilibrium of the dissociation reaction and can be considered a
special case of the equilibrium constant of the law of mass action.
3.2.1 Diffusion-limited Reactions
If there are no serious conformational changes of the reaction partners, then the binding
itself is very fast due to the nature of interaction forces and low activation barriers. The
binding reaction is often only limited by the frequency of encounters of ligands and
receptors. In an unbiased reaction volume ligands and receptors move by diffusion, and
thus such binding reactions are called diffusion-limited.
Under these assumptions, the association constant is given by
kA = 4 · π · DRL · (rR + rL) · NA (3.16)
with the diffusion constant DRL = DR + DL, the radii of the receptor and the ligand rR
and rL, respectively, and the Avogadro constant NA.
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Figure 3.2: Theoretical evaluation of the concentration of bound receptor [RL] in depen-
dence of the total ligand concentration [L]tot for various binding affinities. The affinity
K increases with brightness of color from dark to light green. Total concentration of
receptor [R]tot = 1 nM.
3.3 Strength of Binding and Strong Binding Model
First conclusions can be drawn from the shape and the position of the binding curve. In
Figure 3.2, theoretical titration curves for a fixed concentration of receptors [R]tot and
various binding affinities K are shown. If the curve increases weakly with concentration
and transits very smoothly into the plateaus, then the binding affinity is low. If the
increase is very steep, this indicates a high affinity. In this case, the position of the
curve depends only on the concentration of the receptor [R]tot. In the special case of
strong binding, the position of the kink reaching saturation, gives an estimate of the
concentration of binding sites. If the value for K is very high due to low values of
kD, the process can be considered irreversible on microscopic time-scales. For such
interactions the usage of equilibrium concepts to describe adsorption may no longer
be appropriate [65]. A strong binding model as proposed by Milani et al. seems to be
more suited [21]. The model assumes a strong interaction of proteins with the bare NP
surface and a negligible interaction of proteins and NPs covered with proteins. Resulting
from this, proteins (P) bind to the NP until the surface is completely covered. In order
to apply the strong binding analysis, the fraction bound is plotted against the molar
ratio x = [P]/[NP]. Data that is represented in this way falls on a single universal curve
as shown in Figure 3.3. A full adsorption up to x∗c with a decreasing fraction bound is
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Figure 3.3: Comparison of the strong binding model for protein-NP interactions (dashed
black line) and analysis using the law of mass action described by Equation 3.7 (solid red
line). Gray circles represent generic data.
observed. The fraction bound according to the strong binding model is defined by
Y =
[P/NP]
[P]tot
=



1 if x ≤ x∗c
x∗c /x if x > x∗c
(3.17)
where x∗c is the critical molar ratio of a full monolayer coverage and additionally gives
an estimation of the average number of available binding sites per NP. The advantage
of this approach is, that there is no need to measure a complete binding isotherm as
necessary for Langmuir adsorption isotherms. This is especially useful, if one is only
interested in the stoichiometry and not the exact value of the binding affinity K.
3.4 Binding Probed by FCS
FCS uses the fact that the diffusion of particles depends on their size and that binding
causes a change of this diffusion behavior. In a typical FCS experiment, the smaller
proteins are fluorescently labeled and kept at a fixed concentration - so they act as
receptors. This way, we are able to observe a more pronounced change in diffusion
behavior, if a fast diffusing protein binds to a slower NP. We measure the number of free
proteins Nfree with respect to the initial amount of proteins in solution (N0). The fraction
bound is given by
Y = 1− Nfree
N0
. (3.18)
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We determine the binding isotherms as a function of the concentration of NP. From the
isotherms we can extract the binding affinity K with a fit according to Equation 3.7 if we
assume that the binding constants are always independent of the state of occupation of
the s ligand’s binding sites [66–69].
In this thesis, interactions of proteins with solid NPs and TSLs are studied. Both types
of ligands have a diameter of about 100 nm and can be considered as ligands with s
independent binding sites for proteins. So, the fraction of proteins bound to the ligand
NPs can be expressed in terms of free ligands [L]tot using Relation 3.8. In this case,
the value of K relies heavily on the homogeneity of the size and the related available
surface of the nanocarrier under observation. In order to overcome this limitation, a more
general form is desirable which is independent of the size of the ligand. The total number
of available ligand binding sites S is defined by the product of the average number of
binding sites per ligand s and the total concentration of ligands [L]tot in solution
[S] = s · [L]tot . (3.19)
In the case of TSL, it is assumed that every lipid can act as a potential binding site. Thus,
the binding constant is often defined in terms of the lipid concentration instead [S] of the
concentration of liposomes [L]tot. This leads to the following definition of the fraction of
proteins bound to TSLs:
Y =
K · [L]tot
1 + K[L]tot
=
K · s · [L]tot
1 + K · s · [L]tot
=
K · [S]
1 + K[S]
. (3.20)
[L]tot is the initial concentration of TSLs in solution and [S] represents the total concen-
tration of lipids in the sample. Liposomes consist of a lipid bilayer. Due to this, only half
of the lipids are accessible for binding. This fact can be considered by expressing K in
terms of accessible lipids [S]/2 instead of the total lipid concentration [S] [70].
Since measurements mainly dealt with binding under the excess of available ligand
binding sites [S], Equation 3.20 was used for analysis of the binding isotherms. Where
the limit [L]tot  [R]tot was not valid, Equation 3.7 was applied.
3.5 Binding Probed by Microscale Thermophoresis
In microscale thermophoresis (MST), the directed movement of fluorescent molecules in
a local temperature gradient is measured. The underlying effect is called thermophoresis
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and was first mentioned by Carl Ludwig in 1856 [71]. MST is a technology that allows
the evaluation of the interaction of molecules such as binding or unbinding by studying
the changes in the characteristic motion of the sample molecules [72, 73].
3.5.1 Basics of Microscale Thermophoresis
In a temperature gradient ∇T in a liquid, molecules with thermophoretic mobility DT
move with pace v = DT · ∇T. Differences in the local concentration c are induced by the
thermophoretic motion, which causes diffusion of the molecules along the gradient. The
resulting total molecular flow is described by [71]:
j = jD + jDT = −∇c · D− c · ∇T · DT . (3.21)
D is the diffusive mobility. In equilibrium, thermophoresis and ordinary mass diffusion
(j = 0) compensate each other:
dc
c
= −DT
D
· dT . (3.22)
From this relation the equilibrium distribution of the concentration can be obtained:
c(x)
c0
= exp
[
−DT
D
· (T(x)− T(x0))
]
. (3.23)
c0 describes the concentration at site x0. The Soret coefficient ST, a measure for the
intensity of thermodiffusion in the stationary state, is defined as
ST =
DT
D
. (3.24)
The distribution of the concentration caused by thermophoretic motion can be interpreted
as a local change in the Gibbs free enthalpy G using a Boltzmann distribution for small,
quasi-continuous temperature steps [74] :
c(T1)
c(T2)
= exp
[
−G(T1)− G(T2)
kBT
]
. (3.25)
From the last two equations, we deduce an expression that relates the Soret coefficient to
the overall entropy H:
−H = ∆G
∆T
= ST · kBT . (3.26)
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H describes the local negative entropy of the solvent-solute system for individual parti-
cles at constant pressure. For biophysical experiments, this solvent is ordinarily water or
watery solutions. In this case, the entropy of the particles is determined by the entropy
of ionic shielding and the entropy of hydration, described by
ST =
A
kBT
(
−shydr +
βσ2eff
4εε0T
· λDH
)
(3.27)
with the hydration entropy shydr per surface area A, the effective surface charge density
σeff, the dielectric constant of water ε, the vacuum permittivity ε0 and the Debye screening
length λDH. λDH depends on the concentration of salt of the solution. The relative change
of the solvent’s dielectric constant ε(T) and λDH with temperature is characterized by β.
3.5.2 Analysis of Binding
The Soret coefficient ST depends on several parameters: size, conformation, charge and
solvation entropy of a particle. Interactions such as binding may alter some or all of the
named characteristics. The impact on at least one of these parameters is used in MST to
put the interaction of molecules on a quantitative level. The change in concentration in
the stationary state with the temperature change ∆T = T(x)− T(x0) at the respective
position x is determined by ST [75]:
chot = ccold · exp (−ST · ∆T) . (3.28)
In practice, the temperature gradient inside the sample chamber is generated by a
low-powered infrared laser [76]. Usually, the sample chamber is a capillary. Fluo-
rescent labelling of the molecules under observation allows the visualization of the
thermophoretic motion as a change in the fluorescence intensity detected (see Figure
3.4). The ratio Fhot/Fcold = Fnorm of the averaged fluorescence intensity during the times
when the laser is switched on (Fhot) and off (Fcold), respectively, is used to quantify the
thermophoretic behavior. Normally, the amount of the unlabeled interaction partner is
titrated against a fixed concentration of the fluorescently labeled partner. This unlabeled
partner acts as receptor. If the thermophoretic depletion is plotted against the concentra-
tion of receptors, we obtain a binding isotherm that can be analyzed using the formalism
presented in the previous section (Equation 3.7 or 3.8, respectively).
3.5 Binding Probed by Microscale Thermophoresis 33
a) b) IR on IR off
F c
ol
d
F h
ot
time
flu
or
es
ce
nc
e
capillary -
IR beam -
fluorescence -
excitation -
objective -
Figure 3.4: MST. a) Thermophoresis in a sample solution containing biomolecules
is induced by a focused infrared laser. The directed motion of the molecules in the
established temperature gradient is detected via the local change in fluorescence. The
fluorescent particles are excited using an LED. The thermophoretic motion causes a
concentration gradient inside the capillary. b) Fluorescence time trace. Before the
infrared laser is switched on, the cold fluorescence Fcold is measured. After starting
heating, a steep decrease in fluorescence is detected. This phase is followed by the
chracteristic thermophoretic motion, from which Fhot is gained. After turning the laser
off, the fluorescent molecules start to diffuse back.
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Chapter 4
Proteins and Plasma
In this chapter the background of the used biomaterial is presented. The binding of
various proteins to different NPs is discussed in this dissertation (Chapter 5 and 6).
Knowledge of the protein properties and its biological function is essential for experi-
ments and interpretation of results. Additionally, experiments are performed in complex
media such as plasma or serum. Biofluids are scattering media, which are crowded by
macromolecules and hence strongly disturb FCS experiments by distortion of the confo-
cal volume. The distinction between plasma and serum is explained. The dependence of
the viscosity on the temperature and the composition of the medium is demonstrated for
mixtures of phosphate buffered saline (PBS) and FBS. The impact of these solutions on
FCS measurements is discussed.
4.1 Biomolecular Corona
When bare NPs are exposed to biological fluids, proteins and other biomolecules adsorb
to them. The resulting layer(s) of biomaterial is called “protein corona” or “biomolecular
corona” (Figure 4.1 a) [8–11]. The composition of the corona gives the NP its biological
identity and therefore determines the fate of the NP inside a living system in dependence
on its composition [77]. However, the corona is not static. It evolves with time and
environmental changes when traveling through different compartments of the body.
Certain proteins will be replaced with fresh ones from the new local environment,
resulting in a change of the biological identity. The particle may then show characteristics
of both the original milieu and the new one [9, 78]. Understanding of the evolution
of the corona is mandatory regarding the general safety of NPs, but also for potential
36 4. Proteins and Plasma
a) b) 
Figure 4.1: a) Inside an organism, NPs will almost invariably be surrounded by a mixture
of biomolecules. These biomolecules adsorb fast and strongly onto the NP’s surface. Due
to very strong adsorption, the biomolecules might never come off again. This implies
that the identity of the NP is effectively hidden by the covering biomolecules on its
surface. The corona is divided into two sections. The hard corona (inner circle, dark
colors) and the soft corona (outer circle, light colors). The hard corona is often considered
to be irreversibly bound due to its slow exchange, while the loosely associated molecules
of the soft corona exhibit dynamic exchange with its surroundings. b) NP with hard
corona after removal of the surrounding protein solution. Removal can be performed
by centrifugation as in publication P1 in Chapter 5. This way, the hard corona becomes
analytically accessible.
therapeutic applications as drug carriers. Biomolecules within organisms, such as lipids,
sugars or proteins, adsorb strongly to the NP’s surface. In the beginning, abundant
proteins bind that are slowly replaced by proteins with a higher affinity. The original NP
and its physico-chemical properties are thereby effectively masked. These biophysical
properties may differ significantly for the coated and the uncoated NP. Thus, the object
whose eventual hazards need to be investigated, is not the original bare NP, but rather
the complex consisting of NP and the involved biomolecules from the organism. The
biomolecular corona itself can be divided into two parts: the hard and the soft corona
(Figure 4.1 a). The molecules of the hard corona are in direct contact with the bare
NP surface and remain there for a relevant time [79]. In comparison, the molecules
of the soft corona are only loosely associated and exhibit a dynamic exchange with
its environment. While the soft corona can be almost completely replaced, the hard
corona is robust and long-lived in the presence of added full plasma. Depending on
the time-scale of the experiment, the hard corona is also termed irreversible [21, 80].
Studies of the biomolecular corona often use techniques to separate the hard corona-NP
complexes from solutions (Figure 4.1 b). Methods such as centrifugation, size exclusion
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chromatography or magnetic isolation are applied for separation, followed by analysis
by gel electrophoresis, liquid chromatography mass spectrometry or nuclear resonance
spectroscopy [81, 82].
Interactions of the NP’s corona with the biological machinery have to be considered in
cell experiments. Significant differences in the uptake of NPs in cell medium with and
without serum have been observed [83, 84]. The adhesion of protein-NP complexes to
cells is strongly reduced compared to the effect for the bare NPs. The presence of the
corona reduces the unspecific interactions between the pristine NP and the membrane of
the cells. Specific corona-receptor interaction may be possible and trigger the biological
recognition, if signaling molecules are present in the corona. Still the extent of cellular
uptake depends on the detailed system. Already in the year 1962, the effect of protein
adsorption to flat surfaces was discussed by L. Vroman [85, 86]. This concept is adapted
to the exchange kinetics of NP’s corona molecules. The “Vroman effect” postulates
competitive protein adsorption on a surface. Although the total amount of adsorbed
biomolecules stays roughly constant, the identities of the adsorbed proteins can change
over time. The effect also describes the evolution of the protein corona from abundant,
not weakly binding proteins to the subsequent replacement by less abundant but stronger
binding molecules [87–89].
4.2 Plasma Proteins
In this work, the following representative proteins are considered. Although there are
more than 3,500 proteins in human plasma present, only a few hundreds are usually part
of the corona of NPs [90]. The selected proteins are numerous in plasma and have been
detected in the corona of solid NPs or liposomes [89, 91–95].
4.2.1 Serum Albumin
Serum albumins are the most abundant protein in blood plasma and serum. For instance
human serum albumin (HSA) makes up almost 55% of plasma proteins in humans
(35-50 g l−1). It is a single chain protein with a globular shape and a molecular weight
of 67 kDa. In the liver, serum albumin (SA) is produced and secreted into circulation.
The task of SA is the regulation of the oncotic pressure of plasma to keep the blood
within circulation [90]. It sequesters and transports many metabolites within the body,
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especially less soluble, and hydrophobic ones such as lipids, vitamins or hormones. For
binding and transport, SA possesses three binding domains which are specific for metal
ions, lipids and nucleotides, respectively [96]. In addition, SA is an important antioxidant
and has enzymatic properties such as binding and activation of drug conjugates (e.g.
ibuprofen) [97]. It also acts as a chaperone molecule promoting the folding of proteins
[98]. In research, SA is often used as blocking agent to avoid nonspecific protein-surface
interactions [96]. SA is used to avoid protein-protein interactions and is added as a
stabilizer to solutions, for instance in cryopreservation. For modeling and simulations,
SA offer a distribution of exposed residues that provide the opportunity to study regions
with different degree of hydropacy.
4.2.2 Fibrinogen
Fibrinogen (Fib) is a heavy (340 kDa) rod-like molecule that plays a key role in coagula-
tion. It is known as coagulation factor I and is converted to fibrin during coagulation.
It can support both platelet-platelet and platelet-surface interactions by binding to the
glycoprotein IIb-IIIa receptor [99]. Fib consists of three subunits, the so called α, β and
γ chains. Its concentration in plasma varies from 1.7 to 4.5 mg ml−1, corresponding to
about 7% of the total serum proteins. Fib obtains a high surface affinity and usually
displaces preadsorbed proteins [100]. Bound Fib might interact with the Mac-1 receptor,
which would increase NP uptake by phagocytosis [101, 102].
4.2.3 Fibronectin
Another high-molecular weight protein of the extracellular matrix is fibronectin (FN).
It usually exists as a dimer and has a molecular weight of 440 kDa. FN is abundant in
body fluids as well as part of the insoluble extracellular matrix. This protein obtains
binding sites for heparin, integrins or collagen. FN is important to cell adhesion, growth,
migration and differentiation [103].
4.2.4 Transferrin
Transferrin (Tf) is a glycoprotein with a molecular weight of 80 kDa. The task of Tf is
the transport of iron in the human body. At least 80% of the iron bound to circulating
Tf is delivered to the bone marrow and incorporated into newly formed erythrocytes
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as shown by radioactive tracer studies [104, 105]. The spleen and the liver, which is a
basic depot for stored iron, are further major sites of iron delivery. At its homologous
N-terminal and C-terminal iron-binding domains, Tf can bind up to two Fe3+ ions [106].
Only in the presence of an anion (usually carbonate), ferric iron couples to Tf with an
association constant of about 1020 M−1 at pH 7.4 [107]. The anion acts as a bridging
ligand between metal and protein [108, 109]. The iron binding to Tf is neglectable without
the anion cofactor. Normally, about one-third of the iron-binding sites of Tf are occupied.
Therefore, almost no iron occurs in circulation that is not bound to Tf. Through receptor-
mediated endocytosis of Tf, iron is taken into vertebrate cells. Iron-loaded Tf binds to
receptors on the outer face of the cell membrane with a very high affinity. The receptor
binding seems to be mediated by the C-terminal domain [110]. Its concentration in blood
is about 3 mg ml−1, or 25 mM, respectively. Hence, cellular Tf receptors are ordinarily
fully saturated. After adsorption to its receptor on the cell membrane, Tf is quickly
internalized by invagination of clathrin-coated pits with formation of endocytic vesicles
[111, 112]. In an acidic environment such as inside the endosome (pH = 5.5) [113, 114],
the release of iron is favored [115]. The release of bound iron is induced by the reduction
of bound Fe3+ to Fe2+ [116, 117]. Upon release, the metal-protein bond is loosened by
protonation of the anion. After the release of iron, receptor bound transferrin (Tf) is
transported to the cell surface. Here, Tf is released from its receptor and circulates again
and undergoes further rounds of iron delivery [110–112, 118]. Due to overexpression of
endogenous Tf receptors on various cancer cells, Tf has been used as a targeting agent to
overcome the shortage of specificity of conventional therapeutic NPs or contrast media
[119–122].
4.2.5 Apolipoprotein A1
Apolipoprotein A1 (ApoA1) is a lipid-binding protein that acts as a transporter for
cholesterol in plasma. ApoA1 is produced mainly by the liver and the intestine as a
preproprotein. After maturation, the protein is secreted into plasma as a lipid-poor/-free
protein with a molecular weight of 28 kDa. ApoA1 is the main acceptor of cholesterol
from artery wall cells, freeing them from excess fats [127]. Chlosterol, phospholipids,
triglycerides and ApoA1 form precursors of high-density lipoproteins (HDLs) [128]. The
major protein component of HDL is ApoA1 [129]. α-helices form amphipathic regions
to which lipids can bind reversibly. A lack of ApoA1 is associated with atherosclerosis
[130]. Moreover, a cardioprotective effect of HDL in humans is suspected [131]. The
40 4. Proteins and Plasma
SA Fib Tf FN ApoA1
mass [kDa] 69 340 80 440 28
amino acids 585 2800 679 2355 243
average concen-
tration in blood
plasma [mg/ml]
40 3 3 0.3 1.3-1.6
isoelectric point 4.8 5.5 5.2-5.9 5.5-6.0 5.6
spherical Rh [nm] 3.3-3.6 9 3.6 9 3
size [nm] 8x8x3 6.7x11 4.2x10x7 15.5x8.8 3.6x6.3
shape globular rod-like prolate elongated ellipsoid,
ellipsoid horseshoe
Table 4.1: Overview of the properties of proteins used for NP binding studies. Molecular
weight, number of amino acids, average concentration in plasma, isoelectric point,
spherical hydrodynamic radius, geometrical size and shape. [100, 123–126]
role of lipoproteins for barrier crossing is under discussion [78, 132]. In Alzheimer’s
Disease (AD) patients, ApoA1 binds to Aβ and prevents the neurodegenerative impact
of this protein [133]. In addition, a potential therapeutic benefit in cancer treatment has
been highlighted [134, 135].
4.3 Amyloidogenic Proteins
Amyloidogenic proteins are related to serious diseases such as Alzheimer’s Disease (AD)
or Parkinson’s Disease. The proteins involved aggregate into characteristic fibrils. This
process is not only of interest due to medical reasons, it is also valuable for engineering
new nanomaterials that are based on hierarchical self-assembly. In this thesis, we study
the aggregation process of amyloid beta (Aβ) and characterize several species of α-
synuclein (α-syn).
4.3.1 Amyloid β1−42
Aβ is a peptide that is present in the brain and is under suspicion to cause a common
form of dementia: AD. The concentration of Aβ in the cerebrospinal fluid (CSF) is in
the nanomolar range (≈ 500 ng l−1) [136, 137]. It is a product of the normal cellular
metabolism and thus Aβ appears in the brain fluids of all humans. Therefore, it is
assumed that Aβ might be of physiological relevance in the central nervous system.
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The list of suggested tasks ranges from ion channel modulation, kinease activation and
regulation of the cholesterol transport to learning and memory [138]. In AD, the balance
between generation and clearance of Aβ is disturbed. Either too much Aβ is released into
the CSF or the removal does not work properly. Both lead to an increased level of Aβ in
the CSF, later to the aggregation of Aβ and AD. So far, the only known natural source of
Aβ is the amyloid precursor protein which is a tansmembrane protein that is expressed
in most cell types [138]. The amyloid precursor protein is cleaved by several secretases
and the resulting product is Aβ. Depending on the cutting point, Aβ molecules with
various length can be produced, ranging from 39-43 amino acids. In this work, the focus
lies on Aβ1−42 due to its prominent role in the process of aggregation. Monomeric Aβ
has a molecular weight of approx. 4.5 kDa and a hydrodynamic radius of 0.90 ± 0.05 nm
[139]. An α-helical structure or random-coil structure was found for the monomer [138].
The Aβ monomer is assumed to evolve into a β-hairpin conformation in water that is
stabilized by intramolecular H-bonds and antiparallel β-strands [140]. At physiological
pH, Aβ adopts quickly β-sheet structure [141]. Assembled forms of synthetic Aβ are
highly sensitive to preparation and incubation [142] and are therefore called metastable.
Synthetic Aβ in aqueous solution also tends to self-aggregate [143, 144]. Factors that
favor aggregation are the presence of detergents, a high ionic strength or the addition of
salts to Aβ solutions [141].
4.3.2 α-synuclein
The presynaptic protein α-syn is related to Parkinson’s Disease in a similar way as Aβ
is to AD. Deposits of α-syn, so-called Lewy bodies, in the brain are the pathological
hallmark of the disease. α-syn has a molecular weight of 14 kDa and is mainly found at
the tips of neurons. It may be involved in the transport and regulation of dopamine, but
the function of α-syn in healthy people is not well understood yet [145–147]. Interactions
of α-syn with a variety of proteins and with lipid vesicles are known [148–151]. The
latter leads to the assumption that α-syn may play a role in lipid metabolism [152, 153].
In the cytosol, α-syn exhibits a random-coil secondary structure in aqueous solution
[154, 155]. The sequence of α-syn consists of three main regions: the N-terminal region,
the NAC region and the C-terminal region. An amphipathic helical conformation in
its N-terminal and the NAC region is induced upon the interaction with phospholipid
membranes [156, 157]. The NAC region is mainly hydrophobic and seems to be essential
for fibrillation [158].
42 4. Proteins and Plasma
4.4 Blood Plasma and Serum
In order to perform preliminary experiments under closer to physiological conditions, but
before the more complex in vivo experiments, the used buffer is replaced by a biological
fluid, such as blood plasma or serum. For instance, instead of a conventional buffer,
plasma or plasma buffer mixtures are used to mimic the in vivo situation partially. In
literature, the expressions “serum” and “plasma” are repeatedly used interchangeable,
although these blood extracts are not the same from a physiological point of view.
Both fluids are prepared in dissimilar ways, using no or different chemical additives
and therefore different biomolecules are inactivated or even precipitated from the final
solution [159]. For the extraction of plasma, blood is treated with a substance to avoid co-
agulation. Anticoagulants used are sodium citrate, heparin or ethylenediaminetetraacetic
acid (EDTA). A careful selection of the anticoagulant is necessary to ensure that the
biological phenomena observed are representative. For instance, coagulation factors
such as factor VIII or fibrinogen (Fib), stay active in citrate blood, but they are inactivated
when EDTA is used [160, 161]. EDTA removes calcium or other divalent ions from the
sample to avoid coagulation. In this way, enzymes that require calcium, are inactivated,
e.g. ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 motifs
13) that regulates the length distribution of the protein von Willebrand factor [162]. This
is essential for experiments or diagnostic tests, in which the activity of an enzyme is
determined or even quantified [163]. Furthermore, plasma can be gained without any
additives during plasmapheresis. In contrast, serum is produced by the centrifugation
of coagulated blood. The supernatant is collected and contains all natural components
of blood, except for the coagulation agents that were used during coagulation. Never-
theless, it is observed that the total protein content in serum is lower than in plasma
[164]. Strongly simplified, serum can be defined as blood plasma without or only with
low amounts of coagulation factors such as fibrin or Fib. Centrifugation is crucial for
both extracts to get rid of all cells contained in solution. The difference in protein corona
composition of NPs incubated in human serum and plasma was shown by Mirshafiee et
al. [95]. An actual difference in the composition was found, indicating that plasma is the
more realistic system for in vitro experiments mimicking the in vivo situation.
Instead of human plasma, fetal bovine serum (FBS), is often used to imitate the physio-
logical situations. FBS plays a major role in cell culture as a part of medium to grow cells.
Thus, it is a common product that is easily accessible in large amounts as a by-product
of the industrial production of dairy products and meat. An advantage of FBS is that
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it is possible to sterilize it by filtering, decreasing the risk of bacterial contaminations
for experiments. For mimicking molecular effects such as molecular crowding and
establishing new routines, FBS is a good alternative to human serum or plasma.
4.5 Viscosity of Mixtures of Fetal Bovine Serum and Phos-
phate Buffered Saline
There is a certain trend towards applying FCS in the area of medicine, e.g. to characterize
drug nanocarriers, or clinical applications such as diagnostics [22, 165, 166]. Measure-
ments in plasma, serum or mixtures of biofluids and buffer are often used to perform
experiments under closer to physiological conditions. In Chapter 5 of this thesis, FBS is
added to precoated NPs to study the reversibility of protein binding and in Chapter 6
the influence of biofluids from different species on the release profile of thermosensitive
liposomes (TSLs) is investigated. It has been stated that FCS is suitable to measure in
complex fluids such as plasma or serum, but there is no systematic study that considers
all the various aspects that have to be taken into account when measuring in biofluids.
Measuring in complex biofluids provides additional challenges in the evaluation of data.
Scattering and hydrodynamic effects due to crowding have to be considered [167–169].
Crowding occurs when high concentrations of macromolecules are present and that this
presence can alter the properties and interactions of biomolecules in solution. Properly
determined values of the viscosity in literature are rare. Often important information
on the underlying experiments are missing such as the ionic strength of the dilution
buffer or the temperature at which the viscosity or density of a medium was determined.
Although temperature-dependency of media and diffusion is known, it is not always
considered properly in analysis. In order to ensure proper results from FCS measure-
ments and analysis of experiments in mixtures of FBS and PBS, physical properties of
these solutions, such as density and viscosity, are determined in a systematic way and at
experimentally relevant temperatures: room temperature 22 ◦C and body temperature
37 ◦C. GFP is used as a test molecule, since no binding to serum components was ob-
served in previous experiments. Crowding leads to an increase of the dynamic viscosity
and a slowing down of the diffusion. This effect has to be considered in the analysis,
especially for the conversion from diffusion constant D to the hydrodynamic size using
the Stokes-Einstein equation (Equation 2.35), where the correct value for the viscosity of
the surrounding medium η(T) has to be used. The density of mixtures of FBS and PBS
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Figure 4.2: Density of mixtures of PBS and FBS ranging from 0 to 100% FBS at room
temperature 22 ◦C (blue squares) and physiological temperature 37 ◦C (red circles). Data
is the average of 30 measurements. Linear fits to guide the eye. Error bars represent the
standard deviation.
was measured at 22 and 37 ◦C using a Gay-Lussac pycnometer (Figure 4.2). The density
is an input parameter for viscosity measurements. The viscosity was determined with a
capillary viscometer with a heating element (Anton Paar).
The dependence of the viscosity on temperature and the fraction of FBS is shown in
Figure 4.3. These results are clearly contradictory to statements such as “Although the
viscosity of plasma is variable and higher than that of PBS, which could alter the diffusion
time, 1:1 or greater dilution is sufficient to normalize the viscosity to that of water” [165].
The suitability of estimations should be questioned carefully, and in case of doubt be
rechecked, before use. Assuming a viscosity of water of η(22 ◦C) = 0.955 mPa s and
η(37 ◦C) = 0.692 mPa s, a deviation of up to 13-15% is observed for 40% FBS at the corre-
sponding temperature. The impact of a crowded solution on the structure parameter was
evaluated in a study of crowded vesicle solutions by Engelke et. al [170]. The conclusions
of this paper are transferable to measurements in biofluids. The importance of control
measurements and a well-defined calibration cannot be emphasized enough for FCS
measurements in complex media [170, 171]. In an appropriate calibration measurement,
the distortion of the focal volume due to scattering is independent and can thus be
determined separately. A correct calibration can compensate for several artifacts, making
FCS measurements in complex and scattering media reliable.
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Figure 4.3: Viscosity of mixtures of PBS and FBS ranging from 0 to 100% FBS at room
temperature 22 ◦C (red circles) and body temperature 37 ◦C (blue squares). Data is the
average of at least 50 measurements. Linear fits to guide the eye. Error bars represent the
standard deviation.
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Chapter 5
Interaction of Proteins with Solid
Nanoparticles
The objective of the work described in this chapter is to gain insights into the interactions
of proteins and solid NPs from a fundamental point of view. Knowledge of these
processes is relevant for understanding how NPs interact with living organisms. As
outlined in Chapter 4, NPs acquire a biomolecular corona when they are in contact with
biological fluids. The interaction with and the uptake by cells is dominated by the corona,
for instance dictating the biocompatibility and efficacy of nanotherapeutics. In order to
be able to elucidate how the biomolecular corona affects these reactions, one has to first
understand the corona itself, in particular its kinetics, meaning the types of biomolecules
that form it, their abundance and their residence times. To this end, four representative
blood plasma proteins, that are presented in Section 4.1, and several types of NPs are
chosen. The used NPs are characterized in the following section.
5.1 Solid Nanoparticles
Many different types of nanoparticles are available to address the diverse and evolving
needs of research. Polymer, silica and further NPs are available with different surface
chemistries and in a range of sizes. A NP is defined as a particle with a spherical size
between 1 and 100 nm in diameter, in a broader definition NPs can have a size of up
to 10,000 nm. Nano-sized objects behave in a very unique fashion in many respects,
compared to their bulk form and therefore have to be characterized separately.
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5.1.1 Silica
The application of silica NPs is widely spread in all areas of industry. Silica particles are
inherently hydrophilic and negatively charged. NPs made of silica are very stable com-
pared to polymer microspheres. These NPs are available with various chemical surface
modifications that allow to tune their physico-chemical properties. Their mesoporous
structure makes them suited to load drugs into them and use them as biomedical devices
[172–174]. Silica NPs are supposed to have a large specific surface area. Small-diameter
spheres present more surface area per unit mass, while larger spheres present more
surface area per bead.
5.1.2 Polystyrene Latex
Polystyrene NPs are as widely distributed as silica. Due to their hydrophobicity, they
strongly bind hydrophobic molecules such as proteins or nucleic acids. Thus, these NP
can be easily coated with specific proteins by covalent binding, reducing the capacity
to bind biomolecules non-specifically. Polystyrene NPs are available with various sur-
face chemistries. In particular, particles with carboxyl (PSCOOH) surfaces are popular.
PSCOOH particles are negatively charged, sensitive to low concentrations and multi-
valent cations. These beads are made by the formation of many single chain polymers
which may be likened to a ball of “wool”. Thus, the determination of the surface area
is complicated and this area may be much greater that predicted. This is important for
protein binding and charge calculations.
5.1.3 Further Nanoparticles
The following particles in suspension were kindly provides from the JRC Nanomaterials
repository NanoMILE project.
Fe dex SPION
Superparamagnetic iron oxide nanoparticles (SPION) coated with dextran (Dextran-
SPION) are widely applied for clinical magnetic resonance imaging of cancer tumors and
have been utilized to detect metastases and to delineate primary tumors [175]. Moreover
Dextran-SPION have been used for imaging inflammatory components of atherosclerosis
[176]. These NPs are injected directly into circulation. Due to their common application
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in medicine, there is a need to investigate their potential hazards and nanosafety. To
determine protein corona assembly Dextran-SPION particles with a primary size of
20 nm were chosen (NanoMILE code: N4I121114b).
Titania
Titania (TiO2) is especially known for its usage in food industry, its presence in sunscreen
and its application in paint industries [177]. Is is used as a catalyst or in self-cleaning
surfaces [178]. Titania NPs are considered to be poorly soluble. NPs made out of titania
are negatively charged and have a hydrophilic surface [124]. They are considered to be
not harmful to the environment, making them a popular ”negative control” in in vitro and
in vivo experiments [179]. In the context of protein corona studies, an understanding of
how the interaction of proteins with titania particles affects the harmlessness is necessary.
Therefore, uncoated TiO2 particles with a primary size of 70 nm were chosen (NanoMILE
code: NIST-TiO2-SRM1898-240214b).
Ceria
There is a wide range of applications of ceria (CeO2) NPs. They are used as UV-absorbent,
polishing agent for silicon wafers and as a fuel additive to decrease diesel particle
emission [180, 181]. Moreover, ceria nanoparticles can store hydrogen [182]. With this
diverse applicability, the need for understanding the biocompatibility and thus for the
protein corona formation comes up. To this end, uncoated CeO2 particles with a primary
size of 33 nm were chosen (NanoMILE code: NM-212).
5.2 Understanding the Kinetics of Protein-Nanoparticle
Corona Formation
The content of the work presented in this section is the subject of publication P1 [183].
The following text and figures are adapted from this publication, with only a few editorial
changes. Theory and simulations in P1 were performed by O. Vilanova. P. M. Kelly
contributed sodium dodecyl-sulphate polacrylamide gel electrophoresis (SDS-PAGE)
and differential centrifugation sedimentation (DCS) to P1 [183]. The original article is
attached in Appendix · P1.
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5.2.1 Motivation
New types of NPs for various applications are developed every year as nanotechnology
advances. The sheer number of already existing and newly developed NPs makes it
impractical to investigate the interactions of each type of NP with biological fluids and
to test completely if they are eventually harmful to humans or nature. The interaction
of the NPs with cells is often mediated by the biomolecular corona and not directly
by physico-chemical properties of the nanomaterial itself. The underlying molecular
mechanisms that regulate corona formation and kinetics are still poorly understood.
In order to overcome this limitation, an approach that combines theory and basic ex-
periments is needed to develop mathematical models for the potential hazards caused
by nano-sized particles. With this combination the large relevant time span ranging
from 100 µs to hours can be probed either by simulations or experiment, respectively. If
there is a systematic understanding of the kinetics of protein-NP corona formation, it
might be possible to predict eventual hazards and control the NP composition based on
a hierarchy of equilibrium binding constants and some basic physical key parameters of
the nanomaterial. Here, the aim is to understand the time evolution of the composition of
the protein corona in a three-component simplified model plasma. The results of four ex-
perimental techniques, FCS, DCS, microscale thermophoresis (MST) and SDS-PAGE, are
compared to two independent theoretical approaches, molecular dynamics simulations
and non-Langmuir differential rate equation (NLDRE) theory. By using the experimental
results for single protein solutions as an input and combining two theoretical approaches,
it is possible to predict the kinetics of the protein corona.
5.2.2 Computational and Theoretical Approach
For molecular dynamics simulations, a coarse-grained model is implemented that adopts
a description within the framework of the DLVO theory to qualify the protein-NP
interaction. The theoretical approach is based on NLDREs. A combination of simulation
and analytic theory is necessary to extrapolate the numerical results to physiologically
relevant time scales (∼ 1 h). The full simulations would take much longer than those
achievable within a reasonable time. Details on the computational and theoretical
approach can be found in the attached article in Appendix · P1 and its associated
supplementary information [183].
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Figure 5.1: Experimental determination of binding affinity for silica NPs in monocompo-
nent protein solutions of HSA (red), Fib (green), or Tf (blue), as a function of the molar
concentration of proteins. For each set, the concentration at which the normalized data
has the value 0.5 corresponds to the protein dissociation constant KD = K−1 (Table 5.1).
(a) Normalized DCS apparent diameter of the NP coated by proteins with respect to the
value with no proteins. (b) Normalized MST relative fluorescence Fnorm after diffusion of
fluorescently labeled NPs under thermal gradient. In both subfigures, symbols represent
the experimental data, and lines are the best fits using the Equation 3.8. Molar concentra-
tion is expressed in M = mol l−1. Reprinted with permission from [183]. Copyright 2016
American Chemical Society.
5.2.3 Equilibrium Binding Constants in Single-Protein Solutions
Due to the essential role of the binding affinities K, respectively its inverse KD = K−1, in
the presented approach, their values are measured by two independent experimental
techniques: DCS and MST. While MST probes the interaction of proteins and NPs
directly in solution, for DCS the NPs are extracted from protein solutions after incubation
[65, 184–186]. A combination of these two approaches ensures that reliable values for
each of the proteins interacting with silica NPs are obtained. The results are shown
in Figure 5.1. The fits were performed applying the law of mass action in the limit
of low concentration of NPs ([L]tot  [R]tot) in terms of Equation 3.8. The sole free
fitting parameter is KD which marks the concentration for Y = 0.5. The values from both
techniques agree on the order of magnitude, with the following hierarchy of dissociation
constants: KFibD  KTfD < KHSAD . As shown in Table 5.1 the values for HSA coincide
within the error bars and agree with previous literature [87, 187, 188]. The results for Tf
and Fib are only of the same order of magnitude, however the MST measurements are
biased more strongly by agglomerates of NPs than the DCS measurements [189]. The KD
values are used to determine the respective DLVO’s Hamaker constants needed for the
molecular dynamic simulations (see Equation S8 of the supporting information of [183]).
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protein KDCSD [µM] K
MST
D [µM]
HSA 2.8± 0.2 2.4± 0.6
Tf 0.65± 0.08 1.8± 0.4
Fib (11± 0.2) · 10−3 (2.2± 0.9) · 10−3
Table 5.1: Dissociation constants KD determined with DCS and MST for HSA, Tf and
Fib. Adapted with permission from [183]. Copyright 2016 American Chemical Society.
5.2.4 Competitive Adsorption in Two-Component Protein Solutions
Solutions containing two of the three named proteins are considered to test the competi-
tive adsorption between different kinds of proteins. A sequential protocol in which we
introduce one type of protein at a time into the initial NP suspension, enables a better
comparison between experiments and simulations. Firstly, 100 µg/ml silica NPs are
incubated with different concentrations of HSA. After equilibration of the precoating
step, 5 µg/ml Fib are added to the solution and the adsorption kinetics of Fib onto the NP
are studied. Simulations are performed before the experiments to check the predictive
power of the approach.
Due to the hierarchy of the dissociation constants KFibD  KHSAD , Fib is expected to
displace the adsorbed HSA molecules on the surface of the NPs. As illustrated in Fig-
ure 5.2 a, the adsorption kinetics of Fib strongly depend on the initial concentration of
HSA. The rate of adsorption of Fib clearly decreases for increasing concentration of HSA
as shown by simulation. When the concentration of HSA changes from 0 to 10 mg/ml,
the adsorbed amount of Fib on the NP decreases from ' 90 % to ' 35 % after 10 seconds
of simulated time, respectively. Using the NLDRE theory to extrapolate the long-time
behavior of the system, the following is predicted: Despite the much higher affinity of
Fib to the silica surface, it would take more than 5 minutes for Fib to displace HSA and
to have more than 50 % of Fib adsorbed at 10 mg/ml HSA. Even after 30 minutes, the
adsorption of Fib is still slower relative to pristine NPs and the saturation level is reached
within the time frame of 100 minutes.
In order to validate the theoretical predictions, FCS experiments are performed following
the same protocol as mentioned above. An excellent overall agreement of experimental
results and theoretical predictions is obtained (Figure 5.2 a) and a change in the adsorp-
tion kinetics of Fib in the presence of competing proteins is verified. To further validate
the quality of the theoretical predictions, the relative mass of proteins on the NP surface
was determined using SDS-PAGE and densitometry (Figure 5.2 b). Again, the experi-
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Figure 5.2: Two-component protein solution: Competitive adsorption of Fib onto silica
NPs precoated with HSA at different concentrations. (a) Simulation results (open sym-
bols without error bars) of the fraction bound of adsorbed Fib as a function of time are
extrapolated to large time-scales, applying the NLDRE theory (lines), to enable us to
compare our predictions with experimental data from FCS (symbols with error bars).
The agreement is excellent. Concentrations are 5 µg/ml for Fib, 100 µg/ml for silica NPs,
and for the lines from top to bottom, 0.00, 0.18, 0.35, 0.70, 1.00, 3.50, 7.00, and 10.00
mg/ml for HSA. Lines and symbols with matching colors correspond to the same HSA
concentration. Inset: Schematic representation of Fib (green) displacing HSA (red) on
the NP surface (golden). (b) Relative surface mass concentration of HSA (red) and Fib
(green) after 120 min as a function of the HSA concentration in solution, as predicted
from NLDRE theory (open symbols connected by a dashed line), and compared with
data from SDS-PAGE (symbols with error bars). Reprinted with permission from [183].
Copyright 2016 American Chemical Society.
mental data follows the theoretical predictions with very good agreement, confirming the
capability of the theory to predict the outcome for binary solutions. As a final test of the
predictive power of the approach, simulations, theoretical evaluations and experiments
are repeated using Tf instead of HSA during the precoating step. Experiments and theory
match (Figure 5.3). This verifies the general applicability to other binary solutions.
5.2.5 Competitive Adsorption in Three-Component Protein Solutions
and Memory Effect
For systematic extension of the approach to more complex solutions, the same procedure
is used to study a ternary suspension of HSA, Tf and Fib. Therefore, a three steps
exposure protocol is applied:
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Figure 5.3: Competitive adsorption of Fib displacing a protein corona of Tf after incuba-
tion. a) As in Figure 5.2 but for Tf concentrations (for the lines from top to bottom) 0.00,
0.50, 1.00, 2.00, 3.00, 4.78, and 7.00 mg/ml. b) NP surface coverage of Tf from numerical
simulations (open symbols) and non-Langmuir differential rate equation (NLDRE) the-
ory (lines). Lines from bottom to top are for 0.50, 1.00, 2.00, 3.00, 4.78, and 7.00 mg/ml for
Tf. Reprinted with permission from [183]. Copyright 2016 American Chemical Society.
1. Incubation of NPs in HSA
2. Addition of Tf, competition with HSA for NP surface is expected
3. Addition of Fib, competition with both present proteins for the corona
This process is visualized in Figure 5.4 a). Two cases of equal concentrations of HSA and
Tf are considered in the following:
1. Low concentration case: 0.07 mg/ml of each protein, HSA and Tf
2. High concentration case: 3.50 mg/ml of each protein, HSA and Tf
The concentration of the silica NPs is fixed at 100 µg/ml and the one of Fib at 5 µg/ml.
Again, the single preincubation steps are run until equilibrium is reached and after
the addition of Fib simulations are performed spanning ' 0.1 min. The long-time
kinetics of Fib adsorption were extrapolated using the NLDRE theory. For the low
concentration case, saturation of Fib is predicted to be reached ≈ 10 min (Figure 5.4 b),
for the high protein case after roughly 50 min (Figure 5.4 c). FCS experiments confirm
these predictions.
Comparing the results for ternary and binary solutions for the low concentration case,
it is observed that for ternary solutions the adsorption of Fib is slightly slower than for
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Figure 5.4: Three-component protein solution: Competitive adsorption of Fib on silica
NPs precoated with HSA first and Tf next. (a) Schematic representation of the three-steps
adsorption protocol with Fib (green) displacing Tf (blue) and HSA (red) on the NP surface
(golden). (b) Normalized surface coverage of HSA (red circles) and Tf (blue squares) for
the low concentration case (both at 0.07 mg/ml), and Fib (green triangles, at 5 µg/ml)
adsorbed on 100 µg/ml silica NPs as a function of time, calculated by simulations at
short times (t ≤ 0.1 min) and extrapolated to long time (t ≥ 200 min) by the NLDRE
theory (dotted line for HSA, dot-dashed line for Tf, dashed line for Fib, and solid line
for the total surface coverage). The prediction for Fib compares well with the fraction
bound of Fib measured by FCS (symbols with error bars) for t ≤ 3 min. The two sets of
experimental data refer to (circles) first precoating with HSA and next with Tf and to
(squares) the vice versa order. The saturation value for the Fib surface coverage is reached
for t ≈ 10 min. Inset: Fraction bound of adsorbed proteins corresponding to the surface
coverage in the main panel in double-logarithmic scale. (c) Same as in (b) but for HSA
and Tf in the high concentration case (both at 3.5 µg/ml). Here, the saturation value for
the Fib surface coverage is reached for t = 50 min. Reprinted with permission from [183].
Copyright 2016 American Chemical Society.
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the binary case at a comparable total mass concentration. In the high concentration case,
such an effect was not observed. A possible interpretation is that this is a consequence
of the fact that the dissociation constants of HSA and Tf are comparable and both
significantly higher than the one of Fib. As a result, the adsorption kinetics of Fib might
be regulated only by the total mass concentration of the competing proteins. Within the
error bar of simulation and experiment, no difference in the kinetics of Fib is observed,
independent of whether NPs are incubated in the order HSA-Tf or vice versa. This
observation supports the previous interpretation. Nevertheless, the experiments show an
interesting phenomenon regarding the kinetics before the addition of Fib to the protein
solution. A dependence on the order of incubation is observed. This effect is termed
memory effect.
In order to quantify this phenomenon experimentally, two different incubation protocols
are established. In protocol A, the silica NPs are incubated in 3.5 mg/ml HSA, then Tf is
added at the same concentration for another hour. In protocol B the order of incubation
is inverted with the same concentrations and times. The NPs are separated from the
unbound proteins and their corona is analyzed using SDS-PAGE. The relative abundance
of HSA and Tf is determined (Figure 5.5). The final amount of each protein depends on
the protocol applied. In particular, the first incubated protein is always more abundant
in the corona at the end of the procedure (Figure 5.5 b). The same qualitative result is
obtained for low concentrations of proteins (0.07 mg/ml). This implies that the memory
effect does not depend strongly on the initial concentration of proteins.
Possible mechanisms that induce the memory effect for the competition of HSA and
Tf for the NP surface are discussed. For the computational model, the two different
incubation protocols give the same corona after a transient time. Hence, the appearance
of the memory effect implies that other interactions among proteins and NPs besides
those included in the model exist. Under the assumption that the adsortion of proteins
in the NP causes a change in the protein-protein interaction, a possible interpretation is
that this difference is a result of a conformational variation of protein upon adsorption.
More specifically, it is supposed that the change can be included in the model as a three-
body interaction between proteins and NPs. This hypothesis proved to be sufficient to
simulate the memory effect (Figure 5.5 c and d). As a result, the memory effect can be
interpreted as a consequence of how the adsorption on the NP affects the interaction
of the first-added protein with those adsorb at a later time, e.g., due to conformational
changes, impeding the replacement of the first by the latter proteins.
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Figure 5.5: Memory effect in experiments and simulations for the high protein concentra-
tion case (a) SDS-PAGE gel analysis after incubating the NPs in HSA and Tf, in different
orders: (from left to right, as indicated by labels) HSA alone; protocol A with HSA first
and Tf second (three different samples); Tf alone; protocol B with Tf first and HSA second
(three different samples). (b) Densitometry results for the percentage of protein corona
composition after the gel analysis with NP incubation with HSA (red) and Tf (blue)
following the same protocols as in panel a (as indicated by the labels on the bottom). The
error bars are estimated as standard deviation among the three independent samples.
Results are calculated after subtracting background noise. (c) Simulation results for the
kinetics of the competitive protein adsorption of the model with three-body interaction
between HSA, Tf, and NP: We show the relative protein adsorption on the NP of Tf
(blue) and HSA (red) following the two protocols (protocol A: circle for Tf and squares
for HSA, protocol B: triangles upward facing for Tf and triangles downward facing for
HSA), as a function of time t. In both protocols, the incubation time is 0.075 s, and the
quantities are normalized to the value of the main component at this time. (d) Relative
surface mass concentration from simulations in panel c after t = 0.3 s, to compare with
experimental results in panel b. Reprinted with permission from [183]. Copyright 2016
American Chemical Society.
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5.2.6 Conclusions
A combination of simulations and theory with limited experimental information on
single-protein solutions allowed for prediction of the composition of the corona in a
ternary protein solution. When the environment changes, evidence of memory in the
corona formation are found. The approach presented shows that it is possible to imple-
ment a concept toward the prediction of the kinetics of the corona and its composition in
complex solution changing over time. This is especially important considering NPs that
move around in the body. The key for understanding the modulation of the corona is
the presented knowledge. Tuning the protein corona in a controlled way may be used to
design specific NP properties such as better engineered drug delivery carriers.
5.3 Hierarchy of Protein Nanoparticle Binding Affinities
The content of the work presented in this section is the subject of manuscript M2. Ex-
periments presented in manuscript M2 were performed by A. Das and T. Preiß. The
following text and figures are adapted manuscript M2, with only a few editorial changes.
The original manuscript is attached in Appendix ·M2.
Differences in the interaction of proteins and NPs depend on the size, charge and stability
of the NP as well as the size and charge of the proteins. Variation in adsorption affinities
thus seems to be caused by the different protein structure and chemical nature of the
NPs, resulting in diverging surface properties and consequently a hierarchy of binding
proteins. In Section 5.2, an attempt to understand the corona composition in the presence
of multiple kinds of proteins is presented. Experiments, simulations and theory are
combined to investigate the corona kinetics of three blood plasma proteins. In this
section, the experimental studies are extended to a range of NPs of comparable sizes,
but different hydrophobicity. The protein-NP affinities in of four representative plasma
proteins and six different kinds of NPs are explored:
• SA, Tf, Fib and FN
• silica, ceria, titania, PSCOOH, PSOSO3H and Fe dex SPION.
Detailed portraits of the proteins and NPs can be found in Table 4.1 and Section 5.1,
respectively. FCS is used to systematically study the binding of all possible combinations
of the above mentioned proteins and NPs. The results are discussed in the protein-NP
5.3 Hierarchy of Protein Nanoparticle Binding Affinities 59
binding no binding aggregates
Figure 5.6: Typical evolution of the correlation curves of proteins after the addition of
NPs. The kinetics fall into one of three categories: binding (I), weak or no binding (II), or
aggregation (III).
interaction matrix. In the case of binding without aggregation, the binding curves in
terms of the fraction of protein bound, as a function of increasing molar protein/NP-
ratio, are measured. The determined binding curves ar described by the law of mass
action (Equation 3.7) allowing the determination of the adsorption area per protein. The
binding affinities were compared to the off-kinetics of the corona proteins in the presence
of competitive full serum proteins.
5.3.1 Systematic Measurement of Protein-Nanoparticle Combinations
All combinations of four representative blood proteins interacting with six kinds of NPs
are studied. The change in the correlation function of the fluorescently labeled proteins
after the addition of NPs is measured. Protein adsorption is found to fall into one of three
categories: strongly binding (I), weakly binding or non-binding (II) and aggregating (III)
(Figure 5.6).
In the first case, the amplitude of the FCS curves can increase with time, while the
characteristic times shift slightly to larger values. Here, the proteins bind strongly to
the NPs. The effective number of fluorescent objects decreases as proteins adsorb onto
the NPs, while the correlation function develops a second slower component due to
reduced diffusion of the bound proteins. Secondly, proteins may not bind to NPs or the
interaction is so weak that binding is not detectable within the scope of the presented
experiments. Here, the correlation curves do show no or little deviations from the curves
of pure protein. The third case, frequently observed, is the appearance of extremely large
amplitudes and broad tails of the correlation curves towards the longer time regime. In
addition, the fluctuations of the raw fluorescence signal show abnormally high bursts.
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Both observations indicate the presence of large aggregates of undefined size that diffuse
sparsely and irregularly through the confocal volume with slow diffusion times. The
evolution of the FCS correlation curves with time for all measured combinations of
proteins and NPs is summarized in the interaction matrix (Figure 5.7).
Typical correlation functions at various time points from 0 to 60 minutes are presented.
The observed kinetics are classified according to the criteria defined in Figure 5.7. The
matrix demonstrates that after the interaction of proteins and NPs it is not always
possible to preserve monodisperse systems. Instead, clear signatures of NP aggregation
are observed. For instance, Fib gives rise to aggregates (Figure 5.7, second column). In
contrast, bovine serum albumin (BSA) forms a stable coating on PSCOOH and PSOSO3H,
while it is weakly adsorbed on the remaining four NPs, although silica and polystyrene
particles have similar size.
5.3.2 Theoretical Model of Protein Adsorption to Nanoparticles
Based on the theory presented in Chapter 3, the limits of weak and strong binding are
discussed. The binding of protein P to nanoparticles NP is generally described as an
adsorption process in analogy to the Langmuir adsorption model for adsorbates from
liquids to a flat solid surface. In many studies, changes inferred to the NPs due to
protein adsorption are measured. For instance, the measurement of the hydrodynamic
diameter of the NP by FCS [66, 88, 190–193] or dynamic light scattering [194], or changes
induced by proteins as measured in surface plasmon resonance [195], affinity capillary
electrophoresis [196, 197] or fluorescence quenching [196, 198, 199]. In this chapter, the
notation P/NP is used. Equation 3.8 turns into
ϑ(P)NP =
[PS]
[S]
=
[P/NP]
[P/NP] + KD/NP
(5.1)
where S is the total number of available binding sites in solution, S = NP · s with s
being the number of binding sites per NP. KD/NP describes the normalized equilibirum
dissociation constant.
However, an important caveat needs to be addressed when this equation is used in
experiments, where the protein is titrated against the NP. Applying Equation 5.1, it is
assumed that the total concentration of protein added to NP solution is almost equal to
the concentration of unbound protein P. In the case of strong binding, the free proteins
are depleted, leading to strong deviations of Equation 5.1 from the non-approximated
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Fib
Figure 5.7: Matrix of FCS kinetics of all possible combinations of proteins and NPs
showing the time dependent evolution of the FCS correlation: pure protein: dotted,
5 min after NP addition: black, 10 min: orange, 20 min: light blue, 30 min: green, 45 min:
yellow, 60 min: dark blue. The data is highlighted according to the behavior: aggregation
(red), strong binding (green) and weak or no binding (white).
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law of mass action
ϑ(P)NP =
[PS]
[PS] + [Sfree]
=
([s] + [P/NP] + KD/NP)−
√
([s] + [P/NP] + KD/NP)2 − 4[s][P/NP]
2[s]
.
(5.2)
A comparison of the results for both equations is shown in Figure 5.8a). The deviations
for strong binding (KD/NP < 100) are visible. While for weak binding the Langmuir
isotherm is applicable, it is not appropriate for the determination of KD/NP in case of
strong binding and leads to significant overestimation of the binding affinity.
As mentioned in Section 3.4, the amount of free and bound protein is determined. The
concentration of the labeled protein is fixed, while the concentration of NP is varied. For
this case, Equation 3.7 can be rewritten in the P/NP notation as
Y(P/NP)p =
[PS]
[PS] + [Pfree]
=
([s] + [P/NP] + KD/NP)−
√
([s] + [P/NP] + KD/NP)2 − 4[s][P/NP]
2[P/NP]
,
(5.3)
that merges into the strong binding model of Milani et al. [21] for KD/NP 1, discussed
in Section 3.3. Equation 5.3 is theoretically evaluated for various KD/NP but fixed
concentration of binding sites per NP, s, in Figure 5.8b). The transition to the strong
binding model for decreasing KD/NP is clearly visible. In short, the strong binding
model assumes that proteins are strongly bound to NP in such a way that all proteins are
adsorbed up to the point when all binding sites available on NP are occupied by proteins.
The sharp discontinuity at this point is illustrated in Figure 5.8b) and gives the number
of available binding sites per NP.
5.3.3 Determination of Protein Adsorption Area and Binding Affinity
If the fraction bound is plotted versus P/NP, the maximum number of molecules adsorb-
ing in a monolayer per NP, i.e. the number of binding sites per NP, can be directly read
from the graph. Knowledge of the number of binding sites per NP enables estimating
the surface area available for each protein. For instance, the binding of FN to silica NPs
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Figure 5.8: Theoretical analysis of protein-NP binding curves a) Analysis of the surface
coverage of NPs. Fraction of NP coated according to the Langmuir adsorption model
(dashed) and according to the exact solution of the law of mass action shown in Equation
5.2 (solid line). Data are plotted for different KD/NP: 1 (green), 10 (blue) and 100 (orange)
b) Fraction of protein bound to NPs according to the law of mass action for the case of
strong binding (dashed lines) and for its exact solution. c) Adsorption measurements
for FN/silica and BSA/PSCOOH. Solid red lines are fits according to Equation 5.3. Fits
according to the strong binding model (Equation 3.17) are represented by the dashed
black line. The number of binding sites per NP may be read off from the position of the
kink (vertical dotted line). d) To-scale representation of the proteins BSA and FN and a
NP with a diameter of 100 nm.
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FN Tf BSA
material NP silica PSOSO3H PSCOOH
s 16 300±100∗ 200
surface area per protein [nm2] 1963 105 157
KD/NP 0.15 0.31 0.41
desorption rate koff [min−1] 2.7× 10−3 8.3× 10−3 8.8× 10−3
Table 5.2: Values determined from fitting in Figures 5.8 and 5.8c). A correlation between
the desorption rate koff and the normalized dissociation constant is KD/NP indicated.
∗ from Milani et al. [21]
and of BSA to PSCOOH NPs are analyzed in Figure 5.8 c. Both NPs have a diameter
of 100 nm. The red line is the best fit to Equation 3.7. For FN/silica s = 16 binding
sites per NP and a normalized equilibrium constant KD/NP = 0.15 is obtained, and for
BSA/PSCOOH s = 200 and KD/NP = 0.41 (Table 5.2). The average area available per
protein is 1963 nm2 for the first combination, and 157 nm2 for the second one. The results
of BSA/PSCOOH are in good agreement with former studies of Milani et al. [21]. There,
the binding of Tf to PSOSO3H NPs of the same size were evaluated. Considering that Tf
is only slightly larger than BSA, it is consistent that the available surface area per protein
is of the same order of magnitude. The data reflects the correct tendency that BSA has
a smaller adsorption area than FN in accordance with the fact that the hydrodynamic
radius is smaller by a factor of 3 compared to FN.
The results of the interaction matrix are only a first indicator of the binding behavior. In
the case of weak or no binding, a systematic screening trough a wide range of protein
and NP concentrations is necessary to obtain a meaningful representation of the fraction
bound versus P/NP. Three combinations are selected that showed no aggregation in
the interaction matrix: BSA/PSCOOH, BSA/TiO2 and BSA/CeO2. The concentration
of BSA ranges from 45 nM to 45 µM, while the NPs’ ranges from 1 µg/ml to 1 mg/ml
(Figure 5.9). In the case of binding of PSCOOH, the fraction bound is high at low
protein concentration and high NP concentration and falls off with increasing protein
and decreasing NP concentrations. For TiO2 and CeO2, only a very low fraction bound
in all measured cases is observed. These measurements confirm that in both cases
the proteins bind very weakly to NPs, which, in principle, was already shown in the
interaction matrix, but has now been confirmed over a larger range of protein and NP
concentrations.
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Figure 5.9: Fraction bound of BSA to a) PSCOOH NPs, b) TiO2 NPs and c) CeO2 NPs
from zero (blue) to 50% (red) as a function the concentration of BSA and NPs. While
PSCOOH shows relevant binding with BSA that depends on both, the concentration of
protein and NP, TiO2 and CeO2 show very little to no binding.
5.3.4 Hierarchy of Desorption Kinetics
A relation of the binding affinities to the resistance to competitive binding is probed. To
this end, NP with a layer of adsorbed labeled proteins are formed by incubation for at
least one hour. The off-kinetics are measured after the addition of competitive serum
proteins (10% FBS). The amount of free and bound protein is measured using FCS in
the time course of 1 hour. This type of experiment is performed for those combinations
that showed strong binding in the interaction matrix. The desorption kinetics follow
an exponential decay (Figure 5.10). However, the majority of protein adsorbed is not
fully removed within the time of our experiment, as indicated by considerable offsets
in the time courses. This offset may be interpreted as the hard corona that seems to
be irreversible bound to the NP on the time scale of the reversibility experiments. The
characteristic desorption rates koff is determined. The desorption rate (koff = 1/toff)
is calculated from these values. In general, the smaller proteins (BSA and Tf) are re-
placed more efficiently than larger proteins such as FN. Furthermore, the kinetics of the
protein desorption depends on the NP type. For instance, BSA shows a faster desorp-
tion rate from PSCOOH than PSOSO3H (8.8× 10−3 min−1 vs. 2.4× 10−3 min−1). Most
importantly, however, there seems to be a correlation between the desorption rate koff
and the experimentally determined normalized dissociation constant KD/NP. Knowing
that koff = KD · kon and assuming that kon is independent of protein and NP type, an
increasing off-rate with increasing values for KD/NP is expected. The values determined
66 5. Interaction of Proteins with Solid Nanoparticles
Figure 5.10: Desorption kinetics of protein coated NPs in FBS for various combinations
of proteins and NPs. The characteristic desorption rates are determined by exponential
fitting. The desorption rate koff for BSA with PSCOOH (star) is 8.8× 10−3 min−1, Tf with
PSOSO3H (diamonds) 8.3× 10−3 min−1, Tf with PSCOOH (squares) 5.6× 10−3 min−1,
FN with silica (upwards triangles) 2.7× 10−3 min−1, BSA with PSOSO3H (downwards
triangles) 2.4× 10−3 min−1 and for FN with PSCOOH (circles) 3.0× 10−4 min−1.
for BSA/PSCOOH, Tf/PSOSO3H and FN/silica are in agreement with this expectation
(Table 5.2). It is worth noting that the addition of serum to aggregates did not lead to a
desorption or redispersion of the complexes.
5.3.5 Conclusion
This study is an attempt to find a systematic behavior of the interactions of representative
blood proteins and NPs. The interactions may be classified as aggregation, strong
binding, and weak or no binding. All three classes are identified in the interaction
matrix. The data suggests that proteins that are large and act as natural coagulators,
such as Fib and FN, are more susceptible to aggregation. These proteins are likely to
shield NPs, reduce the overall charges of the NPs and promote cross-bridging between
NPs by binding to other proteins. When proteins bind to NPs without disturbing their
colloidal stability, binding isotherms in accordance with thermodynamic models of
protein adsorption are observed. The importance of usage of the full law of mass action
in the case of strong binding is stressed, since protein concentrations are readily depleted
in the presence of strongly adsorbing NPs. In case of strong binding, KD/NP, as well
as the average area occupied by the adsorbed proteins, have been determined. These
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characteristic parameters of the protein-NP interaction are meaningful values and have
predictive power. For instance, it is shown that the protein adsorption area correlates
with the hydrodynamic bulk size of the protein. The stability of the protein layers in the
presence of competing serum and the desorption kinetics are evaluated. The desorption
kinetics of proteins is directly related to the hierarchical order of KD/NP. Competitive
binding biomolecules are able to quickly detach protein layers, which are weakly bound,
whereas some proteins are strongly bound. This reinforces the hypothesis that the NPs
retain ”memory” of the strong binding proteins, which they first encounter in their
travel trough different environments, as discussed in Section 5.2. Hence, the study
of thermodynamic binding of each kind of protein allows for ranking of protein-NP
affinities and represents a step towards a better understanding of protein-NP interaction
in biological environment, for instance in serum or plasma. Systematic measurement of
protein-NP interactions will be valuable to the biomedical community but requires the
consideration of protein and NP concentrations especially in the case of strong binding.
The dissemination of tabulated protein-NP data in publicaly accessible libraries, such
as nanosafetycluster.eu, is beginning to emerge. There is hope that databases combined
with theoretical modeling tools will enable the prediction of the protein corona on NPs
and possibly first estimations on the impact of NP toxicity.
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Chapter 6
Thermosensitive Liposomes as Drug
Delivery Systems
The content of the work presented in this chapter is the subject of manuscript M3. TSLs
and fluorescence spectroscopy (FS) measurements were provided by Barbara Kneidl.
The following text and figures are adapted from the publication, with only a few editorial
changes. The original manuscript is attached in Appendix ·M3.
6.1 Motivation
A proper biophysical characterization of drug nanocarriers becomes more and more
important due to strict rules concerning approval procedures for new medication. Quan-
titative assays allow finding potential for improvement of a drug delivery system and
offer a tool for continuous validation in the development process and afterwards. In
addition, possible obstacles that can arise during in vivo testing might be discovered in
such assays beforehand.
The advantages of liposomes for drug delivery were already recognized in the 1970s
[200–202]: they are biocompatible, biodegradeable and show little or no antigenic or
allergenic activity. Many FDA-approved and therapeutically applied NP-based drug
delivery vehicles fall into this class, such as Doxil, DaunoXome or Marqibo [203–207]. In
order to allow localized therapy and thus a reduction of side-effects, a controllable drug
release mechanism is desirable. Such promising stimulus-responsive drug nanocarriers
are TSLs. The release of TSLs is triggered by an increase in the temperature in the tumor
area in response to local hyperthermia or focused high-intensity ultrasound [208–211].
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Figure 6.1: Illustration of the experimental setting and the processes studied: Release of
dye (green hexagons) from liposomes in buffer (1), in the presence of a specific plasma
protein (2, yellow spheres) and in the presence of whole plasma (3, mixed colors). The
reversible binding of selected plasma proteins to DPPG2-TSLs (4) was also studied.
The lipid composition of TSLs is designed to have a melting phase-transition temperature
(Tm) a few degrees above a chosen target temperature. At this point, the structure of the
lipid bilayer changes from a solid-gel phase to a liquid-crystalline phase. The permeabil-
ity of the membrane for the encapsulated drug increases at temperatures in the vicinity of
Tm, causing a release of the cargo by passive transfer along a concentration gradient [208].
In the following, we use TSLs composed of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC)/1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC)/1,2-dipalmitoyl-sn-glycero-
3-phosphodiglycerol (DPPG2) (50/20/30 mol/mol) as proposed by Lindner et al. [212].
The phase transition of these TSLs proceeds above mammalian body temperature, here
at Tm ∼ 43 ◦C [213, 214]. In comparison to the more generally used Lyso-PC containing
TSL formulations, this mixture proved to be more stable in serum and showed prolonged
circulation time in rodents and in cats [212, 214–216]. Therefore, DPPG2-TSLs seem well
applicable for in vivo use in clinical settings.
A profound impact on the Tm of DPPG2-TSLs and the efficiency of drug release by the
presence of plasma or serum have been noted in several studies [217, 218]. The op-
sonization and/or penetration of proteins into the lipid bilayer is assumed to destabilize
the membrane. This is usually reflected by a shift of Tm to lower values [219, 220]. In
the context of therapeutic planning and safety issues raised by uncontrolled release,
investigation of these alterations in Tm is very important for the translatability of in vitro
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studies into clinical practice. Furthermore, the development of a biomolecular corona
can affect both the circulation time of a drug nanocarrier and its final destination. In
practice, this effect equates with unwanted uptake by the liver or spleen.
Here, the impacts of plasma proteins on the Tm of DPPG2-TSLs and the temperature-
dependent release of cargo molecules are studied (Figure 6.1). A novel assay using
fluorescein di-β-D-galactopyranoside (FDG) and FCS is presented. This assay is applied
to determine the molar release ratio per TSLs in buffer, for four representative plasma
proteins and physiological fluids of different species (rat, mouse, human, cow). In an
additional set of experiments to look for a correlation of release profiles and protein
properties, the binding isotherms of the four plasma proteins to DPPG2-TSLs and their
equilibrium binding constants are measured.
6.2 Evaluation of Basic Parameters of Thermosensitive Li-
posomes
6.2.1 Characterization of Thermosensitive Liposomes
The established method to assess the response of liposome formulations to external
triggers, such as temperature or the addition of a detergent, is to measure changes in the
fluorescence intensity of released carboxyfluorescein (CF) by fluorescence spectroscopy
(FS) [221, 222]. It is assumed that the concentration of CF inside the liposome is so high
that the fluorescent molecules are self-quenched, and that they dequench only after
release from the liposome [223, 224].
For initial characterization of the TSLs, a similar liposome construct as in the standard
FS assay is used. Inside the TSLs CF is encapsulated (λex = 488 nm). The membrane is
partially labeled with rhodamine (λex = 543 nm). The two different fluorescent labels
allow characterizing the behavior of DPPG2-TSLs and the encapsulated dye in different
media. This is of importance to ensure that there is no uncontrolled release due to
changes of medium, e.g. while injection into blood stream, and in order to be able to
quantify the release with precision later on. There is a good agreement of the results of
size measurements by dynamic light scattering (DLS) and FCS in buffer (0.9% NaCl) for
TSLs with the rhodamine membrane label (Dh,DLS = 105 nm vs. Dh,FCS = 96.1± 4.1 nm).
At the same time, the concentration of TSLs in a standard sample was evaluated to be
0.28 nM using an excitation of λex = 543 nm. In contrast to DLS, FCS can be used to
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cargo 100 mM CF 1 mM FDG empty
membrane label RhPE - -
phosphate concentration [nM] 41.5 38 45
z-potential [mV] -28.5 -25.9 -30.5
DLS diameter [nm], z-average 105 114 105
PDI 0.068 0.134 0.083
FCS Dh [nm], ex. 488 nm 82.6± 5.4 - -
FCS Dh [nm], ex. 543 nm 96.1± 4.1 - -
FCS Dh [nm], ex. 488 nm in FBS 99.1± 4.1 - -
Table 6.1: Characterization of different types of DPPG2-TSLs by DLS and FCS measure-
ments. FCS data are averages (± standard deviation) of three independently prepared
samples. PDI, polydispersity index, Dh hydrodynamic diameter.
measure the size distribution of DPPG2-TSLs not only in buffer but also in complex
fluids such as FBS. FCS selectively detects the fluorescently labeled liposomes and thus
avoids interfering signals by other components of the fluid [225]. Characterization under
essentially physiological conditions is important to learn about the stability of DPPG2-
TSLs and possible obstacles to their use for drug delivery in living organsims. The size
of TSLs was determined in FBS with FCS. For FCS measurements with λex = 488 nm,
TSL with CF as a payload are used to determine the size of the liposomes. The obtained
hydrodynamic diameter (99.1± 4.1 nm) is in good agreement with the values determined
in buffer (see Table 6.1). This confirms that FBS has no significant effect on DPPG2-TSL
size.
6.2.2 FCS-based FDG assay
After characterization, the release behavior of DPPG2-TSL is studied from liposomes
filled with CF. This requires that the released substance yields a clear signal that is
not obscured by non-released substances or buffer components. The dye in the TSL
should diffuse significantly more slowly than the released dye, permitting unambiguous
discrimination between the two signals. Due to significant differences in the brightness of
a single free dye molecule relative to that of a filled TSL, precise analysis of the dynamics
of release is quite complex and does not provide single-molecule resolution. To overcome
this limitation, a novel assay to measure the release from liposomes is developed. The
underlying idea is to load into the TSL a dye that becomes fluorescent only after being
released. Here, the only signal measured in the FCS experiments is that originating from
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Figure 6.2: (a) Experimental set-up. FDG within the TSL is non-fluorescent. FDG that
was not removed during purification of TSLs is also shown (I). β-gal hydrolyzes external
FDG, generating the strongly fluorescent compound fluorescein (II), and subsequently
allows one to monitor the temperature-dependent release of FDG from TSLs (III). (b)
Count rates for scenarios I-III. In the absence of β-gal, the fluorescence is indistinguishable
from background noise (I). For II a weak signal from the FDG that was not removed
by purification is observed. For III a high signal is obtained due to the large amount of
FDG that is released at T > Tm. (c) Corresponding fluorescence correlation curves. The
correlation curve of I corresponds to background noise and is not analyzable.
the released dye (see Figure 6.2). As a result, the correlation curve is not compromised
by the presence of fluorescent TSLs. In order to achieve this improvement in signal
resolution, FCS is combined with the use of fluorescein di-β-D-galactopyranoside (FDG)
as cargo load of the TSLs.
FDG is non-fluorescent, but becomes fluorescent when cleaved by β-gal following its
release (Figure 6.3). The enzyme β-gal is membrane-impermeable. Consequently, no
fluorescence signal will be detected as long as FDG is confined within the TSL (Figure
6.2 b), I). If β-gal is added to the solution, free FDG is hydrolyzed and the resulting
fluorescence signal can be characterized using FCS. The levels of release are determined
from this measurement (Figure 6.2 b), II and III). The versatile applications and its high
sensitivity, even for concentrations in the pico- to nanomolar range, make FCS an ideal
method for characterizing TSLs, their release behavior and their interaction with proteins.
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β-galactosidase β-galactosidase
Figure 6.3: Sequential hydrolysis of non-fluorescent FDG to fluorescent fluorescein by
β-gal.
6.2.3 Encapsulation and Purification Efficiency
DPPG2-TSLs are loaded in highly concentrated FDG solution (1 mM). Subsequently, the
remaining free dye is removed by filtration. The level of fluorescent dye associated with
the purified TSLs is measured as a control. This measurement after purification yields a
weak signal. It corresponds to a concentration of 3.36 nM of non-encapsulated FDG in the
sample solution that contains 0.28 nM TSLs (Figure 6.2 II). Thus, for quantification of the
absolute release in the succeeding experiments, this offset value has to be considered for
correction. Otherwise, the magnitude of the induced release is seriously overestimated,
especially at low temperatures.
In light of these observations, the encapsulation efficiency of the DPPG2-TSLs is deter-
mined in two different ways. In both cases, the ratio of the experimental to the theoretical
value is calculated. Firstly, the common definition of the cargo/lipid ratio in terms of
molecular concentrations of each is applied. A value of 8.0± 0.7% is obtained. This value
is in good agreement with the expected encapsulation efficiency of ∼ 6.1% for DPPG2-
TSLs, according to Lindner et al. [212]. Nonetheless, this value seems surprisingly low.
For this reason, an additional comparison of the measured amount of [fluorescein]/[TSL]
to a theoretical estimate of this value is performed. Applying this definition, an encap-
sulation efficiency of 53.7± 9.4% is obtained. Intuitively, this value seems more likely.
The different definitions of the encapsulation efficiency might lead to this difference.
While the cargo/lipid ratio is appropriate for drugs that bind to the lipid membrane,
the definition of drug/TSL is more suited for cargo that remains free in solution, such
as FDG. In the supplementary data of M3, both calculations are presented in detail
(Appendix ·M3).
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Figure 6.4: Temperature-dependent release of fluorescein from FDG-loaded DPPG2-TSLs
in HBS + 1 mM MgCl2 (triangles, dashed line) and FBS (circles, line). (a) Molar ratio
of fluorescein released per DPPG2-TSL, measured using FCS. (b) Relative fluorescence
intensity compared to total release determined by fluorescence spectroscopy (FS). Lines
are sigmoidal fits.
6.3 Release from Thermosensitive Liposomes
Given that the offset concentration of FDG is known, it can be corrected with great
precision. The FDG assay enables the study of the temperature-dependent release
profiles of FDG from TSLs. DPPG2-TSLs are expected to undergo a phase transition
that disrupts the membrane integrity at temperatures around 43 ◦C. The disruption
leads to the release of the cargo inside the TSLs, here FDG. The DPPG2-TSL solution
is heated to temperatures ranging from 37-45 ◦C to actively induce release. In order to
provide constant measurement conditions, the liposome solution is then cooled down
to 4 ◦C. After this step, β-gal is added and FCS measurements are performed at room
temperature (22 ◦C). Addition of β-gal after cooling ensures that the enzyme is unable
to cross the membrane and no FDG inside the TSL is hydrolyzed. The concentration
of FDG in the surrounding medium is determined from the FCS data and is expressed
relative to the concentration of TSLs in the sample solution, i.e. as [fluorescein]/[TSL] in
the following.
6.3.1 Release in Buffer and FBS
The amounts of cargo released at various temperatures is determined with the approach.
The results are displayed in Figure 6.4 a). No release is found up to 37 ◦C, with the first
discharge of cargo being detected at 38 ◦C. The amount of FDG released then increases
with increasing temperature, yielding an S-shaped curve that reaches saturation at
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Figure 6.5: Release profile of TSL in buffer (blue) and FBS (red) determined by normal-
ization of the measured count rate (fluorescence intensity) analogous to the analysis of
FS measurements. Physically unrealistic release values above 100% are obtained using
this approach for analysis.
around 43 ◦C. As a control, the release induced by the detergent Triton is measured.
Triton completely disrupts the TSL membranes leading to the release of all encapsulated
FDG molecules. Within the margin of error, the measured value is equal to the saturation
value for the release at high temperatures. In conclusion, all FDG is released from the
DPPG2-TSL at temperatures above 43 ◦C.
The results of this novel assay are compared to conventional FS data to further validate
the performance of the FCS-based assay. The relative change in fluorescence normalized
with respect to the Triton value is shown in Figure 6.4 b). Both release profiles (Fig-
ure 6.4 a and b) follow the same trend of strongly increasing release around a critical
temperature of 40-41 ◦C, saturation at temperature about 43 ◦C, and barely detectable
release below 40 ◦C, indicating that the membrane is practically impermeable within the
last temperature range. FCS data shows the molar ratio of FDG molecules released per
TSL, while FS data show the total fluorescence intensity and hence the amount of FDG
release relative to the total release caused by membrane disintegration upon addition
of Triton. It is worth noting, that the data shown in Figure 6.4 b shifts below 0% and
exceed 100%. This is an intrinsic artifact of the FS approach, which is due to impact of
Triton on the brightness of the dye and therefore on the normalization. These values
can be reproduced when performing the same analysis as for FS, using the count rates
measured with FCS (Figure 6.5).
In FCS experiments, it is observed that the level of emission by the dye molecules is
decreased compared to a solution without Triton (see Figure S5 in Appendix · M3).
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Figure 6.6: Impact of plasma on the temperature-dependent release profile: mouse
plasma (red circles), rat plasma (green squares), human plasma (black inverted triangles),
human plasma doped with Lyso-PC (blue diamonds) and fetal bovine serum (asterisks,
gray trace). Lines are sigmoidal fits.
Due to this observation, it is assumed that methods that solely rely on the analysis
of changes in fluorescence intensity in the presence of Triton, which is often used to
determine the release behavior, are not optimally suited for highly precise measurements,
at least not for fluorescein [221, 222]. The FCS approach presented may provide a more
reliable alternative. Instead of solely depending on absolute brightness measurements,
FCS measures absolute concentrations. This is especially useful for determinations of
spurious release.
Subsequently, the temperature-dependent release profile is measured in the more physi-
ologically relevant medium FBS. Here, the release curves are similar to those in buffer,
irrespective of the measurement technique employed, proving that FBS does not influ-
ence the release behavior significantly (Figure 6.4, circles).
6.3.2 Release in Plasma of Various Species
Animal testing plays a key role in the further drug development for use in humans.
In order to identify possible obstacles before in vivo testing, repetition of the above in
situ experiments in the presence of plasma from various species is of interest. Here, the
release profiles in mouse, rat and human plasma are compared to the results obtained
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in FBS (Figure 6.6). Corresponding FS data are available in Figure S6 of the attached
manuscript M3. The same general trend is observed for FBS, human and rat plasma.
Strikingly, for mouse plasma a clear deviation from the other curves is observed. The
release profile is characterized by a significant release even at 37 ◦C. This behavior was
previously reported by Hossann et al. [214]. The increased Lyso-lipid content of mouse
plasma might be a possible cause of this difference [226, 227].
In order to check this hypothesis, human plasma is supplemented with Lyso-PC until
a level that is comparable to the one in mouse plasma is obtained. Upon addition of
Lyso-PC, a slight shift of the release curve towards lower temperatures, relative to human
plasma without Lyso-PC, is observed. Similarly, the onset of release in mouse plasma
is shifted to lower temperatures relative to plasma from other mammals. However, the
effect in mouse plasma is much more pronounced than in human plasma enriched in
Lyso-PC, indicating that Lyso-PC might contribute to this phenomenon, but does not
explain it entirely.
6.3.3 Release in Protein Solutions
Considering that plasma consists of numerous components, a multitude of molecules
or molecular interactions could conceivably contribute to the observed differences in
human and mouse plasma. In order to better understand these results, the impact of
several prominent blood proteins on the temperature-dependent release is evaluated by
using single-protein solutions as the external medium (Figure 6.7).
ApoA1 (7.1 µM), Fib (1.7 µM), SA (15.2 µM) and Tf (12.6 µM) are chosen. Detailed por-
traits of the used plasma proteins are presented in Section 4.2. Lower concentrations
of ApoA1 and Fib are used because they have been observed to bind strongly to drug
nanocarriers in other studies [91, 228, 229].
ApoA1 seems to impede the cargo release in comparison to the results in the absence
of proteins. SA and Fib cause a more pronounced release at lower temperatures than
in pure buffer. This shift of SA was described before. The partial penetration of the
adsorbed protein is assumed to affect the integrity of the lipid membrane [230–232]. The
change in the release profile that is induced by ApoA1 can be explained analogously.
ApoA1 probably acts to seal the packing defects that form in the membrane, thereby
reducing cargo release from DPPG2-TSL. Relative to cargo loss in pure buffer, Tf seems
to have only a minor influence.
In full plasma, the observed effects of the single proteins seem to largely compensate for
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Figure 6.7: Temperature-dependent molar release in the presence of specific proteins
from plasma: SA (blue diamonds), Tf (green squares), Fib (black circles) and ApoA1
(red triangles). For reference, the release profile in HBS + 1 mM MgCl2 is shown in gray
(asterisks). Lines are sigmoidal fits.
each other. They might contribute, however, to the differences observed between the
kinetics of release in plasma of different species (Figure 6.6).
6.4 Binding of Proteins to Thermosensitive Liposomes and
its Reversibility
In the next series of experiments, the binding of the four representative plasma proteins
from the previous section is evaluated: SA, Fib, ApoA1 and Tf. The question of interest
is, if there is a correlation of the release profile determined in Subsection 6.3.3 and the
binding affinities of the named proteins. The dissociation constant KD of fluorescently
labeled proteins is determined using FCS, which is especially suited to study the binding
behavior of strong binders, as shown before [21, 66, 166]. A fixed concentration of
fluorescently labeled protein is measured to determine the concentration of free proteins
in solution. Varying concentrations of unlabeled TSLs are added to the solution. After
one hour of incubation, the fraction bound of the labeled protein is measured. In
Figure 6.8 the normalized binding isotherms for various proteins to DPPG2-TSL are
shown. For analysis, Equation 3.8 is used instead of Equation 3.7, because the number of
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Figure 6.8: Normalized binding isotherms of labeled proteins to DPPG2-TSL. The con-
centration of the TSLs is titrated against a fixed concentration of labeled protein: ApoA1
(red inverted triangles), Fib (black circles), SA (blue diamonds) and Tf (green squares).
protein ApoA1 Fib SA Tf
KD [nM] 0.053± 0.004 2.951± 0.174 5.393± 0.405 9.652± 0.001
Table 6.2: Dissociation constants KD of the plasma proteins ApoA1, Fib, SA and Tf.
available ligands, i.e. binding sites on the DPPG2-TSL, is much larger than the number
of receptors, i.e. the mole fraction of the labeled protein as discussed in Section 3.4.
Table 6.2 summarizes the results of the analysis. For ApoA1 strong binding is observed.
The binding constant of ApoA1 is two orders of magnitude higher than those for the
other proteins. This strong binding might be an explanation why ApoA1 is the only
protein tested that reduced the efficiency of release (Figure 6.7). Efficient binding and
blocking of packing defects might presumably leads to a reduction in release. The other
three proteins showed weaker binding. Only SA strongly affects the release profile. It is
suggested that SA increases the permeability of the liposome bilayer, which causes an
enhanced release, while its weak binding prevents the high surface coverage that might
well reduce this effect.
In order to clarify if the proteins used in these experiments are the ones that build a part
of the protein corona on the DPPG2-TSL, and that influence the release profile in plasma
or serum, FBS is added to the protein-TSL complexes. Reversibility experiments provide
a means to do this. The kinetics of the protein detachment are monitored for one hour.
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Figure 6.9: Example kinetics for different proteins after the addition of FBS: ApoA1
(orange), Fib (red), BSA (blue) and Tf (green). The last three proteins are replaced
immediately after the addition of FBS, while the amount of adsorbed ApoA1 decreases
slowly with time. After 1 hour, all ApoA1 is replaced as well. ApoA1 is fitted with an
exponential fit.
It is observed that all four proteins come off the TSLs over the course of one hour (Figure
6.10). While SA, Fib and Tf are immediately displaced, ApoA1 is displaced slowly
(Figure 6.9). A possible explanation for this observation might be that other biomolecules
in FBS possess a much higher affinity for the liposome surface than the four tested
proteins. Thus, the molecules from FBS replace the labeled proteins bound to the surface
of the TSLs. The displacement of proteins from the DPPG2-TSL in FBS explains why their
impacts on the temperature-dependent release in the presence of FBS is not observed.
Interestingly, ApoA1 is removed slower from TSL than the other three proteins. This
could be used as a natural coating for DPPG2-TSL. For instance, higher concentrations
of ApoA1 for incubation can be applied to fully cover the surface of the liposomes. Thus,
it might be possible to increase circulation times as apolipoproteins are stated to prevent
opsonization. This is in agreement with the slow replacement which was observed in the
above reversibility experiments [227]. In addition, the selectivity of DPPG2-TSL might
be increased, leading to an improved targeting of the liposomes. Similar tests could be
performed for other substances as well.
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Figure 6.10: Normalized correlation curves of protein alone (black), protein and DPPG2-
TSL (blue) after one hour of incubation and after the addition of FBS and another hour of
incubation (red). The signal of free proteins (black) shifts towards larger diffusion times
after one hour of incubation with DPPG2-TSL (blue) and back to the starting curve, after
the addition of FBS and incubation for another hour (red). This means that the binding
of all tested proteins is reversible. (a) BSA, (b) ApoA1, (c) Fib and (d) Tf.
6.5 Conclusion
A novel and highly sensitive assay for quantification of the temperature-dependent
release of FDG-loaded TSLs based on FCS, is presented. The FCS approach is validated by
comparing the measurements of the temperature release profile of FDG-loaded DPPG2-
TSL to standard fluorescein FS studies. With regard to determining spurious release at
temperatures below Tm, the FCS-based assay proves to be superior. In order to ensure
that TSL membranes remain sealed at room temperature, the assessment of low drug
release is important. This is a prerequisite for controlling the dosage dispensed and
avoiding non-specific delivery to healthy tissue. Furthermore, the approach based on
FCS yields information on size and encapsulation efficiency, as well as interactions of
liposomes with blood plasma proteins. For the first time, the binding of selected blood
components to DPPG2-TSL and the resulting shift in the critical release temperature
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are determined. While Fib, ApoA1 and Tf bound to DPPG2-TSL did not affect the
temperature release profile, SA induced a noteworthy shift. The FCS data confirms that
the temperature of release is shifted in the presence of mouse plasma towards lower
values for Tm, but remains largely unaffected by rat and human plasma, as well as by
FBS. There seems to be no systematic correlation between the binding affinity and the
shift in the temperature of release. Nevertheless, binding of proteins to TSLs is very
probably an essential precondition for any change in the intrinsic thermal properties
upon contact with physiological fluids.
The presented approach is applicable to a broad field of possible interactions of lipo-
somes with their environment. In the context of medical use of TSLs, for instance, such
interactions can be specific proteolytic plasma cascades. The design of alternative mem-
brane coatings based on combinations of plasma proteins will be facilitated by a better
understanding of protein adsorption onto and desorption from TSLs and drug-delivery
nanocarriers in general. Such synthetic coronas are biocompatible, and could possibly
prevent further opsonization and increase the circulation time. To this end, quantita-
tive biophysical assays for multiple protein-membrane interaction parameters will be
instrumental for the realization of improved targeting strategies.
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Chapter 7
Protein Self-assembly in Health and
Disease
The content of this chapter is the subject of the publications P4 [49], M5 and P6 [233]. The
following text and figures are adapted from these publications, with only a few editorial
changes.
7.1 Background on Self-assembly
Self-assembly of proteins is relevant in terms of fundamental research in Biophysics,
Biology, Pharmacology and Medicine. This process is often mentioned in the context of
neurodegenerative diseases such as Parkinson’s, Alzheimer’s or Huntington’s Disease.
A hallmark of these afflictions is the appearance of protein deposits, so-called plaques
in the brain. The protein that is the major building block of these deposits is charac-
teristic for the particular disease. For instance, aggregates of α-syn are associated with
Parkinson’s Disease [235], Aβ with Alzheimer’s Disease (AD) [236] and polyglutamine
with Huntington’s Disease [237]. Although the proteins show no common features in
their sequences length or native structure, the morphologies of their amyloid fibrils are
remarkably similar [238, 239]. Understanding the underlying biophysical and molecular
mechanisms in detail is key to the development of effective treatment. Self-assembly
leads to the co-existence and interaction of several subspecies of different size and charge
that have to be considered when proposing a mechanistic model. Namely, these highly
heterogeneous species are monomers, oligomers, protofibrils and fibrils (Figure 7.1). At
present, there is growing evidence that oligomers are the most toxic subspecies assumed
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Figure 7.1: a) Characteristic curve of the macroscopic process during amyloid fibrillation.
The aggregation process is typically divided into a lag phase (I), a growth or elongation
phase (II) and a final plateau (III). b) Nucleated self-assembly process of amyloid ag-
gregation. The formation of fibrils proceeds through a multistage process. Monomers
(1) form low molecular weight aggregates (2), then higher molecular weight aggregates
(3) in the nucleation phase, which has a characteristic lag time before the formation of
protofibrils (4) and fibrils (5) dominates the kinetics. A secondary nucleation process
leading to the formation of larger subspecies via fibril-catalyzed reactions has also been
suggested (not shown) [234]. The final step is the deposit of plaques on neurons, the
pathological hallmark of the mentioned amyloid diseases.
to be responsible for neuronal injury, although the specific forms that cause damage in
vivo have not been identified yet [141, 144, 240]. It is hypothesized that a common path-
way of agglomeration for all amyloidogenic proteins exists. Although several models
are under discussion, they all have a common major feature on the macroscopic level
and only differ in issues considering the microscopic level (Figure 7.1) [239, 241]. The
known starting material in the process of protein agglomeration is the monomer. The
following step is already under discussion, however. It is not clear, whether the protein
starts the aggregation process in its native form or not. A nonspecific conformational
change of the monomeric protein, often termed “misfolding”, might take place. This
process, and the involved change of properties of the protein, might be the initial step
that give the monomer a higher propensity to aggregate [242, 243]. The transition from
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the monomeric state to small oligomers is assumed to be the critical step in many models.
Oligomers are suspected to act as nuclei of fibrillation. They consist of 3-50 monomers
and are often metastable. Early forms such as trimers, tetramers and octamers are also
termed oligomers [141]. Compared to the rod-like shape of larger assemblies, they are
often called spherical. Another class of intermediates in the process of self-assembly are
protofibrils. These precursors of amyloid fibrils are flexible rod-like structures with a
high β-sheet content. The final product of aggregation are fibrils with a highly ordered
cross-β structure [238]. They are expected to be in a dynamic equilibrium with low-order
oligomers and monomers. Fibrils are composed of several protofibrils which are twisted
around each other to form a left-handed double helix [244]. They further grow from their
ends by addition of monomers. Plaques are not considered in kinetic models although
they are used as pathological markers for disease. They are composed of insoluble amy-
loid fibrils. For many amyloidogenic proteins, no correlation between their appearance
and neurotoxicity has been found [234]. On the contrary, plaques remove and inactivate
smaller, toxic aggregates by binding them [141].
The kinetics of the nucleated self-assembly reaction display a sigmoidal behavior on
the macroscopic scale consisting of three phases (Figure 7.1 a) [138, 245]. A lag phase (I)
is followed by a steep increase during the elongation or growth phase (II) ending in
a final plateau (III). The elongation phase is short compared to the lag phase. This
rapid process is followed by a saturation phase, where the aggregation curve plateaus
[138, 141, 246]. No single microscopic process can be ascribed to a single phase, since
the law of mass action does not allow a discontinuity in the reaction rates [247, 248].
Every process takes place at every phase, sometimes more pronounced, sometimes less.
During the growth phase, the overall conversion rate of peptides and proteins into
amyloids is greatest. An equilibrium of monomers and other species is reached in the
final plateau. The largest uncertainties concern the processes in the lag phase. There
is growing evidence that the lag phase is not solely a waiting time for the occurrence
of nuclei. A collective waiting behavior of millions of nuclei is not in agreement with
the law of mass action and may be possible only for single-molecule reactions [239].
Instead, multiple reactions proceed in parallel. The dominating processes are assumed
to be the growth and proliferation of millions of initially formed primary nuclei. The
formation of such primary nuclei is termed primary nucleation. This is in agreement
with the simplified nucleation-dependent polymerization model for amyloid aggregation
[138, 141, 245, 246]. More recent results indicate the presence of secondary nucleation
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processes which appear more frequently in the growth phase [249, 250]. A catalytic effect
of the surface of fibrils was observed for Aβ and α-syn [234, 240, 251]. The breakage of
fibrils might speed up the process of fibrillation by providing additional free fibrils ends
available for monomers to bind to.
The lag time can be shortened in experiments by seeding with preformed nuclei that fas-
ten the aggregation process [138]. The current knowledge on amyloidogenic aggregation
is still rather limited. The existence of distinct, parallel aggregation pathways depending
on the surrounding conditions cannot be excluded [141]. The lack of a definite model
proves that it is challenging to study protein aggregates and their kinetics because classi-
cal biophysical techniques, such as scattering, spectroscopic and calorimetric methods,
are not well adapted for their study [233]. In particular, the concentrations of inter-
mediate species are challenging to measure. Therefore, new experimental approaches
are needed to overcome the limitations of the established techniques. In the following,
two approaches to accomplish this, based on FCS and thermophoresis, respectively, are
presented.
7.2 Quantification of Amyloid β1−42 Fibrillogenesis Using
FCS
The content of this chapter is the subject of publications P4 [49] and M5. The following
text and figures are adapted from the publications, with only a few editorial changes.
The original publication and manuscript are attached in Appendix · P4 and M5.
Small aggregates (oligomers) of Aβ are suspected to cause the neuronal injury leading
to Alzheimer’s Disease (AD). In this work, the aggregation process, especially the
development of oligomers in the subcritical concentration regime is studied by FCS.
The experimental approach and pitfalls as well as analytical obstacles of peptide self-
assembly are discussed in manuscript M5 in detail (Appendix ·M5). Usage of FCS for
the study of self-assembly needs careful and consistent sample preparation to ensure that
the fitting methods produce results based on robust data. In the attached manuscript, the
procedure for performing the measurements and the options for analysis are described
in a general fashion.
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7.2.1 Aggregation of Aβ1−42 in sodium phosphate buffer
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Figure 7.2: Normalized average correlation curves over 48 h for a sample containing
20 µM Aβ1−42 (0.01% labeled). Over the course of the experiment the curves shift to the
right and a buckling develops, suggesting an increase in the number of various species
and particle sizes. Reprinted from [49] with permission from Elsevier.
The aggregation of Aβ1−42 is studied at 10 and 20 µM in the presence of 0.01% labeled
Aβ1−42 in sodium phosphate buffer by FCS. Differences in the time before onset of
oligomer formation may depend on preparation conditions, and/or additional stresses
applied to the sample to speed up this process [141, 252–255]. Consistent preparation
methods are used to minimize these effects. Measurements are taken systematically
over 48 h. The evolution of an autocorrelation function over the time course of a typical
experiment is shown in Figure 7.2. The development of the exemplary sample suggests
that species of higher molecular weight appear over several hours, as indicated by a shift
in the delay time to higher values.
7.2.2 Comparison of MEMFCS and GDM fitting
A one-component fit works only for the first few time points. Thereafter, it leads to
unsatisfactory and physically unrealistic results. Thus, a more sophisticated approach
for fitting is needed.
The established maximum entropy method for FCS data analysis (MEMFCS) is utilized
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Figure 7.3: Size distribution determined with a) MEMFCS and b) 5GDM. Both fitting
approaches provide similar trends, but the GDM fitting gives sharper and defined peaks,
especially in the range of low molecular weight oligomers. Measurements taken at 0,
5, 16, 20, 40 and 48 h. c-e) Direct comparison of the results of MEMFCS (dashed) and
5GDM (solid line) for c) 0 h, d) 20 h and e) 48 h. Both fitting methods provide consistent
results. Reprinted from [49] with permission from Elsevier.
to analyze the correlation curves at various time points throughout the experiment
(Figure 7.3 a) [39, 256]. Analyzing the first measurement reveals a single peak with a
hydrodynamic radius (Rh) maximum at 1.44 nm and a shoulder towards larger hydro-
dynamic radii. At the end of the experiment, three peaks are present, corresponding to
the following spherical hydrodynamic radii: 2.09 nm, 101.17 nm and 4.5 µm. The broad
peaks obtained with MEMFCS are likely to include size distribution data for several
different species in solution (see Section 2.2.5).
Size distribution curves resulting from MEMFCS show Gaussian-type distribution char-
acteristics. Thus, the experimental data was fit with a Gaussian distribution model (GDM)
with a fixed number of peaks. This approach was inspired by initial work by Pal. et al.,
who used this concept as an alternative to MEMFCS for microemulsion droplets [47].
The underlying idea is that a species is not monodisperse with a single value for its
size or diffusion time τD, but rather a Gaussian distribution on a logarithmic time-scale
with peak diffusion times τP. The work of Pal et al. is extended to using more than one
single peak and to varying further fitting parameters. The fraction of each component
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is determined using Equation 2.32. More details on the theoretical background are pre-
sented in Section 2.2.5. The validity of the GDM is verified by extensive testing of the
well characterized dye Alexa488. Here, using one Gaussian peak worked successfully,
while a higher number of distributions is rejected by the fitting algorithm correctly. For
the analysis of Aβ aggregation the usage of five peaks for the GDM analysis is chosen.
This choice is a good balance between distinguishing the various species in solution
(monomer, small oligomer, larger oligomer, protofibril and firbril) and not having so
many free parameters that the outcome of the fits is physically unrealistic. Consistent
results are obtained for the analysis of many curves using this approach. An inappro-
priate description of the system is observed for the usage of less than five peaks. In this
case, the algorithm leads to results such as component sizes smaller than monomeric Aβ
together with very large particles at early time points. The results of the analysis with
the 5GDM are presented in more detail in Figure 7.4.
Compared to MEMFCS, there is a larger number of more sharply defined peaks repre-
senting different levels of Aβ1−42 aggregation. At early time points of the experiment,
5GDM fitting gives two peaks at 1.17 nm and 1.62 nm. If a weighted sum of these first
two peaks is calculated using the relative amplitudes, a Rh of 1.44 nm is obtained. This
value corresponds exactly to the one for the first peak determined with MEMFCS fitting.
A direct comparison of the results of both fitting methods for selected time points (0,
20 and 40 h) is shown in Figures 7.3. 5GDM and MEMFCS are in good agreement and
show the same trends for all three time points. However, significant differences for
the determined size of the fibrils are observed at later times (48 h): Rh = 4.5 µm for
MEMFCS versus Rh = 0.85 µm for GDM. These particle sizes are beyond the reasonable
measurable range for FCS, and the values must be artifacts of the fitting procedure in
both approaches.
7.2.3 Evaluation of the Four Fractions of Aβ1−42 Aggregates
5GDM reveals a larger number of components within the system than MEMFCS, but
each of these species represents a range of particle sizes. It is impossible to analyze
the first two peaks separately, since they fuse and separate several times during the
experiment (Figure 7.3 d and e). Thus, the percentages of these two peaks are pooled
and treated as one. Consequently, a four level fraction model for Aβ1−42 aggregation
is obtained, although a five peak fitting algorithm is applied. An explanation for the
fusion of the first two peaks might be a dynamic equilibrium that is assumed between
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Figure 7.4: Development of the fractions of the four aggregate levels of Aβ1−42 in sodium
phosphate buffer, dashed lines represent 10 µM samples, solid lines represent 20 µM
samples. The fractions were determined using 5GDM analysis. The proportion of small
components/monomers (blue) decreases over time, while the amount of protofibrils
(orange) and fibrils (red) increases after a certain lag time (16 h). The fraction of high
molecular weight oligomers stays constant (green). The experiments are performed in
triplicate to ensure reproducibility. Adapted from [49] with permission from Elsevier.
monomers and small oligomers [257, 258]. The following size ranges are defined based
on the fitting:
1. small components including monomers and oligomers with low molecular weight
2. oligomers with higher molecular weight
3. protofibrils
4. fibrils
5GDM fitting and Equation 2.32 are used to determine the fractions of the various Aβ
species in solution. The averaged values of the development of the fractions with time
are shown in Figure 7.4. In the lower concentration samples the rate of aggregation is
slower, which is consistent with previous experiments [259]. After 48 h, the proportion
of monomers and small oligomers (fraction 1) is higher in the lower concentration
sample: 72.4% for 10 µM versus 64.9% for 20 µM. The proportion of the fibrils behaves
accordingly. For 10 µM, 3.6% are obtained, as opposed to 7.5% fibrils for 20 µM. The
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amount of fraction 1 decreases as fibrillation proceeds, while the Rh of this component is
fairly stable. Taken together, these results indicate a real decrease of the proportion of
monomers/small oligomers in solution. The evolution of the first two peaks, which are
summarized as fraction 1, is shown in Figure S1 of Publictaion P4 (Appendix · P4). Only
some data points lie in the monomer range between 0.8 and 1 nm, and most of the data
points lie between 1 and 2 nm [139]. This size range represents mixtures of monomers
and small oligomers. For this reason, 5GDM is not able to differentiate between these
two species reliably and hence these components are pooled in fraction 1. Nonetheless, a
clear difference between fraction 1 and larger aggregates is determined. At the initial
stage of the experiment, small components are the dominant species (Figure 7.4). The
mixture of monomers and small oligomers are part of the starting material. Purely
monomeric samples do not aggregate on a reasonable experimental time scale [139]. The
proportion of high molecular weight oligomers (fraction 2) stays constant throughout the
experiment (14% for 10 µM and 19% for 20 µM). The Rh increases slowly in size for this
fraction, and is in the range of 10 nm. Due to these observations, it is assumed that an
equilibrium between small components (fraction 1) and larger oligomers is established
before the first measurement. At the beginning of the experiment, neither protofibrils
nor fibrils are present in FCS data, but they appear after a lag time. This observation is
consistent with a nucleation-dependent polymerization model [138]. Both species show
a sigmoidal behavior with a mean lag time of∼ 16 h. A saturation level of 10% for 20 µM
and 8% for 10 µM, is reached for the proportion of the protofibrils, while the amount of
fibrils continues to increase until the end of the experiment. Fibril formation is confirmed
additionally by transmission electron micrography (see Figure S3 of Publication P4). The
presence of fibrils is consistent with 5GDM analysis and the size values obtained for
fibrils are in agreement with published studies [244, 246, 260].
7.2.4 Preliminary Experiments in Artificial CSF
In order to change over to physiological conditions, experiments are repeated in artificial
CSF, which is a special buffer that mimics natural CSF. Immediately after mixing stock
Aβ with this buffer, large sedimenting particles are observed. During the following FCS
measurement, this manifests as decreasing number of particles because of the loss of
material to the large precipitating aggregates. The remaining monomers are now at a
much lower concentration. Since their concentration is now below the concentration
needed for the onset of fibrillation, no higher order oligomers are formed. The higher
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ionic strength of artificial CSF accelerates the kinetics for Aβ1−42 in the µM range [141].
An attempt to find a regime in which a broader distribution of particles sizes by an
incremental decrease of the concentration of Aβ to the nM range failed. Similar results
are obtained for adding labeled Aβ to pre-aggregated samples in artificial CSF. In
these experiments, only single events in the count rate plots are observed, but these
bursts correspond to fibrils rather than to oligomers. A systematic evaluation is not
performed because these single events do not meet the requirements of the statistical
basis needed for quantitative FCS analysis. These results are consistent with Nag et al.
[139]. They suggested that Aβ1−42 aggregation depends on physiological factors at low
concentrations of Aβ1−42. Furthermore, aggregates are expected to dissociate below a
certain critical concentration because they are thermodynamically unstable. However,
beyond the limitation of this special experimental system, there are no technical barriers
to applying FCS and 5GDM analysis in artificial or real CSF or other complex biological
fluids.
7.2.5 Conclusion
A novel fitting algorithm for FCS data capable of discriminating several different sized
components in solution simultaneously, has been developed. The fibrillation of Aβ1−42
was studied and four aggregates types were identified in solution: small components
(including monomer and low molecular weight oligomers), high molecular weight
oligomers, protofibrils and fibrils. Over 48 h, each component is observed for a range
of protein concentrations. Clearly, the general features of the aggregating system are
consistent using both methods, but the 5GDM provides a more detailed and potentially
more realistic description of the aggregating system with a better resolution of the species
with low molecular weight than MEMFCS. The presented analysis method may also be
useful for monitoring the aggregation of other proteins or characterizing systems with a
size distribution such as NPs and colloids [16].
7.3 Quantitative Study of α-synuclein Aggregates
In this chapter, FCS is used as a complementary technique in the context of thermophore-
sis of complex polymers and of advanced theoretical modeling of microscale ther-
mophoresis (MST) with quantitative predictions for the protein α-synuclein (α-syn).
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Thermophoresis, atomic force microscopy (AFM) and free flow electrophoresis exper-
iments in P6 were performed by M. Wolff and A. K. Buell [233]. The original article is
attached in Appendix · P6. The following text and figures are adapted from the publica-
tion P6, with only a few editorial changes within the framework of Creative Common
License 4.0.
Although MST is an emerging technique with high potential in the field of quantification
of binding of proteins in their native environment, the thermophoresis of such complex
systems is not entirely understood yet. There is still a lack of a theory that allows the
prediction of the value of the Soret coefficient ST of any protein under a given set of
conditions. The issue of quantitative measurements of thermophoresis of proteins or
protein assemblies has only been investigated by a few studies so far [261, 262]. The
presented approach includes a precise control of sample preparation, independent and
quantitative determination of size, electrophoretic and thermophoretic mobility, as well
as theoretical modeling. In short, the Soret coefficient ST of polymers is assumed to be a
combination of three main contributions:
ST = SCMT + S
EL
T︸ ︷︷ ︸
charge−dependent
+SNIT . (7.1)
For charged biopolymers, the capacitor effect (SCMT ) and the Seebeck effect (S
EL
T ) are of
importance. At present, the nonionic contribution (SNIT ) cannot be modeled completely.
Likely, surface properties of the macromolecule undergoing thermophoresis are involved
in this contribution, such as hydrophobicity [74]. The complete thermophoretic model is
discussed in detail in publication P6 and its attached supplement [233].
7.3.1 Results
In order to examine the importance of electrostatic effects in protein thermophoresis, FCS
and free flow electrophoresis are used together with thermophoretical measurements
of the Soret coefficient of α-syn. The properties of α-syn are studied in its monomeric,
oligomeric and fibrillar form. A minimally invasive labeling strategy was applied, in
which only a few protein molecules are labeled within each aggregate. The diffusion
constant and the hydrodynamic size of the various forms were determined with FCS
(Figure 7.5 and Table 7.1). AFM is used as an additional control technique for the size
96 7. Protein Self-assembly in Health and Disease
1.0
0.8
0.6
0.4
0.2
0.0
N
or
m
al
iz
ed
 C
or
re
la
tio
n 
G
(τ
)
10
1
10
2
10
3
10
4
10
5
10
6
delay time τ [µs]
 Monomer
 Oligomer
 Fibrils
Figure 7.5: Normalized autocorrelation curves of monomeric (blue), oligomeric (green)
and fibrillar (red) α-syn. Accurate determination of the diffusion constant and the
(effective) hydrodynamic radii of the different species is possible using FCS and the
Stokes-Einstein equation (Equation 2.35). The shift of the curves to the right towards
longer diffusion times is an indicator for an increase in size. Reprinted with permission
from [233].
form D spherical el. mob. charge charge [-e]
[µm2 s−1] Rh [nm] [µm s−1 V−1 cm−1] [-e] (thermophoresis)
monomer 82± 3.4 2.8± 0.1 −2.06± 0.11 -10.9 -6.6
oligomer 35± 3.4 7.5± 0.7 −3.09± 0.46 -50.4 -22.1
fibril 4.1± 0.4 - −2.91± 0.02 -(200-300) -78
Table 7.1: Results of FCS and microfluidic free flow electrophoresis measurements. The
data is averages of several independent experiments.
values. Microfluidic free flow electrophoresis enables the independent determination of
electrophoretic mobility and an estimation of the effective charge [263].
Figure 7.5 clearly demonstrates the difference in the diffusive behavior of the different
forms of α-syn. A shift to longer diffusion times with increasing size and molecular
weight of the complex is observed. The hydrodynamic radii of the monomeric and
the oligomeric form almost differ by a factor of three, while the values for the charges
determined by free flow electrophoresis only differ by a factor of five, even though a
typical oligomer is built by 30 monomers (Figure 7.6) [264]. For fibrils, a radius of 4 nm
and an average length of 200 nm was obtained by AFM. The charge increases 20- to
30-fold compared to the monomer.
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Figure 7.6: Charges determined with various approaches for different subspecies
of α-syn. Inset: The diffusion properties of fluorescently labeled monomeric (red),
oligomeric (green) and fibrillar (blue) α-syn, determined with FCS, in dependence on the
free flow electrophoretic mobilities. Reprinted with permission from [233].
Knowledge of the electrostatic properties and the size of proteins may be used to predict
the Soret coefficient. It is demonstrated that the current model describes the change of ST
caused by a change of the ionic environment. ST depends on the salt concentration of the
surrounding medium. The Soret coefficients were determined for all three species using
thermophoresis. The Soret coefficient of different species of α-syn varies mainly due to
their dependence on their size and charge. The values of the charges obtained by best fit
of the thermophoretic model are in a plausible range, as shown in Table 7.1. Nevertheless,
the charges determined by the complementary techniques free flow electrophoresis and
thermophoresis vary significantly. This deviation might be caused by models that are
still too simplified, uncertainties in ST of salts or still additional unknown factors of the
Soret coefficient.
In order to test if the change in thermophoretic behavior of fibrils in the presence of
additional unlabeled monomeric α-syn is caused by an increase in size due to monomer
incorporation, α-syn fibrils are measured with FCS before and after incubation with addi-
tional unlabeled monomers at 70◦C. The structural rearrangements and/or desolvation
that are required for this reaction are greatly accelerated by the increase in tempera-
ture [251, 265]. The increase in size of the fibrils is clearly visible in the corresponding
correlation curves determined by FCS (Figure 7.7).
98 7. Protein Self-assembly in Health and Disease
1.0
0.8
0.6
0.4
0.2
0.0
N
or
m
al
iz
ed
 C
or
re
la
tio
n 
G
(τ
)
10
1
10
2
10
3
10
4
10
5
10
6
delay time τ [µs]
 Fibrils before incubation
 Fibrils after incubation
Figure 7.7: Normalized autocorrelation curves of fibrillar α-syn before and after incuba-
tion with 70 µM unlabeled monomeric protein at 70◦C. The shift to the right towards
longer diffusion times indicates an increase in size. The diffusion constant changes from
3.8± 0.2 · 10−12m2 s−1 to 2.4± 0.2 · 10−12m2 s−1. Adapted with permission from [233].
Additionally, FCS is used to measure the longtime stability of purified oligomers. A
sample of oligomers is measured continuously for more than 60 h at room temperature
(Figure 7.8). Only a very slight trend towards growing sizes is observed. This finding
validates that oligomers are thermodynamically highly stable and display negligible
kinetics of dissociation over days.
The established general principles regarding the thermophoresis of protein aggregates
are applied for two exemplary binding studies to test the concept for ligand screening.
Firstly, the interaction with a single domain nanobody is investigated. Secondly, the
binding of the small biomolecule epigallocatechin gallate is studied. Both substances are
potential drug candidates that are supposed to influence α-syn upon binding, so their
binding affinities are determined. Details on these projects are shown in the attached
publication P6 [233].
7.3.2 Conclusion
In the attached publication P6, a quantitative description of the thermophoretic behavior
of different forms of the complex protein α-syn is provided. The determined Soret
coefficients are in good agreement with the theoretical model based on charge effects.
This is key towards a quantitative understanding of the thermophoresis of charged
proteins in their various forms. Herein, electrostatic effects and the size of proteins play an
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Figure 7.8: Time resolved size measurement of labeled α-syn oligomers over more than
60 h obtained with FCS at room temperature. The data is a confirmation of the high
structural stability of these types of aggregates. Reprinted with permission from [233].
important role. For instance, oligomeric and fibrillar α-syn show similar electrophoretic
properties, but very different thermophoretic ones. Complementary techniques such as
FCS and AFM are relevant to promote new promising technological developments such
as MST and to make progress in the corresponding theoretical model as demonstrated
in this study. The approach presented may be applied to similar proteins, such as Aβ,
to screen for new drugs. The low sample volume requirements and the rapidity of
each measurement offer a potential for high throughput screening for diagnostics or
theoretical development.
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Chapter 8
Conclusion and Future Prospects
In the presented work, biophysical questions considering binding interactions with a
background in pharmacology and medicine are addressed. Here, FCS proved to be a
versatile method for the investigation of interactions of proteins and drug nanocarriers,
the impact of the adsorbed proteins on the release and protein self-assembly.
The binding of proteins to solid NPs and liposomes was evaluated. An excellent agree-
ment of the evolution of the protein corona on silica NP in experiments and the pre-
dictions by simulations and non-Langmuir differential rate equation (NLDRE) theory
in a three-component model plasma were obtained. The combined simulation-theory
approach uses only information determined from easily performable single protein-
NP experiments. Evidence of “memory” in the evolution of the protein corona was
found upon changes in the molecular composition of the environment, which confirms
the assumption that the initial corona is not completely exchanged upon transition of
biological compartments. This effect would have significant implications for medical
applications and warrants further investigation. Building on this, a systematic study of
single protein-NP interactions was performed using representative proteins and NPs.
For strong binders, equilibrium binding constants and the average area occupied by a
single protein were determined. Desorption rates of proteins from NPs were measured
in the presence of FBS and linked to the hierarchical order of the protein-NP affinity.
All of this is key for comprehension of the modulation of the corona and its natural
development inside the body. In the end, this allows understanding where a NP might
end up and which proteins influence this location. Tuning the protein corona in a
controlled way may be used to design specific NP properties and thus control the fate
of NP in mammalian bodies. In this way, more advanced drug delivery carriers can be
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created by stable binding of target molecules, such as Tf or ApoA1, on the NP surface.
Hazardous NPs might be coated, so that they are eliminated quickly from the human
body and cause less damage. Given the prominence of NPs already present in products
of our every day life, such as in food, sunscreen and cosmetics, and any of a multitude
of promising future uses of NPs yet to be discovered, knowledge and control of such
coatings would be invaluable.
The discussed future prospects can be assigned equally well to TSLs, which are con-
ceptualized for therapeutic application. The stability of TSLs was shown in different
media. A novel assay based on FDG as a cargo load and FCS to determine the release
from liposomes with high precision was established. To clarify whether the presence of
proteins alters the behavior upon intentional release, the temperature-dependent release
profiles of TSLs were measured in buffer, serum or plasma from different species, as well
as in single-protein solutions. A correlation between the release behavior and the binding
affinities of the four selected proteins was not observed. The FCS data confirmed a shift
towards lower values of Tm in the presence of mouse plasma. Evaluation of such in
situ information is important to avoid obstacles and serious misinterpretation of results
during in vivo animal testing. The presented approach is applicable to a broad field of
possible interactions of all kinds of liposomes with their environment. TSLs themselves
offer the chance to become a valuable tool in controlled drug delivery. When filled with
a contrast agent, TSLs can be used together with magnetic resonance imaging for guided
drug delivery, allowing online monitoring of the release and hence controlling of the
released drug concentrations. This would be a unique characteristic of the combination
of TSLs and magnetic resonance imaging guided drug delivery in medicine.
The problematic of amyloidogenic proteins such as α-syn and Aβ is both an interesting
biophysical question with a wide impact as well as an inspiration to the development
of novel approaches and existing methods. In this thesis, the self-assembly of Aβ, with
focus on the toxic intermediate species was studied. To this end, an alternative algorithm
to MEMFCS for the analysis of polydisperse samples was successfully implemented: the
GDM. A protocol for the evaluation of self-assembling proteins for FCS was established.
In the context of α-syn studies, FCS served as a complementary technique to take ther-
mophoresis to the next level. Together, both methods hold the potential to contribute a
little bit to understanding the biophysical mechanisms of self-assembly and in both cases
the non-invasiveness of FCS and MST is crucial in order to measure processes that would
easily be disturbed by changes to the environment. Potential therapeutical candidates
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Figure 8.1: PIE-FCCS. a) Crosstalk of two dyes. The emission spectra of the blue and the
red dye overlap. Spectrum of blue dye shown in green, of red dye shown in orange. The
signal tail of the blue dye, distorts the real signal of the red dye. b) The excitation lasers
are interleaved in a way that the fluorescence emission caused by one pulse is finished,
before the next light pulse arrives. An unambiguous assignment of excitation pulse and
emission is possible, allowing elimination of the spectral crosstalk. For instance, the
crosstalk in the red detection channel caused by excitation is shown in gray. This signal
can be excluded from further analysis.
could be screened by FCS or thermophoresis, and any change in the behavior of the
self-assembly of Aβ, α-syn or other amyloidogenic proteins would be instantly visible in
vitro. This could help reduce the need for animal testing and at the same time identify
promising drugs that should be studied as to their in vivo applicability.
Although conventional FCS proved useful in these studies, it faces some limitations. For
instance, the FCS-approach works well in case of strong binding, but comes to its limits
for weak interactions such as the ones shown in the interaction matrix in Section 5.3. FCS
measurements, as presented in this work, rely on a size/mass difference of the binding
partners. Interactions of receptor-ligand combinations that possess similar hydrodynamic
sizes are difficult to detect in this setting. Such processes include the binding of proteins
to nanoparticles with a size of only 10− 20 nm, but also protein-protein interactions
during early self-assembly.
In order to overcome limitations of standard FCS to study binding interactions, further
developments of FCS may be applied: pulsed-interleaved excitation (PIE)-fluorescence
cross correlation spectroscopy (FCCS). PIE-FCCS was introduced in 2005 to extend the
capabilities of FCS and FCCS [266].
For cross correlation, multiple excitation sources are used to excite differently fluores-
cently labeled ligand and receptor. Thus, the two particle types can be separated by the
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color of the emitted light and the simultaneous appearance (colocalization) of both colors,
and therefore the presence of both molecules, is an indicator for binding. The cross
correlation of both is a measure of the fraction of built complexes. A disadvantage of
using a conventional FCCS set-up with continuous laser is spectral crosstalk (Figure 8.1
a). For instance, photons which are are detected in the red channel after blue excitation
are either emitted from a blue fluorophore or red fluorophore which is directly excited
by the blue light. This effect then leads to an increased amplitude in the cross correla-
tion, overestimating the intensity of binding. One way to overcome this limitation is to
interleave the excitation sources, as in PIE, allowing the detected fluorescene emission
to be assigned to the light pulse that generated it (Figure 8.1 b, gray). In PIE, this is put
into practice by alternating the different light sources with sufficient delay so that all
emitted photons from one laser pulse are detected before the next pulse of a different
color arrives. In this way, the signals are not only separated spectrally but also temporally.
Only photons in the blue channel are correlated after a blue excitation pulse and photons
in the red channel only after red excitation. In this way, spectral crosstalk as mentioned
above, and thus biased interaction activities, are eliminated and the contrast in the longer
wavelength channel can be increased (Figure 8.1 b) [267].
PIE-FCCS enables measuring of weak interactions with high sensitivity that are not acces-
sible to conventional FCS. This approach might be a useful extension for more detailed
studies of the memory effect, the hierarchy of protein-NP interactions or the protein-TSL
binding discussed in Chapters 5 and 6, respectively. Additionally, this technique provides
a means to characterize interactions of receptor-ligand combinations that possess similar
hydrodynamic sizes, leading to only a small change in the diffusion properties upon
binding. In particular, this is useful to consider interactions of proteins with each other
such as SA and Tf, but it also enables studying the first steps of protein self-assembly
with a higher resolution. This way, a better understanding of the nucleation processes of
amyloidogenic proteins might be obtainable, helping in pharmacological development.
Given the immense stability of the fibrillar proteins resulting from these self-assembly
processes in amyloidogenic diseases, there is also great interest in understanding and
being able to replicate these processes to build other fibril materials. Already hybrid
membranes of β-lactoglobulin amyloid fibrils and activated carbon are used to remove
heavy metal and radioactive waste from water [26]. Of course, in order to truly be able
to control these self-assembly processes, knowledge and understanding of the initial
nucleation steps, that cannot be resolved by conventional FCS, are extremely crucial.
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PIE-FCCS should be capable of sheeding a light onto these processes and thus enlarge
our understanding and reproduction capabilities thereof.
Taken together, these findings will contribute to a better understanding of biophysical
binding interactions and consequently will contribute to better engineered drug deliv-
ery vehicles made from solid NPs or liposomes. The presented platform technologies
have the potential for further development and might contribute to the combat of amy-
loidogenic diseases by providing a means to efficiently screen for novel medication.
Research nowadays is becoming increasingly interdisciplinary, and thus it should come
as no surprise that physics, in the form of FCS and sophisticated evaluation algorithms,
can add a valuable contribution to things that in the past would have been considered
purely medical questions, and might have been impossible or at least significantly more
challenging to answer.
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ABSTRACT: When a pristine nanoparticle (NP) encoun-
ters a biological fluid, biomolecules spontaneously form
adsorption layers around the NP, called “protein corona”.
The corona composition depends on the time-dependent
environmental conditions and determines the NP’s fate
within living organisms. Understanding how the corona
evolves is fundamental in nanotoxicology as well as medical
applications. However, the process of corona formation is
challenging due to the large number of molecules involved
and to the large span of relevant time scales ranging from
100 μs, hard to probe in experiments, to hours, out of reach
of all-atoms simulations. Here we combine experiments,
simulations, and theory to study (i) the corona kinetics
(over 10−3−103 s) and (ii) its final composition for silica NPs in a model plasma made of three blood proteins (human
serum albumin, transferrin, and fibrinogen). When computer simulations are calibrated by experimental protein−NP
binding affinities measured in single-protein solutions, the theoretical model correctly reproduces competitive protein
replacement as proven by independent experiments. When we change the order of administration of the three proteins, we
observe a memory effect in the final corona composition that we can explain within our model. Our combined experimental
and computational approach is a step toward the development of systematic prediction and control of protein−NP corona
composition based on a hierarchy of equilibrium protein binding constants.
KEYWORDS: protein−nanoparticle interactions, competitive protein adsorption, protein corona, FCS, DCS, SDS-PAGE,
microscale thermophoresis, molecular simulation
The interaction of NPs with biological media is key inthe transport of NPs across the cell membrane. WhenNPs are exposed to fluids that contain proteins and
other biomolecules, part of those biomolecules are immediately
adsorbed forming the so-called “protein corona”. This corona is
believed to depend on the different biological environments
crossed by the NP as well as on the current surroundings.1,2
Therefore, layers of adsorbed proteins that are formed while the
NPs move from a biological milieu to another evolve as the
concentration of protein and the media composition change.3
Nowadays it is generally accepted that part of the proteins in
the corona can remain for a relevant time on the NP surface
(hard corona),4 possibly preventing the adsorption of other
molecules. Other proteins, instead, dynamically exchange with
those in solution (soft corona).5,6 Nevertheless, our knowledge
about the dynamic exchange of the corona in response to
changes in the composition of the milieu is still very limited.
Due to the relevant role that the evolution of the corona plays
in the way that NPs interact with biological systems, e.g., in
their targeting of specific cellular receptors,7 it is crucial for any
possible biological application8 to understand how the
processes of protein adsorption and exchange occur in the
corona.9 Hence, there is a need for an accurate modeling of the
kinetics of the protein corona in order to decipher the
biological identity of the NPs.
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Coarse-grained (CG) molecular simulations have proven to
be a powerful tool for the study of NPs interacting with
biological systems at the macromolecular scale.10,11 Recently
Vilaseca et al. developed a computational approach to simulate
the adsorption of proteins on flat surfaces.12 These theoretical
results suggest that the corona composition, after exposure to a
multicomponent system, undergoes a relaxation scenario. In
particular, fast-diffusing but weakly adsorbing proteins reach the
surface first, but are replaced by strong-binding proteins next.
The mechanism of formation of the corona of the NP can be
separated into two main stages: (i) the bare NP enters the
biological environment and comes in contact with biomolecules
that first adsorb forming the initial corona; and (ii) the corona
composition starts to evolve due to competition between
proteins. An atomistic description of such a complex
mechanism of formation and evolution of the protein corona
is at the moment computationally unfeasible and, more
importantly, avoidable. Here we show that by combining
experiments, computer simulations, and theory, we are able to
develop an approach that allows us to predict the corona
composition in a variety of cases. We present results for a three-
component model plasma, and we describe how the approach
can be extended in a systematic way to more complex protein
solutions.
We consider a solution composed of different combinations
of the following representative blood plasma proteins: human
serum albumin (HSA), transferrin (Tf), and human fibrinogen
(Fib). These proteins are very numerous in plasma and are
present in the corona of silica (SiO2) NPs.
13 HSA is the most
abundant protein in plasma, representing almost 55% of its
composition.14 It is a globular protein, with a small mass of
67 kDa, that regulates the osmotic pressure of plasma. Tf has a
concentration in plasma of 3 mg/mL, with a mass of about
80 kDa. This protein transports iron through the body and
maintains the iron homeostasis. Fib is a rod-like protein with a
large mass of 340 kDa and has a key role in coagulation. Its
concentration in plasma varies from 1.7 to 4.5 mg/mL.
We measure the affinity of each protein for the silica NPs
using two independent approaches, namely differential
centrifugal sedimentation (DCS) and microscale thermopho-
resis (MST). While the DCS characterization9,15−17 is
performed by extracting the NPs from the solution, with
MST we probe the interactions of NPs with proteins directly in
solution. Using a combination of these two experimental
techniques, we obtain reliable binding constants for each of the
individual proteins interacting with silica NPs. Next, we use the
measured NP affinitiesand other known parametersof the
proteins to define a CG model that includes protein−NP and
protein−protein interactions, up to three-body contributions.
Yet the model is simple enough to allow us to perform
molecular dynamics (MD) simulations for NPs in binary and
ternary protein solutions up to 10 s. This time scale is out of
reach of atomistic simulations and approaches the lower limit of
the experimental time resolution. However, the relevant time
scale for the experiments and the biological applications is as
long as hours. Therefore, we develop an original theoretical
approach, based on the non-Langmuir differential rate equation
(NLDRE), to extrapolate the adsorption kinetics over hours.
We test our theoretical predictions about the adsorption
kinetics by using fluorescence correlation spectroscopy (FCS).
With this technique, we label one protein species at a time and
follow its binding on NPs precoated with other proteins. This
allows us to monitor the adsorption kinetics and the
displacement from a precoated corona by competitive binding.
Finally, we verify our theoretical predictions about the relative
composition of the hard corona using sodium dodecyl-sulfate
polyacrylamide gel electrophoresis (SDS-PAGE).
RESULTS AND DISCUSSION
Binding Affinities Measurements in Single-Protein
Solutions. We prepare solutions of HSA, Tf, and Fib with
silica NPs and measure by DCS the change in the
sedimentation time with respect to conditions with no proteins
(eq 3 and Figure 1a). By MST, we measure the normalized
relative fluorescence Fnorm of fluorescently labeled NPs in a
monocomponent protein solution under a thermal gradient (eq
4 and Figure 1b). We fit both quantities (Figure 1) with the law
of mass action, eq S1 in Supporting Information (SI), in the
limit of low NP concentration, whose solution Γeq is the
normalized surface coverage, as a function of the protein
concentration CP:
Γ =
+
C
C
K C
( )eq P
P
D P (1)
where KD for each of the three proteins separately (Table 1) is
the only fitting parameter of the experimental data and marks
the concentration at which Γeq = 0.5. The estimates from the
two techniques agree in order of magnitude, with KD
Fib ≪KDTf <
KD
HSA. Hence we establish a hierachy of the tendency to absorb
on the NP surface, that for Fib is much larger than for Tf and
for Tf larger than for HSA.
Figure 1. Experimental characterization of NPs in monocomponent protein solutions of HSA, Fib, or Tf, as a function of protein molar
concentration along binding isotherms. For each set, the concentration at which the normalized data has the value 0.5 corresponds to the
protein binding affinity KD (Table 1). (a) Normalized DCS apparent diameter, eq 3, of the NP coated by proteins with respect to the value
with no proteins. (b) Normalized MST relative fluorescence Fnorm, eq 4, after diffusion of fluorescently labeled NPs under thermal gradient. In
both panels, symbols are the experimental data, and lines are the best fits with eq 1. Molar concentration is expressed in M = mol/L.
ACS Nano Article
DOI: 10.1021/acsnano.6b04858
ACS Nano XXXX, XXX, XXX−XXX
B
The CG Model. Our goal is to unveil the molecular
mechanisms that regulate the corona formation, and
simulations are potentially helpful to this aim. However, a
direct comparison with experiments is unfeasible with all-atoms
simulations. Hence, we resort to a model where we coarse-grain
many degrees of freedom, and in this way, we step up the size
and duration of our MD simulations, approaching the
experimental scale.
In our CG approach, we introduce effective potentials for
protein−NP and protein−protein (two-body and three-body
interactions) with implicit solvent. For the protein−NP
effective interaction, we adopt a description within the
framework of the well-established DLVO theory for colloidal
dispersions (Figure 2a and eq S8 in SI).18,19
For the two-body protein−protein effective interaction, we
follow Vilaseca et al.12 and consider an interaction potential that
encodes two different conformations for each protein (eq S9 in
SI and Figure 2b). This model, adopted to describe the
competition among proteins near a surface, compares well with
the experimental data without preassumptions about the
adsorption mechanisms or the adsorption rates.
At high concentrations of protein, we introduce a three-body
correction to the protein−protein interactions. We find that
this term is essential to get simulation results consistent with
the experimental data. This effective three-body interaction (eq
S10 in SI) is due to correlations between pairs of proteins near
the surface of the NP and could arise from conformational
changes of surface-adsorbed proteins.
The model’s parameters (Tables 2 and S1 in SI) are all
known but the DLVO’s Hamaker constant AH in eq S8 in SI.
We estimate AH (Figure S3 in SI) based on our knowledge of
the binding affinities KD
Fib, KD
Tf, and KD
HSA given by the eq 1
derived from the fit of the experimental data.
Competitive Protein Adsorption in Two-Component
Protein Solutions. In order to test the competitive adsorption
between different kinds of proteins, we consider solutions
containing two among the three proteins, HSA, Tf, and Fib. To
allow a better comparison between simulations and experi-
ments, we follow a sequential protocol in which we introduce
one kind of protein at a time into the initial NP suspension.
First, we perform simulations of silica NPs suspensions, at a
concentration of 100 μg/mL, with HSA at different
concentrations, chosen within the range of accessible
experimental values. After equilibrating the precoating, we
add to the solution Fib at 5 μg/mL concentration and study the
adsorption kinetics of Fib (Figure 3).
Because KD
Fib ≪ KDHSA, we expect that Fib would displace the
adsorbed HSA proteins. However, we find a strong dependence
of the Fib adsorption kinetics on the concentration of HSA.
Table 1. Binding Affinity KD ≡ koff/kon Determined With
DCS (center column) and MST (right column) for the
Three Proteins Used in This Worka
protein KD [μM] (DCS) KD [μM] (MST)
HSA 2.8 ± 0.2 2.4 ± 0.6
Tf 0.65 ± 0.08 1.8 ± 0.4
Fib (11 ± 2) × 10−3 (2.2 ± 0.9) × 10−3
aThe values for HSA coincide within the error bars and are consistent
with previous literature.24−26 Those for Tf and Fib agree only in order
of magnitude, however the MST measurements are possibly biased by
agglomerates of NPs27 and are based on less data and with larger noise
(Figure 1) than the DCS measures. KD is expressed in μM = 10
−6 M.
Figure 2. Schematic representation of the CG model. (a) The protein−NP interaction potential (continuous line, eq S8 in SI) as a function of
the distance between the surface of the silica NP (sketched as a portion of a large sphere on the left) and the center of the protein (red line for
HSA, blue for Tf, and green for Fib). For sake of clarity, in the panel we sketch only the HSA as an ellipsoid (on the right). (b) The protein−
protein interaction potential (continuous line, eq S9 in SI) as a function of the distance between the centers of two HSA proteins. The dashed
horizontal line marks the characteristic interaction energy ε. Inset: sketch of two possible HSA conformations defining the characteristic
distances Rh and RS (both marked by dashed vertical lines in the main panel). (c) Snapshot of the simulation box showing the NP (golden
sphere in the center) suspended in the protein solution (small spheres). The highlighted red zone corresponds to the buffer region, which we
use to maintain the protein concentration constant as in the experimental setup.
Table 2. Parameters for the CG Model of Proteinsa
HSA Tf Fib
Rh [nm] 2.7
28 3.7216 8.529
RS [nm] 3.6
30 3.725 11.030,31
ε [kBT] 2
12 212 212
M [kDa] 67 80 340
ϕ [mV] −1532 −1033,34 −2031
AH [kBT] 9.75 8.4 7
Nmax 550 450 120
aRh and RS are the two characteristic length-scales of a protein in each
conformation: Rh is obtained from the maximum surface concentration
of each protein, and RS is the hydrodynamic radius. ε is the repulsion
energy between two adsorbed proteins at the shorter diameter distance
in eq S9 in SI. M is the mass of the protein (as specified by Sigma-
Aldrich), ϕ is the zeta-potential in PBS, AH is the Hamaker constant,
calibrated as explained in the text, for the DLVO interaction potential
with silica NP in eq S8 in SI. Nmax is the maximum number of
adsorbed molecules forming a full monolayer on the NP, as computed
by simulations. We indicate the adopted units near the parameters and
the used references, if applicable, near their values.
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The simulations clearly show that the rate of adsorption of Fib
decreases for increasing concentration of HSA in solution. In
particular, after 10 s of simulated time, we find that the Fib
adsorbed on the NP decreases from ≃90% to ≃35% when the
HSA concentration changes from 0 to 10 mg/mL, respectively.
To better understand this effect with the numerical approach,
simulations much longer than those achievable within a
reasonable time would be necessary. However, we develop an
analytic theory that allows us to extrapolate our numerical
results to physiologically relevant time scales (∼1 h). Our
NLDRE theory is based on the law of mass action and differs
from the standard Langmuir theory of adsorption because we
do not assume constant adsorption rates. The essential
parameters of our theory are the binding affinities and the
adsorption/desorption rates of the molecules, that we assume
to be dependent on each protein surface coverage and the
concentration of NPs and proteins. As explained in SI, these
parameters can be fitted from adsorption data at an early stage.
We use the NLDRE theory to extrapolate the long-time
behavior of the system (Figure 3) and predict that at the
highest HSA concentration (10 mg/mL), it would take more
than 5 min for Fib to displace HSA and to have more than 50%
Figure 3. Two-component protein solution: Competitive adsorption of Fib on silica NPs precoated with HSA at different concentrations. (a)
Simulation results (open symbols without error bars) of the fraction bound of adsorbed Fib as a function of time are extrapolated to large
time-scales, using the NLDRE theory (lines), to allow us to compare our predictions with our experimental data (symbols with error bars).
The agreement is excellent. Concentrations are 5 μg/mL for Fib, 100 μg/mL for silica NPs, and for the lines from top to bottom, 0.00, 0.18,
0.35, 0.70, 1.00, 3.50, 7.00, and 10.00 mg/mL for HSA. Lines and symbols with matching colors correspond to the same HSA concentration.
Inset: Schematic representation of Fib (green) displacing HSA (red) on the NP surface (golden). (b) Relative surface mass concentration of
HSA (red) and Fib (green) after 120 min as a function of the HSA concentration in solution, as predicted from NLDRE theory (open symbols
connected by a dashed line), and compared with data from SDS-PAGE (symbols with error bars).
Figure 4. Three-component protein solution: Competitive adsorption of Fib on silica NPs precoated with HSA first and Tf next for 2 h. (a)
Schematic representation of the three-steps adsorption protocol with Fib (green) displacing Tf (blue) and HSA (red) on the NP surface
(golden). (b) Normalized surface coverage, eq 1, of HSA (red circles, at concentration 0.07 mg/mL), TF (blue squares, at 0.07 mg/mL), and
Fib (green triangles, at 5 μg/mL) adsorbed on 100 μg/mL silica NPs as a function of time, calculated by simulations at short times (t ≤ 0.1
min, Figure S6 in SI) and extrapolated to long time (t ≥ 200 min) by the NLDRE theory (dotted line for HSA, dot-dashed line for Tf, dashed
line for Fib, and solid line for the total surface coverage). In simulations we precoat the NPs first with HSA, until equilibrium, and next with
Tf, until equilibrium, before adding Fib at t = 0. The prediction for Fib compares well with the fraction bound of Fib measured by FCS
(symbols with error bars) for t ≥ 3 min. The two sets of experimental data refer to (circles) first precoating with HSA for 1 h and next with Tf
for 2 h and to (squares) first Tf (1 h) and next HSA (2 h). The saturation value for the Fib surface coverage is reached for t ≈ 10 min. Inset:
Fraction bound, eq 6, of adsorbed proteins corresponding to the surface coverage in the main panel in double-logarithmic scale. (c) Same as
in panel b but for HSA and Tf at 3.5 mg/mL concentrations. In this case, the saturation value for the Fib surface coverage is reached for t ≃ 50
min.
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of Fib adsorbed, despite the much higher tendency of Fib to
adsorb on the NP surface. Our theory predicts that after
30 min, the Fib adsorption kinetics on NPs precoated with
HSA at 10 mg/mL concentration is still relatively slower
compared to pristine NPs (Figure 3) and that the saturation
level is reached within the time frame of 100 min (Figure 3b).
In order to test our theoretical predictions, we perform
experiments following the same protocol as in the simulations,
i.e., adding Fib at 5 μg/mL concentration to silica NPs (at
100 μg/mL) precoated with HSA at different concentrations.
We study the adsorption kinetics by estimating the Fib fraction
bound with FCS. The faction bound is defined in eq 6. We
verify that the Fib adsorption kinetics change due to the
presence of competing proteins on the corona with an overall
excellent agreement with our theoretical predictions (Figure
3a).
We repeat the experiment with different HSA incubation
times, remove the adsorbed proteins from the NP surface,
separate them using SDS-PAGE technique (Figure S4 in SI),
and finally estimate the relative mass of each protein on the NP
surface by densitometry (Figure 3b). We find that the
experimental data follow our theory with very good agreement,
confirming the predictive capability of the theory for binary
solutions.
Furthermore, we test that the theory can be applied to other
binary solutions. In particular, we repeat simulations, theoretical
calculations, and experiments using Tf instead of HSA during
the precoating step and then adding Fib in solution. Again, we
find that our theory for binary solutions, based on short-time
simulations, allows us to make predictions about the adsorption
kinetics in excellent agreement with the experiments (Figure S5
in SI).
Competitive Protein Adsorption in Three-Component
Protein Solutions. To verify if our approach can be extended
in a systematic way to more complex protein solutions, we
apply the same procedure to a ternary suspension with HSA,
Tf, and Fib. In this case, we follow a three steps exposure
protocol: (i) we first incubate NPs in HSA, (ii) we add Tf in
solution expecting competition with HSA for the NP surface,
and (iii) we finally add Fib that will compete with both Tf and
HSA for the corona (Figure 4a).
As for the binary solution, we run short-time simulations for
a selected number of cases. Specifically, we consider equal
concentrations for HSA and Tf. We first simulate the
precoating of silica NPs (at 100 μg/mL) with HSA at
0.07 mg/mL until the system is equilibrated. Then we run
the simulation adding Tf (at 0.07 mg/mL) until a stable corona
of HSA and Tf is formed. Then we add Fib (at 5 μg/mL) and
perform a simulation for ≃0.1 min. Finally, we calculate the
long-time behavior of the Fib adsorption using our NLDRE
theory. We predict that the corona kinetics reaches the
saturation of Fib in ≈10 min (Figure 4b).
Figure 5. Memory effect in experiments and simulations when we invert the NP incubation order of HSA and Tf both at 3.5 mg/mL
concentration. (a) SDS-PAGE gel analysis after incubating the NP in HSA and Tf, in different orders: (from left to right, as indicated by
labels) HSA alone; protocol A with HSA first and Tf second (three different samples); Tf alone; protocol B with Tf first and HSA second
(three different samples). (b) Densitometry results for the percent of protein corona composition after the gel analysis with NP incubation
with HSA (red) and Tf (blue) following the same protocols as in panel a (as indicated by the labels on the bottom). The error bars are
estimated as statistical deviation among the three independent samples in panel a. Results are calculated after subtracting background noise.
(c) Simulation results for the kinetics of the competitive protein adsorption of the model with three-body interaction between HSA, Tf, and
NP (eq S10 in SI): We show the relative protein adsorption on the NP of Tf (blue) and HSA (red), both at 3.5 mg/mL concentration,
following the two protocols (protocol A: circle for Tf and squares for HSA, protocol B: triangles up for Tf and triangles down for HSA), as a
function of time t. In both protocols, the incubation time is tinc = 0.075 s, and the quantities are normalized to the value of the main
component at tinc. (d) Relative surface mass concentration from simulations in panel c after t = 0.3 s, to compare with experimental results in
panel b.
ACS Nano Article
DOI: 10.1021/acsnano.6b04858
ACS Nano XXXX, XXX, XXX−XXX
E
As in the case of the two-component solution, we test the
theoretical prediction by FCS experiments. In particular, we
measure the Fib fraction bound after incubating the NPs for 1 h
with HSA and, later, for another hour with Tf, both at 0.07
mg/mL concentration (Figure 4a). The comparison of the
experimental data with the theoretical prediction is, also for this
ternary solution, very good (Figure 4b).
We find a similar good agreement between the experiments
(Figure 4c) and the theoretical predictions when we consider
the case of NPs sequentially precoated with HSA and Tf at
higher concentrations (3.5 mg/mL each). In this case the
theory predicts a large slowing down of the protein corona
kinetics with respect to the case at lower HSA and Tf
concentration, with a saturation of Fib only after ≈50 min
(Figure 4c). Experiments confirm this prediction.
We observe that the competition with HSA and Tf makes the
Fib adsorption slightly slower than the competition with solely
HSA at a comparable total mass concentration. For example,
for HSA and Tf at 0.07 mg/mL, the time needed for reaching
50% of Fib fraction bound is t ≃ 0.2 min (Figure 4b), while for
HSA at 0.18 mg/mL, it is t ≃ 0.1 min (Figure 3). However, the
time difference between the two cases is negligible when we
compare the Fib adsorption kinetics for HSA and Tf at 3.5
mg/mL (Figure 4c) and for HSA at 7.0 mg/mL (Figure 3).
This could be interpreted as a consequence of the fact that the
binding affinities of HSA and Tf are comparable and both much
higher than that of Fib, hence the Fib kinetics is regulated only
by the total mass concentration of the competing proteins.
Furthermore, we find, both in simulations and experiments,
that within the error bar, there is no difference in Fib kinetics if
we incubate first with HSA and then add Tf or vice versa
(Figure S7 in SI). However, our experiments show that the
kinetics before the addition of Fib displays a memory effect if we
change the incubation order, as we discuss in the next section.
Memory Effects in Competitive Protein Adsorption of
HSA and Tf. After a preliminary screening showing differences
in the kinetics when we invert the incubation sequence of HSA
and Tf, we investigate experimentally the memory effect
considering two different incubation protocols. In protocol A,
we first incubate the silica NP for 1 h with HSA at 3.5 mg/mL,
then we add Tf at the same concentration (3.5 mg/mL) for
another hour. In protocol B, we invert the order of incubation,
first Tf and next HSA, with the same concentrations and times.
After each protocol, we wash the NP to remove unbound
proteins, and next we remove the attached proteins and
electrophoretically separate them inside a gel matrix (SDS-
PAGE gel analysis, Figure 5a). Finally, after visualization, we
quantify the relative abundance of each protein.
We find that the final amount of each protein depends on the
protocol. Specifically, the first incubated protein is always more
abundant in the corona at the end of the process (Figure 5b).
We repeat the experiments for HSA and Tf at smaller
concentration, 0.07 mg/mL (Figure S8 in SI), and find the
same qualitative result, suggesting that the memory effect does
not depend strongly on the initial protein concentrations. On
the other hand, by adding Fib after each incubation protocol,
we do not find any strong effect on the Fib adsorption (Figure
S7 in SI), i.e., the memory effect occurs in our samples before
the addition of Fib.
Based on these experimental evidence, we focus on
investigating the possible mechanism causing the memory
effect for the competitive adsorption between HSA and Tf. In
particular, we compare the experiments with the results from
our computational model. We observe that for the model
defined by eqs S8 and S9 in SI, the two different incubation
protocols lead to the same corona after a transient time (Figure
S9 in SI). Therefore, the memory effect implies the existence of
other interactions among proteins and NP beside those
described by eqs S8 and S9 in SI. Hence we hypothesize that
the protein adsorption on the NP induces a change in the
protein−protein interaction. This change can be interpreted as
a consequence of a protein conformational variation upon
adsorption. Specifically, we assume that the change can be
modeled by a three-body interaction between the proteins and
the NP (eq S10 in SI).
We find that our hypothesis is sufficient to simulate the
memory effect (Figure 5c,d). Hence the memory effect can be
interpreted as a consequence of how the adsorption on the NP
changes the interaction of the first-incubated protein with those
adsorbed at a later time, e.g., due to conformational variations,
hampering the replacement of the first by the latter proteins.
CONCLUSIONS
We study by experiments, simulations and theory the kinetics
of the protein corona forming on 100 nm silica NPs suspended
in a ternary solution made of HSA, Tf, and Fib. With the goal
of developing a predictive computational model based on a
limited knowledge of the protein−NP interactions, we first
evaluate the NP binding affinities of each of these three
proteins in monocomponent solutions by DCS and MST. We
use the estimates of KD
Fib ≪KDTf < KDHSA as parameters in a CG
model for the protein−NP interactions and perform ≈10 s
numerical simulations of the model for the competitive protein
adsorption on silica NP in binary solutions. To extrapolate the
Fib kinetics at physiologically relevant time scales (∼1 h) and
compare with FCS and SDS-PAGE techniques, we develop a
NLDRE theory predicting a strong slowing down of Fib
adsorption on HSA-precoated NPs compared to pristine NPs.
While pristine NPs are covered with more than 50% of the Fib
in solution within seconds, it takes more than 5 min when the
NPs has been incubated with HSA at 10 mg/mL concentration.
All our results show that the Fib kinetics slows down when the
NPs are incubated with a higher HSA concentration. Therefore,
the kinetic slowdown would become even more relevant for
HSA concentrations as high as in human plasma (from 35 to 50
mg/mL). The analysis of the Fib adsorption kinetics on NPs
after Tf incubation shows a similar slowdown and a similar
good agreement between our theoretical predictions and the
experiments. We expect a stronger kinetic effect when the
competing proteins have similar affinities. For example, our
preliminary results for Fibrinogen competing with Fibronectin
show a kinetic effect lasting for tens of hours, a time-scale
relevant for the evolution of the protein corona in NP uptake
scenarios.
To test further the predictive power of our computational
model, we perform ≈10 s numerical simulations of a three step
exposure protocol, first incubating the NPs with HSA, then
with Tf, and finally adding Fib. Next we extrapolate the results
up to hours with the NLDRE theory. For this ternary solution,
we predict a Fib adsorption kinetics that slows down with the
total mass concentration of the two competing proteins in a
fashion comparable to the case of the binary solutions. We
understand this similarity as a consequence of the fact that both
HSA and Tf have a binding affinity orders of magnitude higher
than KD
Fib. In this sense the relevant parameter determining the
Fib adsorption slowdown is the total mass concentration of the
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competing proteins and not their relative amount. Also in this
case, we test the theoretical predictions by comparing with FCS
and SDS-PAGE techniques, and we find a very good agreement
for the Fib kinetics, independent of the incubation order.
Nevertheless, a detailed experimental analysis of the kinetics
before the addition of Fib shows a memory effect when we
invert the order of precoating between HSA and Tf. The
protein incubated first is always more abundant in the final
corona. We realize that for reproducing this experimental
feature, it is sufficient to add to our computational model a
three-body interaction among the proteins and the NP. This
additional term mimics the effect that the protein adsorption on
the NP has on the protein−protein interaction. We interpret
this mechanism as a consequence of possible irreversible
degeneration of proteins at the NP surface.
In conclusion, by combining simulations and theory with
limited experimental information on single-protein solutions,
we are able to predict the protein corona composition in a
ternary solution. We find evidence of memory in the corona
formation when the environment changes, and we propose a
mechanism that can account for this effect. Our results show
that it is possible to develop an approach toward the prediction
of the protein corona kinetics and composition in complex
milieus that are changing with time. This is particularly relevant
in those cases, e.g., in which a NP is traveling through the body.
This knowledge is key for understanding how to modulate the
protein corona. As a matter of fact, tuning the protein corona
could be exploited to design specific NP properties. It can help
to better engineer drug delivery carriers or a generation of
biocomplexes for nanotheranostics. It may allow the develop-
ment of patient-optimized NPs, making use of the fact that the
protein corona will change when the NP is incubated in blood
plasma extracted from patients with different diseases.
MATERIALS AND METHODS
Experimental Approach. Silica NPs (nominal diameter 100 nm)
were purchased from Polysciences Inc. (cat no. 24041). FITC-labeled
silica NPs were purchased from Kisker Biotech (cat no. PSi-G0.1).
NPs were characterized by DLS to determine their size (Figure S10 in
SI) and z-potential before use. Proteins (Fib, Tf, BSA) labeled with
Alexa488 were purchased from Invitrogen (Life Technology) and
treated as recommended from the supplier. Unlabeled Fib, holo-Tf,
and HSA were purchased from Sigma-Aldrich.
Differential Centrifugation Sedimentation. DCS measures the
sedimentation time of objects. It is then possible to calculate their
diameter by assuming a value of the density of these objects (eq 2).15
When proteins or other molecules bind to the surface of NPs, they not
only change their overall size but also the net density of the object.
This causes a change in the sedimentation properties of the NP. It is
convenient, from an experimental perspective, to assume a density of
the core material and observe the change in apparent diameter as a
function of protein concentration. The term apparent diameter is used
as the size reported does not reflect the true size of the NP−protein
complex, but it actually reflects the combination of changes in both the
size and density which occur after the formation of the protein corona.
The diameter is computed as
η
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where D is the particle diameter (cm), η is the fluid viscosity (poise), r0
and rf are the initial and the final radius of rotation (cm), ρNP is the
particle density (g/mL), ρf is the fluid density (g/mL), ω is the
rotational velocity (rad/s), and tS is the time required to sediment
from r0 to rf (s).
Prior to DCS analysis, silica NPs were incubated in different
concentrations of single protein solutions for 1 h at room temperature.
After this, the solution was injected neat into the spinning DCS disk.
The particles then sediment through a sucrose gradient at 30 °C ±
4 °C. Due to the different sedimentation rates of the free protein and
the NPs, it is assumed that, upon injection, the NPs would be
immediately separated from the surrounding protein as they pass
through the disk. This gives the opportunity for proteins to desorb as
the particles are no longer in equilibrium with their surroundings. The
typical measurement time for these particles was on the order of 1−2
min.
After data acquisition, the changes in sedimentation can be
rationalized by considering the object as more complex and modeling
the sedimentation using a core−shell model (eq 3). This assumes that
the object formed of a core of known size and density and a shell of
protein of known density and variable thickness, with apparent
diameter:
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where Da is the apparent diameter of the NPs, Dc and ρc are the NP
core diameter and density, respectively, DT is the total diameter of the
core and the shell, and ρs and ρf are the shell and fluid densities,
respectively. This equation describes a NP with a shell composed of
species with a single density.15
In all cases the particles are assumed to be spherical and the layers
homogeneous and discrete. For most cases, a progressive increase in
shell thickness causes a nonlinear change in the sedimentation
properties. However, we observe (Figure S1d in SI) that the reported
shifts can be rationalized using eq 3: For this system and suitably small
shifts (<12 nm), a linear approximation between the surface coverage
of the NP and the protein concentration is acceptable. Hence, the
apparent diameter, in this case, can be used to directly reflect the shell
thickness of proteins. Assuming that the maximum saturation point of
the curves is indicative of full surface coverage, the shell thickness can
be normalized to represent a surface coverage percentage.
DCS is not biased by agglomerates, as it measures the time each
particle takes to sediment. The time separation between the large
agglomerates, that sediment first, and the individual particles, that
sediment later, guarantees that even in the case of agglomeration, the
single particle population can be monitored. In particular, by
monitoring the main population peak in DCS, it is possible to follow
the adsorption of protein (Figure S1a−c in SI), even with colloidal
instability present, most obvious around the 50% coverage for Fib
(Figure S1c in SI).
Microscale Thermophoresis. MST is a technique for binding
studies and allows us to determine the binding affinities of the proteins
to the NPs. In a standard assay, the binder (NP) is fluorescently
labeled and kept at constant concentration, while the ligand (protein)
is not. These conditions are very useful for proteins with low binding
affinities or for measurements in complex fluids like plasma. As
described in refs 20 and 21, we measure how the binding induces
changes of the fluorescent signal in a thermal gradient by determining
the relative fluorescence:
≡F
F
Fnorm
hot
cold (4)
where Fhot is the fluorescence after thermodiffusion and Fcold is the
initial fluorescence. By fitting Fnorm as a function of the protein
concentration using a Hill equation (eq 1), we estimate the binding
affinity. However, when there is NP aggregation, the technique
averages agglomerates and single particles data, introducing noise in
the affinity constants estimate.
MST measurements were perfomed on a Monolith NT 0.15
(NanoTemper, Germany) using 40% of blue LED (488 nm) and 1 V
IR-laser power. Laser on and off times were set at 35 s and 5 s,
respectively. Standard treated capillaries from NanoTemper were used.
FITC-labeled silica NPs were used at a constant concentration of
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0.313 mg/mL, while for the protein of interest, a 1:1 dilution series
was prepared.
Fluorescence Correlation Spectroscopy. FCS is a highly
sensitive fluorescence technique that allows for the determination of
the number and the size of particles simultaneously in solution. By
diffusing into and out of the confocal volume, labeled particles, i.e.,
proteins, create fluctuations in the fluorescence intensity. The
fluorescence signal is temporally correlated for the analysis. A two
component fit to the time−correlation function G(τ) is used to
determine quantitatively the amplitude and the diffusion time of the
fast freely diffusing proteins τProtein and the slower bound proteins
τProtein+NP. We follow the procedure described by Rusu et al.
22 and
Milani et al.5 using a two component fitting formula:
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From these results, we can determine the fraction bound of proteins
on the NP surface5 that is
≡ −f
N
N
1b
free
0 (6)
where N0 is the initial protein number from a fit in a monocomponent
solution and Nfree ≤ N0 is the amount of unbound protein after
incubation with NPs.
FCS measurements were performed on a LSM10 microscope
equipped with a ConfoCor2 unit (Carl Zeiss Jena, Germany), an argon
laser (488 nm), and an apochromatic 40× water-immersion objective
with a NA of 1.2 (Carl Zeiss Jena, Germany). Fluorescence emission
was separated from excitation light by using the corresponding band-
pass filter 525/25 nm. All measurements were performed at room
temperature (22° C) using NUNC eight-well slides (Thermo
Scientific) and a sample volume of at least 200 μL. To avoid
unwanted adsorption of proteins to the walls, the chambers were
precoated with 5 mg/mL BSA for 1 h. Afterward the chambers were
rinsed with Milli-Q to remove unbound BSA.
SDS-PAGE. SDS-PAGE is a method by which proteins in a
complex mixture can be separated based on their molecular weight.
This technique has been applied previously to study the proteins
which make up the biomolecular corona.13,23 Briefly the proteins
adsorbed on the NPs are removed from their surface, denatured, and
loaded on a gel, whereby they are separated by applying an electric
field. The protein bands can subsequently be visualized by staining the
proteins with Coomassie Brilliant Blue dye.
Silica NPs (100 μg/mL, 0.5 mL) were incubated in different HSA
concentrations (0.35−7 mg/mL) for 1 h at room temperature. After
that, Fib was added to a final concentration of 5 μg/mL. The NPs were
incubated with Fib for varying lengths of time (0−120 min), and the
times reported correspond to the incubation time with Fib before hard
corona preparation. The hard corona samples were prepared by
removing the excess proteins from the sample, achieved through 4
successive cycles of centrifugation (20000 × g, 10 min) and
resuspension in PBS. The final NP pellet was suspended in 10 μL
PBS with an additional 5 μL loading buffer. The samples were
subsequently boiled for 5 min before loading on a 6−4%
discontinuous Tris-glycine gel.
The samples were run for 1 h at 130 V. The gels were then
extracted and fixed in 40% EtOh, 10% acetic acid for 1h. Following
this, the gel was placed in 0.025% w/w Coomassie Brilliant Blue
dispersed in 10% EtOH and 10% acetic acid. The gel was left
overnight to stain before imaging.
Computational and Theoretical Approach. For our computa-
tional and theoretical calculations we used a computer cluster with
dedicated Graphical Processing Units (GPUs):
• CPU processors: 4× PCs with an INTEL i7-870 and 6 GB
RAM, 1× PC with an INTEL i7-3770 and 8 GB RAM.
• GPU processors: 4× NVIDIA GTX 460, 2× NVIDIA GTX
660, 1× NVIDIA GTX 760, 1× NVIDIA Tesla C2075.
All machines were running under GNU/Linux Ubuntu 12.04. The
programming codes were compiled using CUDA-C version 5.0 and
GCC 4.6.
MD Simulations. We performed MD simulations of the CG model
at constant volume and constant temperature, using a Langevin
thermostat. We fixed the simulation box size based on the NP
concentration, having one single NP in our volume (Figure 2c).
We kept a constant concentration of proteins in solution, regardless
of the number of proteins adsorbed on the NP surface, adopting a
method that mimics the experimental buffer. Specifically, we divided
the system in two regions: the inner region, containing the NP with all
the proteins concentrations fixed to the experimental values, and the
outer region, which is used as a resevoir to control the concentration
of proteins in the inner region. The outer region is not considered for
the calculation of the observable quantities.
We compute the adsorption kinetics by counting the number of
adsorbed proteins at every time-step. A protein is considered to be
adsorbed when the minimum surface-to-surface distance between the
protein and the NP is <0.5 times the specific protein’s radius.
Rescaling of Numerical Time Scale to Real Time Scale. Our CG
calculations give us qualitative information about the kinetics, and only
after the comparison with the experiments, we can extract the correct
time scales and make our predictions quantitative. To match the time
scales of simulations, numerical NLDRE solutions and experiments in,
e.g., Figure 3, we fit the experimental results with the NLDRE solution
of eq S4 in SI, assuming kFib
off ≃ 0 and adjusting the value of kFibon . This
assumption is justified by the large affinity of Fib to the NP.
Furthermore, in eq S4 in SI also kHSA
on and kHSA
off are free parameters.
Because we verify that the specific values of these two parameters do
not affect the behavior of the Fib fraction bound, we assume kHSA
on =
kFib
on . This procedure allows us to calculate the value of the Fib fraction
bound at early stages, not available from experiments, within the
NLDRE formalism with eq S3 in SI and match it with our
computational results. Therefore, on the one hand, we match the
NLDRE curve with the experimental fraction bound and, on the other
hand, the NLDRE curve with the computational fraction bound. In
this way we are able to calculate the scaling factor Ct (Table S1) in
treal = Ct × tsim, where tsim is the simulation time and treal is the time in
real units. We observe that this procedure leads to the same scaling
factor Ct for data in Figures 3 and 4.
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Analysis of DCS data
Figure S1: DCS measurements for silica NPs incubated in protein solutions. The main peak
(insets) is used to monitor the surface coverage in all cases for low (red line), medium (green
line) and high protein concentrations (blue line) and for silica NP without protein (black
line), for (a) HSA, (b) Tf, (c) Fib. (d) Apparent diameter as function of the shell thickness
for the core shell modeling (Eq. (3)) of 100 nm silica NP (ρ=2.2 g/ml) coated in a shell of
protein (ρ=1.05 g/ml) sedimenting through a solution with average density ρf=1.064 g/ml.
2
Non-Langmuir Differential Rate Equations (NLDRE) Theory
The law of mass action describes the adsorption process of a protein onto a binding site of
a NP by the differential equation:
d
dt
Γ = kon(C0 − CSΓ)(1− Γ)− koffΓ (S1)
where t is the time since the addition of NPs to the system, Γ ≡ Nads/Nmax is the normal-
ized surface coverage of proteins, Nads is the number of adsorbed proteins and Nmax is the
maximum number of binding sites on the NP surface, kon and koff are the rates of adsorption
and desorption, respectively, C0 is the concentration of proteins in solution and CS is the
concentration of binding sites on the NP surface.
The classical Langmuir model assumes that the rates kon, koff and the binding affinity
KD ≡ koff/kon are constants. We find that, with this very strong assumption, we are unable
to fit our data. Therefore, we make the plausible assumption that the rates depend on the
surface coverage:
kon(Γ) = kon∅ (1− αΓ)
koff(Γ) = koff∅ (1− βΓ).
(S2)
Here, the parameters kon∅ and k
off
∅ are the rates of adsorption at null surface coverage and
can be fitted from kinetic data; α and β are fitting parameters for the binding isotherm of a
protein and take into account, in an effective way, the protein-protein interactions between
adsorbing proteins.
The equilibrium surface coverage Γeq is obtained at very long times for dΓ/dt = 0. This
quantity can be related to the experimental values of the fraction bound f , Eq. (S3), with
the following relation:
Γeq =
fC0
CS
. (S3)
The problem of protein solutions with more than one kind of protein is more complex. For
instance, we consider the case in which the NP is initially incubated in a solution containing
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one kind of protein (e.g., HSA), with the further addition of another kind of protein (e.g.,
Fib) that competes with the previously adsorbed protein for the surface binding sites. In
this case, the adsorption processes of each protein need to be described separately. This
translates into a set of coupled non-linear differential equations for the surface coverage of
each kind of protein on the NP surface:
dΓFib
dt
= konFibCFib(ΓFib)(1− ΓFib − ΓHSA)− koffFibΓFib
dΓHSA
dt
= konHSACHSA(ΓHSA)(1− ΓFib − ΓHSA)− koffHSAΓHSA
(S4)
where t is the time since the addition of the second protein (Fib). In Eq. (S4) all the symbols
are equivalent to those in Eq. (S1) with CHSA and CFib being the protein concentrations
of HSA and Fib, respectively, and with indices for kon, koff and Γ indicating the protein to
which they are related. The initial conditions of this system are defined to be:
ΓFib(0) = 0
ΓHSA(0) = Γ
prec
HSA
(S5)
where ΓprecHSA is the equilibrium surface coverage of proteins at the end of the preliminary
incubation step.
Again, assuming that the rates of adsorption are functions of the surface coverage of each
protein, we introduce the cross-interactions between different kinds of proteins:
konHSA(ΓHSA,ΓFib) = k
on
∅,HSA(1− αHSA,HSAΓHSA − αHSA,FibΓFib)
koffHSA(ΓHSA,ΓFib) = k
off
∅,HSA(1− βHSA,HSAΓHSA − βHSA,FibΓFib)
konFib(ΓHSA,ΓFib) = k
on
∅,Fib(1− αFib,HSAΓHSA − αFib,FibΓFib)
koffFib(ΓHSA,ΓFib) = k
off
∅,Fib(1− βFib,HSAΓHSA − βFib,FibΓFib)
(S6)
where the indices for kon∅ and k
off
∅ indicate the protein to which they are related.
We set the parameters αHSA,HSA, αFib,Fib, βHSA,HSA and βFib,Fib equal the those for the one-
4
component systems, Eq. (S2), and we make the following hypothesis for the cross-interaction
parameters:
αHSA,Fib = αFib,HSA =
1
2
(αHSA,HSA + αFib,Fib)
βHSA,Fib = βFib,HSA =
1
2
(βHSA,HSA + βFib,Fib).
(S7)
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The computational model
Effective potentials: Protein-NP interaction
The functional form of the protein-NP interaction (Fig. 2a) is defined as
UDLVO(d) ≡ ULJDLVO(d) + UElecDLVO(d)
with ULJDLVO(d) ≡
AH
2520
2RhRNP
Rh +RNP
[σ
d
]6 1
d
− AH
12
2RhRNP
Rh +RNP
1
d
and UElecDLVO(d) ≡
64πkBTγprotγNPρ∞
κ2
RhRNP
Rh +RNP
e−κd
(S8)
where AH is an energy related to the Hamaker constants of the NP and the protein, RNP is the
NP radius, Rh is the shortest characterisctic length-scales of the folded protein, σ ' 0.5 nm is
the minimum approach distance between the NP and the protein,1,2 and d ≡ r−RNP−Rh ≥
σ, is the separation distance between the surfaces of the NP and the center of the protein.
The parameters of the electrostatic part UElecDLVO are the thermal energy kBT , the reduced
surface potential defined as γα ≡ tanh[zeφα/4kBT ] where α is an index that correspond to
one of the proteins or the NP, φα the zeta-potential (Table S3), κ
−1 = 0.304/
√
I(M)3 is
the Debye-Hükel screening length, ze and ρ∞ are the valence in electron charges e and the
concentration of ions in solution, respectively.4,5 Table 2 and table S1 summarize the set of
parameters derived from the experiments and used in our simulations.
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Table S1: Other parameters for the coarse-grained model
PBS Ionic strength (pH 7.5) 24 mM
Valence of ions in solution ze = 1e
Inverse Debye-Hükel length κ = 0.508 nm−1
Temperature T = 24 0C (kBT = 25.6 meV)
SiO2 NP φ −24 mV6
εHSA,HSA −0.2 kBT
εTf,Tf −2.5 kBT
εFib,Fib 0.0 kBT
εα,β with α 6= β and α, β = HSA,Tf,Fib 0.0 kBT
d3 60 nm
Ct 7.5× 103 sec/sec
tinc 0.075 sec
KHSAD 2.7µM
KTfD 1.2µM
KFibD 0 M
Table S2: Parameters for the NLDRE
kon∅ (HSA) 1.5× 107 sec−1M−1
kon∅ (Tf) 1.5× 107 sec−1M−1
kon∅ (Fib) 1.5× 107 sec−1M−1
koff∅ (HSA) 5.0 sec
−1
koff∅ (Tf) 0.5 sec
−1
koff∅ (Fib) 0.0 sec
−1
αHSA-HSA −0.5
αTf-Tf −0.98
αFib-Fib 0.0
βHSA-HSA 10
βTf-Tf 50
βFib-Fib 0.1
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Effective potentials: Protein-protein interaction, 2-body contribution
The protein-protein 2-body interaction potential (Fig. 2b) is defined as7
U2(rij) ≡ Uh2 (rij) + U s2 (rij)
with Uh2 (rij) ≡ ε
[
Rh,i +Rh,j
rij
]24
and U s2 (rij) ≡ ε
1
1 + exp
[
30
rij−(Rs,i+Rs,j)
Rh,i+Rh,j
]
(S9)
where rij = |~ri − ~rj| is the distance between the centers of two proteins i and j, and ε is
a characteristic interaction energy between the two proteins. We describe the proteins as
ellipsoids with a larger diameter 2Rs and a smaller diameter 2Rh, that mimic their asym-
metric shapes. The smaller radius Rh is calculated from experimental data on the highest
surface adsorption concentration of the protein on a flat surface.8 The larger radius Rs is
given by the hydrodynamic radius computed from the experimental measure of the diffusion
coefficient D of each protein, which can be obtained by the Stokes-Einstein law (Table 2).
We assume that the parameters Rs are constant within the investigated range of protein
concentrations. We verify this hypothesis by computing DFib for Fib in solution with HSA
at increasing concentrations (Fig. S2).
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Figure S2: Mean squared displacement (MSD) 〈r2〉 of Fib at 0.005 mg/ml in solution with
HSA at different concentrations, from 0.18 to 1.00 mg/ml. The fitting of the long-time
diffusive regime gives a diffusion coefficient DFib = 1.33nm
2/µs independent on HSA con-
centration.
Effective potentials: Protein-protein interaction, 3-body contribution
We define the protein-protein 3-body interaction potential as
U3(~ri, ~rj, ~rNP) = εi,j exp
[
−
√
didj
d3
]
exp
[
−(rij − δi,j)
2
2ω2i,j
]
(S10)
where ~ri is the position vector of protein i, ~rNP is the position vector of the NP, di ≡
|~ri − ~rNP| − Rh,i − RNP is the relative distance of the center of a protein to the NP surface,
RNP is the NP radius, Rh,i is the smaller radius of the protein i, rij ≡ |~ri−~rj| is the protein-
protein relative distance, εi,j is a characteristic energy, d3 is the range of this interaction from
the NP surface, δi,j ≡ Rh,i + Rh,j is the smaller protein-protein distance and ωi,j ≡ δi,j/4 is
a cutoff range. The parameters of this interaction depend on the types of proteins i and j
and are given in Table S1.
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Figure S3: The adsorption isotherms for (a) HSA and (b) Tf with calibrated values AHSAH =
9.75 kBT and A
Tf
H = 8.4 kBT . We estimate Nmax from the fitting of the surface coverage
percentage 100Nads/Nmax with Eq. (S1) (Table 2).
Estimate of free parameters AH and Nmax
For each protein we make an initial guess for AH and simulate the adsorption in a mono-
component solution at CP = KD and at larger protein concentrations. We fit the resulting
adsorption isotherm to the large-time solution of Eq. (S1), fixing KD and leaving Nmax
as free parameter. We compare Nmax with the number Nads(KD) of adsorbed proteins at
concentration KD and fine-tune AH, in successive iterations, until we find Nmax = 2Nads(KD)
corresponding to Γeq(KD) = 0.5 (Fig. S3). The resulting fitting parameters are reported in
Table 2.
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HSA - Fib competition. Gel analysis
Figure S4: Gel samples showing the competitive adsorption of Fib displacing a protein corona
made of HSA after incubation for 30, 60, 120 minutes, for different concentration of HSA,
from 0 to 7 mg/ml, as indicated near each gel sample. Labels “HSA” and “Fib” on the left
of the gels indicate the gel signatures of HSA and Fib, respectively.
11
Transferrin - Fibrinogen competition
(a) (b)
Figure S5: Competitive adsorption of Fib displacing a protein corona of Tf after incubation.
a) As in Fig. 3 but for Tf concentrations (for the lines from top to bottom) 0.00, 0.50, 1.00,
2.00, 3.00, 4.78, and 7.00 mg/ml. b) NP Surface coverage of Tf from numerical simulations
(open symbols) and NLDRE theory (lines). Lines from bottom to top are for 0.50, 1.00,
2.00, 3.00, 4.78, and 7.00 mg/ml for Tf.
HSA-Tf-Fib competition and memory effects
(Fig. S6, S7 and S8)
(a) (b)
Figure S6: a) Snapshot of a simulation corresponding to Fig. 4b at t = 0.1 min. b) Same as
in a) but for Fig. 4c.
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Figure S7: a) FCS experiment results of the kinetics analysis of Fib at 5 µg/ml adsorbed on
100 µg/ml silica NPs incubated following the protocol A (red triangles: incubation first in
HSA at 0.07 mg/ml for 1 hour and next in Tf at 0.07 mg/ml for another hour), compared
with the case in which we follow the protocol B (blue squares: incubation first Tf and next
HSA, with same concentrations and times). b) Same as in panel a but for HSA and Tf at 3.5
mg/ml HSA. Within the error bar there is no difference in Fib kinetics between the different
orders of protein addition.
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Figure S8: Same as in Fig. 5a,b but for HSA and Tf both at 0.07 mg/ml concentration. a)
SDS-PAGE gel analysis. b) Densitometry results.
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Simulations of different incubation protocols without three-body
interaction contribution
0.0
0.2
0.4
0.6
0.8
1.0
 0  0.05  0.1  0.15  0.2  0.25  0.3
R
el
at
iv
e 
su
rf
ac
e 
co
v
er
ag
e
Time t [sec]
Tf (HSA+Tf)
HSA (HSA+Tf)
Tf (Tf+HSA)
HSA (Tf+HSA)
(a)
0.0
0.2
0.4
0.6
0.8
1.0
0.0 0.5 1.0 1.5 2.0
R
el
at
iv
e 
su
rf
ac
e 
co
v
er
ag
e
Time t [sec]
Tf (HSA+Tf)
HSA (HSA+Tf)
Tf (Tf+HSA)
HSA (Tf+HSA)
(b)
Figure S9: Simulation results of HSA and Tf competitive adsorption without the three-body
contribution to the protein-protein interaction (Eq. (S10)). a) As in Fig. 5c with HSA and
Tf at 3.5 mg/ml. In this case, both incubation protocols lead to the same relative protein
adsorption, independent on the incubation order, after a short transient time (∆t ' 0.15 sec).
b) Simulation results for HSA and Tf concentrations at 0.007 mg/ml. Under these conditions,
the incubation time needed to equilibrate the system before adding the next protein is longer
compared to systems at higher concentrations (tinc = 0.75 sec).
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Fluorescence Correlation Spectroscopy basics
The FCS technique analyzes the fluctuations in the intensity of the measured particle fluo-
rescence. The fluorescence signal F (t) at time t is hardware processed into the normalized
autocorrelation function
G(τ) ≡ 1 + 〈F (t)F (t+ τ)〉
〈F (t)〉2
, (S11)
where angular brackets denote the average over time t. Indicating with S ≡ z0/w0 the
structure parameter of the laser beam, where z0 is the half axes and w0 the radius of the
beam, and assuming an ideal three dimensional Gaussian shape for the confocal volume, the
autocorrelation curve for N freely diffusing identical molecules (single component solution)
is described by
G(τ) =
1
N
(
1 +
τ
τD
)−1(
1 +
τ
S2 τD
)−1/2
+ 1, (S12)
where τ is the correlation time and τD is the translational diffusion time of the molecule. In
a multicomponent sytem, the measured autocorrelation function is a weighted sum of the
autocorrelation functions of its components.
The translational diffusion time is defined as the average dwell time of a molecule with
diffusion constant D in the confocal volume:
τD ≡
ω20
4D
. (S13)
For all experiments, we average 10 independent measurements (30s each) and use a
10 nM dye solution with known diffusion coefficient (Alexa488 D = 435µm2/s) to determine
the structure parameter S and to calibrate the instrument.
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NP characterization
Table S3: Size and Z-Potential of silica NPs used in this study as measured by DLS and
DCS.
Diameter (nm) PDI Z-Potential (mV) Conductivity (MS/cm2)
DLS 123±1 0.030±0.003 -24±2 -1.8±0.2
DCS 114.4±0.1 - - -
Figure S10: Nanoparticle Characterization. Size distribution of SiO2 nanoparticles used
for this study as measured by DLS. Both Intensity (upper) and number weighted distributions
(lower) are shown. Measurements represent stock particles dispersed in water.
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ABSTRACT. Protein adsorption and desorption from nanoparticles (NPs) governs the fate of 
nanoparticles interacting with living cells. Proteins may bind weakly or strongly and hence will 
show different tendency to remain bound when facing competitive binding with abundant blood 
proteins depending upon the protein itself as well as the type of NP. Here, we explore protein-NP 
affinities in case of four representative plasma proteins and six different kinds of NPs. Using 
fluorescence correlation spectroscopy (FCS) we systematically study the interactions between all 
combinations of proteins and NPs. In the case of binding without aggregation the fraction of 
protein bound is determined as a function of increasing molar protein/NP-ratio. The binding 
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isotherms are described in terms of adsorption models based on the law of mass action and 
discussed in the limits of weak and strong binding. We show that the adsorption layers of strong 
binders, such as fibronectin, bovine serum albumin and transferrin, are displaced by competitive 
binding of full blood serum proteins with off-kinetics following the order of the measured 
equilibrium affinities. Hence, measurement of thermodynamic binding constants brings forth 
some degree of predictability of protein-NP corona formation and competitive displacement 
under exposure to serum conditions. 
 
INTRODUCTION. Nanoparticles (NPs) are of importance for their diverse utility in technology 
and biomedical applications owing to their wide range of tunable optical, mechanical as well as 
physicochemical properties 1-3. In particular due to the virtue of small size, NPs are effective in 
accessing living systems. The in vivo application of NPs, however, demands careful analysis of 
the immediate and distant interaction of the NPs with biomolecules and insights into their impact 
on human health and environment. Upon entering the body, NPs are exposed to a great number 
of biological components. Some of them, particularly proteins, are adsorbed on the NPs 
depending upon its surface property. This adsorbed layer of protein on the NPs surface is termed 
protein corona4-7. When the binding of protein to the NP is irreversible or of long duration it is 
called “hard corona”. On the other hand, when the protein layer is reversibly bound to the NP 
surface, i.e. it comes off quickly in dilute solutions or in the presence of other biomolecules, it is 
referred to as “soft corona”8-11. The protein corona has significant biological impact since the 
behavior of a NP now depends on the corona rather than the NP surface alone4, 6. Proteins in the 
corona can both enhance and inhibit biological responses to NPs, and therefore intimately affect 
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the fate of the NP. It has been proposed that proteins bound tightly in the corona might provide a 
map of the pathway that a particle takes as it crosses various biological compartments6, 12-13. 
Adsorption patterns have been regarded as an adsorption sequence where the most abundant 
proteins with lower affinity are displaced by less abundant proteins with higher affinity to the 
investigated surface. This displacement is known as “Vroman-effect”14-16. The adsorption and 
competitive binding of proteins to nanoparticles have been in the focus of various theoretical 
studies using protein structure data and molecular dynamics (MD) to predict the composition of 
the NP protein coronae17-21. 
The formation of a protein corona has been studied in experiment by numerous methods 
including surface plasmon resonance22, ITC8, DCS23, thermophoresis24, AFM25 and fluorescence 
correlation spectroscopy (FCS)9, 26-31. FCS stands out among those techniques as binding of 
particular fluorescently labeled protein can also be measured in the presence of other abundant 
proteins or full blood plasma26, 28, 32. Secondly, FCS allows for measurement of the fraction of 
protein bound to NPs and hence can determine binding isotherms quantitatively. Recently, we 
used FCS to study the formation of layers of proteins on NPs. There, we found that the measured 
fraction of proteins bound to the NP is in quantitative agreement with a “strong binding model” 
that assumes that the first layer of proteins is strongly bound and not or only very slowly 
exchanging9. The interaction of protein with the NPs differs depending on the size, charge, 
stability of the NP as well as the size and charge of the proteins6, 33-34. Variation in adsorption 
affinities thus seems to be caused by the different protein structure and chemical nature of the 
nanoparticles, resulting in diverging surface properties and consequently a hierarchy of binding 
proteins. In an attempt to understand the corona composition in the presence of multiple kinds of 
proteins, we combined experiments, simulations, and theory to investigate the corona kinetics of 
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three blood proteins (human serum albumin, transferrin, and fibrinogen)29. In the present work, 
we extend the experimental studies to serum proteins having different molecular weight, similar 
isoelectric point and different abundance in plasma, and nanoparticles having comparable sizes, 
but different hydrophobicity. The proteins used are fibronectin (FN), fibrinogen (FG), transferrin 
(Tf) and bovine serum albumin (BSA). The molecular weight along with their isoelectric point 
and hydrodynamic radius is listed in Table 135-37. BSA is a globular protein which is a major 
constituent of the cow blood plasma. It binds effectively with chemical agents and is widely used 
as a blocking agent38. The blood glycoprotein Tf with its oblate spheroid shape is primarily 
associated with binding to and transportation of iron39-40. BSA and Tf are comparatively smaller 
in size than FN and FG. FG and FN are large and complex glycoproteins that help in blood 
coagulation41. The NPs chosen are: silica (silicon dioxide, SiO2), ceria (cerium oxide, CeO2), 
titania (titanium dioxide, TiO2), carboxylated polystyrene (PSCOOH), sulphonated polystyrene 
(PSOSO3H) and iron dextrane SPION (Fe dex SPION). All particles studied here were 
previously characterized in the context of concerted activities with EU funded research consortia. 
 
In this article, we study all combinations of the above mentioned proteins and nanoparticles 
using FCS. Protein adsorption is found to fall into one of three categories: strongly binding, 
weakly binding or non-binding and aggregating. In case of binding and non-aggregating proteins, 
the fraction of bound protein as a function of the molar protein/NP-ratio is measured. We 
demonstrate that the measured isotherms are described by the law of mass-action allowing for 
attribution of equilibrium constants and adsorption area per protein. While binding constants of 
order follow Langmuir isotherm behavior, we emphasize that in case of strong binding 
(KD/NP<100) depletion of free protein needs to be considered to reproduce strong binding 
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isotherms. The binding affinities were compared to the off-kinetics of the corona proteins in the 
presence of competitive full serum proteins.  
 
RESULTS AND DISCUSSION. In order to examine protein binding to NPs, different types of 
NPs were incubated in a solution of proteins and characterized in situ by means of FCS 
autocorrelation functions. Four of the most abundant serum proteins with significant differences 
in their size and shape were chosen as model systems for the investigation.  
Fluorescence correlation spectroscopy study of protein adsorption to NPs 
We use FCS to measure the fraction of bound proteins. Herein labeled proteins and unlabeled 
NPs are used. Figure 1a shows a schematic drawing of a FCS experiment where unlabeled NPs 
and labeled proteins diffuse in a solution illuminated by a focus laser beam. Labeled molecules 
diffusing through the detection volume provoke a fluctuating fluorescent signal. The 
characteristic time dependence of the fluctuations are described by the normalized time 
correlation function 𝐺(𝜏). For identical fluorescent particles undergoing Brownian motion 𝐺(𝜏) 
is given by the following equation42 
𝐺(𝜏) =
1
𝑁
(1 +
𝜏
𝜏𝐷
)
−1
(1 +
𝜏
𝑆2𝜏𝐷
)
−
1
2
+ 1   (Equation 1) 
where S is the structural parameter of the laser focus, N the average number of fluorescent 
molecules in the focal volume, 𝜏𝐷 the characteristic diffusion time of the fluorescently labeled 
molecules. Adding unlabeled NPs to a solution of labeled proteins alters the diffusion of those 
proteins that are adsorbed onto the NPs. In this case, we obtain a two-component system and the 
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measured autocorrelation function is the weighted sum of the autocorrelation functions of each 
component:  
𝐺(𝜏) = 𝐴1𝐺𝑝𝑟𝑜𝑡𝑒𝑖𝑛(𝜏) + 𝐴2𝐺𝑁𝑃(𝜏)                                    (Equation 2) 
Figure 1b schematically depicts a time autocorrelation function showing two characteristic 
diffusion times. A two-component fit to 𝐺(𝜏) allows for determination of the amplitude A2 of the 
slow (bound proteins) and A1 of fast component (free proteins) in the system (see vertical lines in 
red and blue in Figure 1b). The fraction of protein bound to the NP surface is quantified by a 
two-component fit to the time autocorrelation function of the FCS signal (see supplementary 
material, Figure S1). Here, in order to improve the robustness of the fitting, the diffusion 
constant of the labeled protein is previously determined in a separate experiment and then used 
as a fixed parameter in two-component fits. 
 
Measurement of protein – nanoparticle combinations 
In the following section, we study all combinations of four prototypical proteins interacting 
with six kinds of NPs. We use FCS and measure the time correlation function of the 
fluorescently labeled proteins after addition of NPs. We find three different scenarios for the 
evolution of the fluorescence autocorrelation signal as prototypically shown in Figure 1c, I-III. 
Firstly, the amplitude of the FCS signal can increase with time after NP addition, while the 
characteristic times shift slightly to larger values. In this case, the proteins bind to NPs. The 
effective number of fluorescent objects decreases as proteins adsorb to NPs, while the correlation 
function develops a second slower component due to the reduced diffusion of proteins bound to 
NPs. Secondly, proteins may not bind to NPs or the interaction is so weak that binding is not 
detectable with FCS. Here, the correlation curves do show none or little deviations from the 
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correlation curves of the pure protein. The third case, frequently observed, is that the correlation 
curves exhibit extremely large amplitudes and broad tails towards the longer time regime. In 
addition, the fluctuations of the raw fluorescence signal show abnormally high bursts. Both facts 
indicate the presence of large aggregates of undefined sizes that diffuse sparsely and irregularly 
through the confocal volume with slow diffusion times. 
The evolution of the FCS correlation function with time for all measured combinations of 
proteins and NPs is shown in Figure 2. According to the criteria shown in Figure 1c we made a 
rough categorization of the observed binding behavior. Typical correlation functions at various 
time intervals from 0 to 60 minutes are shown in matrix- like representation for all proteins and 
NPs (Figure 2). The overview demonstrates that after addition of protein it is not always possible 
to preserve monodisperse systems. Instead clear signatures of NP aggregation are observed, that 
are likely induced by protein adsorption. For example FG gives rise to aggregates. On the other 
hand some proteins have a low affinity for a few surfaces. An example of the wide variation in 
affinity with respect to the surface adsorption of proteins to NP is found in the binding patterns 
of BSA for silica and polystyrene NPs, although these particles have similar size. Albumin forms 
a stable coating on PSCOOH and PSOSO3H, while it is weakly adsorbed on SiO2 particles. The 
varying degree of surface coverage of the NP for serum albumin may be attributed to 
hydrophobicity. The hydrophobicity of metal oxides leads to non-adhesion for other small 
proteins such as Tf and BSA. Smaller proteins own a lesser amount of interaction sites which 
leads to lesser adsorption.43 
 
Theoretical model of protein adsorption to NPs 
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The binding of protein P to nanoparticles NP is generally described as an adsorption process in 
analogy to the Langmuir adsorption model for adsorbates from liquids to a flat solid surface. 
Adsorption is considered as a reversible reaction of a protein P with a free binding site S on the 
NP surface. 
𝑃 + 𝑆 ⇌ 𝑃𝑆      (Equation 3) 
where S denotes the total number of binding sites presented on NPs, P the protein 
concentration and PS the concentration of occupied binding sites. In this case, the fraction of 
occupied binding sites to the total concentration of binding sites, S, i.e. the fraction of NPs 
coated, is:  
𝜗(𝑃)𝑁𝑃 =
[𝑃𝑆]
[𝑆]
=
[𝑃]
[𝑃]+𝐾𝐷
       (Equation 4). 
Where 𝐾𝐷 = ([𝑃] ⋅ [𝑆])/[𝑃𝑆] denotes the equilibrium dissociation constant. Equation 4 is 
generally used to determine the dissociation constant from experimental adsorption isotherms30-32, 
44-45. In these experiments protein is titrated against a fixed concentration of NPs. Changes 
inferred to the NPs due to protein adsorption are measured. For instance, the measurement of the 
hydrodynamic diameter of the NP by FCS28, 30-32, 44-45 or dynamic light scattering27, or changes 
induced by proteins as measured in surface plasmon resonance46, affinity capillary 
electrophoresis47-48 or fluorescence quenching47, 49-50. However, an important caveat needs to be 
addressed when Equation 4 is used in these kinds of titration experiments. It is generally 
assumed that the total concentration of protein added to the NP solution is almost equal to the 
concentration of unbound protein, P, which enters Equation 4. However, if the binding affinity of 
protein to NPs is strong, free proteins P are depleted as schematically depicted in Figure 3a. In 
the later case that proteins are strongly bound, 𝑃𝑓𝑟𝑒𝑒 ≪ 𝑃𝑡𝑜𝑡𝑎𝑙, the rigorous solution of the mass 
action Equation 3 has to be used 51: 
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 𝜗(𝑃)𝑁𝑃 =
[𝑃𝑆]
[𝑃𝑆]+[𝑆𝑓𝑟𝑒𝑒]
= 
([𝑠]+[
𝑃
𝑁𝑃
]+𝐾𝐷/𝑁𝑃)−√([𝑠]+[
𝑃
𝑁𝑃
]+𝐾𝐷/𝑁𝑃)
2
−4∙[𝑠]∙[
𝑃
𝑁𝑃
]
2∙[𝑠]
        (Equation 5) 
Here, the ratio of protein to NP concentration, P/NP has been introduced and becomes the 
relevant variable. Likewise the total number of binding sites is replaced by the number of 
binding sites per NP, 𝑠 = 𝑆 𝑁𝑃⁄ . Note that the exact form of Equation 5 turns into Equation 4 in 
the limit of weak adsorption (𝐾𝐷 𝑁𝑃 ≫ 1 ⁄ ). To illustrate this point, Figure 3a demonstrates 
theoretical isotherms 𝜗(𝑃)𝑁𝑃 for both, the exact law of mass action (full lines) and the 
approximate Langmuir-type (dashed lines). It appears that the deviations for strong binding 
(values of 𝐾𝐷 𝑁𝑃 < 100 ⁄ ) are clearly visible. While for weak binding the Langmuir isotherm is 
applicable, it is not appropriate for the determination of KD/NP in case of strong binding and 
leads to a significant overestimation of the binding affinity.  
 
In the present study, we do not measure the fraction of coated NP surface but rather determine 
the amount of free and bound protein, since it is the protein that is fluorescently labeled in the 
FCS study. To this end, we remodel Equation 3 and solve for the fraction of bound protein 
 𝑌(𝑃/𝑁𝑃)𝑝𝑟𝑜𝑡𝑒𝑖𝑛 =  
[𝑃𝑆]
[𝑃]
  as a function of the molar P/NP-ratio. 
In order to illustrate the dependence of isotherms as measured in our experiments, we have 
plotted the theoretical fraction bound 𝑌(𝑃, 𝑁𝑃)𝑝𝑟𝑜𝑡𝑒𝑖𝑛 versus P/NP-ratio for various KD/NP but 
fixed concentration of binding sites per NP, s, i.e. constant NP size (see Figure 3b). Note that in 
the limit of low values of KD/NP the exact expression of the law of mass action, 
𝑌(𝑃/𝑁𝑃)𝑝𝑟𝑜𝑡𝑒𝑖𝑛 =
[𝑃𝑆]
[𝑃𝑆]+𝑃𝑓𝑟𝑒𝑒
=
([𝑠]+[
𝑃
𝑁𝑃
]+𝐾𝐷/𝑁𝑃)−√([𝑠]+[
𝑃
𝑁𝑃
]+𝐾𝐷/𝑁𝑃)
2
−4∙[𝑠]∙[
𝑃
𝑁𝑃
]
2[
𝑃
𝑁𝑃
]
           (Equation 6),  
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merges into the strong binding model. In the strong binding model of Milani et al.9, it is assumed 
that proteins are strongly bound to NP in such a way that all proteins are bound up to the point 
when all binding sites are occupied by proteins. The sharp discontinuity at this point in the 
𝑌(𝑃/𝑁𝑃)𝑝𝑟𝑜𝑡𝑒𝑖𝑛 curve is illustrated in Figure 3b. Secondly, it is noteworthy that Equation 6 
describes the most general case, when the amount of available binding sites 𝑆𝑓𝑟𝑒𝑒, is not assumed 
to equal the total amount of interaction sites S. However, if the free concentration of binding 
sites on the NPs is approximately equal to the total concentration, 𝑆 ≈ 𝑆𝑓𝑟𝑒𝑒, Equation 6 reduces 
to 
 𝑌(𝑁𝑃)𝑝𝑟𝑜𝑡𝑒𝑖𝑛 =
[𝑠]
[𝑠]+𝐾𝐷/𝑁𝑃
      (Equation 7). 
Equation 7 corresponds to experiments, where NPs with many binding sites are added to a 
protein solution and the fraction of bound protein is measured. For low protein concentration,  
𝑌(𝑃/𝑁𝑃)𝑝𝑟𝑜𝑡𝑒𝑖𝑛 becomes quasi independent of the protein concentration as can be seen by the 
plateau regime in Figure 3b. However, if the free concentration of binding sites  
 
Measurement of the protein adsorption area and binding affinity 
In order to analyze binding isotherms it is convenient to plot the fraction bound versus the P/NP 
ratio, since the maximum number of molecules adsorbing in a monolayer per NP, i.e. the number 
of binding sites per NP, s, can be directly read from the presentation. Knowing the number of 
binding sites per NP in turn enables us to estimate the surface area available for each protein. As 
an example Figure 3c shows measurements of the fraction of FN bound to silica NPs and BSA to 
PSCOOH. The red line exhibits the best fit to Equation 5. In this case we obtain s=16 binding 
sites per 100nm NP and a normalized equilibrium constant of KD/NP=0.15. In comparison BSA 
adsorbing to PSCOOH beads of same size shows a number of binding sites per NP, s=200 and 
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KD/NP=0.41 (Table 1). In this table, the average area occupied by a single protein is calculated 
from s and compared to the hydrodynamic radius of the protein as obtained from the FCS 
diffusion times. The data reflect the correct tendency that BSA has a smaller protein adsorption 
area than FN in accordance with the fact that the hydrodynamic radius is smaller by a factor of 3 
compared to FN. Furthermore the literature values of the molecular weight of the protein are 
given. 
Our theoretical considerations showed that the fraction of bound protein is a function of both the 
protein as well as NP concentration. To demonstrate this fact, we measured the fraction bound 
through a wide range of protein and NP concentrations for three model systems that showed no 
aggregation in the interaction matrix. Figure 4 shows 𝑌(𝑃)𝑝𝑟𝑜𝑡𝑒𝑖𝑛 for BSA/PSCOOH, BSA/TiO2 
and BSA/CeO2, within a range of 45 nM to 45 µM of BSA and within a range of 1µg/ml to 
1mg/ml NP concentration. In case of BSA/PSCOOH we observe, as expected from Equation 6, 
that the fraction bound is high at low protein concentration and high NP concentration and falls 
off with increasing protein and decreasing NP concentrations. For TiO2 and CeO2 NPs, we 
observed only a very low fraction bound in all measured cases. These measurements confirm that 
in both cases the proteins are very weakly binding to NPs, which in principle was already shown 
in Figure 2, but has now been confirmed over a larger range of protein and NP concentrations.  
 
Hierarchy in desorption kinetics  
Next we ask the question whether the binding affinity correlates with the resistance to 
competitive binding. To this end we form NP decorated with a labeled protein adsorption layer 
and measure the off-kinetics after exposure of the NPs to serum proteins. The particles are 
incubated for at least one hour in a suitable concentration of the selected protein, which allows a 
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monolayer to form. These protein coated particles are then exposed to 10% fetal bovine serum. 
The schematic diagram in Figure 5a illustrates the process of desorption due to competitive 
binding in serum. The amount of free and bound protein is measured using FCS. Figure 5 shows 
the resulting time courses of the fraction of bound protein for various protein-NP combinations 
that exhibited strong binding. The data show desorption kinetics with exponential decay rates. 
However, the majority of protein adsorbed is not fully removed as seen from considerable offsets 
in the time courses (Note that the fraction bound axis terminates at ~0.6 in Figure 5b). This offset 
may be interpreted as the hard corona that seems to be irreversible bound to the NP on the time 
scale of our experiments. The characteristic desorption-times are determined by exponential fits 
with offset and the corresponding kinetic off-rates, 𝑘𝑜𝑓𝑓, listed in Table 1. In general, it was 
observed that smaller proteins (BSA and Tf) are replaced more efficiently than larger proteins 
(FN) in the presence of serum. Also, the kinetics of protein desorption depends on the NP type. 
For instance, BSA has a higher kinetic off-rate in presence of PSCOOH than PSOSO3H (8.8·10-3 
versus 2.4·10-3 min-1). Most importantly, however, there seems to be a correlation between the 
off-rate 𝑘𝑜𝑓𝑓  and the measured normalized dissociation constant KD/NP. Knowing that 𝑘𝑜𝑓𝑓 =
 𝐾𝐷 ∙  𝑘𝑜𝑛 and assuming that 𝑘𝑜𝑛 is independent of protein and NP type, we expect an increasing 
off-rate with increasing dissociation constant. The values listed in the last rows of Table 1 are in 
agreement with this expected dependency. The raw data of the evolution of autocorrelation 
function of two representative P-NP interactions with serum can be found in Figure S1. It is 
noteworthy that the addition of serum to aggregates of NPs and proteins were carried out but no 
desorption or redispersion effect has been observed.  
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CONCLUSION. In this article, we studied the interaction between selected proteins and NPs in 
an attempt to systematically cover the formation of protein corona. Primarily, three categories of 
protein-NP interaction have been noticed– strong binding, weak or no binding and aggregation. 
The data suggests that proteins that are large and natural coagulators, such as FG and FN, are 
more susceptible to aggregation. These proteins are likely to shield NPs, reduce the overall 
charges of NPs and promote cross-bridging between NPs by binding to other proteins. When 
proteins bind to NPs without disturbing their colloidal stability, we measured binding isotherms 
in accordance with thermodynamic models of protein adsorption. We discussed the importance 
of using the full mass action description since protein concentrations are readily depleted in the 
presence of strongly adsorbing NPs. In this case equilibrium binding constants as well as the 
average area occupied by the adsorbed proteins have been determined. These characteristic 
determinants of the protein-NP interaction are meaningful values and have predictive power. For 
example we showed that the protein adsorption area correlates with the hydrodynamic bulk size 
of the protein. We also tested for stability of the protein layers in presence of serum and showed 
that desorption kinetics of proteins is directly linked to the hierarchical order of the protein-NP 
dissociation constants. Competitive binding proteins are able to quickly detach protein layers, 
which are weakly bound, whereas some proteins are strongly bound. This shows that the NPs 
retain “memory” of the strong binding proteins, which first encounter in their travel through 
body compartments. A fact that was recently confirmed by theoretical modeling29. Hence, the 
study of thermodynamic binding of each protein component allows for ranking of protein-NP 
affinities and can be used towards a better understanding of the protein-NP interaction in 
biological environment such as blood serum or plasma. Systematic measurement of protein-NP 
interactions will be valuable to the community but requires the consideration of protein as well 
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as NP concentrations especially in case of strong binding. The dissemination of tabulated 
protein-NP data in publically accessible libraries, such as nanosafetycluster.eu, is beginning to 
emerge. There is hope that databases combined with theoretical modeling tools will enable 
predictive capability for the composition of protein corona on NPs and possibly pre-estimate 
impact of NP toxicity. 
 
 
MATERIALS. All proteins (BSA, Tf, FN, FG) were purchased from Invitrogen (Life 
Technology). BSA, Tf and FN were labeled with Alexa-488 whereas FG was labeled with 
Alexa-647. Silica, polystyrene carboxylated (PSCOOH) and polystyrene sulphonated 
(PSOSO3H) beads with a diameter of 100nm were purchased from Polysciences Inc. 
(Warrington, USA). Further nanoparticles were obtained from the FP7 EU grants NanoMILE: 
TiO2 [NIST SRM1898 (500nm), CeO2 [JRC NM212] (300nm) and Fe dextrane SPION 
[N4I1121114] (20nm). Nanoparticles were checked for their sizes by DLS experiments (see 
Figure S2 in supplementary material). An initial stock solution of 5mg/ml was prepared in PBS 
or PB (Sigma) and later diluted as required in the corresponding medium.  
CeO2 and TiO2 are larger size and this may be due to aggregation. However, the aggregated 
and precipitated NPs do not contribute to the fluorescence signal as we have used labeled 
proteins.  
 
METHODS. FCS measurements were carried out on a LSM10 microscope fitted with a 
ConfoCor2 unit (Carl Zeiss Jena, Germany). We used two kinds of excitation – an argon ion 
laser of 488nm (TF, BSA and FN) and HeNe2 of 633nm (FG). All measurements were 
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performed with water immersion with an objective of 40X. A bandpass filter 525/25nm was used 
to separate the fluorescence emission from excitation light. Experiments were performed at room 
temperature regulated at 22°C. 384 well plates were used for measurements (Greiner bio one). 
The wells were precoated by pluronic acid in MilliQ for one hour and washed carefully with 
MilliQ later to wash off excess pluronic acid.  
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FIGURES  
 
Figure 1. Protein-NP binding measurements using fluorescence correlation spectroscopy  
a) Schematic drawing of labeled proteins binding to unlabeled nanoparticles detected by 
fluorescence in the laser focus volume. b) Time autocorrelation function of freely diffusing 
proteins and proteins adsorbed to NPs. In binding equilibrium the time correlation exhibits a free 
fraction with diffusion time  and a fraction bound with diffusion time . c) Typical evolution 
of the time correlation functions of the proteins after addition of NPs. The interactions fall into 
one of three categories corresponding to binding (I), no binding (II) or aggregation (III). 
1 2
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Figure 2. Matrix of FCS kinetics from all possible combinations of NP and proteins showing the 
time dependent evolution of the FCS autocorrelation (pure protein = dotted, after 5 min after NP 
addition = black, 10 min = orange, 20 min = light blue, 30 min=green, 45 min= yellow, 60 min = 
dark blue). Data are highlighted according to the behavior: aggregation: red, strong binding: 
green and weak binding or no binding: white.
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Figure 3. Theoretical analysis of protein-NP binding isotherms: a) Fraction of NP coated 
according to Langmuir adsorption model (dashed) and according to the exact solution of the law 
of mass action (solid line). Data are plotted for various KD/NP values: 1 (green), 10 (blue) and 
100 (orange). b) Fraction of protein bound to NPs according to the strong binding model (black 
dashed line) and according to the exact solution of the law of mass action (solid line). c) 
Adsorption isotherms measured for FN/silica and BSA/PSCOOH. Solid red lines represent 
fitting according to Equation 6 and dashed black lines according to the strong binding model. 
The position of full monolayer coverage (vertical dotted line) yields the number of binding sites 
per NP. d) To-scale representation of the proteins BSA and FN and the NP with diameter 100 
nm.  
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Figure 4. Fraction of bound of BSA to a) PSCOOH NPs, b) TiO2 NPs and c) CeO2 NPs from 
zero (blue) to 50% (red) as a function of BSA concentration and NP concentration. While 
PSCOOH NPs show relevant binding with BSA that is depended of both, concentration of 
protein and NP, TiO2 and CeO2 NPs show very little to no binding.  
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Figure 5. a) Schematic drawing of adsorption of labeled protein and following desorption 
by serum. b) Desorption kinetics of protein coated NPs in serum are shown for various 
combinations of protein and NPs. The solid lines were obtained with a single exponential fit, 
yielding desorption-time values. The characteristic desorption-rates 𝑘𝑜𝑓𝑓 are as follows: 8.8·10
-3 
min-1 for BSA with PSCOOH (stars); 8.3·10-3 min-1 for Tf with PSOSO3H (diamonds); 5.6·10-3 
min-1 for Tf with PSCOOH (squares); 2.7·10-3 min-1 for FN with silica (upwards triangles);  
2.4·10-3 min-1 for BSA with PSOSO3H (downwards triangles); 3.0·10-4 min-1 for FN with 
PSCOOH (circles).  
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TABLES.  
Table 1 
Properties of proteins 
 FN FG Tf BSA 
Molecular weight[kDa] 440 340 77 67 
Hydrodynamic radius [nm] 9.0±0.7 8.5±0.9 3.6±0.1 3.3±0.1 
Isoelectric point 5.6-6.1 5.8 5.6 5.4 
Type of NP silica - PSOSO3H PSCOOH 
Number of sites per NP 16 - 300±100 a) 200 
surface area per protein [nm²] 1963 - 105 157 
KD/NP 0.15 - 0.31 0.41 
koff [min-1] 2.7·10-3   8.3·10-3 8.8·10-3 
a) from Milani et al.9  
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SUPPORTING INFORMATION. Autocorrelation function of desorption kinetics of proteins 
coated NP in 10% serum and stability of NPs in different media are shown (Figures S1 and S2). 
This material is available free of charge via the internet at http://pubs.acs.org.  
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ABBREVIATIONS 
BSA, bovine serum albumin; CeO2, cerium oxide; FCS, fluorescence correlation spectroscopy; 
FG, fibrinogen; FN, fibronectin; NP, nanoparticle; PSCOOH, carboxylated polystyrene; 
PSOSO3H, sulphonated polystyrene; SiO2, silicon dioxide; Tf, transferrin; TiO2, titanium 
dioxide; CeO2, Ceria 
SYNOPSIS 
In this work, we investigated binding of selected proteins and NPs in all possible combinations 
using fluorescence correlation spectroscopy. We found three categories of interactions, namely- 
binding, weak/no binding and aggregation. In case of binding we measured the fraction of bound 
protein vs. the protein/NP molar ratio and described these isotherms by the law of mass action 
allowing for attribution of equilibrium constants and adsorption area per protein. The normalized 
dissociation constant are shown to correlate with measured desorption rates, when protein coated 
NP are placed in serum protein. The data indicate that there is some degree of predictability in 
binding behavior of protein-NP mixtures based on the size of the protein and protein binding 
affinity to the NP. 
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Figure S1. Different proteins have different off-rates on exposure to serum. The strength of 
binding also depends on NPs used. Here, autocorrelation function (ACF) of desorption 
kinetics of protein (BSA and Tf) coated nanoparticles (PSOSO3H, PSCOOH) in 10% serum 
are shown: a) BSA and PSOSO3H, b) Tf and PSCOOH. Black lines are the ACF of pure 
proteins, red lines represent ACF of coated NPs in PB, and solid lines are in presence of 
serum at different times. The different times are at 10, 20, 30, 40, and 50 minutes (green to 
yellow). 
 
Figure S2. Various NPs are found to be stable in various media. This figure shows some 
representative DLS data for the stability of NPs in different media.  
The sizes of the NPs are checked for all the NPs. DLS figures for Fe dex SPION (red), titania 
(blue) and ceria (green) are shown in the upper panel. The first was found to be stable in PB 
whereas later two in PBS.  
Silica was found to be most stable in PB (blue) as seen in the lower panel of the figure. Silica 
in water (green) and PBS (red) are also shown in the same panel. 
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Abstract 
Thermosensitive liposomes (TSLs) whose phase-transition temperature (Tm) lies slightly 
above body temperature are ideal candidates for controlled drug release via local 
hyperthermia. Recent studies, however, have revealed disruptive shifts in the transition 
temperature in mouse plasma, which are attributed to undefined interactions with blood 
proteins. Here, we study the effects of four major plasma proteins – serum albumin (SA), 
transferrin (Tf), apolipoprotein A1 (ApoA1) and fibrinogen (Fib) – on the temperature-
dependent release of fluorescein di-β-D-galactopyranoside (FDG) from TSLs. The amount of 
fluorescein released was quantified by fluorescence correlation spectroscopy (FCS) after 
hydrolysis of FDG with β-galactosidase (-Gal). This approach is more sensitive and thus 
superior to previous release assays, as it is impervious to the confounding effects of Triton on 
conventional fluorescence measurements. The assay determines the molar release ratio, i.e. 
the number of molecules released per liposome. We show that shifts in the Tm of release do 
not reflect protein affinities for the liposomes derived from adsorption isotherms. We confirm 
a remarkable shift in induced release towards lower temperatures in the presence of mouse 
plasma. In contrast, exposure to rat or human plasma, or fetal bovine serum (FBS), has no 
effect on the release profile. 
Introduction 
In the 1970s, Gregory Gregoriadis first proposed the use of liposomes for drug delivery [1–3]. 
Liposomes have many obvious advantages in this context: they are biocompatible, 
biodegradable and show little or no antigenic or allergenic activity. These features largely 
explain why the majority of FDA-approved and therapeutically applied nanoparticle-based 
delivery vehicles falls into the category of liposomal or lipid-based formulations, such as 
Doxil, DaunoXome or Marqibo [4–8]. A potential limitation of these products is the absence 
of a controllable drug release mechanism, which would enable localized therapy and thus 
reduce side-effects. Therefore, the next step in the development of lipid-based delivery 
platforms was the implementation of stimulus-responsive drug delivery. Thermosensitive 
liposomes (TSLs) are the most promising triggered systems, with one formulation 
(Thermodox) having successfully undergone clinical phase I studies in humans [9,10]. TSLs 
allow for temperature-controlled drug release in response to local hyperthermia or focused 
high-intensity ultrasound [11–14]. 
TSLs are composed of a lipid mixture that is designed to have a melting phase-transition 
temperature (Tm) a few degrees above a chosen target temperature. At this point, the structure 
of the lipid bilayer changes from a solid-gel phase to a liquid-crystalline phase. This change 
increases the permeability of the membrane for the encapsulated drug at temperatures in the 
vicinity of Tm, leading to the release of the drug by passive transfer along a concentration 
gradient [11]. In the present study, we use TSLs composed of DPPC/DSPC/DPPG2 (50/20/30 
mol/mol) (DPPG2-TSL) as proposed by Lindner et al. [15]. The phase transition takes place at 
Tm ~ 42°C, i.e., above mammalian body temperature [16,17]. This mixture proved to be more 
stable in serum than the more generally used Lyso-PC-containing TSL formulations [18] and 
showed a prolonged circulation time in rodents [15,19] and cats [20]. Hence, DPPG2-TSLs 
seem well suited for in-vivo applications in clinical settings. 
Recent release studies have noted that body fluids such as plasma or serum can have a 
profound effect on the transition temperature of liposomes and the efficiency of drug release 
[21,22]. It is thought that protein opsonization and/or penetration of proteins into the lipid 
bilayer are responsible for these changes, which usually shift Tm to lower values by 
destabilizing the membrane. (Figure 1A) [23,24]. In light of the therapeutic implications and 
safety issues raised by uncontrolled release, investigation of these alterations in Tm is 
extremely important for the translatability of in-vitro studies into clinical practice. In addition, 
the formation of a protein corona can affect both the circulation time of a drug carrier and its 
final destination, e.g., resulting in many cases in unwanted uptake by the liver or spleen. 
 
 
 
Figure 1: A Pictogram that illustrates the experimental setting and the processes studied: 
Release of dye (green hexagons) from liposomes in buffer (1), in the presence of a specific 
plasma protein (2, yellow spheres) and in the presence of whole plasma (3, mixed colors). The 
reversible binding of selected plasma proteins to DPPG2-TSL (4) was also studied. B The 
confocal volume in an FCS experiment: Fluorescently labeled particles diffuse through the 
confocal volume, leading to fluctuations in the fluorescence intensity (not drawn to scale), 
from which several physical parameters of interest, such as particle concentration and size, 
can be determined. 
 
The standard way to determine the temperature response of a TSL formulation is to measure 
changes in the fluorescence intensity of released carboxyfluorescein (CF) by fluorescence 
spectroscopy (FS) [25,26]. This assay is based on the assumption that the concentration of CF 
inside the liposome is so high that the fluorescent molecules are self-quenched, and dequench 
only after release from the liposome [27,28]. 
In our assay for the quantification of release, we instead combine fluorescence correlation 
spectroscopy (FCS) with the use of fluorescein di-β-D-galactopyranoside (FDG). FDG is non-
fluorescent, and formation of the fluorescein emitter requires the membrane-impermeable 
enzyme β-galactosidase (β-Gal). Thus, as long as FDG is confined within the liposomes, no 
signal will be detected (Figure 2B, I). If β-Gal is added to the dispersion, free FDG is cleaved 
and the resulting fluorescence can be characterized, and the levels of release measured, with 
high sensitivity by FCS (Figure 2B, II and III). This technique is an established method that 
allows one to determine not only concentrations of fluorescent particles in the pico- to 
nanomolar range (10-12-10-9 M, Figure S1), but also their diffusion coefficients, 
hydrodynamic radii and binding or cleavage interactions [29–34] – even in complex media 
like plasma or serum [35,36]. Diffusion of the fluorescently labeled particles through the 
confocal volume induces fluctuations in the fluorescence signal (Figure 1B). A model fit to 
the time correlation of the signal yields the physical characteristics mentioned above. Its 
flexibility makes FCS an ideal method for characterizing TSLs, their release behavior and 
their interaction with proteins. 
 
Figure 2: A Experimental set-up. FDG within the TSL is non-fluorescent. FDG that was not 
removed during purification of TSLs is also shown (I). β-Galactosidase hydrolyzes external 
FDG, generating the strongly fluorescent compound fluorescein (II), and subsequently allows 
one to monitor the temperature-dependent release of FDG from TSLs (III). B Count rates for 
scenarios I-III. In the absence of β-Gal, the fluorescence is indistinguishable from background 
noise (I). For II a weak signal from the FDG that was not removed by purification is 
observed. For III a high signal is obtained due to the large amount of FDG that is released at 
T>Tm. C Corresponding fluorescence correlation curves. 
However, the potential of FCS for measurements of physicochemical parameters of TSLs and 
the quantification of drug release has not yet been fully exploited. Earlier publications focused 
on single features such as the interaction of proteins and liposomes [35,37] or the leakage or 
release of dyes from liposomes [38–41], but so far no study has attempted to characterize both 
of these processes simultaneously. However, understanding the interaction of liposomes with 
their protein environment and quantifying levels of unwanted release of drug molecules are 
vital prerequisites for the successful pharmaceutical development of targeted, liposome-based 
drug-delivery systems. 
Here we study the effects of plasma proteins on the phase-transition temperature Tm
(*) of 
DPPG2-TSLs and the temperature-dependent release of cargo molecules. We use FDG 
encapsulated in DPPG2-TSLs combined with FCS to quantify the molar release ratio of FDG 
per DPPG2-TSL for four representative plasma proteins. In a second set of experiments we 
use FCS to measure the binding isotherms of the four plasma proteins to DPPG2-TSL and 
determine their equilibrium binding constants. We show that FCS is capable of quantifying 
the release profile in buffer and allows for measurements in blood plasma. The FCS data 
confirm that the temperature of release is shifted in the presence of mouse plasma, but 
remains largely unaffected by rat and human plasma and by fetal bovine serum (FBS). 
 
Materials and Methods 
Chemicals 
All lipids were obtained from Corden Pharma Switzerland LLC. The phospholipid DPPG2 
was synthesized as described before [42]. FDG and β-Gal were supplied by AAT Bioquest 
and Merck Millipore, respectively. 
FBS (Gibco, Life Technologies), human plasma (from a volunteer donor) and animal plasma 
(Sera Laboratories) were aliquoted, stored at -20°C and thawed in a water bath at 37°C before 
use. For calibration of the FCS assay, Alexa 488 and Alexa 543 (Invitrogen, Life 
Technologies) and eGFP were used. All other chemicals and proteins were purchased from 
Sigma Aldrich GmbH, Carl Roth GmbH, Invitrogen or YoProteins. Proteins were dissolved in 
PBS as recommended by the suppliers and further diluted as required with HEPES-buffered 
saline (HBS, 20 mM HEPES, 150 mM NaCl, pH 7.4) supplemented with 1 mM MgCl2. 
 
Preparation and characterization of TSLs 
DPPG2-TSLs were prepared and characterized by DLS as described in detail elsewhere 
[16,17]. In brief, the hydrodynamic diameter (z-average), size vs. intensity distribution plot 
and zeta-potential were determined by DLS using a Zetasizer Nano ZS (Malvern Instruments, 
Worcestershire, UK). The instrument was calibrated with a NanosphereTM size standard 
(125 nm, Thermo Fisher Scientific, Waltham, MA, USA). Phospholipid composition was 
determined by phosphate analysis [42]. 
 
Fluorescence spectroscopy 
Fluorescence intensity was measured with a Cary Eclipse fluorescence spectrometer (Varian 
Inc., Palo Alto, CA, USA) at room temperature (excitation/emission: 493/513 nm) and 
analyzed as described before [18]. The extent of cargo release was determined using the 
formula: Release [%] = (I(T)-I0)/(Iend – I0) * 100, where I(T) is the fluorescence intensity at 
the temperature T and I0 is the background signal at room temperature. Iend is the signal 
obtained after treatment of a sample with 10% Triton X-100, which disrupts the liposomes, 
resulting in complete release of their contents. 
To determine the temperature dependence of FDG release, the TSL stock solution was first 
diluted 1:50 (vol/vol) with 0.9% NaCl (=VL). A 100-µl sample of VL was further diluted 1:10 
(vol/vol) with FBS or HBS + 1 mM MgCl2 (pH 7.4), and 20 µl-aliquots of this solution were 
incubated at temperatures ranging from 37-45°C for 5 min in a thermocycler. Then ice-cold 
Tris solution (pH 7.4, 1 ml) was added to stop the reaction. A mixture of 100 µl of VL and 
100 µl of 10% Triton that had been incubated for 15 min at 45°C and then diluted with 900 µl 
of 0.9% NaCl served as the positive control (=TL). FDG release was measured by FS after 
adding to 20 µl TL to 1 ml Tris. Prior to measurement, 100 µl β-Gal (5.12 U/ml) was added to 
each sample and incubated for 30 min at room temperature in the dark. 
 
Fluorescence Correlation Spectroscopy 
Measurements were performed on an Axiovert 100 microscope equipped with a ConfoCor2 
unit (Carl Zeiss Jena, Germany), an argon laser (488 nm), a helium-neon laser (543 nm) and 
an apochromatic 40x water-immersion objective with NA of 1.2 (Carl Zeiss Jena, Germany). 
Fluorescence emission was separated from excitation light by using the appropriate band-pass 
filters (500-530 nm and 560-615 nm, respectively). All measurements were performed at 
room temperature (22°C). NUNC 8-well slides (Thermo Scientific) and sample volumes of 
200 µl were used for release measurements. 
 
In order to monitor the temperature-dependent release of FDG from liposomes the TSL stock 
solution was diluted 1:150 (vol/vol) with the appropriate medium (buffer, plasma, or protein 
solution), and 20 µl-samples were incubated at defined temperatures between 37°C and 45°C 
for 5 min in a thermocycler (Eppendorf). The reaction was stopped by adding 175 µl 
HBS + 1 mM MgCl2 and 5 µl β-Gal (51.2U/ml) that had been stored on ice. The samples were 
then incubated for 30 min at room temperature in the dark prior to analysis by FCS. As the 
positive control (complete release), a solution containing 20 µl of diluted TSL and 20 µl 
10% Triton X100 was incubated for 15 min at 45°C, then 155 µl of ice-cold HBS + 1 mM 
MgCl2 and 5 µl β-Gal (51.2 U/ml) were added and the samples were incubated for 30 min at 
room temperature in the dark. 
 
Analysis of FCS data 
 
The one-component fitting function 
𝐺(𝜏) = 1 +
1
𝑁
 (1 +
𝜏
𝜏𝐷
)
−1
(1 +
𝜏
𝑆2𝜏𝐷
)
−1/2
 
is used to fit the correlation data from the FCS measurements for samples containing only one 
fluorescent species. The fit parameters N and D are variables, and the structure parameter S 
was determined from the calibration with a solution containing eGFP in FBS or Alexa dye in 
HBS + 1 mM MgCl2. Corrections for expansion of the confocal volume in the presence of 
Triton or FBS were applied (see SI). The finite size correction was used for size analysis of 
TSLs [43]. 
The hydrodynamic radius Rh of a spherical molecule can be determined with the Stokes-
Einstein equation (see SI). Fitting of a sigmoidal function to the temperature-dependent 
release allows one to estimate the phase transition temperature Tm*. 
 
Measurements of protein binding by FCS 
 
Measurement chambers (Sensoplate plus, 384-well plate, Greiner Bio-One) were precoated 
with 5 mg/ml BSA for 1 h to avoid unwanted adsorption of proteins to the walls. Afterwards 
the chambers were rinsed with MilliQ water to remove unbound BSA. 
The samples were measured and analyzed essentially as described previously [37,44]. First 
we measured samples of the proteins labeled with Alexa 488 in the absence of DPPG2-TSLs, 
in order to determine the size (D1) and number (N0) of particles present. Then the DPPG2-
TSLs were added and the samples were measured after 1 h of incubation. To determine the 
fraction of bound protein, we used a two-component fit (see SI). The diffusion time of the 
free protein was fixed to the value D1. The diffusion time of the protein bound to TSLs D2 
was treated as a free parameter. The fraction bound was then determined using the equation 
𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑏𝑜𝑢𝑛𝑑 = 1 −
𝑁𝑢𝑛𝑏𝑜𝑢𝑛𝑑
𝑁0
= 1 −  
𝑁 ∙ 𝐹1
𝑁0
 
where N is the total number of particles in the confocal volume after the addition of TSLs, F1 
is the fraction of unbound fast diffusing protein in solution and N0 is the initial number of 
proteins in the sample. 
 
The KD values were determined with fitting to a Hill-equation, and the reversibility of the 
binding was tested by adding FBS to the protein-TSL solutions and incubating for a further 
hour prior to measurement. 
 
Statistical analysis 
The data are expressed as the mean ± standard deviation of at least three independent 
experiments. 
 
Results and Discussion 
Characterization of the TSLs 
In order to ensure that there is no uncontrolled release due to changes of medium and in order 
to be able to quantify the release with precision later on, we first characterized the behavior of 
DPPG2-TSLs containing the encapsulated dye in different media. 
DPPG2-TSLs were prepared with various payloads and with or without a membrane label 
depending on the experiment, and standard parameters such as z-potential, phosphate content 
and size were determined for each condition (see Table 1). The results of the size 
measurements by DLS and FCS in buffer (0.9% NaCl) show good agreement for TSLs with 
the rhodamine membrane label (Dh, DLS = 105 nm vs. Dh, FCS = 96.1 ± 4.1 nm). At the same 
time, we evaluated the concentration of TSLs in a standard sample to be 0.28 nM using an 
excitation of ex =543 nm. In contrast to DLS, FCS can be used to measure the size 
distribution of DPPG2-TSLs not only in buffer but also in complex fluids such as FBS. FCS 
selectively detects the fluorescently labeled DPPG2-TSL and thus avoids interfering signals 
by other components of the fluid [45]. Characterization under essentially physiological 
conditions is important, given that we wish to learn about the stability of DPPG2-TSLs and 
possible obstacles to their use for drug delivery in living organisms. Therefore, we chose FCS 
to measure the DPPG2-TSL size in FBS. For FCS measurements with ex =488 nm we use 
TSL with CF as a payload to determine the size of the liposomes. We obtain a hydrodynamic 
diameter (99.1±4.1 nm) that is in good agreement with the values determined in buffer (see 
Table 1). This confirms that FBS has no significant effect on DPPG2-TSL size. 
After characterization of the DPPG2-TSLs, we sought to measure release from the liposomes 
with high precision by FCS. This requires that the released substance – here, CF – yields a 
clear signal that is not obscured by non-released substances or buffer components. The 
simplest way to perform such an experiment is to load the carrier – in our case the TSL – with 
the cargo CF. The dye in the TSL should diffuse significantly more slowly than the released 
dye, permitting unambiguous discrimination between the two signals. Due to significant 
differences in the brightness of a single free dye molecule relative to that of a filled TSL, 
precise analysis of the dynamics of release is quite complex and does not provide single-
molecule resolution. To overcome this limitation, we developed a novel assay to measure 
release from TSLs. The underlying idea is to load into the TSL a dye that becomes fluorescent 
only after being released. Here, the only signal measured in the FCS experiments is that 
originating from the released dye (see Figure 2). As a result, the correlation curve is not 
compromised by the presence of fluorescent TSLs. To achieve this improvement in signal 
resolution, we chose FDG as the cargo, as it only becomes fluorescent when cleaved by β-Gal 
following its release (Figure S2). 
Cargo 100 mM CF 1 mM FDG Empty 
Membrane label RhPE - - 
Phosphate concentration 
[mM] 
41.5 38 45 
Z-potential [mV] -28.5 -25.9 -30.5 
DLS diameter [nm] 
z-average 
105 114 105 
PDI 0.068 0.134 0.083 
FCS Dh [nm], ex. 488 nm 82.6±5.4 - - 
FCS Dh [nm], ex. 543 nm 96.1±4.1 - - 
FCS Dh [nm], ex. 488 nm 
in FBS 
99.1±4.1 - - 
Table 1: Characterization of different types of DPPG2-TSL  by DLS and FCS measurements. 
FCS data are averages (±standard deviation) of three independently prepared samples. PDI, 
polydispersity index; Dh, hydrodynamic diameter. 
 
Encapsulation and purification efficiency 
Loading of DPPG2-TSL is performed in highly concentrated FDG solution (1 mM). 
Subsequently, the excess dye was removed by filtration through Sephadex columns. As a 
control we measured the level of fluorescent dye associated with the purified TSLs. This 
measurement after purification yields a weak signal of FDG corresponding to a concentration 
of 3.36 nM of non-encapsulated FDG in the sample solution, which contains 0.28 nM TSLs 
(Figure 2, II). Hence, in order to quantify the absolute release in the following experiments, 
this offset value has to be applied as a correction. Otherwise, adventitious release, at low 
temperatures in particular, leads to serious overestimates of the magnitude of induced release. 
We determined the encapsulation efficiency of the TSL in two different ways. In both cases, 
we calculated the ratio of the experimental to the theoretical value. Firstly, we used the 
common definition of the cargo/lipid ratio in terms of the molar concentrations of each. We 
obtain a value of 8.0 ± 0.7 %. This value seems surprisingly low. So we decided to compare 
the measured amount of [fluorescein]/[TSL] to a theoretical estimate of this value. Using this 
approach, we obtain an encapsulation efficiency of 53.7 ± 9.4 %. Intuitively, this value seems 
more likely. Both calculations are presented in detail in the SI. The difference arises from the 
different definitions of the encapsulation efficiency. While the cargo/lipid ratio is suited for 
drugs that bind to the lipid membrane, the definition of drug/TSL is more appropriate for 
cargo that remains free in solution, such as FDG.  
 
Measurements of release in buffer and plasma 
With knowledge of the offset concentration of FDG, it can be corrected with great precision, 
allowing us to study the concentration of the temperature-dependent release of FDG. 
At temperatures around 42°C, TSLs are expected to undergo a phase transition that disrupts 
membrane integrity, which should result in release of the loaded FDG. In order to actively 
induce release, the DPPG2-TSL solution was heated to temperatures ranging from 37-45°C. 
To provide constant measurement conditions, the liposome solution was then cooled down to 
4°C. After cooling, β-Gal was added and FCS was performed at room temperature (22°C). 
Addition of β-Gal after cooling ensures that the enzyme is unable to cross the membrane and 
no FDG inside the TSL is hydrolyzed. The concentration of FDG in the external medium was 
determined from the FCS curve and is expressed relative to the concentration of TSL in the 
dispersion, i.e. as [fluorescein]/[TSL] in the following. 
With this assay we measured the amounts of cargo released at various temperatures, as 
displayed in Figure 3A (raw data in Figure S3 and S4). We find no release up to 37°C, and 
release is first detected at 38°C. The amount of FDG released then increases with increasing 
temperature, yielding an S-shaped curve that reaches saturation at around 43°C. As a control, 
we measured the release induced by Triton, which completely disrupts the TSL membranes 
leading to release of all FDG molecules. Within the margin of error, the measured value is 
equal to the saturation value for release at high temperatures. Hence, we can conclude that all 
FDG is released from the liposomes at temperatures above 43°C. 
 
Figure 3: Temperature-dependent release of fluorescein from FDG-loaded DPPG2-TSLs in 
HBS + 1 mM MgCl2 (triangles, dashed line) and FBS (circles, line). A Molar ratio of 
fluorescein released per DPPG2-TSL measured using FCS. B Relative fluorescence intensity 
compared to total release determined by fluorescence spectroscopy (FS). 
To further evaluate the performance of the FCS-based assay, we compare the results with 
conventional FS data. Figure 3B shows the relative change in fluorescence normalized with 
respect to the Triton value. Both release profiles (Figures 3A und B) follow the same trend of 
strongly increasing release around a critical temperature of 40-41°C, saturation at temperature 
about 43°C, and barely detectable release below 40°C, indicating that the membrane is 
practically impermeable within this last temperature range. FCS data determine the molar 
ratio of FDG molecules released per liposome, while FS data show the total fluorescence 
intensity and hence the amount of FDG release relative to the total release caused by 
membrane disintegration upon addition of Triton. Note that the data shown in Figure 3B 
exceed 100% and shift below 0%. This is an intrinsic artefact of the FS approach, which is 
due to impact of Triton on the brightness of the dye and therefore on the normalization. We 
can reproduce these values when we perform the same analysis as for FS using the count rates 
measured with FCS (Figure S4). In FCS experiments, we observed that the level of emission 
by the dye molecules was decreased compared to a solution without Triton (see Figure S5). 
Due to this observation, we assume that methods that solely rely on the analysis of changes in 
fluorescence intensity in the presence of Triton, which is often used to determine release 
behavior [25,26], are not optimally suited for highly precise measurements, at least not for 
fluorescein. The FCS method employed here may provide a more reliable alternative, since it 
measures absolute concentrations and does not depend solely on absolute brightness 
measurements. This is especially useful for determinations of spurious release. 
Next, we measured temperature-dependent release in the more physiologically relevant 
medium FBS. Here, the release curves are similar to those in buffer, irrespective of the 
measurement technique employed, showing that FBS does not influence temperature-
dependent release significantly (Figure 3, circles). 
In further drug development for use in humans, animal testing plays an important role. 
Therefore, we measured the release in the presence of mouse, rat and human plasma and 
compared it to the data for FBS (Figure 4). Corresponding FS data are shown in Figure S6. 
For FBS, human and rat plasma we observe the same general trend. Strikingly, for mouse 
plasma we observe a marked deviation from the other curves, characterized by significant 
release even at 37°C. This behavior was previously reported by Hossann et al. [18]. One 
possible cause is the increased lyso-lipid content of mouse plasma [46,47]. 
To test this hypothesis, we supplemented human plasma with Lyso-PC to generate a level that 
is comparable to that of mouse plasma. Upon addition of Lyso-PC, we observe a slight shift 
of the release curve towards lower temperatures, relative to human plasma without Lyso-PC. 
Similarly, the onset of release in mouse plasma is shifted to lower temperatures relative to 
plasma from other mammals. However, the effect in mouse plasma is much more pronounced 
than in human plasma enriched in Lyso-PC, indicating that Lyso-PC might contribute to this 
phenomenon, but does not explain it entirely. 
 
Figure 4: Effect of plasma on the temperature-dependent release profile: mouse plasma 
(circles), rat plasma (squares), human plasma (inverted triangles), human plasma doped with 
Lyso-PC (diamonds) and fetal bovine serum (asterisks, gray trace).  
 
Release measurements in monodisperse protein solutions 
Given that plasma consists of many components, a multitude of molecules or molecular 
interactions could conceivably contribute to this difference in human and mouse plasma. To 
better understand these observations, we evaluated the effect of several prominent blood 
proteins on release by using single-protein solutions as the external medium (Figure 5). 
We chose to test the plasma proteins serum albumin (SA), transferrin (Tf), apolipoprotein A1 
(ApoA1) and fibrinogen (Fib). The release of FDG from DPPG2-TSLs was evaluated in 
15.2 µM SA, 12.6 µM Tf, 1.7 µM Fib and 7.1 µM ApoA1. We decided to use lower 
concentrations of Fib and ApoA1 because they have been observed to bind strongly to drug 
nanocarriers in other studies [48–50]. 
Compared to the results in the absence of proteins, SA and Fib cause more pronounced 
release at lower temperatures, while ApoA1 seems to impede release (see Figure 5). The shift 
in the release of SA was described before. It is assumed that the adsorbed protein affects the 
integrity of the membrane by partial penetration [51–53]. A similar explanation can account 
for the change in release behavior induced by ApoA1. ApoA1 probably acts to seal the 
packing defects that form in the membrane, thereby reducing cargo release from DPPG2-TSL. 
Tf seems to have only a minor influence on release relative to cargo loss in pure buffer. 
In plasma the observed effects of the single proteins seem to largely compensate for each 
other. However, they might contribute to the differences observed between the kinetics of 
release in plasma of different species (Figure 4). 
 
Figure 5: Temperature-dependent molar release in the presence of specific proteins from 
plasma: SA (diamonds), transferrin (squares), fibrinogen (circles) and apolipoprotein A1 
(triangles). For reference, the release profile in HBS + 1 mM MgCl2 is shown in gray 
(asterisks). 
 
Binding of proteins to TSLs 
Next, we evaluated the binding behavior of these plasma proteins to check whether there is 
any relationship between the effects of the proteins on release and their affinities for the 
TSLs. FCS allows us to determine the dissociation constant KD for binding of fluorescently 
Alexa 488-labeled proteins, and is therefore well suited to the study of binding behavior, 
especially for strong binders, as shown before [37,44,54] (Figure S8). The results of titration 
series of DPPG2-TSL for the various proteins are shown in Figure 6. For analysis we used a 
Hill-equation instead of the law of mass action, because the number of available ligands, i.e. 
binding sites on the DPPG2-TSL, is much larger than the number of receptors, i.e. the mole 
fraction of the labeled protein, in agreement with Rusu et al. [37]. The results of the analysis 
are summarized in Table 2. For ApoA1 we observe strong binding, with a binding constant 
two orders of magnitude higher than those for the other proteins. This strong binding may 
explain why ApoA1 was the only protein tested that reduced the efficiency of release. A 
reduction in release can presumably be achieved by efficient binding and blocking of packing 
defects. Of the three other proteins with weaker binding constants, only serum albumin 
strongly affects release. As described above, SA is suggested to increase the permeability of 
the liposome bilayer, which leads to enhanced release, while its weak binding prevents the 
high surface coverage that might well reduce this effect. 
To test the reversibility of binding, we added FBS to the TSL-protein mixtures after 
incubation and monitored the kinetics of protein detachment (Figures S9 and S10). 
Reversibility experiments provide a means to exclude or identify the proteins that are mainly 
responsible for the changes in release kinetics in plasma. All four tested proteins desorbed 
from the liposomes after addition of FBS. SA, Fib and Tf were immediately displaced, while 
ApoA1 detached from the liposomes over the course of 1 h (Figure S10). One explanation for 
this effect might be that other biomolecules in FBS have a much higher affinity for the 
liposomes than the tested proteins, and therefore replace the labeled proteins on the surface of 
the liposomes. Alternatively, molecules that bind more strongly to the DPPG2-TSLs than do 
the test proteins (other than ApoA1) may be present in the FBS solution and thus displace 
them from the liposomes. A combination of the two effects is also possible. The detachment 
of the proteins from the DPPG2-TSL in FBS explains why we did not observe their impacts on 
temperature-dependent release in the presence of FBS. 
Interestingly, ApoA1 was removed slower from the DPPG2-TSL than the other proteins. By 
using higher concentrations of ApoA1 for incubation, this could be employed as a natural 
coating for the TSL. In this way, it might be possible to increase circulation times as 
apolipoproteins are stated to prevent opsonization [47] and improve targeting of DPPG2-TSL 
by increasing their selectivity. Similar tests could be performed for other substances as well. 
 
 
Figure 6: Binding isotherms of Alexa 488-labeled proteins to DPPG2-TSL (normalized data). 
The concentration of the labeled proteins was kept constant while the concentration of TSL 
was varied; ApoA1 (inverted triangles), fibrinogen (circles), SA (diamonds) and transferrin 
(squares). 
 
protein Apolipoprotein 
A1 
Fibrinogen Serum albumin Transferrin 
KD [nM] 0.053±0.004 2.951±0.174 5.393±0.405 9.652±0.001 
|ΔTm*| [°C] 0.01±0.12 0.12±0.11 0.92±0.09 0.21±0.11 
Table 2: Dissociation constants KD and |ΔTm*| of the tested plasma proteins ApoA1, Fib, SA 
and Tf. |ΔTm*| is the absolute difference between the Tm* determined in protein solution and 
in pure buffer.  
 
Conclusion 
We have used a novel and highly sensitive assay based on FCS to quantify the temperature-
dependent release of the contents of dye-loaded TSL. We validated the FCS approach by 
measuring the temperature release profile of FDG-loaded DPPG2-TSL and comparing it to 
standard fluorescein FS studies. The FCS-based assay is superior with regard to determining 
spurious release at temperatures lower than the Tm. Assessment of low drug release is 
important to ensure that TSL membranes remain sealed at room temperature, which is a 
prerequisite both for controlling the dosage dispensed and avoiding non-specific delivery to 
healthy tissue. In addition, the FCS-based approach yields information on size and 
encapsulation efficiency, as well as interactions of TSLs with blood proteins. Here we have 
been able to monitor, for the first time, the binding of standard blood components to DPPG2-
TSL as well as the resulting shift in the critical release temperature. Surprisingly, only one of 
the tested proteins (SA) induced such a shift, while others (Fib, ApoA1, Tf) bound but did not 
affect the temperature profile of release. Likewise plasma derived from human and rat, and 
whole bovine serum, had no effect in the temperature profile, in stark contrast to mouse 
plasma. Hence there seems to be no systematic relationship between binding affinity and shift 
in the temperature of release, yet protein binding is very probably an essential prerequisite for 
any change in the intrinsic thermal properties of TSL upon contact with body fluids. The 
assay is applicable to a broad field of possible interactions of liposomes with their 
environment such as interactions with specific proteolytic plasma casacdes, to screen for the 
suitability of TSLs for medical use. A better understanding of protein adsorption to TSL and 
drug-delivery liposomes in general will facilitate the design of alternative membrane coatings 
based on combinations of plasma proteins. Such synthetic coronas are biocompatible, and 
could possibly prevent further opsonization and increase circulation time. To this end, 
quantitative biophysical assays for multiple protein-membrane interaction parameters will be 
instrumental for the elaboration of improved targeting strategies. 
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Basics of Fluorescence Correlation Spectroscopy Analysis 
The normalised correlation function G(τ) is defined as 
 
𝐺(𝜏) =
〈𝐹(𝑡)𝐹(𝑡+𝜏)〉
〈𝐹(𝑡)〉2
  (Equation S1), 
 
where angular brackets denote the average over time t, F(t) the fluorescence signal at time t and F(t 
+ τ) the fluorescence signal at time t + τ. 
It is assumed that the confocal volume has an ideal three dimensional Gaussian shape. The ratio of 
the half axes z0 to the radius of the laser beam w0 is called structure parameter ω und is a measure for 
the size of the confocal volume. Physically relevant information can be extracted from the correlation 
curve by fitting a model to the experimental data. The autocorrelation curve for a single component 
freely diffusing in a 3D Gaussian element can be described by: 
 
𝐺(𝜏) =
1
𝑁
 (
1
1+
𝜏
𝜏𝐷
) (
1
1+
𝜏
𝜔2𝜏𝐷
)
1
2
+ 1  (Equation S2) 
 
where N is the number of particles inside the confocal volume, τD is the translational diffusion time 
of the species, τ is the correlation time and ω the structure parameter. 
The translational diffusion time τD describes the average dwell time of a molecule with diffusion 
constant D in the confocal volume. 
 
𝜏𝐷 = 
𝜔0
2
4𝐷
  (Equation S3). 
 
For samples containing more than one component, the following equation is applicable 
 
𝐺(𝜏) =  
∑𝑞𝑖²𝑁𝑖² 𝑔𝑖(𝜏)
(∑𝑞𝑖𝑁𝑖)
=  ∑𝐴𝑖  𝑔𝑖(𝜏) =  
1
𝐵
 ∑ 𝑓𝑖 𝑔𝑖(𝜏)   (Equation S4) 
 
With Ni being the number of particles inside the confocal volume and qi represents the brightness of 
the ith component. B is a normalization factor, fi represents the fraction of the i
th component and gi is 
its time-dependent correlation function. This notation of the correlation functions makes it possible 
to differentiate between diffusing species with different diffusion behavior. Here, we use this 
approach to determine binding of small fluorescently labeled proteins to larger TSLs. 
We did observe no difference in the overall intensity of a measurement without TSLs and one at a 
liposome concentration, where binding takes place. Therefore, we neglect possible quenching of the 
dye upon binding and use qi= q for both components. 
 
For samples containing two components of different size a two component fit is used 
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      (Equation S5) 
 
Where D1 and D2 are the diffusion times of the two components and F1 is the fraction of the first 
component. Here, we fix D1 to the value of the freely diffusing protein, so F1 represents the fraction 
of unbound fast diffusing protein in solution. F2 represents the fraction of slow diffusing liposomes 
with proteins bound to them with a diffusion time D2. 
 
 
To take optical dark states of the dye into account, a function that describes the triplet can be integrated 
into the fitting equation 
 
𝐺𝑇𝑟𝑖𝑝𝑙𝑒𝑡(𝜏) = (1 +
𝑇
1−𝑇
exp (−
𝜏
𝜏𝑇
))  (Equation S6) 
 
T is the triplet state relaxation time and T the fraction of fluorophores in dark state. 
The total correlation curve then becomes a product of the triplet function and the model G () 
 
𝐺𝑡𝑜𝑡𝑎𝑙(𝜏) =  𝐺𝑇𝑟𝑖𝑝𝑙𝑒𝑡 (𝜏) ∗ 𝐺(𝜏)  (Equation S7) 
 
The hydrodynamic radius Rh of a spherical molecule can be determined with the Stokes-Einstein-
equation 
 
𝑅ℎ =
𝑘𝐵𝑇
6𝜋𝜂𝐷
    (Equation S8) 
 
where D = ω0
2/4D is the diffusion constant, ω0 the radius of the confocal volume in the xy-plane, kB, 
is the Boltzman constant, T is the temperature in [K] and the viscosity of the surrounding medium η. 
 
 
Determination of the linear regime of FCS 
A titration series of FDG+β-Galactosidase was performed to determine the linear regime of the FCS 
to obtain stable FCS results. Concentration of FDG+β-Galactosidase for all experiments falls on the 
linear regime for FCS concentration measurements. This range was determined to be approximately 
1-900 nM.  
 
Figure S1: Titration series of FDG+β-Galactosidase in HN-buffer + 1mM MgCl2 to determine the linear range of FCS 
measurements (error bars are smaller than the symbols) 
 
 
Correction of the FCS data  
In comparison to our reference Alexa488 in water, we observe a slowdown of the diffusion times of 
the released FDG in the presence of unlabeled proteins or Triton. 
Firstly, we checked if this due to an expansion of the confocal volume by the addition of these 
components or due to interactions with FDG. A sample using Alexa488 with and without Triton 
showed that the structure parameter is increased, leading to a relative increase in the confocal volume 
of 17-25%. This is equivalent to a correction factor B for the confocal volume of 1.17-1.25. 
To correct for this effect in the determination of absolute concentration values in [M] we used the 
following correction: 
 
𝐵 =  
𝑉𝑟𝑒𝑎𝑙
𝑉𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛
 (Equation S9) 
 
𝐶𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 = 
𝑁
𝑁𝐴 𝑉𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛
∗ 𝐵 (Equation S10) 
 
where ccorrected is the concentration in [M], N is the number of the particles obtained from Equation S2, 
NA is the Avogadro constant, Vcalibration is the determined confocal volume from a calibration 
measurement using Alexa488, Vreal is the expanded confocal volume and B is the correction factor. 
The same procedure of concentration correction is applied to all samples containing unlabeled 
proteins or/and Triton. 
 
 
Fundamental concept of the FDG-TSL 
 
 
Figure S2: Sequential hydrolysis of FDG by -Galactosidase 
 
FDG (Fluorescein Di-galactoside) is a fluorescent substrate for the detection of β-Galactosidase. 
Non-fluorescent FDG is sequentially hydrolized by the enzyme β-Galactosidase. Firstly, FDG is 
turned into fluorescein monogalactosidase (FMG) and then in a second step to strongly fluorescent 
fluorescein. 
This assay is standardly used to detect even smallest amounts of β-Galactosidase as an indicator for 
LacZ gene expression. We use this concept the other way around, to prove the presence of tiny 
amounts of released FDG into a solution containing sufficient amounts of β-Galactosidase. 
The liposomes are filled with 1mM FDG: The release of FDG by heating is verified by the addition 
of β-Galactosidase after stopping the release by cooling using ice-cold buffer. FDG is then turned into 
fluorescein. This concept allows us to measure released FDG/fluorescein on a single molecule level, 
obtaining a FCS-signal that is not influenced by partly filled liposomes. 
 
 
Determination of the concentration of TSL in a standard sample 
Six independent samples of DPPG2-TSL with CF (24-24C) inside were prepared to have the same 
phosphate content as the TSL that were used for release measurements (26-16). For dilution 0.9% 
NaCl was used to be sure that no release is caused by different osmolarity inside and outside of the 
TSL. The measurements were performed at ex =543 nm to solely excite the membrane label 
(Rhodamine PE). This way bias caused by non-encapsulated free dye can be excluded/avoided. 
 
 
 
0.3255 nM 
0.3120 nM 
0.2558 nM  
0.2977 nM 
0.2401 nM 
0.2685 nM 
0.2833 nM ± 0.0307 nM 
 
 
Estimation of the encapsulation efficiency for FDG-TSL 
I. Determination via drug per liposome 
 
We know the diameter of a liposome and the thickness of the lipid bilayer and can calculate the 
volume of a liposome using these values: 
Diameter of a liposome (DLS): d=114nm  radius r = 57nm - 5nm (thickness of lipid bilayer) = 
52nm 
 
Volume inside of a liposome = 4/3 π r3 = 5.88977 * 10-22 m3 = 5.88977 * 10-19 l 
 
A solution containing 1mM FDG is used to hydrate the lipid film. If the same concentration is present 
inside the TSL, we expect for 100% encapsulation of 1mM FDG a number of molecules per liposome 
that is equal to: 
 
FDG /TSL = 1*10-3 mol/l * 5.88977*10-19 l * NA = 354.69025 = 355 
 
NA = Avogadro constant 
 
The measured value of FDG/TSL (Triton value) is: 190.6597±16.2715= 191±16 
 
From that we estimate, the encapsulation efficiency to be 
Encapsulation efficiency = (measured FDG/TSL)/(theoretical FDG/TSL) *100% = (191±16)/355 * 
100% = 53.7±9.4% 
 
II. Determination via drug/lipid 
 
loading: drug/lipid = 1mM FDG/50mM lipid= 0.02 
 
Measured drug concentration in sample: 54.1±4.6nM 
Lipid concentration in sample: 33.333µM 
Measured drug/lipid: 0.0016±0.00014 
 
Encapsulation efficiency = (measured/loading)*100 = 8.0±0.7% 
 
This value is in good agreement with the expected encapsulation efficiency of ~ 6.1% according to 
Lindner et al.[4].   
 
 
 
Determination of Release using FDG-TSL 
 
Figure S3: Correlation curves for different temperatures of FDG-TSL. The amplitude decreases with increasing 
temperature representing the increase in the concentration of released FDG. 
 
a)       b) 
  
Figure S4: a) Corresponding count rate plot. The increase of signal with release is easily observable. The decrease in 
count rate for the Triton sample is clearly visible. Error bars are not shown, since they are smaller than the line thickness 
used. b) Corresponding count rate per molecule plot. The lower value of the count rate per molecule for the Triton sample 
is clearly visible, indicating an effect of Triton on the dye properties/brightness. This supports our assumption that an 
analysis completely relying on the total count rate can only provide a trend, but no single molecule precision. 
 
Effect of Triton on the Release – Fluorescence intensity dependency in analysis 
We are able to reproduce the same effect in release as in FS data (release >100%), if we use the count 
rate of the FCS measurements for analysis (b). The values above 100% might be the result of the 
effect of Triton on the brightness of the molecule (see sections below & above). 
a)       b) 
    
Figure S5: Release of FDG-TSL measured with FCS. A) The percentage release was determined by normalization of the 
measured concentration analogous to the FS measurements. b) The percentage release was determined by normalization 
of the measured count rate (fluorescence intensity) analogous to the FS measurements. 
 
 
Release in different media measured by FS 
 
Figure S6: Percentage release of FDG-TSL determined in various media using FS. Data are averages of 3 individually 
prepared samples and their standard deviation. 
 
 
 
 
 
 
 
 
 
 
 
 
Time-dependent release at different temperatures in FBS measured by FS 
 
 
Figure S7: Time-dependent release in FBS measured with FS for 37°C (filled squares), 38°C (filled circles), 39°C 
(diamond), 40°C (triangle), 41°C (circle) and 42°C (square) 
 
 
Binding studies 
We investigated the equilibration time of the system after the addition of the DPPG2-TSL to the 
labeled protein solution. We found that Fib binds at room temperature and reaches a plateau level of 
the fraction bound of around 80% after 15 minutes. ApoA1 binds strongly at room temperature and 
reaches a fraction bound of nearly 100% after 15 minutes. In comparison, BSA binds more slowly 
than Fib and reaches a plateau level of 28% after 40 minutes at room temperature. For the tested 
concentration of Tf we do not observe an analysable change in the data compared to the reference 
measurements without unlabelled TSL. From these data we conclude that an incubation time of 1h is 
enough for the system to equilibrate. 
 
Figure S8: Kinetics of fraction of protein that is bound to DPPG2-TSL. Fraction of Fib bound to TSL (light blue). For 
these measurements 7 µg/ml (20.6nM) of labelled Fib was used. Fraction of BSA bound to TSL (red). For these 
measurements 10 µg/ml (152nM) of labelled BSA was used. Fraction of ApoA1 bound to TSL (dark blue). For these 
measurements ~1 µg/ml (35.7nM) labelled ApoA1 was used. 
 
 
 
 
Examples for binding of unlabelled proteins and its reversibility are shown in Figure S9. Firstly, the 
labelled protein is alone in solution (red). Then DPPG2-TSL were added and incubated and after 1h 
measured. For binding a clear shift of the normalised correlation curves to the right is visible (blue). 
FBS was added and after another hour of incubation a last measurement was performed. These curves 
(black) are overlapping with the mono-protein solutions indicating that the binding of the labeled 
proteins to DPPG2-TSL is reversed. A time series of the reversibility is shown in Figure S10. 
a)       b) 
 
c)       d) 
  
Figure S9: Normalised Correlation curves of protein alone (black), protein and DPPG2-TSL (blue) after one hour of 
incubation and after the addition of FBS and another hour of incubation (red). The signal of free proteins (black) shifts 
towards larger diffusion times after one hour of incubation with DPPG2-TSL (blue) and back to the starting curve, after 
the addition of FBS and incubation for another hour (red). This means the binding of all tested proteins is reversible.  
a) BSA, b) Tf, c) Fib and d) ApoA1 
 
 
Figure S10: Kinetics for different proteins after the addition of FBS: Apo A1(orange), Fibrinogen (red), BSA (blue) and 
Transferrin (green). The last three proteins are replaced immediately after the addition of FBS, while the amount of bound 
ApoA1 decreases slowly with time. After 1h all ApoA1 is replaced as well. 
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a b s t r a c t
Low molecular weight oligomers of amyloid beta (Ab) are important drivers of Alzheimer’s disease. A
decrease in Ab monomer levels in human cerebrospinal fluid (CSF) is observed in Alzheimers’ patients
and is a robust biomarker of the disease. It has been suggested that the decrease in monomer levels in
CSF is due to the formation of Ab oligomers. A robust technique capable of identifying Ab oligomers in
CSF is therefore desirable. We have used fluorescence correlation spectroscopy and a five Gaussian dis-
tribution model (5GDM) to monitor the aggregation of Ab1–42 in sodium phosphate buffer and in artificial
cerebrospinal fluid (ACSF). In buffer, several different sized components (monomer, oligomers, protofi-
brils and fibrils) can be identified simultaneously using 5GDM. In ACSF, the faster kinetics of fibrillogen-
esis leads to the formation of fibrils on very short timescales. This analysis method can also be used to
monitor the aggregation of other proteins, nanoparticles or colloids, even in complex biological fluids.
 2014 Elsevier Inc. All rights reserved.
1. Introduction
The accumulation of fibrils formed from the amyloid beta-pro-
tein (Ab) is a defining pathological hallmark of Alzheimer’s disease
(AD) [1]. However, recent evidence suggests that low molecular
weight (MW) diffusible aggregates of Ab (commonly referred to
as Ab oligomers) are more important drivers of AD than the Ab
fibrils found in amyloid deposits [2–4]. Several studies have shown
that small protein aggregates are cytotoxic and contribute to syn-
aptic dysfunction [5–10]. In nature, there are at least 20 different
Ab alloforms all of which have the same common core of about
30 residues, but differ in the length of their N- and C-termini
[11]. Within this family of peptides, primary sequences terminat-
ing at Ala42 are particularly associated with AD [12].
A lowering of Ab1–42 monomer levels in human cerebrospinal
fluid (CSF) has been widely validated as a robust biomarker for
the diagnosis of AD [13], including in pre-symptomatic individuals
that subsequently developed AD [14,15]. Mechanistically, the pro-
gressive accumulation of both soluble and insoluble Ab aggregates
has been postulated to explain the decline in Ab1–42 monomer
observed in CSF. Consequently, it is believed that measurement
of Ab oligomer levels in CSF could offer an even more sensitive
indicator than current biomarkers [13]. Despite intense efforts
there are currently no validated, reliable and sensitive means to
detect Ab oligomers in CSF. The oligomerization and subsequent
formation of protein fibrils of Ab is a complex interplay of many
peptides and mechanisms and is not yet fully understood
[16–20]. However, the majority of studies find that the mechanism
for fibrillogenesis is consistent with a nucleation-dependent poly-
merization model [5,18,21] as illustrated in Fig. 1(A). More recent
work has suggested that a second nucleation step occurs [22].
The major difficulty in monitoring the progression of Ab fibrillo-
genesis is the range of particles sizes present. Even at the early
stages of fibrillogenesis Ab will exist as monomer, heterogenous
oligomers, protofibrils and fibrils. Few techniques can measure
and track the components of such a heterogenous mixture of dif-
ferent sized species simultaneously. Several methods have been
used to map the progression of peptide aggregation, from mono-
mer to fibril, including, high performance liquid chromatography,
gel electrophoresis, atomic force microscopy, transmission elec-
tron microscopy (TEM), Thioflavin T assays, dynamic light scatter-
ing and others [16]. Monomeric Ab has a hydrodynamic radius (Rh)
http://dx.doi.org/10.1016/j.bbrc.2014.04.088
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of 0.9 ± 0.1 nm [23], while oligomeric and fibril forms range in size
from several nanometers to several microns [16–19].
It is challenging to quantitatively measure the sizes of different
oligomers, which co-exist with Ab monomer, protofibrils and
fibrils during a typical measurement. Fluorescence correlation
spectroscopy (FCS) can be used to differentiate multiple compo-
nents in a polydisperse solution and has already been used to study
the aggregation of other amyloidogenic proteins. Notably, the
aggregation of polyglutamine in cells [24], a-synuclein aggregation
[25] and its binding to vesicles [26] have been studied. In relation
to Ab, FCS has been used to establish an in vitro saturation concen-
tration of Ab1–40 [27], to test the interaction with aggregation
inhibitors [28] and membranes [29,30], to study the depletion of
oligomers under physiological conditions [23] and to determine
the size distribution of Ab1–40 aggregates in solution [27,31,32].
Garai et al. [27] used a maximum entropy fitting method (MEM-
FCS), which allowed multiple aggregating species within the sys-
tem to be analyzed. While this is an improvement over standard
fitting methods, it did not distinguish clearly between the oligo-
meric species in solution. Therefore, a need for a fitting procedure
which can distinguish more clearly the different sized forms of Ab
during fibrillogenesis exists.
Here, we have approached this problem by defining several
sizes ranges (up to five) as Gaussian profiles (5GDM) and using
these to fit the FCS autocorrelation function. This allows each
pre-defined component to be fit to the data simultaneously, allow-
ing more of the different sized components in the aggregating sys-
tem to be determined at any particular time point during the
experiment. The size distributions obtained using 5GDM analysis
are compared to those obtained using MEMFCS. To our knowledge
no previous work has used such a high number of Gaussian-shaped
peaks and the same free variables for analysis of FCS data for poly-
disperse systems. This approach is not specific to Ab, and we
expect that it will be readily applied to study of other aggregating
or amyloidogenic proteins.
2. Material and methods
2.1. Sample preparation
Synthetic Ab1–42 was purchased from W. M. Keck Biotechnology
Facility at Yale University and Hilyte Fluor488™ labeled Ab1–42 was
purchased from Anaspec Inc., Fremont (CA). The latter was dis-
solved in 1% NH4OH and diluted to a final concentration of 1 mg/
ml in 10 mM sodium phosphate buffer [33]. Ab1–42 was dissolved
in 0.1% NH4OH and then diluted with 100 mM Tris buffer at
1 mM, aliquoted and stored at 20 C. Once thawed, peptide solu-
tions were centrifuged at 100,000g and 4 C for 1 h in a Beckman
Optima Max XP ultracentrifuge (Indianapolis, IN) to remove pre-
existing fibrils. The upper 75% of the supernatant was collected
and the concentration of Ab1–42 determined by absorbance at
275 nm. Thereafter the supernatant was further diluted to the
desired concentrations using 10 mM sodium phosphate buffer or
artificial CSF (119 mM NaCl, 26.2 mM NaHCO3, 2.5 mM KCl,
1 mM NaH2PO4, 1.3 mM MgSO4-7H2O, 11 mM D-(+)-Glucose and
2.5 mM CaCl2.2H2O, pH adjusted to 7.3–7.4).
2.2. FCS experiments
FCS measurements were performed on a LSM10 microscope
equipped with a ConfoCor2 unit (Carl Zeiss Jena, Germany), a
488 nm Argon laser and an apochromatic 40 water-immersion
objective with a NA of 1.2. Fluorescence emission was separated
from laser light using a bandpass filter (505–550 nm). Calibration
was performed with Alexa 488 to determine the dimensions of the
observation volume. Samples were filled in NUNC 8-Well-Plates
(Thermo Scientific), which were coated with 15 lg/ml poly-L-lysine
(Biochrom AG). All measurements were performed at room temper-
ature. Autocorrelation functions obtained from FCS measurements
were analyzed as described in Supplementary information.
3. Results and discussion
3.1. Aggregation of Ab1–42 in sodium phosphate buffer
The aggregation of Ab1–42 was measured at 10 and 20 lM in the
presence of 0.01% labeled Ab1–42 in 10 mM sodium phosphate buf-
fer, pH 7.4 by FCS. Variability in the time before onset of oligomer
formation can depend on preparation conditions [16], and/or addi-
tional stresses applied to the sample to speed up the process
[25,34–36]. Measurements were taken systematically over 48 h
using consistent preparation methods to minimize these effects.
Fig. 2 shows the evolution of an autocorrelation function over
the time course of a typical experiment. This sample, at 20 lM,
indicates that higher MW species appear over several hours,
indicated by a shift in the delay time to higher values.
3.2. Comparison of MEMFCS and 5GDM fitting
Beyond the first few measurements, a one-component fit (SI Eq.
(2)) leads to unsatisfactory and physically unrealistic results (not
shown). Thus, a more sophisticated fitting method is required.
1 2 3 4 5
nucleation phase
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elongation phase
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Fig. 1. (A) The standard nucleation-dependent polymerization (single nucleation)
model for amyloid aggregation: formation of fibrils proceeds through a multistage
process. Monomers (1) form low molecular weight aggregates (2), then higher
molecular weight aggregates (3) in the nucleation stage, which has a characteristic
lag time before the formation of protofibrils (4) and fibrils (5). A secondary
nucleation step leading to the formation of oligomers via a fibril-catalyzed process
has also been suggested [22] (not shown). (B) The confocal volume for FCS
measurements: fluorescently labeled monomers and peptides diffuse into and out
of the confocal volume leading to fluctuations in the fluorescence signal.
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Fig. 2. Normalized average correlation curves over 48 h for a 20 lM Ab1–42 sample
(0.01% labeled). During the experiment the curves shift to the right and a buckling
develops, indicating an increase in the number of different species and of particle
sizes.
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We first applied the MEMFCS fitting method [27,37] to autocorre-
lation functions at different time points throughout the experi-
ment (Fig. 3A). A fit of the first measurement, reveals a single
peak with a Rh maximum at 1.44 nm and a shoulder towards larger
hydrodynamic radii. After 48 h, three peaks corresponding to
spherical hydrodynamic radii of 2.09 nm, 101.17 nm and 4.5 lm
were observed (Fig. 3E).
Due to the assumption of maximum uncertainty and to avoid
over interpretation of the data, MEMFCS fitting finds the widest
size distribution that is consistent with the data [37]. Thus, the
broad peaks obtained with MEMFCS are likely to include size dis-
tribution data for several different species in solution. Distribution
curves resulting from MEMFCS analysis show Gaussian-type distri-
bution features. Therefore, we used a Gaussian-shaped size distri-
bution with a fixed number of peaks to fit our experimental data.
This was inspired by initial work by Pal et al. [38], who used this
approach as an alternative to MEMFCS for microemulsion droplets.
The idea is that a component is not monodisperse with a single
value for the diffusion time, sD, but rather a Gaussian distribution
on a logarithmic time-scale with a peak diffusion time sP. The fit to
the autocorrelation function is described by:
GðsÞ ¼
Xn
i¼1
aiðsDiÞ
1
1þ ssDi
 !
1
1þ sx2sDi
 !1
2
ð1Þ
with the amplitude distribution
aiðsDiÞ ¼
Xk
n¼1
An exp 
lnðsDiÞ  lnðsPnÞ
bn
  
ð2Þ
where An is the relative amplitude of the components, sPn is the
peak diffusion time of the nth component and bn is related to the
width of the distribution. The sD’s have the same logarithmic
quasi-continuous distribution as for MEMFCS. We have extended
the work of Pal et al. by varying An, sPn and bn rather than using only
a single peak. The fraction of each of the components was then
determined by calculating the areas under the Gaussian peaks and
normalizing them by the sum of the peak areas:
Fractionn ¼
areanPk
n¼1arean
ð3Þ
Hence, each distribution in the Gaussian distribution model
(GDM) will represent a narrow range of particle sizes. The validity
of the GDM was verified by extensive testing of the well-known
dye Alexa 488 (using one distribution successfully, whereas a
higher number of distributions were rejected by the model cor-
rectly). We choose to use five peaks for the fitting of Ab since this
was a good balance between distinguishing the different species in
solution (monomer, small oligomer, larger oligomer, protofibril
and fibril) and not having so many free variables that the outcome
of the fits was physically unrealistic. Analysis of many autocorrela-
tion curves using this method, gave consistent results. Less than
five peaks led to an inappropriate description of the system (i.e.
component sizes smaller than monomeric Ab concomitant with
very large particles at early time points).
In Fig. 3B the results of the analysis with the 5GDM are pre-
sented. There are a larger number of more sharply defined peaks
representing different levels of Ab1–42 aggregation than for MEM-
FCS. 5GDM fits reveal that two peaks at 1.17 nm and 1.62 nm are
present at early time points in the experiment. If a weighted sum
of these first two peaks is calculated using the relative amplitudes,
a Rh of 1.44 nm is determined. This corresponds exactly to the dif-
fusion time for the first peak obtained using MEMFCS fitting. In
Fig. 3C–E, a direct comparison of the results of both fitting methods
is shown for measurements taken at 0 h, 20 h and 48 h. For all
three time points the results of 5GDM and MEMFCS are in good
agreement and show the same trends for the aggregating system.
However, at the later time points (48 h) significant differences
for the calculated size of fibrils are observed (Rh = 4.5 lm for MEM-
FCS and Rh = 0.85 lm for 5GDM). These particle sizes are beyond
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Fig. 3. Size distribution obtained with (A) MEMFCS and (B) 5GDM. Both fitting methods show similar trends, but the GDM fitting provides sharper and more defined peaks,
especially in the range of low MW oligomers. Measurements at 0 h, 5 h, 16 h, 20 h, 40 h and 48 h. (C–E) direct comparison of the results of MEMFCS (dashed) and 5GDM (line)
for (C) 0 h, (D) 20 h and (E) 48 h. Both fitting methods show the same trends.
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the reasonable measureable range for FCS and the values are arti-
facts of the fitting procedure in both methods. A comparison of the
results obtained for each fitting procedure is shown in Fig. 3C–E.
Clearly the general features of the aggregating system are consis-
tent using both methods, but the 5GDM provides a more detailed
and potentially a more realistic description of the aggregating sys-
tem with better resolution of low MW species.
3.3. Evaluation of the four fractions of Ab1–42 aggregates
5GDM reveals a larger number of species within the system
than MEMFCS, but each of these species represents a range of par-
ticle sizes. Since the first two peaks fuse and separate several times
during the experiment, it was impossible to analyze these fractions
separately (Fig. 3D and E). Hence, the percentages of the first two
peaks were pooled and treated as one. This leads to a four level
fraction model for Ab1–42 aggregation (although a five peak fitting
formula is used). The fusion of these first two peaks is probably due
to a dynamic equilibrium that is assumed between monomers and
very small oligomers [39,40]. We have therefore defined each of
the size ranges obtained from the fitting as: (1) small components
including monomers and low MW oligomers; (2) higher MW oligo-
mers; (3) protofibrils and (4) fibrils. The fractions of the various Ab
particles in solution were determined from the 5GDM fitting and
calculated using Eq. (3). The fractions were monitored over time
and the averaged values are shown in Fig. 4.
The rate of aggregation is slower in the lower concentration
samples and is consistent with previous experiments [32]. After
48 h, the proportion of fraction 1 (monomer and small oligomers)
is higher in the lower concentration samples (72.4 for 10 lM com-
pared to 64.9% for 20 lM), with a corresponding lower proportion
of fibrils (3.6% for 10 lM and 7.5% for 20 lM). The proportion of
fraction 1 decreases as fibrillogenesis proceeds (Fig. 4), while the
Rh stays relatively constant (Fig. S1). Combined, these observations
indicate a real decrease of the amount of monomer/small oligo-
mers in solution. In Fig. S1 the evolution of the two peaks, which
we have called fraction 1 (monomer and small oligomer) is shown.
We observe that only a few data points lie in the monomer range
between 0.8 and 1 nm [23], and most of the data points lie between
1 and 2 nm. This size range represents mixtures of monomers and
small oligomers. Therefore with 5GDM it is not possible to differ-
entiate between monomers and small oligomers and hence we
have pooled this data in fraction 1. However, we can clearly sepa-
rate a mixture of monomers and low MW oligomers from larger
aggregates. At the beginning of an experiment the dominating spe-
cies are small components (Fig. 4). This starting material consists of
a mixture of monomer and small oligomers. Monomeric samples
did not aggregate on a reasonable experimental time scale [23].
Examining fraction 2 (higher Mw oligomers), we see that these
remain constant throughout the experiment (Fig. 4) (14% for
10 lM and 19% for 20 lM). For this fraction, the Rh grows slowly
in size, and is in the range of 10 nm (Fig. S2). Hence, before the first
measurement, equilibrium between small components (fraction 1)
and high MW oligomers (fraction 2) is established.
Protofibrils or fibrils are not present in FCS data at the beginning
of the experiment (Fig. 4), but appear after a lag time, consistent
with a nucleation-dependent polymerization model [41]. Both spe-
cies show a sigmoidal behavior and a mean lag time of 16 h. The
fraction of protofibrils reaches a saturation level of 10% at 20 lM
and 8% at 10 lM, respectively, while the proportion of fibrillar
material continues to increase to the end of the experiment. Trans-
mission electron microscopy (TEM) confirmed fibril formation
(Fig. S3). The presence of fibrils is consistent with 5GDM analysis
and the size values obtained for fibrils are in agreement with pub-
lished studies [5,42,43].
3.4. Preliminary experiments in artificial CSF
Using artificial cerebrospinal fluid (ACSF), we assessed if the
5GDM fitting procedure is suitable for analysis in complex buffers
and potentially in biological fluids. Large sedimenting particles are
observed immediately after mixing stock Ab with ACSF. During FCS
measurements, this manifests as decreasing particle numbers due
to loss of material to the large aggregates. The remaining mono-
meric material, now at much lower concentration, does not pro-
ceed to form higher MW oligomers, since it is below the
concentration required for the onset of fibrillogenesis. The higher
ionic strength of ACSF leads to much faster kinetics for fibrillogen-
esis of Ab1–42 in lM concentrations [36]. An incremental decrease
in Ab, to nM concentrations, failed to find a regime in which a
broader distribution of particles sizes was observed. Furthermore,
adding labeled Ab to pre-aggregated samples in ACSF produced
similar results. In these experiments, only single events in the
count rate plots were observed for 1 lM, 500 nM and 50 nM Ab1–
42, and these bursts corresponded to fibrils rather than to oligo-
mers. A systematic evaluation with 5GDM was not performed,
since these single events do not meet the requirements of the sta-
tistical basis needed for quantitative FCS analysis. These observa-
tions are consistent with Nag et al. [23]. They suggested that
Ab1–42 aggregation is dependent on physiological factors at low
concentrations of Ab1–42 and that aggregates dissociate below a
certain concentration because they are thermodynamically unsta-
ble. However, beyond the limitation of this experimental system,
there are no technical barriers to using 5GDM analysis in ACSF,
CSF or other complex biological fluids.
A new fitting procedure for FCS (5GDM), allowing several differ-
ent sized components in solution to be analyzed simultaneously
has been developed to study the fibrillogenesis of Ab1–42. Four
Ab1–42 aggregate types in solution were identified; small compo-
nents (including monomer and low molecular weight oligomers),
high MW oligomers, protofibrils and fibrils. Each component was
observed in solution over 48 h for a range of protein concentra-
tions. A comparison with MEMFCS analysis confirmed that the
results obtained with 5GDM are consistent with the established
method, but that better resolution of particle size distributions in
the nm range were obtained using 5GDM. Given that oligomers
of Ab in CSF have been found at picogram levels [44], concentration
of the sample to pM levels could facilitate measurements in CSF
using FCS with 5GDM. This analysis method could also be usefully
employed to monitor the aggregation of other proteins, nanoparti-
cles and colloids.
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Fig. 4. Development of the fractions of the four aggregate levels of Ab1–42 in sodium
phosphate buffer, dashed lines represent 10 lM Ab samples, solid lines represent
20 lM measurements. The amount of small components/monomers decreases over
time, while the amount of protofibrils and fibrils increases after a certain lag time.
The fraction of high MW oligomers stays constant. The experiments were preformed
in triplicate to ensure reproducibility.
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Material & Methods 
Transmission electron microscopy (TEM) 
A 10 µl Aβ1-42 solution from the FCS experiments was placed on a vacuum cleaned 
formvar/carbon coated grid (SPI supplies) and allowed to adhere for two minutes. The 
solution was removed and the grid washed with 7 µl of 1% uranyl acetate solution. The grids 
were then stained with 7 µl of 1% uranyl acetate solution for 20 seconds. After staining, the 
grids were allowed to dry for 45 minutes. Images were taken with a FastScan-F114camera 
(TVIPS) on a JEM1011 (JEOL) microscope operating at 80 keV. 
 
 
 
FCS data analysis 
Conventional FCS data analysis 
The normalised autocorrelation function G(τ) is defined as 
 
𝐺(𝜏) =
〈𝐹(𝑡)𝐹(𝑡+𝜏)〉
〈𝐹(𝑡)〉2
   (SI Equation 1), 
 
where angular brackets denote the average over time t, F(t) the fluorescence signal at time t 
and F(t + τ) the fluorescence signal at time t + τ. 
It is assumed that the confocal volume has an ideal three dimensional Gaussian shape. The 
structure parameter ω describes the ratio of the half axes z0 to the radius of the laser beam w0. 
By fitting a model to the experimental data, physically relevant information can be extracted 
from the correlation curve. The autocorrelation curve for a single component freely diffusing 
in a 3D Gaussian element can be described by: 
 
𝐺(𝜏) =
1
𝑁
 (
1
1+
𝜏
𝜏𝐷
) (
1
1+
𝜏
𝜔2𝜏𝐷
)
1
2
   (SI Equation 2), 
 
where N is the number of particles in the confocal volume, τD is the translational diffusion 
time of the species, τ is the correlation time and ω the structure parameter. 
The translational diffusion time describes the average dwell time of a molecule with diffusion 
constant D in the confocal volume 
 
𝜏𝐷 =  
𝑟2
4𝐷
  (SI Equation 3) . 
 
The hydrodynamic radius Rh of a spherical molecule can be determined with the Stokes-
Einstein-equation 
 
𝑅ℎ =
𝑘𝐵𝑇
6𝜋𝜂𝐷
    (SI Equation 4) 
 
where kB, is the Boltzman constant, T is the temperature in [K] and the viscosity of the 
surrounding medium η. 
 
Maximum Entropy Method based fitting routine for FCS (MEMFCS) 
Skilling and Bryan proposed the concept of maximum entropy method in 1984 [1]. This 
method was adapted by Sengupta [2] in 2003 for the analysis of FCS data of highly 
polydisperse samples. MEMFCS does not use any a priori assumptions to allow for a 
maximally wide distribution ai (τDi) that is consistent with the data. The fitting formula Eq. 2 
changes to 
 
𝐺(𝜏) =  ∑ 𝑎𝑖
𝑛
𝑖=1 (
1
1+
𝜏
𝜏𝐷𝑖
) (
1
1+
𝜏
𝜔2𝜏𝐷𝑖
)
1
2
 (SI Equation 5) 
 
where n is the number of freely diffusing species and ai the relative amplitude of the i
th 
component. The relative amplitude ai includes variables such as the number of particles or the 
brightness and is a weighting factor for species i. 
MEMFCS looks for a distribution of diffusion times ai (τDi) that minimizes Χ² and maximizes 
the entropy S at the same time. 
The entropy is defined as 
 
S= -∑ 𝑝𝑖 𝑖 ln 𝑝𝑖  (SI Equation 6) 
 
with pi = ai (τDi)/Σ ai (τDi) being the probability of finding a certain component i inside the 
confocal volume. 
Since the range of possible aggregate sizes and therefore possible τDi ‘s spans several orders 
of magnitude, the range of possible τDi’s is transferred to a logarithmic scale for 
computational reasons. This range is then divided into n parts leading to a quasi-continuous 
distribution of particle sizes which is fixed during the fitting process. Only the amplitude 
ai(τDi) is varied. 
 
Gaussian Distribution Model (GDM) 
Pal et al. [3] showed that modelling with GDM can be an alternative for FCS analysis with 
MEMFCS for microemulsion droplets. They used a GDM for the analysis of the narrow size 
distribution of the droplets. The idea is that a component does not have a single sharp value 
for τD but instead a Gaussian distribution on a logarithmic time-scale around a peak diffusion 
time τP. In contrast to MEMFCS, the number of peaks and the shape of the distribution are 
determined. GDM only minimizes X² during fitting. 
Equation 5 is modified to 
 
𝐺(𝜏) =  ∑ 𝑎𝑖(𝜏𝐷𝑖)
𝑛
𝑖=1 (
1
1+
𝜏
𝜏𝐷𝑖
) (
1
1+
𝜏
𝜔² 𝜏𝐷𝑖
)
1/2
(SI Equation 7) 
 
with the amplitude distribution 
 
𝑎𝑖(𝜏𝐷𝑖) = ∑ 𝐴𝑛 𝑒𝑥𝑝 [− (
𝑙𝑛(𝜏𝐷𝑖)−𝑙𝑛(𝜏𝑃𝑛)
𝑏𝑛
) ²]     𝑘𝑛=1 (SI Equation 8) 
 
Where An is the relative amplitude of the components, τPn is the peak diffusion time of the n
th 
component and bn is related to the width of the distribution. The τDi’s have the same 
logarithmic quasi-continuous distribution like for MEMFCS. 
During our fitting An, τPn and bn were varied, while Pal. et al. used only a single peak and 
fixed the peak diffusion time τP of it. 
A total of 500 τDi, logarithmically spaced between 10-10e
6 µs is used to cut of photophysical 
effects for short time-scales. 
The fraction of the different components was determined by calculating the areas under the k 
Gaussian peaks and normalizing them by the sum of the k areas. 
 
𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑛 =
𝑎𝑟𝑒𝑎𝑛
∑ 𝑎𝑟𝑒𝑎𝑛
𝑘
𝑛=1
      (SI Equation 9) 
 
Results 
 
Figure S1: Evolution of the first (filled diamond) and second (open diamond) peak of 5GDM fitting. The 
horizontal lines at 0.8 nm, 1 nm and 2 nm are there to distinguish different components. 
 
Figure S2: Development of the peak diffusion times of high MW oligomers in PB from 20 µM Aβ1-42 starting 
concentration. The black curve represents the fit of all three measurements at once, error bars are the mean 
deviation between the fit and the measured data points (3.4 nm). A slow, but steady increase in the 
hydrodynamic radius is observed 
 
 
a)      b) 
            
Figure S3: a) TEM picture of a fibril that was observed after a FCS experiment. The widths are indicated by 
arrows and have values of 15.64 nm and 13.91 nm (scale bar: 30 nm)  b) Two amyloid fibrils starting to twist 
together.(scale bar: 90 nm) 
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Summary 
Fluorescence correlation spectroscopy (FCS) is a flexible and powerful technique to measure the 
diffusion of fluorescently labeled particles. It has been important in examining a range of biological 
processes, from intracellular transport, to DNA hybridization. It is particularly suited to measuring the 
assembly of peptides, since peptides are often too small to be detected by standard light scattering 
methods, or may not contain aromatic amino acid residues, which limits the use of other spectroscopic 
techniques. In this protocol, we describe state-of-the-art sample preparation for Aβ1-42 peptide solutions 
and the measurement and analysis of the self-assembly of the peptide to form fibrils via a number of 
intermediate states using FCS. 
 
 
Keywords (5-10):  fluorescence correlation spectroscopy, peptide, self-assembly, size distribution, 
complex fluids, polydispersity, Gaussian distribution model 
 
1. Introduction  
Fluorescence correlation spectroscopy (FCS) is a sensitive and versatile technique allowing the diffusion 
of fluorescently labeled nano- and meso-scale objects in solution to be measured down to picomolar 
concentrations (1). The technique was first described in the early 1970s (2-4). FCS monitors the intensity 
fluctuations of a fluorescently labeled particle as it passes through a fixed volume (Fig. 1a and 1b). The 
use of a confocal microscope with FCS reduces the measurement volume to less than 1 femtolitre, 
allowing for single molecule detection (5, 6). By time averaging these fluorescence intensity fluctuations, 
an autocorrelation function is calculated (Fig. 1c), which contains information about the time taken for 
the labeled particle to pass through the measurement volume and the concentration of labeled particles in 
solution. This information in turn can be used to determine the particle size. One (a single label), two or 
more color FCS can be performed when the wavelengths of emission maxima of the different dyes are 
sufficiently separated (or that filters are used) to eliminate cross-talk. If two labeled components (of 
different colors) bind together, this can be detected by measuring a cross –correlation (7, 8). Hence, the 
variety of ways in which measurements can be performed has allowed the technique to be used for a 
diverse range of measurements including the hybridization of DNA (6), the binding of peptides to lipid 
membranes (9) and the assembly of virus capsids (10). 
 One of the limitations of FCS is that it works best for monodisperse solutions, or solutions in 
which there are large differences in sizes between the diffusing species. Recent developments in data 
analysis techniques however has made FCS better suited for measurements of assembly processes where 
heterogeneous particles sizes are obtained (11-15). The formation of a range of particles sizes is a typical 
occurrence in protein and peptide assembly and these more recent analysis techniques therefore offer new 
avenues to monitor the process. For these types of measurements, careful and consistent sample 
preparation is essential to ensure that the fitting methods are producing results based on robust data. We 
have measured the assembly process (fibrillogenesis) of amyloid-beta (Aβ), a peptide associated with the 
pathogenesis of Alzheimer’s disease by FCS (15).  
Here we describe a protocol to prepare peptide solutions containing Aβ1-42 and the methods and 
procedures to acquire robust and reliable data during aggregation and fibril formation of the peptide using 
FCS. Furthermore, we describe in some detail, the types of data analysis that can be performed on these 
heterogeneous solutions, including maximum entropy fitting (MEMFCS) and multi-Gaussian fitting 
(GDM), which recognize that the self-assembling peptide contains a number of different sized species, 
that are not captured well using single component fits.  
 
2. Materials 
Prepare all solutions using ultrapure Milli-Q water and analytical grade reagents.  
1. Unlabeled Aβ1-42 (see Note 1) 
2. Labeled Aβ1-42 (or labeling kit) (see Note 2) 
3. Fluorescent dye with a known diffusion constant (for calibration), e.g. Alexa 488 (see Note 3 and 
Table 1) 
4. Measurement chambers, e.g. LabTek, Nunc 8-well-plates, borosilicate bottom, 200-400 µl sample 
volume per well (Thermo Scientific) or Sensoplate plus, 20-100 µl sample volume per well (384-
well, black, 175 µm glass bottom, Greiner Bio one) (see Note 4) 
5. Poly-L-lysine coating solution: 100 µg/ml poly-L-lysine in Milli-Q water (see Note 5) 
6. Immersion oil (see Note 6) 
7. UV Quartz cuvette (or whatever kind you use) 
8. UV-vis spectrophotometer  
9. Ice  
10. 1% NH4OH solution: 1 g of NH4OH in 100 ml water  
11. Tris buffer: 100 mM Tris, pH 7.4 (see Note 7) 
12. Ultracentrifuge  
13. Bench-top centrifuge 
14. Ultra-filtration unit with a 10 kDa molecular weight cutoff (e.g. Amicon ultra-filtration devices), 
or syringe drive filters with a 0.02 μm pore size (Whatman Anotop). 
15. Glass vial (4ml volume) 
16. Eppendorf tubes  
17. Aluminum foil 
18. Kimwipes 
19. Nitrogen gas 
20. Data Analysis Software, e.g. Origin, Matlab, Igor. 
 
Methods 
3.1 Sample preparation 
3.1.1 Dissolution of peptide 
1. To prepare unlabeled Aβ1-42, add 1.8 ml of a 1% NH4OH solution to 16 mg of the Aβ1-42 peptide 
(Add 1.8 ml of Tris (pH 7.4)), which gives a 1 mM peptide solution (15). Ensure that all the solid material 
is dissolved and avoid the introduction of air bubbles where possible (see Note 8). 
2. Dissolve the labeled peptide (e.g. Aβ Hilyte, Anaspec Inc. Fremont, CA) per the supplier’s 
instructions (see Note 2). 
 
3.1.2 Removal of pre-existing peptide assemblies (e.g. oligomers or larger aggregates) (see Note 9) 
Pre-existing assemblies can be present as artifacts of peptide lyophilization, sample preparation or 
concentration steps. These should be removed prior to measurements. One (or more) of the following 
procedures can be used: 
1. Ultracentrifugation: For Aβ, pre-cool the rotor overnight at 4°C and set the centrifuge temperature to 
4°C about 1 hour before use (cooling may take some time). Use centrifuge tubes designed for 
ultracentrifugation (not the standard lab variety). Ensure an appropriate counterweight is present in 
the rotor. Centrifuge for 1h at 100,000 g. Remove only the upper 75% of the supernatant for further 
use and place on ice.  
2. Ultra-filtration using e.g. Amicon ultra-filtration devices, to exclude components above a molecular 
weight cutoff (e.g. 10 kDa).  
3. Filtration of samples through syringe drive filters e.g. Millipore Durapore 0.22μm filters or Whatman 
Anotop 0.02μm filters. 
 
3.1.3 Concentration Determination 
1. After removing pre-existing aggregates, determine the precise peptide concentration by measuring the 
absorbance at 280 nm for the unlabeled peptide and at 497 nm for the Hilyte 488-labeled Aβ1-42 on a 
UV-vis spectrophotometer. 
2. Measure the concentration of unlabeled peptide using the formula  lAc /  where A is absorbance, 
ε is the molar extinction coefficient (equal to 1,400 M-1 cm-1 (at 280 nm) for Aβ1-42) and l is the path 
length in cm. For labeled protein, calculate the molar concentration using the formula 
𝑐 = (
𝐴280 − (𝐴𝑚𝑎𝑥,𝑑𝑦𝑒 − 𝐶𝐹)
𝜀
) ∙ 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 
where Amax, dye = absorbance maximum of dye, and CF is the correction factor for the dye (supplied by 
the manufacturer; for Hilyte 488, CF = 0.19). 
3. Determine the labeling ratio using the formula:  
𝑑𝑦𝑒𝑠 [𝑚𝑜𝑙𝑒𝑠]
𝑝𝑟𝑜𝑡𝑒𝑖𝑛 [𝑚𝑜𝑙𝑒𝑠]
=  (
𝐴𝑚𝑎𝑥,𝑙𝑎𝑏𝑒𝑙𝑒𝑑
𝜀′ ∙ 𝑐 ∙ 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
) 
where ε’ is the extinction coefficient of the labeled peptide (e.g. For Hilyte 488 = 70,000 M-1 cm-1 at 
497 nm). 
 
 
 
3.2 Procedure for coating measurement chambers with Poly-L-lysine (16)– (see Note 5)  
1. Dilute 0.5 mL poly-L-lysine stock solution into 2.83 ml water (or dilute to 15 µg/ml, total volume 
3.33 ml). 
2. Fill each chamber with 400 µl of the coating solution.  
3. Incubate at room temperature for 1 hour in the dark. 
4. Aspirate the solution completely and store it in a glass vial in the fridge. The coating solution can be 
reused for ~3 months. Wrap aluminum foil around the vial (or use an amber vial) to protect the 
solution from light. 
5. Rinse the chambers carefully with 400 µl of Milli-Q water 20 times to remove all unbound poly-L-
lysine. 
6. Dry the glass bottom of the chamber slide carefully with a Kimwipe to avoid water marks. 
7. Allow the chamber to dry in air at room temperature (or use a gentle stream of filtered nitrogen gas). 
 
3.3 FCS setup and optimization 
3.3.1 Preparation of FCS instrument 
Specific instructions for performing steps 1 – 5 below will depend on the type of instrument used (see 
manufacturer instructions for assistance in performing these steps).  
1. Switch on the laser 1 hour prior to setup.  
2. Place a droplet of water or oil on the immersion objective of the microscope.  
3. Place a chamber on the stage above the objective (if using an inverted microscope). 
4. Search for the second reflection, optimize the quality of your signal with the objective collar ring and 
adjust the laser power to a suitable level.  
5. Perform the pinhole alignment.  
6. Calibrate the FCS set-up to determine the size of the confocal volume using a dye with a known 
diffusion constant (see Table 1). A concentration of 10-50 nM for the dye solution is typical 
(depending on the properties of the dye). Use the dilution buffer to dissolve the dye (see Note 7). 
7. Add 200 µl of the dye solution to one of the chambers (or a suitable volume if different chambers are 
used). 
8. Take 10 x 30 second measurements of the dye solution and determine the average.  
9. Perform a one-component fit of the autocorrelation function using the instrumentation software (see 
3.4.2) to determine the diffusion time (τD), and structure parameter (usually called S). Note these 
values. 
10. Using D, the diffusion constant for the dye (from Table 1), first calculate r, using Dr
D
4/
2
 and 
then z, using rzS / . At this point do not change any of the components in the optical pathway or 
the calibration will need to be performed again. 
11. Fix structure parameter (S) in the FCS software for the measurement of all other samples. (see Note 
10). 
 
3.3.2 Optimizing the labeled protein concentration (see Note 7) 
1. Prepare your peptide samples (3.1.1 – 3.1.3). The labeled/unlabeled peptide ratio should be adjusted 
to achieve a labeled peptide concentration of ~ 10 nM (depending on the quality of the dye and the 
laser power used) to ensure a good signal to noise ratio.  
2. If the measured signal is too weak or the signal to noise ratio is not good, increase the concentration 
of labeled peptide.  
 
3.4 Sample measurement and analysis of FCS data 
3.4.1 Measuring an autocorrelation function for a peptide solution. 
1. Add the pre-prepared peptide solution to a sample chamber and seal with Parafilm or adhesive film to 
reduce evaporation. 
2. Take a measurement (see Notes 11, 12, 13 and 14). 
 
 
3.4.2 One component fitting 
To extract physically relevant information from the autocorrelation curve, fit an appropriate model 
function to the experimental data.  The simplest fitting formula is for a single component 3D freely 
diffusing species is:  
𝐺(𝜏) =
1
𝑁
 (
1
1 +
𝜏
𝜏𝐷
) (
1
1 +
𝜏
𝑆2𝜏𝐷
)
1
2
 
where N is the average number of particles inside the confocal volume, τ is the correlation time, S is the 
structure parameter and τD is the translational diffusion time of the molecule. An example of a “good” 
one-component fit is shown in Fig. 2a.  
 
3.4.3 Two component fitting 
For solutions containing two species, fit using a two-component method, which is performed using the 
following expression:  
𝐺(𝜏) =
1
𝑁
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+ 1 
where τ1 and τ2 describe the diffusion times of the first and second diffusing species, y is the fraction of 
the second component in solution. This works particularly well if there is a significant difference in size 
between the two species. Fig. 2b shows a satisfactory two component fit. An example of a fit that does 
not accurately reflect the number of diffusing species in the solution is shown in Fig. 2c (see Note 15). 
 
3.4.4 Higher order fitting: MEMFCS and GDM (multi-component fitting) (see Note 16) 
When more than two components are required to achieve a satisfactory fit, the analysis becomes more 
complicated. Three main approaches for multi-component fits are used: CONTIN (11, 17), MEMFCS 
(12, 13) and GDM (14, 15). The basis of each analysis method is the assumption of a quasi-continuous 
distribution of a large number of diffusing components. The major advantage of MEMFCS is that it 
provides a safe limit for interpretation of the data without any a priori assumptions and thereby reduces 
the risk of over-interpreting the data for highly polydisperse systems. GDM works in a similar way, but 
requires an assumption of the form of the amplitude distribution (i.e. the size ranges of the distributions 
used for the fit). While care must be exercised, it is faster and allows for better resolution of particle sizes 
than MEMFCS (Fig. 2d) (see Note 17). 
 
3.4.5 Triplet decay 
The fluorescence of a molecule can switch on and off several times while diffusing through the confocal 
volume by decay to the triplet (dark) state. These fluctuations can provide an additional contribution to 
the autocorrelation curve. To account for this, a function that describes the triplet decay can be integrated 
into the fitting equation for the model of 3D freely diffusing particles as follows: 
 
𝐺𝑇𝑟𝑖𝑝𝑙𝑒𝑡(𝜏) = (1 +
𝑇
1 − 𝑇
exp (−
𝜏
𝜏𝑇
)) 
 
where τT is the triplet state relaxation time and T is the fraction of fluorophores in the dark state. The total 
autocorrelation curve then becomes a product of the triplet function and the model G(τ) as follows: 
 
𝐺𝑡𝑜𝑡𝑎𝑙(𝜏) =  𝐺𝑇𝑟𝑖𝑝𝑙𝑒𝑡(𝜏)  ∙  𝐺(𝜏) 
 
3.4.6 Determination of the hydrodynamic radius 
Once a suitable fitting procedure has been established, the particle size can be derived from the fitting 
parameters. For spherical molecules the hydrodynamic radius Rh can be calculated using the Stokes-
Einstein-equation:  
D
Tk
R
B
h
6
  
where kB is the Boltzmann constant (1.38 x 10-23 J K-1), T is temperature in Kelvin, η is the solvent 
viscosity (at temperature, T). It is also possible to insert correction factors to account for particles with 
non-spherical geometries (18). 
 
4. Notes 
 
1. Aβ 1-42 is available commercially (e.g. Anaspec, Fremont, CA, USA) from a number of different 
sources or can be produced recombinantly. Other peptides can also be prepared using the same 
protocol. 
2. FCS measurements are usually performed when only a small portion of the peptide used is 
labeled (and hence a mixture of labeled and unlabeled peptide is used). The lowest possible 
amount of labeled peptide should be used. If a labeling kit is used to tag the peptide of interest, 
there are two options; covalent attachment of a fluorescent molecule, usually by conjugation to 
either a primary amine or to a free cysteine; or the use of a binding dye, such as Thioflavin T, for 
which the fluorescence intensity increases significantly upon binding to amyloid-type assemblies. 
The choice will depend on the amino acid sequence of the peptide being examined and the types 
of assembly it will form. For methods that require covalent attachment of a dye, it is important to 
remove all excess (non-conjugated) dye. Exhaustive washing is required. The washings should be 
tested by measuring fluorescence intensity at the emission maximum of the dye in a fluorimeter 
to ensure that all excess dye has been removed. For both pre-labeled peptides and peptides 
labeled using a kit, the characteristics of the fluorescent label chosen should also be carefully 
evaluated for brightness, photostability (to ensure little or no bleaching), quantum efficiency, the 
size of dye (~1 nm) vs the size of peptide (often less than 1 nm), the ability to determine the 
concentration of the labeled peptide and dye/protein ratio. 
3. To effectively calibrate the FCS instrument, the confocal volume is determined by measuring the 
diffusion of a fluorophore for which the diffusion coefficient is known. Choose a dye best suited 
to the excitation lasers available and the filter set installed for emission. The excitation maximum 
for the calibration dye should match the excitation maximum for the fluorescent label used with 
the peptide. A list of commonly used calibration dyes and their corresponding diffusion constants 
are listed in Table 1. 
4. There are a number of possible sample chambers (or micro fluidic devices) that can be used for 
FCS measurements. It is possible to measure FCS in very small volumes and the choice of sample 
chamber may depend on the availability of material. At a minimum, the chamber should 
preferably have a glass base (but not too thick, since this will prohibit the adjustment of the collar 
ring of the objective lens).  
5. FCS measurements are often performed in very low concentration samples. If the peptide binds to 
the sample chamber walls, this can reduce the bulk concentration significantly or indeed be 
responsible for the assembly of the peptide (via surface nucleation). The concentration of peptide 
(in a non-aggregating solution) can be monitored over time from the particle concentration data 
gathered in the autocorrelation function (as 1/N). If the intercept of the autocorrelation function 
increases over time (without a concurrent increase in the diffusion time), peptide binding to the 
chamber walls should be suspected. If this occurs, surface binding can be pacified by coating the 
wells with a variety of other reagents. A procedure using poly-L-lysine has been described, but 
PEG, lipids or BSA can also be used (using the same procedure). 
6. The water used for the objective should be dust free. If present, the measurements may be 
affected. Filter the water through 0.22 µm filters prior to use. 
7. It is important to ensure compatibility of the fluorescent dye and the buffer used. The dye 
brightness can be pH-dependent or the dye may need specific ions to be present (e.g. calcium). 
The solution conditions required for the fluorescent dye may not be compatible with the peptide 
(e.g. close to the isoelectric point, or wrong ionic strength), which could affect the assembly 
process. The selection of an appropriate buffer at a suitable pH and ionic strength should be given 
careful consideration. 
8. Prepare a suitable buffer using analytical grade reagents. Filter through 0.22 µm filters (e.g. 
Millipore Durapore). It is also possible to perform measurements in complex fluids, such as blood 
plasma or cerebrospinal fluid. These are used instead of buffer. It is important that complex fluids 
are cell free, with no large particles (i.e. with sizes comparable to the confocal volume), as this 
will lead to light scattering.   
9. The presence of dimers/oligomers and/or larger aggregates in the stock solution can make 
analysis of the data difficult. If possible, non-native higher order assemblies should be removed 
prior to the beginning of the measurement. If present, it will be difficult to accurately determine 
the size of the tagged peptide monomer and pre-existing assemblies can alter the kinetics of the 
assembly process. Prepare all samples consistently and just before measurements are performed. 
10. If the laser power is increased (after the initial calibration), the calibration must be performed 
again. Increasing the laser power may lead to bleaching effects. 
11. For measurements performed over several hours (typical for peptide assembly), sealing the 
sample chamber is important since evaporation will lead to an increase in concentration of the 
solutes and hence an overestimation of the number of particles. This may also mask a self-
assembly process, which will decrease the particle number. The initial sample volume should also 
be large enough to ensure that evaporation doesn’t dramatically alter the sample concentration. 
12. For longer measurements, use oil immersion rather than water immersion for the objective. If one 
uses water, evaporation of the water droplet on the lens will occur. This needs to be monitored 
and re-applied if necessary. If the sample chamber is moved regularly throughout the experiment 
(e.g. if multiple wells are being measured simultaneously), re-application of the immersion fluid 
may also be required. 
13. If large aggregates and/or dust are present in the sample during measurement, this will result in 
significant spikes in the intensity. Most software packages have integrated “dust filters”. These 
tools exclude count rates that are above a threshold level (that can be specified) and data above 
this threshold is not used in calculating the autocorrelation function. 
14. A large decrease in number of particles may be due to the formation of very large aggregates 
(greater than 1 µm). If these particles are very large, sedimentation will occur and the formation 
will not be recorded in the autocorrelation function. Always visually inspect the sample chamber 
for large sedimented particles. 
15. It can be very difficult to distinguish between a monomer and a dimer for the following reason. 
The autocorrelation function is an average of the time correlated intensity fluctuations of the 
diffusing species, where the intensity is proportional to the sixth power of the hydrodynamic 
radius. To distinguish clearly between two species in solution, one component should have twice 
the hydrodynamic radius of the other component. However, as a broad rule of thumb, a doubling 
in the hydrodynamic radius is equivalent to 8x increase in molecular weight. Therefore, a large 
increase in molecular weight is required to clearly distinguish different diffusing species using 
standard fitting procedures. 
16. A multicomponent fit should be attempted when it is clear that either a one or two component fit 
do not accurately describe your system (i.e. the fit is bad, see Fig. 2). Sample polydispersity is 
indicated when there are significant deviations between the data and the one or two-component 
fits (see Fig. 2c). Even if the initial fit seems good (as indicated by the residuals), a multi-
component fit may still be warranted if the sizes produced by the one or two-component fits are 
physically unrealistic (for example, smaller than either the peptide or the dye molecule), or if 
there is difficulty distinguishing between larger particles (those comparable in size to the confocal 
volume). 
17. Fitting procedures for multi-component, polydisperse solutions e.g. MEMFCS and multi-
Gaussian models require adequate computer power and fitting software (e.g. Igor or Matlab).  
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Figures:  
 
Figure 1: a) Confocal volume for a FCS experiment: fluorescently labeled particles diffuse through the 
confocal volume leading to fluctuations in the fluorescence intensity, b) The fluctuations are recorded 
over the time of the experiment and c), the time averaged intensity fluctuations are recorded as an 
autocorrelation function, which can be used to determine the diffusion time and concentration of diffusing 
particles and therefore their size. 
 
Figure 2: Examples for data fitting.  (a) An example of a “good” one-component fit. (b) A successful 
two-component fit, (c) A “bad” two component fit that deviates from the measured data. This may 
indicate that a higher number of components are required to obtain a satisfactory fit of the data. (data in 
gray, fit as black dashed line) (d) Amplitude distribution of a polydisperse Aβ1-42 solution after 16 hours 
analyzed using MEMFCS (gray) and GDM (black). While both results show similar overall trends, the 
GDM analysis gives more defined peaks than MEMFCS. 
Table 1:  Diffusion coefficients for a number of fluorescent small molecules that can be used for 
calibrating the FCS instrument.  
Dye diffusion  
constant [µm²/s] 
laser   
wavelength [nm] 
temperature 
[°C] 
Reference 
Alexa488 435 488 22.5 +2%/°C (19) 
Alexa546 341 543 22.5 +2%/°C (19) 
eGFP 95 488 22.5 +2%/°C (19) 
Fluorescein 436 488 22.5 +2%/°C (19) 
Rhodamine 
6G 
426 543 22.5 +2%/°C (19) 
Cy5 370 ± 15 633 25 (20) 
Alexa633 340 ± 10 633 25 (21) 
Atto655 390 633 25 (22) 
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Quantitative thermophoretic 
study of disease-related protein 
aggregates
Manuel Wolff 1, Judith J. Mittag2, Therese W. Herling3, Erwin De Genst3, 
Christopher M. Dobson3, Tuomas P. J. Knowles3, Dieter Braun1 & Alexander K. Buell3,†
Amyloid fibrils are a hallmark of a range of neurodegenerative disorders, including Alzheimer’s and 
Parkinson’s diseases. A detailed understanding of the physico-chemical properties of the different 
aggregated forms of proteins, and of their interactions with other compounds of diagnostic or 
therapeutic interest, is crucial for devising effective strategies against such diseases. Protein aggregates 
are situated at the boundary between soluble and insoluble structures, and are challenging to study 
because classical biophysical techniques, such as scattering, spectroscopic and calorimetric methods, 
are not well adapted for their study. Here we present a detailed characterization of the thermophoretic 
behavior of different forms of the protein α-synuclein, whose aggregation is associated with 
Parkinson’s disease. Thermophoresis is the directed net diffusional flux of molecules and colloidal 
particles in a temperature gradient. Because of their low volume requirements and rapidity, analytical 
methods based on this effect have considerable potential for high throughput screening for drug 
discovery. In this paper we rationalize and describe in quantitative terms the thermophoretic behavior 
of monomeric, oligomeric and fibrillar forms of α-synuclein. Furthermore, we demonstrate that 
microscale thermophoresis (MST) is a valuable method for screening for ligands and binding partners of 
even such highly challenging samples as supramolecular protein aggregates.
Protein aggregation into highly ordered, insoluble amyloid fibrils and their oligomeric precursors is a hallmark of 
a range of disorders, many of them neurodegenerative in nature, such as Alzheimer’s and Parkinson’s diseases1. In 
the latter condition, intracellular amyloid deposits, known as Lewy bodies, of the intrinsically disordered protein 
α-synuclein form a major characteristic of the pathology2. To date, no cure for this disease exists, a consequence 
at least in part of the lack of fundamental understanding of the mechanism of aggregation and its associated tox-
icity, as well as the incomplete characterization of the interactions between aggregates of α-synuclein and other 
compounds, including small molecules and proteins.
Such interactions are important for both diagnostic (e.g. for positron emission tomography3) and therapeutic 
purposes (e.g. for targeted aggregation inhibitors4). In this context there is an urgent need for experimental tech-
niques that can be used for high throughput screening to identify such compounds. Standard techniques, such as 
isothermal titration calorimetry (ITC)5 or surface plasmon resonance (SPR)6 can provide important information, 
but suffer from a number of limitations, including high levels of sample consumption (ITC), potential surface 
artifacts (SPR) and high sensitivity to solution conditions (both ITC and SPR).
Analytical methods based on thermophoresis have recently been introduced as alternatives to these estab-
lished methods for the measurement of binding interactions of biomolecular compounds7,8. Thermophoresis, 
also known as the Soret effect9, corresponds to the directed net diffusional flux of particles under the influence of 
a temperature gradient. If the temperature gradient is stationary, the molecular concentration eventually reaches 
a steady state through the simultaneous and opposite effects of thermal diffusion (with coefficient DT) and stand-
ard (Fick) diffusion (with coefficient D). The phenomenon of thermophoresis was first described in the 19th 
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century9,10 and has recently seen a surge in attention, due to its many potential biophysical applications11 and even 
possible role in the origins of life12.
In a thermophoretic experiment, the concentration of thermally diffusing particles or molecules, c, can be 
described by a combination of local equilibrium and non-equilibrium effects, and follows an exponential distri-
bution: = − −   c x c x S T x T x( )/ ( ) exp( ( ( ) ( ))T0 0 0 0 13, where ST = DT/D is the Soret coefficient. Through the crea-
tion of well-defined temperature gradients and the subsequent measurement of concentration distributions at 
steady state, the intrinsic propensities of particles to exhibit thermophoresis can be determined. Temperature 
gradients can be created through Joule heating14, the generation of a hot reservoir15 or by absorption of infrared 
(IR) laser radiation (Fig. 1c)16, and the concentration profiles of the species undergoing thermophoresis can be 
mapped via measurements of variations in refractive index17, light scattering18 or fluorescence intensity16, pro-
vided that the species are suitably labeled or show intrinsic fluorescence11.
The increasing recognition of the potential importance of thermophoresis for the characterization of bio-
molecular binding equilibria is paralleled by extensive fundamental research activity on the thermophoretic 
properties of polymeric and colloidal systems16,19–21, as well as solvent mixtures22. Despite the current lack of an 
overarching theory of thermophoresis of different systems, interesting trends have been observed in a variety 
of systems. For nonionic polymers a saturation of the thermal diffusion coefficient after several Kuhn segments 
has been found in a large set of nonpolar solvents23 as well as in water20,24. Nevertheless, no general tendency of 
increasing or decreasing Soret coefficient with size for uncharged polymers has been observed20,25 and theoretical 
models are still under debate26,27. For charged polymers, substantial progress has been made in the understanding 
of ionic effects in recent years. Thermal gradients lead to the development of concentration gradients for the ionic 
species28, which contribute to the movement of charged polymers by the build-up of electric fields16,29 and diffu-
siophoresis30. Furthermore, thermal gradients also introduce contributions to the Soret coefficient which arise 
from the change in free energy of the Debye layer associated with the temperature change31 and can be described 
by considering local equilibrium13. These models have been successfully tested for spherical particles by variation 
of ionic strength16,32,33 and extended to elongated structures, such as viruses34 and DNA35. The Soret coefficients 
of proteins and various other charged polymers have also been found to increase with temperature in a manner 
that is described by an empirical formula17. Although fundamental research into the origin of this temperature 
dependence is ongoing, the Soret effect has already been exploited for particle separation15 and the detection of 
phase transitions36.
Figure 1. Quantitative thermophoresis of proteins. AFM images of oligomeric (a) and fibrillar (b) forms of 
the protein α-synuclein, associated with Parkinson’s disease. The oligomers have an average diameter of 15 nm 
in solution, as determined by fluorescence correlation spectroscopy. (c) An initially homogeneous solution, 
or a suspension of a protein species, here illustrated with fibrillar aggregates, is subjected to localized heating 
by an IR-laser inside a borosilicate capillary, which leads to directed movement of molecules and complexes 
along the temperature gradient, until a steady state is established. (d) The radially averaged temperature 
profile (typically established within less than a second after turning on the laser), and the concentration profile 
(usually established within seconds to minutes) are illustrated schematically at steady state. A schematic fibril is 
displayed undergoing positive thermophoresis, i.e. migrating away from the heated spot.
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The binding of a ligand to a biomolecule can in many cases induce a change in thermophoretic behavior that 
is sufficiently large to be detected, and hence a binding curve can be obtained through measurements of a dilution 
series of one of the binding partners. It has been shown, for example, that binding constants for protein-ligand 
interactions can be obtained rapidly in this way, even under the most challenging solution conditions and using 
only minute quantities of sample8.
Despite the increasing attention being focused on such effects and the great potential of thermophoresis for 
high throughput screening, it is not yet possible to predict from first principles the value of the Soret coefficient 
of any protein under a given set of conditions, or even the sign and magnitude of a change in the Soret coefficient 
induced by the binding of a ligand. Indeed, very few studies have so far addressed the problem of quantitative 
measurements of the thermophoresis of proteins17 or protein assemblies37. The aim of the studies described here 
is to advance our fundamental understanding of protein thermophoresis through the study of distinct forms of 
the protein α-synuclein. We have chosen this protein because of its relevance to Parkinson’s disease, as well as its 
well-established ability to form different types of stable aggregates, such as oligomeric structures38 and mature 
amyloid fibrils39. In addition, the monomeric protein is kinetically highly stable in bulk solution, and in the 
absence of catalytic surfaces it does not aggregate at a detectable rate even at high concentrations40,41, facilitat-
ing its study by biophysical techniques. Therefore, α-synuclein represents an excellent system through which to 
study the influence of the size and nature of protein assemblies on their thermophoretic behavior. In particular, 
we have used a combination of fluorescence correlation spectroscopy (FCS)42 and microfluidic free flow electro-
phoresis43, along with measurements of the Soret coefficients of fluorescently labeled monomeric and aggregated 
α-synuclein to examine the importance of electrostatic effects in protein thermophoresis. We find that while 
the different aggregated species cannot be discriminated based on their electrophoretic mobilities, they exhibit 
very distinct thermophoretic mobilities. In addition, we show that the binding of a high affinity single domain 
antibody (nanobody) as well as of a natural small molecule, epigallocatechin gallate (EGCG44,45) to α-synuclein 
aggregates can be probed by exploiting changes in thermophoretic behavior upon binding. These results establish 
thermophoresis as a useful method for binding studies to a highly challenging class of target structures.
Results
Thermophoresis of protein structures is size-dependent.  We have produced fluorescently labeled 
monomeric, oligomeric and fibrillar α-synuclein (see supplementary section 2 for detailed protocols) and char-
acterized these different species by atomic force microscopy (AFM, Fig. 1) and FCS (supplementary section 5). 
For the aggregated forms of the protein, we used a minimally invasive labeling strategy, in which only a small 
fraction of the protein molecules within each aggregate is labeled. We then measured the Soret coefficients, ST, of 
these three distinct and well-defined forms of α-synuclein at low ionic strength (1 mM Tris buffer) as a function 
of temperature (Fig. 2a), using a thermophoresis setup with laser heating and a camera16 (see supplementary 
Figure 2. Thermophoretic characterization of three distinct α-synuclein species. (a) The Soret coefficients, 
ST, of monomeric, oligomeric and fibrillar α-synuclein (in 1 mM Tris buffer at pH 7.4) as a function of 
temperature, showing their strong size-dependence. Inset: The thermal diffusion coefficient, DT = DST, as a 
function of temperature. (b) Fit of the temperature dependence of ST of α-synuclein monomers (blue) and 
oligomers (green) at different concentrations of added NaCl. The data are globally fitted to a model that 
includes the electrostatic effects relevant for thermophoresis and where the effective charges of the species and 
the Soret coefficient of the Tris ion are the only free parameters. (c) The charges determined from the fits in 
(b) compared with the charges determined from an analysis of the electrophoretic mobilities (supplementary 
section 6). For the monomer, the charge expected from the amino acid composition is also plotted. Inset: The 
free flow electrophoretic mobilities43 of fluorescently labeled monomeric, oligomeric and fibrillar α-synuclein 
(in 5 mM Tris buffer pH 7.4) are plotted against their diffusion coefficients (from FCS measurements42, and 
supplementary section 5).
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section 4) to record the time evolution and steady-state distribution of the concentration of fluorescently labeled 
protein aggregates. In these experiments unlabeled protein molecules and aggregates are invisible. The absolute 
magnitude of ST was found to increase with the size of the α-synuclein structure (Fig. 2a). A size dependence of 
the Soret coefficient has been observed previously13,21,46, but the question of whether or not the thermal diffusion 
coefficient DT = DST also depends on size has been controversial, although most results point towards the size 
independence of DT for simple colloid systems24,46. We find here that while monomeric and oligomeric forms of 
α-synuclein have very similar thermal diffusion coefficients, DT is markedly smaller for the fibrillar form of the 
protein (Inset to Fig. 2a). In order to investigate the origin of the size dependence of ST in more detail, therefore, 
we have performed experiments under a range of different solution conditions.
The thermophoresis of proteins is dominated by electrostatic effects.  We first explored the effects 
of variations in ionic strength on the thermophoretic behavior of the various proteinacious species studied here, 
as significant effects have been observed previously for DNA16. The magnitude of the Soret coefficient decreases 
when the ionic strength is increased for monomeric and oligomeric α-synuclein species (Fig. 2b). The absolute 
change in ST for a given variation in ionic strength is, however, observed to depend on the size and charge of the 
α-synuclein species, with a more pronounced dependence being observed for the oligomers. Similar experiments 
for fibrillar α-synuclein were not pursued because an increase in ionic strength can induce higher order assembly 
of fibrils, as reported previously39, making an accurate determination of the absolute Soret coefficient difficult.
We have recently presented a theoretical description that for DNA quantitatively captures the various elec-
trostatic effects important in thermophoresis, such as the capacitor effect and the Seebeck effect16 and (see sup-
plementary section 7). The most important parameters in this model are the size, charge and electrophoretic 
mobility of the macromolecule under investigation. We have here been able to determine all of these parameters 
independently for the three distinct types of α-synuclein species (inset to Fig. 2c) by using FCS42 to measure the 
standard (Fick) diffusion coefficients (supplementary section 5); the latter can be used to determine the dimen-
sions of the structures. Assuming spherical geometry38, we obtain hydrodynamic diameters of 5.6 nm and 15 nm 
for the monomeric and oligomeric α-synuclein, respectively. In addition, the (sonicated) fibril length distribu-
tions were characterized in detail by AFM and we found an average length of ~200 nm and a diameter of ~8 nm. 
Furthermore, we used microfluidic free flow electrophoresis43 and (supplementary section 6) to determine the 
electrophoretic mobility of each species (inset to Fig. 2c). We have fitted the data to a model that takes both the 
capacitor and Seebeck effects into account (supplementary section 7), allowing us to decompose the Soret coef-
ficient into charge-dependent effects and non-ionic contributions. The fits yield an effective charge that appears 
to be responsible for the strong dependence of the thermophoresis on the ionic strength of the solution. We can 
also estimate the charges of the distinct α-synuclein species from their electrophoretic mobilities. To that end, the 
monomeric and oligomeric forms of α-synuclein were approximated as spheres and the fibrils as rods, enabling 
us to use the theoretical framework already developed for colloids47, yielding charges of − 10.9 e for the monomer, 
− 50.4 e for the oligomer and a value in the range from − 200 e to − 300 e for the fibrils (supplementary section 
6). The value for the monomer is in good agreement with that calculated from the amino acid composition at 
this pH (− 9.1 e) in addition to the charges carried by the fluorescent label (− 4 e). It is interesting to see that 
the oligomers, despite being composed of ca. 30 monomers on average38, have a net charge only about 5 times 
higher than that of the monomer. This difference between expected and determined charge, which is even more 
pronounced for fibrillar α-synuclein, can be explained through a shift of the pKa values of the ionizable residues 
in the aggregates with respect to the monomeric state, as well as the absorption and incorporation of counter ions 
into the oligomers and fibrils48. The values of the effective charges (see Fig. 2c for an overview) of the α-synuclein 
monomers and oligomers calculated from the thermophoretic data (− 6.9 e and − 29.2 e) are significantly smaller 
than those resulting from the fits to the electrophoretic mobilities (− 10.9 e and − 50.4 e). Due to the lack of exper-
imental data on the ionic strength dependence of the ST values of the fibrils, we cannot estimate the thermopho-
retic charge of the fibrils. Since studies that directly compare effective charges determined from electrophoretic 
and thermophoretic measurements are rare30,33, the data shown here provide an important benchmark through 
which to improve the theoretical descriptions of both electrophoretic and thermophoretic phenomena of complex 
biomolecular structures such as protein molecules and supramolecular protein aggregates. Note that the Soret 
coefficient of the positively charged Tris ion was determined from a global fit to the ionic strength dependence of 
the thermophoresis of monomeric and oligomeric α-synuclein to be 0.0031/K, and the value obtained is at least 
comparable in magnitude to the one of the sodium ion with 0.00469/K16,49.
We next tested whether or not the presence of an excess of unlabeled monomeric α-synuclein leads to a 
change in the thermophoresis of the fluorescently labeled monomeric, oligomeric and fibrillar α-synuclein 
(Fig. 3). We find that the thermophoresis of both labeled monomeric and oligomeric α-synuclein is decreased 
by the presence of an excess (70 μM) of unlabeled monomeric α-synuclein (Fig. 3a). Furthermore, we find that 
the Soret coefficient of fibrillar α-synuclein at 20 °C in the presence of 40 μM unlabeled monomeric α-synuclein 
shows also a decreased value compared to the sample without added monomeric protein (Fig. 3b). Under these 
conditions of low ionic strength and relatively low temperature, the rate of incorporation of monomeric protein 
into the amyloid fibrils is negligibly slow39. However, when we heat the samples for 20 min to 70 °C, and again 
determine the Soret coefficient (Fig. 3b), we find that ST has significantly increased for the sample with the added 
monomer, whereas the increase is smaller for the sample without any added monomer. Analysis of the length 
distributions of the amyloid fibrils before and after the incubation at 70 °C illustrates that the fibrils have increased 
in length due to monomer incorporation (Fig. 3c). As the temperature is increased, the structural rearrangements 
and/or desolvation necessary for the incorporation reaction of the α-synuclein monomers into the fibrils are 
significantly accelerated39,50.
These results suggest that the presence of unlabeled monomeric α-synuclein does indeed affect the thermo-
phoresis of monomeric and aggregated α-synuclein. In order to elucidate the physical origin of this effect, we have 
www.nature.com/scientificreports/
5Scientific RepoRts | 6:22829 | DOI: 10.1038/srep22829
computed the predicted decrease in Soret coefficient due to the additional Seebeck and capacitor effects caused by 
the presence of the unlabeled monomer, treating the latter as an additional salt species with the Soret coefficient 
and charge as determined above for labeled monomer (mean value over the examined temperature range: 
= .S 0 031/KT
mon ). The predictions are shown in Fig. 3a as solid lines and show that the decrease in Soret coeffi-
cient induced by the presence of the unlabeled monomer can be quantitatively described by treating the unlabeled 
α-synuclein monomer as a dissolved electrolyte. It is surprising that this simple approximation yields a relatively 
good description of the observed behavior, given the limited validity of Debye Hückel theory when treating highly 
charged macromolecules, such as the α-synuclein monomers, as counterions in the capacitor effect. Indeed, the 
Debye length at the ionic strength that can be formally attributed to the presence of the 70 μM unlabeled 
α-synuclein (ca. 5 nm) is much shorter than the average distance between the protein molecules at this concen-
tration (ca. 30 nm). Nevertheless, based on the agreement between the experiments and the modeling, the 
decrease in Soret coefficient of the three α-synuclein species in the presence of an excess of unlabeled monomeric 
α-synuclein appears to be caused, at least in part, by the electrostatic effects exerted by the latter on the former. In 
the case of labeled α-synuclein monomer, the addition of unlabeled monomer is of course equivalent to an 
increase in the total concentration of the protein, and it has been reported previously that an increase in concen-
tration of a charged species decreases the Soret coefficient16. Since the concentration of unlabeled monomer is far 
below the overlap concentration (~0.01 Mol/l), effects of the added species upon viscosity are expected to play a 
minor role here. Furthermore, even at higher viscosities, the steady state distributions of molecules in a tempera-
ture gradient are not necessarily affected, due to the dependence of both D and DT on viscosity23, which can lead 
to viscosity independent Soret coefficients ST. Therefore the results of our particular experimental design where 
only part of the protein molecules are visible allow us to conclude that the effect of an increase in concentration 
on thermophoresis can be understood in the general framework of electrostatic interactions in the dilute regime.
Measurement of ligand binding constants to monomeric and aggregated α-synuclein. Having 
established the general principles governing the thermophoresis of protein aggregates, we proceeded to investi-
gate the application of this technique for ligand screening and characterization of the binding of ligands to the 
aggregates. For this purpose, we investigated the effects of the binding of a single domain camelid antibody (nano-
body), which has been shown to bind to the disordered C-terminal region of α-synuclein5, on the thermophoresis 
of different α-synuclein species. We first determined the ST values of monomeric and oligomeric α-synuclein in 
the presence of a saturating concentration of the nanobody (Fig. 4a) and found that in both cases the bound state 
displays a reduced thermophoretic effect. The nanobody is positively charged at neutral pH (+ 1.5 e), and there-
fore the net global charge of the protein-nanobody complex is lower than that of the protein alone. If the observed 
decreases in Soret coefficient are attributed solely to decreases in charge, it would correspond to a change in 
charge of + 2.7 e for the monomer and + 7.0 e for the oligomer (compare solid lines in Fig. 4a). Therefore, at least 
for the monomer, which is known to bind with a stoichiometry of 1:1 to the nanobody, the observed effect appears 
larger than expected purely on electrostatic grounds. One reason for this enhanced effect might be the change in 
overall size and hydrophobicity51 associated with the binding of the nanobody. For the oligomers, the value of the 
reduced charge suggests a stoichiometry much larger than 1:1, which is consistent with the fact that the oligomers 
consist on average of 30 monomers. However, due to lack of detailed structural information for the oligomer, 
and hence the accessibility of the binding epitopes, it is difficult to estimate the stoichiometry. We were unable 
to perform similar experiments with fibrillar α-synuclein, as the charge reduction associated with the binding of 
Figure 3. The effect of unlabeled (and hence invisible) monomeric α-synuclein on the thermophoresis of 
the distinct α-synuclein species. (a) Temperature dependence of ST for labeled monomeric and oligomeric 
α-synuclein in the presence and absence of a high background concentration (70 μM) of unlabeled monomeric 
α-synuclein in 1 mM Tris buffer pH 7.4. The solid lines are predictions if the unlabeled monomer is treated as an 
ionic species within the theoretical thermophoretic model used here (see main text and supplementary section 7). 
(b) The Soret coefficient of fibrillar α-synuclein at 20 °C, in the presence and absence of 40 μM unlabeled 
monomeric α-synuclein, before and after a 20 min period of heating to 70 °C. (c) Length distributions of the  
α-synuclein fibrils with added unlabeled monomer before and after 20 min heating to 70 °C.
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the nanobody led to almost instantaneous formation of macroscopic assemblies of fibrils, that rendered accurate 
determination of the Soret coefficient impossible.
Based on the observed change in Soret coefficient upon nanobody binding, however, we tested if the binding 
constant of the nanobody to both monomeric and oligomeric α-synuclein could be measured by using a sim-
plified thermophoresis setup that monitors the time evolution of the total fluorescence intensity in the area of 
elevated temperature, rather than the full spatial distribution as in the setup used for the determination of the 
Soret coefficients (integrated vs. spatially resolved approach, see supplementary section 4). In Fig. 4b, we show the 
corresponding binding curves from the integrated measurements. We obtain binding affinities of the nanobody 
to monomeric α-synuclein that are in excellent agreement with a previously determined value, obtained from 
ITC measurements (124 ± 35 nM vs. 130 ± 23 nM5). The binding affinity to the oligomers (234 ± 49 nM) had not 
previously been reported, partly due to the challenge of obtaining sufficient quantities of pure oligomers, which 
we have been able to overcome by exploiting the low sample requirements of thermophoresis. Interestingly, the 
thermophoresis values of the oligomer-nanobody system in the fully bound state do not reach a stable plateau, 
but rather decrease linearly. This effect could be caused by the electrostatic influence of the excess free nanobody 
on the thermophoresis of the oligomer-nanobody complex. In general, electrostatic effects of free ligand mole-
cules might in this way be able to distort binding curves of charged molecules determined by thermophoresis, if 
the affinity is sufficiently low such that high ligand concentrations need to be employed. However, in the present 
case, we do not expect a significant influence on the Kd value, due to the small net charge of the nanobody and 
the relatively high affinity.
We then investigated the binding of the small molecule epigallocatechin gallate (EGCG), one of the main con-
stituents of green tea, to α-synuclein aggregates. This molecule has been reported to bind to various species on the 
aggregation pathway of α-synuclein and even to remodel mature amyloid fibrils44. We again first probed whether 
or not the binding to fibrillar and oligomeric α-synuclein manifests itself in a change in Soret coefficient. Despite 
the fact that EGCG is not charged, we measured a decrease in Soret coefficient upon its binding to both oligomeric 
and fibrillar α-synuclein (Fig. 5a). The global charge of the aggregates is not expected to change upon binding; 
indeed, the electrophoretic mobilities of the oligomers and fibrils of α-synuclein are very similar with and without 
bound EGCG (see inset of Fig. 5a). Therefore it is likely that changes in the overall protein-solvent interactions 
are responsible for the observed change in ST. Indeed, it has been proposed that thermophoresis represents a 
way of probing interactions of particles and molecules with the solvent32. Such a proposition is rendered plausi-
ble by a significant, temperature-dependent non-electrostatic contribution to ST (see supplementary section 7) 
that we were able to determine by subtracting the electrostatic contributions from the overall value of ST.
Furthermore, as in the case of the nanobody, the binding constant of EGCG to oligomeric and fibrillar 
α-synuclein can be determined by using the rapid and straightforward integrated approach (Fig. 5b). In these 
experiments, we found that the ratio of labeled to unlabeled protein within the aggregates is an important exper-
imental parameter, in particular in the case of a compound that is able to influence the fluorescence intensity 
of the label upon binding, such as EGCG. In addition, if the ratio of the labeled to the unlabeled protein is 
too high, the surface properties, and hence the binding behavior of α-synuclein aggregates can change signifi-
cantly as compared to a completely unlabeled structure (supplementary section 4). Using an optimized ratio of 
labeled to unlabeled protein of ~0.02–0.03 for both aggregate species, we determined the binding constant of 
EGCG to α-synuclein amyloid fibrils and oligomers under these conditions to be 2.5 ± 0.4 μM and 4.3 ± 0.8 μM, 
Figure 4. Measurements of the effects of the binding of an antibody on the different α-synuclein species. 
(a) Temperature dependence of ST for monomeric and oligomeric α-synuclein in the presence and absence of 
the single domain camelid antibody (nanobody) Nb Syn2 (structure of Nb Syn2 with coordinates taken from 
PDB 2X6M53). The solid lines are fits that allow the determination of the reduction in effective charge due to the 
binding of the nanobody. (b) Binding curves of Nb Syn2 to monomeric and oligomeric α-synuclein obtained 
with a thermophoresis setup that monitored the time course of the fluorescence intensity at the position of 
heating. Each data set combines the results from three independent experiments. The data for the monomer 
were shifted up by 40‰ for better clarity.
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respectively. The affinity for the fibrils is approximately one order of magnitude lower than the value reported 
previously under conditions of higher ionic strength44, whereas the affinity of EGCG for oligomers has not previ-
ously been measured. It has, however, been reported that EGCG can induce structural changes in amyloid fibrils 
and other protein aggregates44, and such a substantial structural rearrangement can be expected to affect the 
thermophoretic behavior, complicating the determination of binding constants. In order to test whether or not 
such effects occurred during our binding studies, we incubated oligomeric and fibrillar α-synuclein for 12 h in 
the presence of 100 μM EGCG followed by AFM imaging, to allow for sufficient time for even slow remodeling 
processes to take place. The resulting images are shown as insets in Fig. 5b and reveal no noticeable change in 
morphology compared to freshly prepared oligomers and fibrils (compare with Fig. 1c,d), suggesting that under 
the conditions employed here, no significant remodeling of fibrils and oligomers is induced by EGCG.
Discussion
We describe in this paper the results of a comprehensive experimental approach that has allowed substantial 
progress to be made towards a quantitative understanding of the thermophoresis of monomeric and aggregated 
forms of proteins. The approach consists of a combination of precise control of sample preparation (solution 
conditions, labeling position and density), independent and quantitative measurements of size, electrophoretic 
mobility and thermophoretic mobility, as well as theoretical modeling. With this strategy, we have shown that 
electrostatic effects, in particular electrophoresis in the field created by the temperature-induced ion gradient 
(‘Seebeck effect’), as well as the temperature dependence of the ion cloud extension and its associated electro-
static energy (‘capacitor effect’) (supplementary section 7 and for details of the modeling process)16, are impor-
tant factors in the thermophoresis of proteins and protein aggregates. These conclusions are consistent with 
those reported previously for nucleic acids16,32, and therefore suggest that there may be universal principles that 
govern the thermophoresis of charged macromolecules. Such a general understanding of the well-established 
physico-chemical phenomenon of thermophoresis represents an important step in the further development of 
this technique as an experimental strategy for characterizing biomolecular interactions.
We were able to combine the advances made using custom built research tools, which allow for the charac-
terization of a range of well-defined physical properties (diffusion coefficient, electrophoretic mobility and Soret 
coefficient), with the ease of use of a simplified thermophoresis setup that can be applied in a straightforward 
manner for the determination of binding constants. This dual strategy has allowed us to exploit the precise control 
of sample preparation for the detection and characterization of the binding of a range of ligands (small molecules 
and macromolecules) to different types of disease-related protein aggregates. Indeed, we were able to investi-
gate structures ranging from soluble monomeric protein molecules to oligomeric structures and mature amyloid 
fibrils. Because of the importance of electrostatic effects in defining the magnitude of the observed thermopho-
retic effect, these results show that thermophoresis is very well suited for the study of binding events that lead to 
a change in charge.
Even in cases where there is no change in global charge, however, we found that thermophoresis allowed for 
detection of binding events, due to the additional dependence on parameters such as size and interaction with the 
solvent. Indeed, we observed that protein aggregates that are very different in size and structure, but which display 
a very similar electrophoretic mobility, such as oligomeric and fibrillar α-synuclein, show a marked difference 
Figure 5. Measurement of binding of EGCG (structure shown in a) to α-synuclein aggregates. (a) Measurements 
of the Soret coefficients of oligomeric and fibrillar α-synuclein in the presence and absence of 100 μM EGCG. In 
contrast to thermophoresis, the electrophoretic mobilities remain virtually unchanged in the presence of EGCG (see 
inset). (b) Binding constants for the interactions of EGCG with oligomeric and fibrillar α-synuclein were measured 
using the integrated thermophoresis approach. Each data set is an average of three independent experiments. The 
insets show AFM images (image sizes are 1 μm × 1 μm) taken after incubation of oligomers and fibrils for 12 h with 
100 μM EGCG. No morphological changes could be detected (compare with Fig. 1a,b).
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in thermophoretic mobility. Furthermore, the binding of a ligand that does not lead to a change in global charge 
and electrophoretic mobility, such as of the compound EGCG, to oligomeric and fibrillar α-synuclein leads to a 
detectable change in thermophoretic behavior. It has recently been shown in this regard that the binding of EGCG 
to α-synuclein oligomers changes their surface properties significantly, and renders them less disruptive to lipid 
membranes45. The thermophoretic response to changes in surface hydrophobicity reflects the physical complexity 
of systems with non-uniform temperature that leads to a potentially greater discriminatory power compared to 
other separation techniques based only on size or electrophoretic mobility.
Conclusions
The results of this study have contributed significantly to the rationalization of the size and charge-dependence 
of protein thermophoresis, and therefore have significantly advanced our fundamental understanding of this 
phenomenon and enabled a general strategy to be outlined that would deepen this understanding further in the 
future. This strategy consists of specifically designed sample preparation and labeling strategies, combined with 
state-of-the-art thermophoretic, electrophoretic and size measurements of the structures under study and theo-
retical analysis and modeling of the physico-chemical factors that determine thermophoresis. We have been able 
to show that species such as oligomeric and fibrillar protein aggregates show very similar electrophoretic, but very 
distinct thermophoretic behavior.
Equally importantly, we have also established the possibility of using thermophoresis for the screening and 
characterization of ligand binding to disease-related protein aggregates. Despite the fact that microscale thermo-
phoresis is in the process of becoming a well-established experimental technique for protein-ligand binding 
affinity measurements, it has not previously been reported for the study of ligand binding to supramolecular 
aggregates, such as amyloid fibrils. Due to their polymeric nature these types of samples are substantially more 
challenging to handle than most soluble monomeric proteins and we present here a comprehensive protocol for 
the use of microscale thermophoresis for amyloid-ligand binding assays. The possibility of characterizing novel 
types of ligands that bind to protein aggregates, both small and large molecules, at high throughput and using 
minute sample quantities is a highly valuable addition to the experimental toolbox available for the develop-
ment of diagnostic and therapeutic strategies against protein misfolding diseases. In particular, we would like to 
emphasize that oligomeric structures, which have been highlighted as the most toxic species on the aggregation 
pathway52, often occur only at low concentration and with short lifetimes and hence experimental methods that 
are rapid and require only small amounts of sample are vital for their study.
Materials and Methods
Detailed protocols for sample preparation and for the measurements of diffusion coefficients, electrophoretic 
mobilities, Soret coefficients and binding curves can be found in the supplementary materials.
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∗authors to whom correspondence should be addressed: dieter.braun@lmu.de, alexander.buell@uni-duesseldorf.de
Content
1. Chemicals and reagents
2. Preparation of protein samples and protein labeling
3. Atomic force microscopy
4. Thermophoresis experiments
5. Fluorescence correlation spectroscopy of monomeric and aggregated α-synuclein
6. Free flow electrophoresis measurements of monomeric and aggregated α-synuclein
7. Modeling the electrostatic effects in protein thermophoresis
8. ComSol simulations of the thermophoresis setup
1 Chemicals and reagents
Thioflavin-T (ThT), Epigallocatechin gallate (EGCG), NaCl, Na2HPO4, NaH2PO4, PBS tablets and Tris-HCl were
purchased from Sigma Aldrich. BCECF, Alexa Fluor R© 568 C5 maleimide and Alexa Fluor R© 647 C2 maleimide were
purchased from Life Technologies Ltd (Paisley, UK).
2 Preparation of protein samples and protein labeling
2.1 Monomeric unlabeled and labeled α-synuclein
Wild type α-synuclein (α-syn) was recombinantly expressed and purified as reported previously [1]. After the last
step of the purification protocol, the protein solution (in 20 mM phosphate buffer) was divided into aliquots of 500-
1000 µl at concentrations between 200 and 300 µM, flash frozen with liquid nitrogen and stored at -80 ◦C. When the
monomeric protein was required in a different buffer, it was dialysed for 24 h against a thousandfold larger volume
of the required buffer. For the fluorescent labeling, we used the N122C variant [2], in order to be able to attach the
fluorescent label. This variant was expressed and purified similarly to the wild type protein, except that the lysis buffer
and all subsequent buffers contained 1 mM EDTA and 1 mM DTT. For the labeling, ca. 0.2 µmol of N122C variant
α-syn in 500 µl buffer was injected into a Superdex 200 Increase 10/300 GL gel filtration column (GE Healthcare,
Little Chalfont, UK) that had been incubated with labeling buffer (Tris or phosphate buffer at ∼pH 7, 5-20 mM).
The fluorescent dyes (maleimide derivatives) were dissolved at 10 mg/ml in DMSO or DMF and 100 µl of this stock
solution were added to the combined protein fractions immediately after elution. The protein was left to react with
the label for 1 h at room temperature and afterwards for 12 h at 4 ◦C. Then the solution was concentrated to 500 µl
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using Amicon centrifugal concentrators with 3 kDa MW cut-off (Millipore, Watford, UK) and injected into a Superdex
200 Increase 10/300 GL gel filtration column that had been incubated with the buffer the protein was required in,
i.e. 20 mM PB buffer pH 6.5 or 5 mM Tris buffer pH 7.4. The most concentrated fractions of the labeled protein
were combined and divided into aliquots of 25 µl. The aliquots were flash frozen in liquid nitrogen and stored at
-80 ◦C until use. Labeling efficiency was evaluated with mass spectrometry (Figure 1 a) and the protein concentration
was determined using amino acid analysis (both services provided by PNAC facility, Department of Biochemistry,
University of Cambridge). We also kept some of the fractions of free dye label for control experiments (see below).
The single chain camelid antibody NbSyn2 was expressed and purified as described in [3].
2.2 Preparation of labeled α-synuclein oligomers
The preparation of stable α-synuclein oligomers is similar to the protocol described in detail in [4]. In short, monomeric
α-synuclein is dialysed for 1-3 days against pure water. The solution is then freeze-dried and the lyophilized protein
is stored at -80 ◦C until use. For oligomer formation, the dry protein is dissolved in phosphate buffer saline (PBS) at
concentrations between 600 and 800 µM and incubated at 37 ◦C for several hours (10-20 h) under quiescent conditions.
In most cases, the protein solution had not visibly aggregated/gelled despite the high protein concentration after this
incubation period. It has been shown that quiescent α-synuclein solutions in the absence of pre-formed seeds [5] and
of other aggregation stimulating conditions, such as lipid bilayers [6] aggregate only very slowly, due to the fact that
the fibril nucleation is a heterogeneous process that requires catalytic interfaces, such as the air-water interface [7].
500 µl of the protein solution are then injected into a Superdex 200 Increase 10/300 GL gel filtration column, which
had been incubated with 5 mM Tris buffer. The protein is eluted at 0.5 ml/min and the oligomers elute as a small
peak of ca. 0.75 ml volume after ca. 20 min, followed by a largely dominant monomer peak (Figure 1 b).
In order to produce fluorescently labeled oligomers, we reasoned that it would be best to minimize the labeling
density; the lowest possible label density corresponds to one dye molecule per oligomer. Using various light scattering
techniques, we have in previous work determined these stable α-synuclein oligomers to consist of ∼30 monomers on
average [4]. Therefore, we used ratios of unlabeled to labeled protein of 30 or higher. Figure 1 b shows an example of
a chromatogram illustrating the relative populations of oligomers and monomers and giving an idea about the labeling
density.
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Figure 1: a) Mass spectrum of α-synculein N122C labeled with Alexa Fluor R© 647, showing the essentially quantitative
labeling. b) Example of a size exclusion chromatogram of a mixture of labeled (with Alexa Fluor R© 647) and unlabeled
α-synuclein, treated according to the protocol described above. The small peak to the left of the large monomer peak
corresponds to the oligomers (red: absorption at 647 nm; blue absorption at 280 nm). Fractions 22 and 23 were
combined and used as the oligomeric species. It can be seen that the labeled and unlabeled monomers have slightly
different retention times. Also, the relative absorptions at 280 and 647 nm are comparable for the monomer and
oligomer peaks, suggesting that the labeled monomer is incorporated statistically into the oligomers and that therefore
the labeling density of the oligomers corresponds to the initial proportion of labeled monomer.
Our attempts to label the oligomers proved insightful regarding their mechanism of formation. Adding the labeled
protein at different points in the oligomer formation protocol led to very different incorporation efficiencies. When
the labeled protein was added after the freeze-dried unlabeled protein had been dissolved in PBS, virtually no labeled
oligomers were obtained. Furthermore, the duration of the incubation had very little effect on the labeling yield.
2
However, the best incorporation efficiency (equal to the ratio of added labeled protein) was achieved when labeled
and unlabeled protein were mixed before the dialysis against water. These findings strongly suggest that these stable
α-synuclein oligomers form during the process of dialysis and/or lyophilisation and are therefore possibly not directly
connected with the molecular pathway that leads to the formation of amyloid fibrils; we have drawn similar conclusions
in the past based on kinetic experiments with these oligomers [4].
After gel filtration, the most concentrated oligomer fractions were combined (typically ∼500 µl) and concentrated to
about ten times the eluted concentration, using Amicon centrifugal concentrators with 3 kDa MW cut-off (see above).
For the measurements of the Soret coefficients, we required the oligomers in 1 mM Tris buffer. In those cases we
diluted the concentrated oligomers 1:4 into water and re-concentrated them to the desired final concentration. Once
the oligomers were purified and concentrated, they were stable and could be used for several days, as confirmed by
fluorescence correlation spectroscopy (see below).
2.3 Preparation of labeled α-synuclein fibrils
Fibrils with varying labeling densities were prepared by seeding a mixture of labeled and unlabeled protein with small
percentages (5% or less) of unlabeled fibrils prepared at pH 6.5 and sonicated to create short seeds as described in [5].
For the accurate measurements of ST , the seeds were incubated with the monomeric fractions (either directly as eluted
or concentrated) from the oligomer purification experiments, yielding the same range of labeling densities as for the
oligomers (≤ 1:30). Under the conditions of low ionic strength (5 mM Tris buffer, pH 7.4) under which the oligomers
were purified, the growth of the seed fibrils is relatively slow, due to electrostatic repulsion between the monomer and
the fibril end [8]. Therefore we incubated the seeded protein solution at elevated temperature (50 ◦C) for 2-3 days
under heavy stirring with a magnetic stirrer. We verified by fluorescence correlation spectroscopy (FCS, see below) that
the monomer content of these fibril samples was below 20%. Under those conditions of very low ionic strength, that
have to our knowledge not been studied in detail before, α-synuclein appears to have a relatively high concentration
of free monomer at equilibrium, presumably because the free energy of aggregation has an unfavorable electrostatic
component [9] that contributes more strongly at lower ionic strength. The yield can be improved by adding NaCl
(10 mM) to the seeded protein solution, which can be tolerated as the subsequent dilution of the fibril sample for the
thermophoretic measurement will sufficiently dilute the NaCl. Due to the slow dissociation of monomer from the fibril
ends, such a diluted fibril suspension will not immediately re-equilibrate to a high free monomer concentration. For
the measurements of the Soret coefficients and for FCS measurements, the fibrils were diluted 30-60 fold (to achieve
suitable signal intensity and particle counts) into 1 mM Tris buffer pH 7.4 and sonicated for 5 min with a Sonopuls
2070 sonicator with a MS 72 tip (Bandelin electronic, Berlin, Germany) at minimal power and 30% pulses.
Our overall strategy of the production of labeled fibrils was based on our previous extensive studies of α-synuclein
fibril formation and growth [5]. We avoided the production of labeled fibrils at higher values of the ionic strength,
as we had previously found that the higher order assembly (’flocculation’) of fibrils induced at higher ionic strength
values is only partly reversible upon dilution into lower ionc strength buffer, even after sonication. In all cases, we
produced labeled fibrils by seeded growth reactions, as we have previously shown that in seeded growth, the kinetics
of aggregation is independent of the ratio of labeled to unlabeled monomer [2]. Therefore, it is reasonable to assume
that the labeled monomer will be incorporated statistically into the growing fibrils, and that therefore the labeling
densities correspond to the initial proportions of labeled to unlabeled monomer.
For the measurements of small molecule binding using the commercially available Monolith instrument (Nanotemper,
Munich, Germany), the absolute concentration of the amyloid fibrils is an important parameter, and hence we prepared
the fibrils from mixtures of unlabeled and labeled protein solutions at known concentrations. 5% seed fibrils were
incubated with a total of 50 µM of monomeric protein with varying proportions of labeled and unlabeled α-synuclein
molecules in 20 mM phosphate buffer pH 6.5. The samples were incubated at 37 ◦C overnight, then they were diluted
1:2 into H2O, sonicated for 3 s and incubated at room temperature overnight. Then the samples were flash frozen in
liquid nitrogen and stored at -80 ◦C until used. No differences in morphology were observed by AFM between fibrils
prepared with different proportions of labeled protein.
3 Atomic force microscopy (AFM)
AFM images of purified oligomers and sonicated fibrils were taken using a Nanowizard II atomic force microscope
(JPK, Berlin, Germany) using tapping mode in air. The samples were diluted to ∼1 µM total protein concentration
in water and 10 µl were deposited on freshly cleaved mica (Agar Scientific, Stansted, UK) and left to dry. The length
distributions were extracted with in-house written Python code, where the ends of the fibrils were manually selected
and the program then draws a line onto the fibril, in order to avoid double-counting of fibrils.
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4 Thermophoresis experiments
We pursued a dual strategy in this work in order to both improve our fundamental understanding of the physical
origins of protein thermophoresis and to demonstrate its usefulness in screening strategies for ligands of disease-related
protein aggregates. We performed measurements of the Soret coefficients of different types of aggregates under different
conditions in order to test the applicability to proteins of the theoretical description of biomolecular thermophoresis
that we have presented in the past for the simpler case of nucleic acids [10, 11]. These experiments were performed
using a home-built setup, based on an inverted fluorescence microscope [11], that records the full spatial distribution
of fluorescence intensity, and hence concentration of α-synuclein species, as a function of time. Having optimized our
experimental protocols (labeling density, solution conditions etc.), we then performed detailed binding experiments
with monomeric, oligomeric and fibrillar α-synuclein and small molecule and protein ligands using a commercially
available instrument, that measures the total fluorescence intensity in the region of interest as a function of time.
For the measurements of Soret coefficients, the concentration of labeled α-synuclein was between 0.1 and 1 µM.
Correspondingly, the total protein concentration (by mass) was 30-50 fold higher in the case of the oligomers and
fibrils, as these species were produced from mixtures of unlabeled protein doped with 2-3% fluorescently labeled
monomer. For the measurements of the binding constants of the antibody NbSyn2 and the small molecule EGCG to
oligomeric and fibrillar aggregates, the total protein concentrations by mass were between 0.2 and 0.5 µM with the
concentration of labeled protein accordingly 30-50 times lower. For accurate measurements of binding constants, it is
important to keep the concentration of one binding partner constant at a value at or below the expected KD. The
resulting low concentrations of labeled α-synuclein were compatible with the sensitivity of the instrument (see below).
4.1 Measurements of Soret coefficients of monomeric and aggregated α-synuclein
Measurements were performed with an upright fluorescence microscope (Zeiss Vario Scope.A1) using an air objective
(Zeiss EC-Plan NeoFluar, 40x, NA=0.9), a CCD camera (Andor Luca DL-658M-TIL) and heating from an infrared
laser (Fibotec, λ = 1480 nm absorbed in water) [11], coupled into the optical path right above the objective. To
keep convection artifacts below experimental error, measurements were performed in borosilicate capillaries with an
inner rectangular cross section of 50 x 500 µm2 (VitroCom Vitrotubes #5005-050). The thin sample, low numerical
aperture and moderate concentration depletion (<50%) ensured that temperature and concentration profiles were
equally averaged along the optical axis. For a sketch of the setup, see Figure 2.
The chamber base temperature was controlled by a PID loop using Peltier elements (Telemeter Electronic GmbH,
PC-128-10-05) and a heat bath. The chamber height of 50 µm and the moderate temperature rise of less than 9 K
above base temperature kept thermal convection small. The measurement was automated and the LED, IR, motorized
stage, temperature, and camera trigger were controlled with LabVIEW. The response of the concentration of labeled
protein in space and time was recorded at 2.5 Hz by fluorescence imaging. Ten seconds of the equilibrated sample
were imaged, followed by different time periods of thermophoretic depletion (depending on the nature of the sample)
under optical heating and different time periods to monitor the back-diffusion after switching off the laser.
The profile of the intermittent local optical heating was measured using the temperature dependent fluorescence
of the dye BCECF (acid form, Invitrogen B-1151) at a concentration of 50 µM in 10 mM Tris, pH 7.8 (Figure
3a and b). First the peak temperature ∆T for the applied laser power was determined in two dimensions by the
assumption of Lorentzian temperature profile T (r) = T0 + ∆T
w2
(r2+w2) . Second the temperature dependence of ∆T as
a function of base temperature was assumed as predicted by COMSOL simulations and confirmed by measurements
(supplementary section 8). The Soret coefficient was deduced by evaluating the radial concentration profile at steady
state in correspondence to the image after temperature jump according to ST∆T (T, r) = − log
(
c(r)
c0
)
(Figure 3c and
d). The error bars for individual Soret coefficients are based on the uncertainties of the temperature jump ∆T (see
also supplementary section 8).
4.2 Measurements of ligand binding affinities of monomeric, oligomeric and fibrillar
α-synuclein
The measurements of the ligand binding constants were performed with a Monolith NT.115 instrument (Nanotemper,
Munich, Germany). We obtained the best experimental results (complete absence of sample absorption onto the inner
walls of the glass capillaries) using the hydrophobically coated glass capillaries provided by Nanotemper.
The binding experiments between monomeric/oligomeric α-synuclein and the nanobody NbSyn2 were performed as
follows. A dilution series was prepared in PBS buffer of the Nb (from 202 µM-6.2 nM, 10 µl at each concentration).
The labeled monomers (in PB pH 6.5) were diluted to a concentration of 0.4 µM into H2O, and then 10 µl of the diluted
protein solution were added to the 10 µl aliquots of the NbSyn2 dilution series, yielding a final monomer concentration
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Figure 2: Schematic illustration [12] of the thermophoresis setup for quantitative measurements of the Soret coefficients
of protein aggregates. The setup is based on a fluorescence microscope. The heating is carried out with an infrared
laser that is coupled into the light path. Detection can be performed either with a CCD camera or with a PMT.
of 0.2 µM. The glass capillaries were filled through capillary action and thermophoretic measurements were performed
(25 ◦C, 15% red LED intensity, 20 and 40% IR laser intensity, 30 s laser on). The labeled oligomers were diluted in
5 mM Tris buffer pH 7.4 to a concentration of approximately 1 µM, as estimated from the size chromatogram during
the isolation and purification of the oligomers. Then 10 µl of the oligomer solution were added to the 10 µl of the
NbSyn 2 dilution series and the capillaries were filled and thermophoresis measurements performed analogously to the
monomer case, except that the LED intensity was 60%. Representative data for nanobody binding to monomeric and
oligomeric α-synuclein are shown in Figure 4. In the case of the oligomers, the thermophoretic amplitude was measured
before steady state was reached (ca. 5 s after the heating laser was switched on), due to the fact that the data became
noisier at later times. This is presumably due to the higher order assembly of the oligomers, that experience a decrease
in charge due to the nanobody binding. In the case of the monomer, the thermophoretic amplitude was measured at
steady state, 30 s after the heating laser was switched on.
For the experiments with EGCG, we first prepared stock solutions of 50 mg/ml (109.08 mM) in dimethylsulfoxide
(DMSO) and then diluted it 50-fold into water to reach a concentration of 2.18 mM with 2% residual DMSO. We then
prepared a dilution series into water with 2% DMSO (10 µl per sample) and added 10 µl of the monomer (1.5 µM
total monomer, 2% labeled, 98% unlabeled monomer), oligomer or fibril (1.5 µM total protein, 2% labeling density)
samples. Then we performed thermophoresis experiments at 25 ◦C and 20 as well as 40% of the IR laser power.
During our experiments that probed EGCG binding to oligomeric and fibrillar α-synuclein, we noticed that the apparent
binding constant changed during the first hour after sample preparation; the binding was observed to become tighter
(Figure 5). While we are not certain about the origin of this change in apparent affinity, it is unlikely to be caused
by a pronounced change in aggregate structure (see AFM images in Figure 5 of main manuscript), but could indicate
multi-step binding with rapid kinetics of initial and slower kinetics of later stages. An alternative explanation could
also be a chemical modification of the fluorescent label by the bound ligand. The experiments shown in the main
manuscript were performed after 1 h incubation of the samples.
For all the measurements of binding constants, we combined data from three independent experiments.
We also performed binding and stability time course experiments with fibrils prepared with different percentages of
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Figure 3: Data evaluation for the quantitative measurements of the Soret coefficient. The temperature gradient which
was induced by the IR-laser was determined by BCECF fluorescence. a) The mean fluorescence on the CCD camera
drops when the temperature gradient is established within 300 ms. Afterwards thermophoresis takes place. When the
IR-laser is turned off the mean fluorescence recovers due to back diffusion. Dividing the picture after the temperature
jump (red bar) by the one beforehand (orange bar) gives the radial fluorescence profile as indicated in b). The radial
fluorescence profile is approximated by a Lorentzian function and the temperature gradient is then determined with
the help of a calibration curve. c) For the α-synuclein species, here illustrated with monomer, the mean fluorescence
is monitored over a longer period of time to reach a steady state. The change of concentration due to thermophoresis
is obtained by division of the mean picture at the steady state (dark blue bar) by the one after temperature jump
(light blue bar). d) The radial concentration profile together with the temperature profile gives the respective Soret
coefficient. Here the measurement of α-synuclein monomer at 1 mM Tris pH 7.4 is shown. The base temperature is
set to 25 ◦C in the presented examples.
incorporated labeled protein. Figure 6 a) shows a comparison of experiments with fibrils with 2% and 50% labeling
density. It can be seen that the apparent affinity and the time-dependent behavior depend on the labeling density. The
overall result of these studies was that the labeling density should be minimized. Obviously, it is always desirable to
minimize the impact that any label might have on the process under study, but if the label concentration is decreased
too much, then the signal is too weak at the low (µM) total protein concentrations that needed to be used in order
to probe the binding affinity accurately. We found that 2% of labeled protein in the fibrils gave consistently the best
results.
We also performed oligomer binding experiments with Thioflavin-T instead of EGCG (Figure 6 b), starting with a
2.33 mM ThT solution in H20 with 2% DMSO. A weak interaction could be detected, that displays no time dependence.
Furthermore, we found that also monomeric α-synuclein interacts with EGCG (Figure 6 c), whereas the free dye label
shows no change in thermophoresis upon incubation with an EGCG concentration series, confirming that the binding
curves presented in this work are not artifacts from ligand-label interactions.
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c)
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Figure 4: Microscale thermophoresis (MST) binding data of monomeric and oligomeric α-synuclein with the nanobody
NbSyn2. a) Raw MST curves for monomeric α-synuclein. b) Binding curve for monomeric α-synuclein. c) Raw MST
curves for oligomeric α-synuclein. d) Binding curve for oligomeric α-synuclein.
Figure 5: Change in apparent binding affinity of EGCG to oligomeric and fibrillar α-synuclein. For both species, the
binding appears to become tighter over the course of an hour, changing from 16.5±1.6 µM and 21.2±2 µM, for fibrils
and oligomers, respectively, to 2.5±0.4 µM and 4.3±0.8 µM.
5 Fluorescence correlation spectroscopy (FCS) of monomeric and ag-
gregated α-synuclein
FCS measurements were performed on a Axiovert 200 microscope equipped with a ConfoCor2 unit (Carl Zeiss Jena,
Germany), a 543 nm and 633 nm helium-neon laser and an apochromatic 40x water-immersion objective with a
NA of 1.2 (Carl Zeiss). Fluorescence emission was separated from laser light using a bandpass filter (560-615 nm)
for excitation with 543nm and a long pass filter (650 nm) for excitation with 633 nm. Calibration was performed
with Alexa546 or Alexa633, respectively, to determine the dimensions of the observation volume. Samples were filled
in NUNC 8-Well-Plates (Thermo Scientific). All measurements were performed at room temperature (22 ◦C, air
conditioned). For analysis the ConfoCor2 software was used.
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Figure 6: a) α-synuclein amyloid fibrils with either 2% or with 50% of the constituent monomers labeled with Alexa 647
are incubated with increasing concentrations of EGCG. Thermophoresis measurements were performed immediately
after sample preparation and again after 1 h incubation period. It is apparent from this data that the labeling density is
an important experimental parameter, and that it should be minimized as much as possible. b) α-synuclein oligomers
show a weak interaction with Thioflavin-T, that does not change over time. c) Monomeric α-synuclein shows a weak
interaction with EGCG, which also displays some time dependence. d) Free Alexa Fluor R© 647 malimide does not
display any interactions with EGCG.
5.1 Data analysis
We follow here the procedures outlines in [13]. The normalized correlation function G(τ) is defined as:
〈F (t)F (t+ τ)〉
〈F (t)〉2
(1)
where angular brackets denote the average over time, F(t) the fluorescence signal at time t and F(t+τ) the fluorescence
signal at a later time t+τ . An ideal three dimensional Gaussian shape is assumed for the confocal volume. The
structure parameter ω describes the ratio of the half axis z0 to the radius of the laser beam w0. By fitting a model to
the experimental data, physically relevant information can be extracted from the correlation curve. The autocorrelation
curve for a single component freely diffusing in a 3D Gaussian element can be described by:
G(τ) =
1
N
(
1
1 + ττD
)(
1
1 + τω2τD
) 1
2
+ 1 (2)
where N is the number of particles inside the confocal volume, τD is the translational diffusion time of the species, τ
is the correlation time and ω the structure parameter. For samples containing two components of different size a two
component fit is used:
G(τ) =
1
N

(1− y)
(
1
1 + ττD1
)(
1
1 + τω2τD1
) 1
2
+ y
(
1
1 + ττD2
)(
1
1 + τω2τD2
) 1
2

+ 1 (3)
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where τD1 and τD2 are the diffusion times of the two components and y is the fraction of the second component. To
take optical dark states of the dye into account, a function that describes the triplet can be integrated into the fitting
equation:
GTriplet(τ) =
(
1 +
T
1− T exp
(
− τ
τT
))
(4)
τT is the triplet state relaxation time and T the fraction of fluorophores in the dark state. The total correlation curve
then becomes a product of the triplet function and the model G (τ):
Gtotal(τ) = GTriplet(τ)G(τ) (5)
The translational diffusion time describes the average dwell time of a molecule with diffusion constant D in the confocal
volume:
τD =
w0
2
4D
(6)
The hydrodynamic radius Rh of a spherical molecule can be determined with the Stokes-Einstein-equation:
Rh =
kBT
6πηD
(7)
where kB , is the Boltzman constant, T is the temperature in [K] and η the viscosity of the surrounding medium.
5.2 Results
We have determined the sizes of fluorescently labeled monomeric, oligomeric and fibrillar α-synuclein using FCS. Figure
7 shows the normalized correlation functions that clearly illustrate the difference in diffusion behavior between the
different species.
Delay time τ [μs]
Figure 7: Normalized correlation curves of monomeric (blue), oligomeric (green) and fibrillar (red) α-synuclein. FCS
measurements enable accurate determination of the diffusion coefficient and hence the (effective) hydrodynamic radii
of the different species, using the Stokes-Einstein equation (Equation 7). The shift to the right towards longer diffusion
times is an indicator for an increase in size.
The experiment shown in Figure 7 yields values of the diffusion coefficient of 8.2±0.34·10−11 m2s (monomer), 3.5±0.34·10−11 m
2
s
(oligomer) and 4.1±0.4·10−12m2s (fibrils). In the case of the monomers and oligomers, the Stokes-Einstein equation
(Eq. 7) can be directly applied in order to determine the hydrodynamic radii, as these species can be approximated as
spheres. As averages from several independent experiments, we obtain RM = 2.8±0.1 nm for the hydrodynamic radius
of the monomer and RO = 7.5±0.7 nm for the hydrodynamic radii of the oligomers. The average diffusion coefficient
measured for the sonicated fibrils is 4.1±0.4 ·10−12 m2s . In all cases when fibrillar samples were measured by FCS,
the quality of a two-component fit was considerably better, where the second component was fixed to have the size
of the monomer. The monomer component of the fibril samples varied between 15 and 23%, which also introduces
an error into the values of the Soret coefficients measured for the fibrils. In order to calculate the diffusion coefficient
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and subsequently the dimensions of the fibrils, we make use of the AFM images that we have taken of these fibrils
(see Figure 3 of main manuscript). These images in principle already provide us with the necessary information about
the dimensions of the fibrils, but we will nevertheless check whether the results of the FCS measurements that are
performed under the same conditions as the thermophoresis and electrophoresis experiments, are consistent with the
AFM images. According to the detailed analysis of the AFM images, the sonicated fibrils have an average length
of 171 nm and a thickness of approximately 8 nm. With these dimensions, we can calculate the rotational diffusion
coefficient, according to:
Dr =
kBT
γr
(8)
where γr is the rotational friction coefficient, given according to Broersma [14] by:
γr =
πηL3
3(log (2L/D)− cr)
(9)
where L is the length of the rod, D is its diameter and cr is a numerical factor that corrects for end effects:
cr = 1.57− 7
(
1
log (2L/D)
− 0.28
)2
(10)
The rotational diffusion coefficient has units of radians2/s. We obtain a value of ∼ 1725 rad2/s. The diffusion time
of a fibril through the confocal volume of the FCS instrument is approximately 5 ms, a value directly obtainable from
the FCS measurements. During this time, the fibril will rotate on average about 168◦. This is probably not enough
to assume complete orientational averaging, but some degree of averaging can be assumed. We can therefore expect
the difference between the measured apparent diffusion coefficient of the fibrils and the calculated diffusion coefficient
of a rod with 171 nm length and 8 nm thickness to be not too large. In order to calculate the translational diffusion
coefficient of a rod, we use the results by de la Torre [15]:
Dt =
kBT (log (L/D) + ct)
3πηL
(11)
where ct is again a numerical correction factor for end effects:
ct =
ct,⊥ + ct,‖
2
(12)
with
ct,⊥ = 0.5 + 4.2
(
1
log (2L/D)
− 0.39
)2
(13)
and
ct,‖ = −0.58 + 7.4
(
1
log (2L/D)
− 0.34
)2
(14)
We obtain ct = 0.0122 and Dt = 8.1·10−12 m
2
s . This value is in acceptable agreement with the value determined from
FCS (4.1±0.4·10−12 m2s , see above). The difference in these values is likely to stem from the polydispersity of the
fibrillar sample. The FCS measurements are likely to be biased towards the shorter fibrils, due to faster diffusion and
less likely absorption on the walls etc., whereas the AFM measurements might be biased towards the longer fibrils,
due to preferential absorption on the AFM substrate.
We have also performed FCS measurements of α-synuclein fibrils before and after incubation with additional
unlabeled monomeric protein at 70 ◦C, as in the experiment shown in Figure 3 of the main manuscript. The correlation
data of this experiment is shown in Figure 8, and the growth of the fibrils is clearly apparent from this data.
Finally, we also used FCS in order to probe the temporal stability of the purified oligomers. We measured a sample
of oligomers continuously for more than 60 h at RT (Figure 9) and found only a very slight trend towards increasing
sizes. This result confirms that the oligomers are thermodynamically highly stable and display negligible kinetics of
dissociation on the time scale of days. Therefore purified samples of oligomers were stored during up to several days
(at RT or 4 ◦C) and used for thermophoresis experiment throughout this period.
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Figure 8: Normalized correlation curves from FCS experiments of α-synuclein amyloid fibrils before and after a 20
min incubation period with 70 µM added unlabeled monomeric protein at 70 ◦C. The shift to the right towards longer
diffusion times is an indicator for an increase in size. This shift corresponds to a change in diffusion coefficient from
3.8±0.2·10−12 m2s to 2.4±0.2·10−12 m
2
s .
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Figure 9: Time course of FCS size measurements of labeled α-synuclein oligomers over more than 60 h, confirming the
high structural stability of these types of aggregates.
6 Free flow electrophoresis measurements of monomeric and aggregated
α-synuclein
As will be discussed in detail in the next section, the net charge and electrophoretic mobility are important parameters
for the quantitative description of thermophoresis. The thermophoresis of the salt ions in solution creates a macroscopic
electric field at steady state that leads to electrophoresis of the macromolecule under study, such as the monomeric
or aggregated α-synuclein in the present case. Furthermore, the potential energy stored in the double layer depends
on both the charge and the temperature and hence yields another temperature-dependent contribution to the Soret
coefficient. Therefore, independent estimates of the effective charges of the different α-synuclein species are important
for the quantitative analysis and understanding of the thermophoretic behavior.
We used a variant of microfluidic free flow electrophoresis that was recently developed in our laboratory [16] in
order to measure the electrophoretic mobilities of monomeric, oligomeric and fibrillar α-synuclein in 5 mM Tris buffer
at pH 7.4 (Figure 10).
The measured electrophoretic mobilities are -2.06±0.11 µm/sV/cm (labeled monomers), -3.09±0.46
µm/s
V/cm (oligomers) and
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Figure 10: Electrophoretic mobilities, measured via microfluidic free-flow electrophoresis [16]. The mobilities were
measured in 5 mM Tris buffer, pH 7.4. Error bars come from two independent repeats with independent sample
preparations.
-2.91±0.02 µm/sV/cm (fibrils). The values for both monomeric and fibrillar α-synuclein are well-defined and display a trend
of increasing mobility with increasing size. However, the variation in the values measured for the oligomers is much
larger, potentially reflecting a degree of polydispersity of the oligomer preparations [4]. In particular, oligomeric and
fibrillar α-synuclein display an essentially identical electrophoretic mobility. In the light of the very different sizes
and structures of oligomers and fibrils, this is a very interesting finding which highlights the power of thermophoresis
to discriminate more easily between different types of particles, compared to electrophoresis. For our quantitative
modeling of the thermophoresis data, we require the surface charge density or the absolute charge of the protein
monomers and aggregates, in addition to the electrophoretic mobilities. A comprehensive theoretical framework for
relating mobilities to surface potentials for colloid-like systems of all sizes has been first presented by Henry [17]. In
particular for particles that can be approximated as spheres, such as monomeric and oligomeric α-synuclein, this is
well-established.
6.1 From electrophoretic mobility to effective charge for monomeric and oligomeric
α-synuclein
The ζ-potential is the potential difference between the (neutral) bulk solution and the surface of a charged particle,
including tightly absorbed counter ions [18], and is therefore a measure for the charge density of the particle surface.
The electrophoretic mobility and the ζ-potential are related through Henry’s formula [17]:
µe =
2ε0εrζf(κR)
3η
(15)
where ζ is the ζ-potential, η the viscosity and f(κR) is Henry’s function with the argument κR, the product of inverse
Debye length κ and particle radius R. Henry’s function varies from 1.0 ≤ f(κR) ≤ 1.5. For κR  1, f(κR) =1.0
(Hückel limit) and for κR  1, f(κR) = 1.5 (Smoluchowski limit). Ohshima has presented a formula for f(κR) that
is valid for all values of κR and accurate to within 1% [19]:
f(κR) = 1 + 0.5
1
(1 + 2.5
κR(1+2e−κR) )
3
(16)
However, the applicability of Henry’s expression for the particle mobility depends on the absolute value of the charge
and mobility, due to the fact that Henry’s treatment neglects relaxation effects of the counterion atmosphere [18]. We
can define a reduced mobility:
µred =
3ηe
2ε0εrkBT
µe (17)
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Depending on the relative values of µred and κR, either Henry’s simplified treatment or a more sophisticated one has
to be applied. We obtain µred,M = -1.74 and µred,O = -2.62. From the FCS measurements (see above), we know that
the radius of the monomeric protein, Rm, is ca. 2.8 nm and the radius of the oligomers, Ro, is ca. 7.5 nm. The
free flow electrophoresis experiments were carried out in 5 mM Tris buffer pH 7.4, where the Debye length λ = 1/κ
= 4.7 nm. Hence κR = 0.6 for monomeric α-synuclein and 1.6 for oligomeric α-synuclein. It turns out that Henry’s
simplified treatment for the calculation of the ζ-potential is applicable for the monomer (with f(κR)=1.02), but for
the oligomer, we need to use Hunter’s inversion [18] of Booth’s formula [20]:
ζr =
µred
f(κR)
−
[
C3(µred/f(κR))
3 + C4(µred/f(κR))
4
f(κR) + 3C3(µred/f(κR))2 + 4C4(µred/f(κR))3
]
(18)
where ζr is the reduced ζ-potential:
ζr =
ζe
kBT
(19)
and where C3 and C4 are numerical coefficients that depend on the product κR and the limiting molar conductance of
the counter- and coions. Hunter [18] gives the expressions for these coefficients that we are not reproducing here. The
limiting conductances of the Tris+ ion and the Cl− ion are 2.97·10−3Ω−1m2mol−1 [21] and 7.64·10−3Ω−1m2mol−1 [22].
We are now in a position to calculate the ζ-potentials for monomeric (44.0 mV) and oligomeric (40.3 mV) α-
synuclein. In order to calculate the charges from these values of the ζ-potentials, we follow the methodology outlined
by Ohshima [23]. We define the dimensionless surface charge density Σ:
Σ =
eσ
ε0εrκkBT
(20)
where σ is the surface charge density. Ohshima derives the following expression relating reduced ζ-potential and
reduced surface charge density:
Σ = 2 sinh (ζr/2)
[
1 +
2
κR cosh2 ( ζr4 )
+
8 log (cosh ( ζr4 ))
(κR)2 sinh2 ( ζr2 )
] 1
2
(21)
The absolute charge Q can be computed from the surface charge density σ as Q = 4πR2σ. Using these expressions, we
obtain values for the absolute charge of QM = -10.9 e for the monomeric protein and QO = -50.4 e for the oligomers.
The value of the monomer is in good agreement with theoretical predictions, based on the combined charge of the
individual amino acids at this pH value (-9.1 e) and the charge of the Alexa 647 label (-4 e). For the oligomers,
on the other hand, the effective charge corresponds to only ∼5 times the charge of a monomer, while each oligomer
consists on average of ∼30 monomers. This strong difference can be explained through processes such as counter ion
incorporation into the oligomer structure, as well as Manning condensation of counterions [24] onto the surface of the
oligomer. Indeed, without such charge compensation mechanisms, the electrostatic contribution to the formation of
an oligomer would render such a structure highly energetically unfavorable.
6.2 Free flow electrophoresis of rod-like particles
The determination of effective charges from electrophoretic mobilities of rod-like particles represents an additional
difficulty, due to the anisotropic nature of the rod and the possibility of alignment in the electric field. In addition, if
the electrophoretic mobility is measured in free (shear) flow, alignment could also occur in the flow direction. We start
by evaluating whether or not alignment effects have to be taken into account in our setup. Dhont and Briels [25] have
given a comprehensive treatment of the behavior of Brownian rods in shear flow. A rotational Péclet number can be
defined that quantifies the relative importance of shear forces and random Brownian rotational motion:
Per =
γ̇
Dr
(22)
where γ̇ = duxdy is the shear rate, ux is the flow velocity and y is a direction perpendicular to the flow. The microfluidic
channel is 2200 µm wide and 25 µm high. It is therefore clear that in the horizontal direction, the shear rate will be
negligibly small in the center of the channel, while it might be considerable in the vertical direction. Therefore we
limit our treatment to this direction. The flow rate is 500 µl per hour, corresponding to an average flow velocity of
2.5·10−3ms . We take the flow rate to be approximately constant throughout the wide dimension of the channel and
approximate the parabolic flow profile across the narrow dimension by a linear one, and therefore the maximum flow
velocity is twice the average flow velocity. Hence we obtain a shear rate of 4·102s−1. The rotational diffusion coefficient
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has been determined above to be 1700 rad
2
s , and hence we obtain Per≈0.24. This is smaller than the threshold for the
beginning of orientation, Per∼1 [26]. Therefore, shear alignment is negligible in our setup for short amyloid fibrils.
Next, we investigate whether the α-synuclein fibrils can be aligned by the electric field applied during the electrophoretic
measurements. Alignment in an electric field can occur by means of a permanent or an induced electric dipole. We
can apply phenomenological, as well as theoretical arguments. Phenomenologically, the electrophoretic mobility is
expected to increase with the applied voltage in the case of significant alignment, as the degree of alignment should
increase with the field strength and aligned rods have a lower friction factor - this argument has been given in favor of
alignment in the case of tobacco mosaic viruses [27]. However, as can be seen in Figure 11, the electrophoretic velocity
increases linearly with the electric field, and therefore an increase in mobility is not detected. This observation hints
towards no significant alignment effects.
Next, we treat the question of whether alignment by the field plays a role or not theoretically. The first question
is whether the fibrils possess a permanent dipole moment. Measurements of permanent dipole moments of rod-like
protein aggregates are rare. It has been reported that β-lactoglobulin amyloid fibrils with an average length of ca. 4 µm
have a permanent dipole moment of 3.1·10−19Cm. This value, which agrees remarkably well with the value calculated
for a chain-like assembly of monomers, has been obtained from electric field-induced birefringence at pH 2.0, where the
protein carries a significant net charge of ∼+20 e. On the other hand, it has been reported that the tobacco mosaic
virus, a rod-like structure of ∼300 nm in length and 18 nm in diameter, possesses a permanent dipole moment of only
8.3·10−26Cm [28] at pH 7.5, where the virus coat protein carries a net charge of -3.4 e. It therefore seems likely that
the α-synuclein fibrils possess a permanent dipole moment, but it is difficult to estimate its magnitude, especially as
no detailed structural information is available for the fibrils.
Furthermore, fibrillar protein structures display a polarizability due to the mobile counterions that are associated with
the charged rod, leading to an induced dipole moment. An expression for this induced dipole moment has been given
by Fixman [29, 30]:
µind =
4πε0εrLKz1E0
γ2(z1 − z2)
(
1− tanh (γL/2)
γL/2
)
(23)
where z1 and z2 are the counter- and co-ion valencies and γ is a characteristic length scale:
γ2 =
4πc1Kb
φ
(24)
where c1 is the bulk concentration of counter ions, K is a numerical factor, given by:
K =
1
2 log (2L/D)− 14/3 (25)
The fraction of bound counter ions φ depends on the mean spacing between charges on the rod-like macromolecule, b,
and the Bjerrum length, λB=
e2
4πεε0kBT
, according to:
φ = 1− b
λB
(26)
With a fibril diameter of 8 nm, a fibril density of 1.35 g/cm3, a molecular mass and charge of the α-synuclein monomer
of 14.46 kDa and -9 e, respectively, we obtain a mean spacing of the charges of 0.4 Å. The Bjerrum length in water
at room temperature is ∼0.7 nm and hence φ ≈ 0.945. Using those values, we obtain an induced dipole moment
of ∼1.1·10−27 Cm. This value is negligible compared to the potential permanent dipole moments mentioned above.
We can now compute the orientational order parameter Φ (Φ ∈ [0,1]) for various values of µ0, the permanent dipole
moment. The orientational order parameter can be calculated as [31]:
Φ = 1− 3coth (β)− 1/β
β
(27)
with β defined as β = µ0EkBT . If we take the range of values for µ0 from the ones reported above: 10
−25 Cm<
µ0 <10
−20 Cm, we obtain values of Φ that vary between 0.0008 and 0.9997, and hence between negligible and complete
alignment. Therefore it is impossible to say from theoretical arguments alone, without a more precise estimate of the
fibrils’ permanent dipole moment, whether or not alignment with the field direction occurs. We will therefore analyze
the electrophoresis data assuming complete and no alignment and compare the results. Expressions relating the
electrophoretic mobilities of aligned and randomly oriented rods have been given by Ohshima [32]:
µ‖ =
ε0εr
η
ζ (28)
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and
µrand =
ε0εr
3η
ζ(1 + 2f(κR)) (29)
where f(κR) is Henry’s function for a cylinder, that varies between 0.5 and 1. Therefore
µ‖
µrand
=
3
1 + 2f(κR)
(30)
varies between 1.5 and 1.0. Henry’s function for a cylinder is given by [32]:
f(κR) = 0.5 + 0.5
1
(1 + 2.55
κR(1+e−κR) )
2
(31)
which yields f(κR) = 0.55 in the case of fibrils of a radius of R = 4 nm in 5 mM Tris buffer. With this value of f(κR),
we can calculate the ζ-potential for the cases of complete alignment (42.2 mV) and random orientation (60.2 mV).
Hunter [18] gives the relationship between the total charge of a cylinder and the ζ-potential:
ζ =
2QFK0(κR)
4πε0εrκR(2R+ L)K1(κR)
(32)
where K0(κR) and K1(κR) are the modified Bessel functions of the second kind (K0(κR)/K1(κR)≈0.85 under these
conditions [18]). Using this relationship, we can calculate average total charges of the fibrils of -205 e (aligned case)
and -292 e (random orientation). Both of these values are in good agreement with a rough estimate of the total charge
based on the fraction of condensed counter ions calculated above. A fraction of bound counterions of 0.945 leaves the
fibrils with a net charge of -238 e. This analysis is therefore consistent with both aligned and randomly oriented fibrils
and we conclude that the fibrils possess a net charge of between 200-300 e.
6.3 Electrophoresis under different solution conditions
In order to check this analysis for its robustness and consistency, we have also performed similar electrophoresis
experiments in 10 mM Tris buffer instead of 5 mM Tris. We obtain electrophoretic mobilities of -1.20 µm/sV/cm and -1.95
µm/s
V/cm for monomeric and oligomeric α-synuclein under these conditions. This translates into charges of -7.2 e and
-37.3 e. This apparent decrease in charge compared to the conditions of lower ionic strength might have its origin in
more pronounced counter-ion binding, but could also stem from the fact that the measurement become more difficult
and inaccurate at higher ionic strengths. The contribution of the fluorescent sample to the overall current, and hence
the measured deflection of the sample beam, decreases with increasing solution ionic strength.
Furthermore, we have also performed experiments in 5 mM Tris buffer in the presence of 100 µM EGCG, and we found
that the measured values for the mobilities are almost indistinguishable in the presence and absence of EGCG for all
α-synuclein species.
7 Modeling electrostatic effects in protein thermophoresis
One of the aims of this study is to be able to quantitatively understand and model the effects of changes in solution
conditions on the thermophoresis of proteins. We have recently presented an analysis of nucleic acid thermophoresis
that highlighted the importance of electrostatic effects [11]. We apply this model to the thermophoresis of proteins
and protein aggregates in the present study.
In our model the Soret coefficient of a biopolymer consists of three main contributions. For charged biomacromolecules,
the capacitor effect
(
SCMT
)
and Seebeck effect
(
SELT
)
play an important role.
ST = S
CM
T + S
EL
T + S
NI
T (33)
The nonionic contribution
(
SNIT
)
cannot, at present, be modeled and is likely to involve surface properties of the
molecule undergoing thermophoresis, such as its hydophobicity. We shown in the present study that changes in such
properties lead to changes in thermophoretic behavior (e.g. the binding of the neutral molecule EGCG to α-synuclein
oligomers and fibrils).
15
10 0 10 20 30 40 50
120
100
80
60
40
20
0
α-syn monomers 5 mM Tris
α-syn oligomers 5 mM Tris
α-syn fibrils 5 mM Tris
α-syn monomers EGCG
α-syn oligomers EGCG
α-syn fibrils EGCG
α-syn monomers 10 mM Tris
α-syn oligomers 10 mM Tris
α-syn fibrils 10 mM Tris
V
el
oc
ity
 [µ
m
/s
]
Electric field [V/cm]
Figure 11: Plot of electrophoretic velocities vs. electric field. Shown is data for monomeric, oligomeric and fibrillar
α-synuclein, in 5 and 10 mM Tris buffer, pH 7.4, as well as in 5 mM Tris buffer in the presence of 100 µM EGCG.
7.1 Capacitor effect
One important contribution to ST of charged macromolecules is given by the capacitor effect S
CM
T . It results from
the change in free energy of the molecule’s ion cloud upon temperature variation and is dependent on the properties
of the Debye layer [11, 33]. The crucial parameters are the Debye length λD, as well as the polymer’s charge Q and
radius R. In addition the density ρ, permittivity ε=ε0εr and temperature T of the solvent water affect the magnitude
of SCMT . Therefore the Soret coefficient of a charged biopolymer at any given temperature is a function of the ionic
strength. For spherical particles or molecules, as monomers and oligomers the capacitor model yields a contribution
to ST of:
SCMT =
(Qe)
2
16πkBT 2ελD (1 +R/λD)
2
(
1− ∂ log[ρ(T )]
∂ log[T ]
− ∂ log[ε(T )]
∂ log[T ]
(
1− 2λD
R
))
(34)
For rodlike structures, such as amyloid fibrils, the capacitance can be expressed as a superposition of a spherical and
a cylindrical capacitor [34].
7.2 Seebeck effect
The salt ions in solution have themselves different Soret coefficients and are therefore affected differently by ther-
mophoresis. As a consequence, a macroscopic electric field builds up if a thermal gradient is applied to a salt so-
lution [11, 35, 36]. The charged macromolecules under study will undergo electrophoresis in the electric field thus
created. This dependence, which in analogy to solid state thermoelectric phenomena has been dubbed the Seebeck
effect, can be expressed as:
SELT = −
kBTµ
eD
∑
i ziciSTi∑
i z
2
i ci
(35)
The mobility is related to the zeta potential via Eq. 15 and ζ = Qe4πεr(1+r/λ) . For the Soret coefficients of single ions
in water, STi, literature values according to the reduction rule were applied ([37] and see also Reichl et al. [11])
SCl
−
T = 7.18 · 10−4/K (36)
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SNa
+
T = 4.69 · 10−3/K (37)
7.3 Nonionic contribution
The non-ionic contribution to the Soret coefficient of biomacromolecules is likely to be linked to surface properties of
the molecule, such as hydrophobicity and hydrogen bonding capacity with water [10]. At present, no general framework
exists that is able to describe these effects quantitatively. Therefore we restrict our theoretical description to the ideal
gas contribution and an empirical temperature dependent part according to Piazza [38].
SNIT =
1
T
+ S∞T (1− e−(T−T0)/T
∗
) (38)
Here S∞T denotes the empirical Soret coefficient at infinite temperature, T0 the temperature where the Soret coefficient
changes sign and T∗ is a measure for the broadness of the range where ST increases with temperature.
7.4 Determination of ’thermophoretic charge’ and nonionic contribution
On the basis of the model for the electrostatic contributions to the Soret coefficient of the protein molecules and ag-
gregates outlined above, the ’thermophoretic charges’, QT , and nonionic contributions, S
NI
T , are determined from the
ionic strength series for the monomeric and oligomeric α-synuclein species (Figure 2 of the main manuscript). Taking
into account the temperature dependent physical parameters of water (viscosity, permittivity, density), as well as salt
concentration, concentration and size of the protein species an optimization of χ2 for the measured data yields the
parameters listed below for monomers and oligomers. Unfortunately it was not possible to perform measurements of
the Soret coefficient as a function of the ionic strength for the α-synuclein amyloid fibrils due to higher order assembly
of the fibrils at higher ionic strengths [5] and sticking interactions with the capillary walls.
For Soret coefficient of the Tris ion, individual parametric sweeps were performed on the salt series of monomeric and
oligomeric α-synuclein. For the two α-synuclein species the best fits yields ST (Tris)
Mon=0.0024/K and ST (Tris)
Oligo=0.0038/K.
Consequently the Soret coefficient was set to the median of both measurements ST (Tris)=0.0031/K. This value is
reasonable since it is quantitatively comparable to the one of sodium with 0.00469/K [11, 37].
The best fit of the model to the data yields the following effective thermophoretic charges and nonionic contributions
for monomeric and oligomeric α-synuclein:
QT S
∞
T [1/K] T0[K] T
∗[K]
Monomer -6.9 e 0.0126 292.4 20.7
Oligomer -29.2 e 0.0161 320.6 33.4
Nonionic Contribution: Interestingly SNIT is higher for the monomers in the observed temperature range, but
increases more strongly for the oligomers over base temperature (Figure 12). Whether hydrophobic effects play a role
here is not clear. It is also under discussion whether the strong temperature dependence of the empirical nonionic
contribution is connected to additional electrostatic effects not currently included. The thermophoresis of salt ions
changes over temperature [39] and can result in further diffusiophoretic or electrophoretic influence on ST of the
macromolecule [36].
Thermophoretic charge Q: Overall the obtained charges on the basis of thermophoresis measurements are sig-
nificantly smaller than the charges determined from electrophoretic measurements: QMonT =-6.9 e, Q
Oligo
T =-29.2 e
from thermophoresis vs. QMonE =-10.9 e, Q
Oligo
E =-50.4 e from electrophoresis. This difference might originate in an
incomplete description of the electrostatic effects involved in thermophoresis and does indeed provide an important
comparison that will be helpful for further theoretical studies of protein electrophoresis and thermophoresis.
Influence of unlabeled monomers (Fig 3a of main manuscript): The Soret coefficient of the additional unla-
beled monomer was set according to the expected contribution for labeled monomers in 1mM Tris: Sunl.monT =
SNI−mon.T + S
CM−mon.
T = 0.031/K. Note that this Soret coefficient corresponds to the median value over the observed
temperature range in Figure 3a of main manuscript. The monomers were then incorporated as additional salt species
in the Seebeck effect and taken into account for the the Debye length (Capacitor Model). The observed decrease in the
Soret coefficient of the labeled monomers and oligomers in the presence of unlabeled monomers coincides with similar
findings on DNA [34] in the dilute regime.
Influence of the nanobody Syn2 (Fig 4a of main manuscript): In the case of nanobodies present, the best fit to
the data yields the following charges:
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Figure 12: The non-ionic contribution to the Soret coefficient, SNIT , for monomeric and oligomer α-synuclein as a
function of temperature.
Monomer Oligomer
No nanobody -4.5 e -27.6 e
Nanobody -1.8 e -20.6 e
The reason for the differences in charge listed here in the absence of nanobody and the charge determined for the
monomers and oligomers stated above is likely to be due to the modified solution conditions (presence of phosphate
ions in the nanobody solution and respectively also added to the control) and the associated altered Seebeck effect. For
monomers, we obtain a ∆Q = +2.7 e, which is in reasonable agreement with the expected binding of one nanobody
(+1.5 e). In the case of the oligomers, the observed value of ∆Q = +7 e is consistent with the attachment of more
than one molecule of nanobody. It is difficult to estimate the expected stoichiometry of binding of nanobody to the
oligomers, due to lack of detailed structural information of the oligomer and hence of the accessibilities of the epitopes.
8 ComSol simulations of the thermophoresis setup
The Soret coefficient determined from the experimentally measured concentration depletion value depends linearly on
the magnitude of the induced temperature jump ∆T. In order to obtain insight into the experimental uncertainty of the
induced temperature gradient, we performed a finite element simulation and compared the results with the measured
values for ∆T. The decrease of ∆T with increasing base temperature T for simulation is in good agreement with the
measurements. Furthermore the effect of errors in capillary thickness (±10%) could be tested in the simulations and
the resulting error for ∆T deduced.
The simulation was performed in COMSOL Multiphysics (COMSOL Inc., USA) whereby the physics of infrared-
absorption and heat transfer were incorporated (Figure 13 a). In our simulation we assumed radial symmetry and
incorporated the capillary with dimensions of 50 µm x 500 µm. The capillary is coupled to a silicon wafer of 350 µm
thickness with high thermal conductivity. For borosilicate, silicon and water standard material properties were used.
Only temperature dependent absorption of water in the IR at the wavelength was additionally incorporated into the
model [40]. As heating source a Gaussian laser profile was assumed with a beam waist of 30 µm.
As boundary conditions the bottom of the silicon was set to a base temperature and the top of the capillary thermally
insulated since heat conduction of the air above is very low. Individual simulation runs were performed for base
temperatures in the range of T=5-65 ◦C. ∆T was extracted by line averaging in the water region over capillary
height and subtracting temperatures at the inner and the outer boundary. It can be observed that ∆T decreases with
increasing base temperature (Figure 13 b). The main reason is found in the decreasing infrared-absorption coefficient of
water with increasing temperature. The result of the numerical evaluation is in good agreement with our measurements
of ∆T which was obtained using the temperature sensitive fluorescence of the dye (2’,7’-Bis-(2-Carboxyethyl)-5-(and-
6)-Carboxyfluorescein) (BCECF). Additionally we probed the effect of variations in capillary thickness (±10%, as
stated by the manufacturer). The resulting shift in ∆T is of the order of ±6.3% and was assumed as statistical error
for our experiments.
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Figure 13: a) Finite Element Simulation for a capillary filled with water which is heated by an infrared (IR)-laser.
In this example the temperature at the bottom of the silicon wafer was set to T = 25 ◦C and the resulting shift by
line averaging is ∆T ∼8 ◦C. b) Since the IR absorbance of water is decreasing with increasing temperature [40], the
extracted values for ∆T decrease with increasing base temperature T. Experimental results are in good agreement
with our simulation results. The numerical evaluation was also performed for varying capillary thickness d of 45, 50
and 55 µm (variation stated by the supplier). A variation of capillary thickness by 10% entails a variation of ∆T of
±6.3% around the mean temperature. This value is used as statistical error of our experiments.
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Abbreviations
Aβ amyloid beta
AD Alzheimer’s Disease
AFM atomic force microscopy
APD avalanche photodiode
ApoA1 apolipoprotein A1
α-syn α-synuclein
β-gal β-galactosidase
BSA bovine serum albumin
CF carboxyfluorescein
CSF cerebrospinal fluid
DCS differential centrifugation sedimentation
DLS dynamic light scattering
DNA deoxyribonucleic acid
DPPC 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
DPPG2 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol
DSPC 1,2-distearoyl-sn-glycero-3-phosphocholine
EDTA ethylenediaminetetraacetic acid
192 Abbreviations
FBS fetal bovine serum, also known as fetal calf serum
FCS fluorescence correlation spectroscopy
FCCS fluorescence cross correlation spectroscopy
FDG fluorescein di-β-D-galactopyranoside
Fib fibrinogen
FN fibronectin
FS fluorescence spectroscopy
GDM Gaussian distribution model
GFP green fluorescent protein
HBS hepes buffered saline
HDL high-density lipoprotein
HSA human serum albumin
ISC intersystem crossing
MEMFCS maximum entropy method for FCS data analysis
MST microscale thermophoresis
NLDRE non-Langmuir differential rate equation
NP nanoparticle
PBS phosphate buffered saline
PIE pulsed-interleaved excitation
Rh hydrodynamic radius
SA serum albumin
SDS-PAGE sodium dodecyl-sulphate polacrylamide gel electrophoresis
Tf transferrin
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Tm melting phase-transition temperature
TSL thermosensitive liposome
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[5] BORM, P. J. ; MÜLLER-SCHULTE, D.: Nanoparticles in drug delivery and environ-
mental exposure: Same size, same risks? Nanomedicine 1 (2006), 235–249
[6] DONALDSON, K.: Resolving the nanoparticles paradox. Nanomedicine 1 (2006),
229–234
[7] STIFTUNG-WARENTEST: Die Welt ist klein. Test 10/2012 (2012), 64–65
[8] CEDERVALL, T. ; LYNCH, I. ; LINDMAN, S. ; BERGGÅRD, T. ; THULIN, E. ; NILSSON,
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GRATTON, E. ; CAVAILLES, V. ; ROYER, C.: The human estrogen receptor alpha
dimer binds a single SRC-1 coactivator molecule with an affinity dictated by agonist
structure. Journal of Molecular Biology 306 (2001), 433–442
[21] MILANI, S. ; BOMBELLI, F. B. ; PITEK, A. S. ; DAWSON, K. A. ; RÄDLER, J.: Reversible
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BUDDE, U. ; NETZ, R. R. ; RÄDLER, J. O.: Shear-induced unfolding and enzymatic
cleavage of full-length VWF multimers. Biophysical Journal 110 (2016), 545–554
[23] KOL, N. ; ADLER-ABRAMOVICH, L. ; BARLAM, D. ; SHNECK, R. Z. ; GAZIT, E.
; ROUSSO, I.: Self-assembled peptide nanotubes are uniquely rigid bioinspired
supramolecular structures. Nano Letters 5 (2005), 1343–1346
[24] KNOWLES, T. P. J. ; OPPENHEIM, T. W. ; BUELL, A. K. ; CHIRGADZE, D. Y. ;
WELLAND, M. E.: Nanostructured films from hierarchical self-assembly of amy-
loidogenic proteins. Nature Nanotechnology 5 (2010), 204–207
[25] ADLER-ABRAMOVICH, L. ; MARCO, P. ; ARNON, Z. A. ; CREASEY, R. C. G. ;
MICHAELS, T. C. T. ; LEVIN, A. ; SCURR, D. J. ; ROBERTS, C. J. ; KNOWLES, T. P. J.
; TENDLER, S. J. B. ; GAZIT, E.: Controlling the physical dimensions of peptide
nanotubes by supramolecular polymer coassembly. ACS Nano 10 (2016), 7436–7442
[26] BOLISETTY, S. ; MEZZENGA, R.: Amyloid–carbon hybrid membranes for universal
water purification. Nature Nanotechnology 11 (2016), 365–371
198 BIBLIOGRAPHY
[27] SCHWILLE, P. ; HAUSTEIN, E.: Fluorescence correlation spectroscopy. An introduc-
tion to its concepts and applications. Biophysics Textbook Online 94 (2001), 1–33
[28] LAKOWICZ, J.: Principles of Fluorescence Spectroscopy. Springer US, 2006
[29] FITZPATRICK, J. A. J. ; LILLEMEIER, B. F.: Fluorescence correlation spectroscopy:
Linking molecular dynamics to biological function in vitro and in situ. Current
Opinion in Structural Biology 21 (2011), 650–660
[30] PETRÁSEK, Z. ; SCHWILLE, P.: Precise measurement of diffusion coefficients
using scanning fluorescence correlation spectroscopy. Biophysical Journal 94 (2008),
1437–1448
[31] KAPUSTA, P.: Absolute diffusion coefficients: Compilation of reference data for
FCS. PicoQuant GmbH Application Note (2010)
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[76] REICHL, M. ; HERZOG, M. ; GÖTZ, A. ; BRAUN, D.: Why charged molecules move
across a temperature gradient: The role of electric fields. Physical Review Letters 112
(2014), 198101
[77] DENG, J. ; YU, D. ; GAO, C.: Biological identity of nanomaterials: Opportunities
and challenges. Science China Chemistry 56 (2013), 1533–1541
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